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1. Introduction 
Nanotechnology, a key technology of the 21th century, encompasses cross-cutting 
research in classical sciences including physics, chemistry, biology as well as modern 
engineering to generate smart molecules at the nanoscale. Nowadays, nanomedicine is 
one of the most demanded and promising sub-disciplines within the broad field of 
nanotechnology. The classical way of administering pharmaceuticals as pure substances 
often shows limited clinical efficacy characterized by low bioavailability, limited 
circulating half-lives or unspecific toxicity profiles. Nanomedicines are capable to 
improve the delivery of therapeutically relevant molecules including imaging agents, 
drugs, nucleic acids, proteins or theranostics to effectively diagnose, treat or prevent 
diseases as well as injuries.[1] The delivery of these biologically active substances is 
accomplished by vectors or so-called nanocarriers, which are predominantly based on 
polymers, liposomes, nanocrystals or inorganic materials.[2-3] Since the first approval of 
the nanodrug Doxil® in the USA in 1995, more than 50 novel nanomedicines have been 
approved by the U. S. Food and Drug Administration (FDA) as well as the European 
Medicines Agency (EMA) to date. However, even more potent products are in the 
pipelines of pre-clinical research or under investigation in clinical trials, but high 
obstacles through regulatory guidelines limit a fast approval.[3-4]  
Due to the broad diversity of chemical compositions with tunable functionalities and, 
consequently, varying physicochemical characteristics including size, shape and surface 
properties, polymers represent a manifold platform for tailor-made delivery systems. 
These features facilitate (i) the bioavailability of (critical) substances to be delivered, 
(ii) the protection of the cargo from enzymatic degradation, acid hydrolysis or 
tissue/organ-specific clearance, (iii) the extrinsic or intrinsic targeting specificity, and 
(iv) the controlled release of the active substances. Dependent on the biomedical 
approach, the delivery strategy of polymeric nanocarriers is commonly distinguished 
into gene delivery, i.e., the transport of nucleic acids (pDNA, siRNA, mRNA, etc.) or 
into drug delivery, i.e., the transport of hydrophilic and hydrophobic pharmaceuticals. 
Despite their benefits and promises, multiple barriers have to be overcome by the 
polymeric nanocarriers during the delivery process. These obstacles are defined by their 
chemical composition with corresponding characteristics but also by various biological 
barriers. Challenges that have to be met are (i) the successful and efficient encapsulation 
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of the cargo into stable nanocarriers, (ii) the interaction of the nanocarrier with cellular 
membranes followed by an internalization and (iii) the transport of the carrier to its 
intracellular site of action with successful release of the cargo (Figure 1.1).[5-6] Although 
gene and drug nanocarriers share similar biological barriers at the cellular level, they 
differ in their delivery performances due to their physicochemical characteristics. These 
differences are evident not only in the formulation of the loaded nanocarriers but also in 
the energy-dependent uptake mechanism (active vs. passive) as well as the kind and site 
of cargo release by corresponding stimuli (Figure 1.1). 
 
 
Figure 1.1. Schematic overview of polymer-mediated gene and drug delivery including nanocarrier 
formulation, cellular internalization and intracellular trafficking. 
 
The principal aim of gene therapy is the delivery of therapeutic nucleic acids to treat 
hereditary diseases, such as heamophilia, but also acquired diseases including infections 
or cancer.[1, 7] Besides viral- or lipid-based systems, polymers represent promising 
alternatives for the delivery of therapeutic nucleic acids, since they provide a variety of 
architectures with tailored functionalities, show low immunogenicity and can be 
produced cost-efficiently on a large scale in combination with the need of comparatively 
simple storage conditions. A straightforward strategy to deliver nucleic acids is the 
formation of polyelectrolyte complexes or so-called polyplexes due to electrostatic 
interactions (Figure 1.1).[8] In particular, long and circular DNA (e.g., pDNA) is 
efficiently encapsulated by condensation into small and compact structures, whereas the 
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complexation of DNA or RNA molecules comprising only a few base pairs (e.g., 
siRNA) is more challenging due to their intrinsic rigid structure and low spatial charge 
density.[9] Polyplexes typically exhibit sizes between 80 to 200 nm and, therefore, are 
too large for a passive uptake mechanism. They predominantly enter cells by various 
energy-dependent endocytic pathways.[10-11] Once internalized, gene delivery vectors 
have to escape from the membrane-bound endocytic vesicles for the successful delivery 
to their specific site of action, i.e., cell nucleus or cytoplasm (Figure 1.1).[12] 
A detailed explanation of the biological barriers during the polyplex-mediated gene 
delivery process with emphasis on the characteristics and pitfalls of endocytic pathways 
including the cellular internalization, the endosomal release and the transport of the 
nucleic acid to its site of action will be given in Chapter 2. 
The development in the polymer design for gene therapy approaches increased in the 
last decades.[13-14] More than 20 years ago, the polycations poly(L-lysine) (PLL), 
poly(amidoamine) (PAMAM) dendrimers, poly(ethylene imine) (PEI) or poly(2-
dimethylamino)ethyl methacrylate (PDMAEMA) became established and well-
characterized polymers for the delivery of nucleic acids in vitro (Figure 1.2 A).[15]  
 
 
Figure 1.2. Schematic representation of an overview of polymers used in gene and drug delivery with 
stealth and targeting moieties for enhanced delivery performances. Selected polymers or polymer classes 
are described in the following chapters.
 
In particular PEI, which exists as a linear (LPEI) and branched (BPEI) form, reveals 
outstanding transfection efficiencies and, thus, is considered as the “gold standard” for 
transfection.[16-17] The good transfection efficiency is attributed to the high cationic 
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charge density based on the polyelectrolyte structure bearing (different) amino groups. 
This feature was shown to be beneficial in terms of polyplex formation, the affinity to 
cellular membranes followed by endocytosis as well as the endosomal escape. In 
general, the binding ability of polymers to nucleic acids was attributed to primary as 
well as secondary amino groups (PLL, PEI, PAMAM), while tertiary amino groups 
(PDMAEMA, PAMAM) are thought to be beneficial for buffering capacity and, thus 
for an efficient endosomal escape. However, the high charge density of these polymers 
leads to severe cytotoxic effects, which harm the membrane integrity or the metabolic 
activity of cells.[18-20] A concept to circumvent such undesired side effects is the 
introduction of biocompatible stealth polymers into the polymer structure (Figure 
1.2 C). The most prominent representative with a stealth effect is the non-ionic polymer 
poly(ethylene glycol) (PEG). PEG facilitates the water solubility as well as the reduction 
of cytotoxicity, aggregation affinity and unspecific interactions with cellular or non-
cellular components due to the decrease in the surface charge and steric hinderance to 
the access to functional groups.[21-22] Despite its widespread utilization, it was recently 
revealed that PEG is able to increase immunogenicity and antigenicity.[23-24] A highly 
suitable alternative to PEG are the non-ionic, water soluble poly(2-oxazoline)s (POx): 
Poly(2-ethyl-2-oxazoline) (PEtOx) and poly(2-methyl-2-oxazoline) (PMeOx). Their 
stealth effect is considered to be responsible for the reduction of unspecific interactions 
with non-cellular and cellular components, elongated blood circulation times, low 
immunogenicity and reduced clearance in vivo.[25-26] Despite their beneficial impact, the 
functionalization of polymers with PEG or POx bears the risk of diminished transfection 
efficiencies due to weak nucleic acid complexation and decreased cell interactions by 
the cell- and protein-repellent properties.[27-28] This phenomenon is known as the “PEG 
dilemma” and should be take into account for the design of polymers. Another common 
strategy to improve the specificity of the nanocarriers is the introduction of targeting 
ligands within the polymer structure (Figure 1.2 D).[10, 29] A large variety of natural 
receptor substrates are used for the targeting of specific cells, tissues or organs. Cancer 
cells, for instance, can be targeted by carbohydrates (breast cancer)[30] or folic acid 
(ovarian, colorectal cancer).[10, 29] A great challenge in gene delivery is the passage of 
the blood-brain barrier to target the brain. This can be realized, for instance, by the use 
of glutathione ligands.[31-32] Nevertheless, in contrast to viral vectors, a commercial 
breakthrough as nanomedicines is still missing. A deeper understanding of the chemical 
composition and the structure-property-relationship of polyplexes on the molecular as 
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well as on the cellular level is required in order to exploit the full potential of this 
promising technology. 
Chapter 3 provides new insights into the influence of different amino functionalities as 
well as PEtOx stealth moieties on the overall gene delivery process utilizing well-
defined homo- and copolymers based on poly(methacrylate)s and linear 
poly(ethylene imine)s (LPEI). Detailed information about the ideal amino substitution 
pattern for the most efficient transfection via poly(methacrylate)s is provided in 
Chapter 3.1. Furthermore, the potential of PEI-based copolymers for targeted gene 
delivery by the introduction of a therapeutic relevant ligand is highlighted in 
Chapter 3.2.  
In contrast to the delivery of genetic material, polymeric vectors for drug delivery must 
meet different requirements to provide improved biocompatibility, pharmacokinetics, 
target specificity as well as a controlled release behavior. The loading of hydrophilic or 
hydrophobic drugs can be accomplished by the conjugation to the polymer molecule, 
encapsulation, covalent attachment or adsorption into as well as onto nanoparticles.[33-
34] Drug carriers are mostly internalized into cells by endocytosis similar to polyplexes. 
However, some carriers are able to enter cells by the passive penetration of the cell 
membrane if their sizes are below 20 nm in diameter.[35] Polymeric drug vectors exhibit 
stimuli-responsive degradation properties that enable the controlled release of the drug. 
The (bio)degradation can be of chemical or enzymatic origin and can be triggered by pH 
value, temperature, ionic strength or enzymatic substrate stimuli.[34, 36] Synthetic 
polymers utilized for the formulation of nanocarriers are for example poly(lactic acid) 
(PLA), poly(lactic-co-glycolic acid) (PLGA), poly(ε-caprolactone) (PCL) or 
poly((meth)acrylate)s (e.g., PMMA) (Figure 1.2 B).[36] The most extensively studied 
polymers for drug delivery are PLA and PLGA. They show high biocompatibility and 
have been approved by the FDA and EMA in drug formulations and medical devices.[37-
38] The presence of hydrolytically labile ester bonds in the polymer backbone provides 
degradation abilities, which are beneficial for a controlled release kinetics of the active 
substance. Furthermore, drug delivery systems are often modified with biocompatible 
but non-degradable PEG or POx (Figure 1.2 C). The majority of polymer-based drug 
nanocarriers exploit non-specific accumulation within diseased tissue by passive 
targeting strategies. In particular, the popularity of anticancer nanomedicines is based 
on the enhanced permeability and retention (EPR) effect.[39] It is thought that nano-
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scaled carriers with sizes between 30 to 200 nm preferably accumulate within the leaky 
vascular structure of tumor tissue leading to improved therapeutic effects.[40-41]  
Chapter 4 is dedicated to the utilization of biodegradable and biocompatible polymers 
based on PLA and POx for the delivery of a range of molecules including fluorescent 
probes and a cytostatic agent.  
 
The scope of this thesis is the evaluation of polymers and polymer derivatives as 
versatile vectors for the enhanced delivery of therapeutic relevant nucleic acids and 
drugs in vitro and in vivo. In addition to the structure-property relationship, the 
convenience of stealth polymers on the overall delivery process with focus on the 
cytocompatibility, the cellular internalization and trafficking as well as delivery 
efficiency is discussed in more detail. 
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2. Exploring the biological barriers for targeted gene delivery 
Parts of this chapter have been published in Pub1: T. Bus, A. Traeger, U. S. Schubert, The great escape: 
How cationic polyplexes overcome the endosomal barrier, J. Mater. Chem. B 2018, 6, 6904-6918. 
Along with the discoveries and developments in the field of polymer-based non-viral 
gene delivery within the last 50 years, powerful technology platforms were established 
with the aim to accelerate gene therapy concepts and to accomplish the vision of 
precision nanomedicine.[13] Several extra- as well as intracellular bottlenecks were 
identified within the entire polymer-mediated gene delivery process that, consequently, 
may impede the transfection efficiency. The most crucial (biological) barriers are 
illustrated in Figure 2.1 comprising (I) the nucleic acid packaging and the nanocarrier 
stability to protect the cargo against (enzymatic) degradation, (II) the internalization 
mechanism and the intracellular pathway, (III) the endo-lysosomal escape into the 
cytoplasm and, finally, (IV) the transport of the cargo to its site of action.[5, 42]  
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Figure 2.1. The general gene delivery process of cationic polymers at a glance. The barriers along this 
process are defined as (I) the nucleic acid packaging and nanocarrier formulation, (II) the cellular 
internalization by endocytosis and intracellular trafficking, (III) the endosomal escape from endo-
lysosomal compartments and (IV) the transport of the cargo to its site of action. Dependent on the nature 
of the delivered nucleic acids, the site of action is either located within the cytoplasm (e.g., siRNA, 
miRNA) or in the nucleus. NPC: nuclear pore complex; ER: endoplasmic reticulum. 
 
Dependent on the nature and the characteristics of nucleic acids, different polymer-based 
strategies can be utilized to achieve a stable and protective packaging of the cargo as 
well as the safe and efficient delivery to its site of action.[43] The first two mentioned 
prerequisites can be accomplished by either (i) the electrostatically binding via complex 
formation, (ii) the encapsulation by means of particle formation, (iii) the covalent 
binding to the polymer structure, or (iv) the adsorption onto micro or nanospheres.[42, 44] 
Furthermore, the efficient and targeted delivery of nucleic acids in vitro and in vivo can 
be achieved by the introduction of functional moieties within the polymer structure or 
by the binding onto the carrier system including targeting ligands (carbohydrates, 
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peptides, vitamins, antibodies, etc.), labels or dyes, shielding domains (e.g., stealth 
moieties) or endosomolytic units.[43, 45-46]  
The most popular method for the delivery of nucleic acids by cationic polymers is the 
formation of polyelectrolyte complexes. Cationic polymers bear protonatable nitrogen 
atoms, responsible for the positive charge at physiological pH conditions. Hence, these 
protonated amino groups will electrostatically interact with the phosphate groups of the 
genetic material, which provokes the spontaneous self-organization of the so-called 
polyplexes (Figure 2.1, (I) polyplex formation). The N/P ratio, which represents the 
ionic balance within the polyplex, is defined as the number of nitrogen (N) of the 
polymer in relation to the number of phosphate groups of the nucleic acid (P). An excess 
of polymer, indicated by a high N/P ratio, has an essential impact on the surface charge, 
size as well as the stability of polyplexes and are recommended for successful gene 
delivery. Therefore, polyplexes mostly feature a positive net charge, which is beneficial 
for the affinity to the cell membrane. Interestingly, the phospholipid bilayer of the 
mammalian plasma membrane is predominantly composed of neutral lipids like 
glycerophospholipids, sphingolipids and sterols (e.g., cholesterol).[47] The affinity of 
cationic polyplexes to the cell membrane is facilitated by the presence of anionic sulfated 
proteoglycans or receptors (e.g., transferrin, epidermal growth factor).[48] After the 
attachment of the polyplex to the plasma membrane, the invagination of the plasma 
membrane leads to the entrapment of the polyplex into membrane-bound vesicles. This 
process is generally known as endocytosis and this broad term encompasses complex 
internalization mechanisms including clathrin-dependent, clathrin-independent, 
caveolae-mediated endocytosis as well as micropinocytosis (Figure 2.1, 
(II) internalization & trafficking).[45] It is known that the exact endocytosis mechanism 
of the nanocarrier is strongly dependent on its size and shape, as well as the type of 
polymer and type of cells.[11, 49-50] Both, clathrin-dependent as well as clathrin-
independent endocytosis will result in the localization of polyplexes within early 
endosomes. Within these compartments the pH value quickly drops from neutral to 
lower pH values (6.5 to 6.0) due to the activity of membrane-bound vacuolar-type 
ATPases (V-ATPase, proton pump). The early endosomes are directed towards sorting 
endosomes destined either for recycling pathways back to the extracellular milieu 
(exocytosis) or to the lysosomal pathway resulting in an enzymatic digestion (Figure 
2.1, (II) internalization & trafficking). In the latter case, the early endosomes will 
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maturate to late endosomes that are characterized by a pH environment of 5.5 to 5.0. 
Late endosomes are furthermore able to fuse with lysosomal compartments, which 
exhibit the most acidic milieu with pH values from 5.0 to 4.5. These conditions are 
optimal for the activity of lysosomal hydrolases and the degradation of the entrapped 
cargo. Besides this “classical” pathway, polyplexes can be furthermore internalized by 
the caveolae-mediated endocytosis, thus being located within caveosomes. In contrast 
to early and late endosomes, caveosomes exhibit a less hostile interior with a neutral pH 
environment (Figure 2.1, (II) internalization & trafficking). The motion of caveosomes 
was reported towards the Golgi apparatus and the endoplasmic reticulum (ER) via 
microtubules.[49] However, it was also reported that caveosomes are able to interact with 
early endosomes, thus getting involved in the acidification processes.[51] As the fate of 
the polyplexes and the related transfection efficiency is strongly dependent on the 
trafficking route, it is assumed that polyplexes should escape endocytic vesicles at an 
early stage of endocytosis, i.e., previous to cellular expulsion or to the enzymatic 
degradation (Figure 2.1, (III) endosomal release). Several strategies were provided to 
overcome the endosomal entrapment. These includes the modification of the vector or 
the chemical composition by the introduction of various functional groups, fusogenic 
ligands, peptides, pH-sensitive polymer properties or photosensitive agents.[12, 46, 52] In 
the past decades, various studies were performed to explore the release mechanism of 
cationic polyplexes. The most popular endosomal escape mechanism of cationic 
polyplexes is the “proton sponge” hypothesis (Figure 2.2 A).[17, 53] It was the first effort 
to explain the outstanding transfection efficiencies of PEI in various cell lines, 
independent of the topology (branched, linear) and without the need of membrane-
disruptive agents. The key characteristics of this hypothesis are (i) the build-up of an 
osmotic gradient within the endo-lysosomal lumen, (ii) the inhibition of the activity of 
degradative enzymes and (iii) the rupture of the vesicle membrane. In brief, once a 
polyplex is entrapped within an endo-lysosomal compartment the remaining non-
protonated amino groups undergo further protonation, resulting in the buffering of the 
endosomal pH value and a slowed acidification. While, the V-ATPases try to maintain 
the proton gradient across the membrane and the acidification of the vesicle, an 
increased influx of chloride counter-ions leads to an osmotic imbalance.[54] This 
evolving imbalance is compensated by the continuous entrance of water, which causes 
the swelling of the endosome. This effect as well as the expansion of the polymer itself 
due to stronger repulsion effects results in a critical membrane tension and finally, in the 
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bursting of the endo-lysosomal compartment followed by the release of its cargo into 
the cytoplasm. This release mechanism was attributed to various cationic polymers 
containing protonatable amino groups, in particular secondary and tertiary amino 
functionalities, and a broad pH value buffering capacity ranging from pH values of 5.0 
to 8.0. Hence, it was assumed that amino functionalized poly(methacrylate)s (e.g., 
PDMAEMA)[55] and poly(amidoamine)s (e.g. PAMAM dendrimers)[56] act in a similar 
way as PEI. Although this hypothesis is still popular and frequently used in literature, it 
needs to be revised due to the lack of vital experimental data and several counter 
evidences.[57-59] In particular, the endosomal membrane rupture or membrane lysis was 
found to be highly implausible and was more or less disproved so far.[59] Certainly, all 
amino-containing polymers will act as a “proton sponge” by capturing a high amount of 
protons. Undoubtedly, pKa values and high buffering capacities in the range of 
physiological and lysosomal pH values are necessary,[60-61] but do not seem to be the 
predominant factors for the efficient endosomal escape of polyplexes. Based on 
numerous experimental studies in vitro and in silico, further release strategies were 
discussed. Another hypothesis describes the endosomal escape by the direct charge-
driven interaction of polyplexes with the exoplasmic membrane (Figure 2.2 B).[62-63] 
This interaction is thought to mediate local membrane destabilization and membrane 
permeability, which leads to the formation of nano-scaled holes.[6, 62] Hence, the 
polyplex or the nucleic acid is able to escape through these holes into the cytoplasm. In 
contrast to the “proton sponge” hypothesis, the endo-lysosomal compartment remains 
intact during and after the escape. Later on, a related version was proposed, explaining 
the endosomal escape of cationic polymeric vectors by the intercalation of free cationic 
polymer chains into the endosomal membrane (Figure 2.2 C).[64-65] It is hypothesized 
that a continuous dynamic equilibrium between polyplex dissociation and rebinding is 
an essential mechanism behind this hypothesis.[66-68] Free polymer chains, that 
dissociated from the polyplex, might intercalate into the cell plasma membrane prior to 
endocytosis. Hence, the polymer chains keep circulating in the membrane during the 
entire endocytosis and endosomal maturation process. The free polymer chains interact 
with the membrane in a so-called “carpet structure” or polymer-supported holes, thus, 
causing defects in the lipid membrane, which results in a leakage of molecules or nano-
sized particles.[69-71] Additionally, this model may also explain cytotoxic effects of 
cationic polymers, in particular of PEI, found to harm the plasma membrane but also to 
permeabilize lipid membranes of mitochondria or the endoplasmic reticulum.[19, 72]  
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Figure 2.2. Graphical illustration of the different escape mechanism of polyplexes from endo-lysosomal 
compartments. (A) “Proton Sponge”-mediated escape: The protonated polyplex is located within the 
endo-lysosomal compartment and will cause a concentration gradient due to the influx of chloride ions, 
which is counteracted by the entrance of water resulting in the swelling of the endo-lysosomal 
compartment and, finally, to the endosomal burst and release of carrier and cargo into the cytoplasm. (B) 
Polyplex-mediated escape: The time-dependent protonation of amino groups in the acidic endo-lysosomal 
compartment leads to a charge-driven interaction of the polyplex with the exoplasmic membrane. Thus, 
causing membrane disintegration, permeability and local hole formation. The endo-lysosomal 
compartment remains intact. (C) Free polymer-mediated escape: Free cationic polymers intercalate into 
cell and vesicle membrane, thus causing membrane disintegration and permeability or polymer-supported 
hole formation. Endo-lysosomal compartment remains intact. 
 
After efficient endosomal escape, the cargo needs to be released from its vector and 
transported to its site of action (Figure 2.1, (IV) transport to site of action). Up to now, 
it is still unclear if the cargo is completely released from its vector during the escape 
process or if the release occurs in the cytoplasm by anionic molecules, e.g., cytoplasmic 
RNA or heparin-like glycosaminoglycans, or even within the nucleus.[73-74] In the case 
of different RNA types including siRNA and miRNA, the release within the cytoplasm 
is sufficient to create the RNA-induced silencing complex (RISC) and to exert their 
activity. In contrast to that, pDNA has to cover a relatively long distance through the 
cytoplasm to reach the nucleus. Thereby, a complete release of the nucleic acid from its 
vector within the periphery of the cytoplasm leads to the loss of protection and increases 
the risk of enzymatic degradation by nucleases. Furthermore, the motion of the naked 
DNA to the nuclear envelope is characterized by Brownian movement and is thought to 
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be highly inefficient dependent on the location of release and the size of DNA. The 
release of pDNA or pDNA-containing polyplexes in the perinuclear region is thought to 
be preferable compared to a release within the outer cellular regions of dense meshed 
cytoplasm.[75-76] Moreover, various studies discussed an active motion of dissociated 
pDNA or the intact polyplex along microtubules or motor proteins to the nucleus, as 
common for viruses.[75, 77-78] Besides the travelling options of pDNA to the nuclear 
envelope, the nuclear translocation itself represents a further critical barrier towards 
efficient gene expression and is highly discussed with regard to cell-division 
dependency and nuclear pore complex involvement.[79-81]  
In summary, several extra- and intracellular barriers were identified for cationic 
polymer-mediated gene delivery. Therefore, a deeper understanding in the chemistry 
and the property-relationship of polyplexes on the molecular and cellular level has to be 
gained to exploit the full potential of the promising polymer-mediated gene delivery 
technology.[59] Once the key parameters for efficient delivery are known, the adaption 
of strategies for the design of more powerful delivery vectors is possible. The time-
efficient endosomal release of nanocarrier was identified to be a crucial bottleneck. 
Various aspects have an essential impact on the overall endosomal escape of polymer-
based vectors and, consequently, on the overall transfection efficiency. These include 
(i) the polymer composition with type and content of amino functionalities, (ii) the cell 
type-specific internalization pathway and (iii) the polymer-specific interaction with lipid 
bilayers.  
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3. The delivery of nucleic acids by cationic polymers 
3.1 Poly(methacrylate)-based polymers 
Parts of this chapter have been published in Pub2 A.-K. Trützschler, T. Bus, M. Reifarth, J. C. Brendel, 
S. Hoeppener, A. Traeger, U. S. Schubert, Beyond gene transfection with methacrylate-based polyplexes 
– the influence of the amino substitution pattern, Bioconjugate Chem. 2018, 29, 2181-2194 and in Pub3 
A.-K. Trützschler, T. Bus, M. Sahn, A. Traeger, C. Weber, U. S. Schubert, The power of shielding – Low 
toxicity and high transfection performance of cationic graft copolymers containing poly(2-oxazoline) side 
chains, Biomacromolecules 2018, 19, 2759-2771. 
Poly(methacrylate)s represent a promising class of polymers for non-viral gene delivery, 
since they offer a large variety of polymer architectures and functionalities beneficial 
for the design of tailor-made vectors. Well-defined poly(methacrylate)s can be 
synthesized by different reversible deactivation radical polymerization techniques, e.g. 
atom transfer radical polymerization (ATRP) or reversible addition-fragmentation 
chain-transfer (RAFT) polymerization. These polymers show low dispersities, well-
defined compositions and functionalities, as well as various macromolecular 
architectures.[82-84] For this reason, they can be used to investigate structure-property-
relationships with regard to their biological activity. As discussed in Chapter 2, the 
efficient endosomal escape of polymer-based gene delivery vectors might be influenced 
by the type and content of amino functionalities. Due to the versatility of radical 
polymerizable methacrylate-based monomers, it is possible to introduce primary, 
secondary, tertiary as well as quaternary amino groups into tailored polymeric structures 
and to investigate their impact on the gene delivery process including the cellular uptake, 
the endosomal release as well as the transfection efficiency (TE).[85-86]  
In the present work, a library of well-defined linear homo- and copolymers based on (2-
aminoethyl)-methacrylate (AEMA), N-methyl-(2-aminoethyl)-methacrylate (MAEMA) 
and N,N-dimethyl-(2-aminoethyl)-methacrylate (DMAEMA) monomers with pendant 
primary, secondary and tertiary amino groups was investigated regarding their 
biological performances (see Figure 3.1, Table 3.1). 
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Figure 3.1. Schematic overview of the amino polymer units AEMA (primary amino groups), MAEMA 
(secondary amino groups) and DMAEMA (tertiary amino groups) and their potential function in gene 
delivery, used for the synthesis of the methacrylate library by RAFT polymerization comprising homo- 
and copolymers of different compositions. Asterisks indicate variable end groups.
 
The poly(methacrylate) library consisted of the three homopolymers P1 (100 mol% 
tertiary amino groups), P2 (100% secondary amino groups) and P3 (100 mol% primary 
amino groups), the statistical copolymers P4, P5, P6 (varying amino group 
compositions) and the terpolymer P7 (comprising all three amino functionalities). All 
polymers revealed molar masses between 21 and 37 kDa with low dispersities. An 
overview of the characteristics of the examined polymers is given in Table 3.1.  
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Table 3.1. Poly(methacrylate) library of homo- and copolymers with selected characterization data. 
Abbr. Polymer Mn
a 
[g mol-1] Ɖ
a
 DPb 
P1 P(DMAEMA100%) 26,200 1.09 185 
P2 P(MAEMA100%) 24,000 1.21 167 
P3 P(AEMA100%) 21,400 1.10 163 
P4 P(DMAEMA60%-stat-MAEMA40%) 31,500 1.14 208 
P5 P(DMAEMA57%-stat-AEMA43%) 37,000 1.12 249 
P6 P(MAEMA50%-stat-AEMA50%) 46,000 1.28 348 
P7 P(DMAEMA33%-stat-MAEMA33%-stat-AEMA33%) 36,000 1.27 250 
a Molar masses and dispersities were determined by AF4 using a MALLS detector. b The degree of 
polymerization (DP) was calculated from AF4 results and molar ratio of monomers determined by 1H-
NMR.
 
The most prominent representative of the library, P1, has been intensively studied in 
several reports and successfully applied for the transfection in vitro and in vivo as well 
as in clinical studies.[44, 87] Its gene delivery efficiency is attributed to the tertiary amino 
groups responsible for the excellent buffering capacities (pKa ~ 7.5) at acidic pH 
conditions. However, the direct comparison of the homopolymer P1 with the other 
members of the methacrylate library (Figure 3.2) demonstrated a poor transfection 
ability of adherent HEK-293 cells with pDNA encoding the enhanced green fluorescein 
protein (EGFP). Herein, P1 revealed the lowest transfection efficiency (TE < 20%) 
independent of increasing polymer concentrations or N/P ratios, respectively. In 
contrast, the highest TE was obtained by utilizing the homopolymer P3 
(TE: 66.3 ± 5.9%), the copolymer P6 (TE: 56.1 ± 2.8%) as well as with the terpolymer 
P7 (TE: 43.6 ± 9.7%). The homopolymer P2 as well as the copolymers P4 and P5 
revealed moderate TEs between 20% and 30%. Based on these results, the reported 
advantage of tertiary amino functionalities for transfection could not be confirmed for 
poly(methacrylate)s with an average molar mass of 20 kDa.[55, 88] Interestingly, 
polymers with a high primary amino content of minimum ~ 40 to 50 mol% was found 
to had a beneficial impact on the successful delivery of nucleic acids, whereas higher 
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amounts of tertiary amino groups within the polymer structure seemed to hamper the 
transfection process (see P1 and P4).  
 
 
Figure 3.2. Transfection study of HEK-293 cells utilizing the methacrylate library at increasing N/P ratios 
for the delivery of pDNA encoding the enhanced green fluorescein protein (EGFP) in serum-reduced 
media (OptiMEM). Transfection efficiency was measured 24 h post-transfection via flow cytometry 
quantifying 10,000 cells. Values represent the mean ± S.D. (n = 3). 
 
In order to find the bottleneck of poly(methacrylate)-mediated gene delivery resulting 
in varying transfection performances, relevant cellular barriers including the cell uptake 
and the endosomal release were investigated in more detail. Uptake kinetic studies at 
37 °C in serum-reduced media (OptiMEM) demonstrated a time-dependent cellular 
internalization (Figure 3.3 A). According to the standard transfection protocol, 
internalized polyplexes were detected within ~ 80% of cells independent on the utilized 
polymers after 4 h. Surprisingly, P1 revealed the highest amount of internalized pDNA 
as shown by the highest mean fluorescence intensity (MFI) of 188 ± 18.3 compared to 
the MFI values of the other investigated polymers (MFIs < 160). This outcome is 
opposed to the transfection data and implies that a fast and enhanced cellular 
internalization is not an exclusive prerequisite for successful gene delivery.[89-90] A high 
uptake rate does not necessarily result in high gene expression, since the endosomal 
release of entrapped polyplexes within endo-lysosomal compartments is another critical 
obstacle in the gene delivery machinery.[62, 91-92]  
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Figure 3.3. (A) Uptake kinetic of methacrylate library in HEK-293 cells using YOYO-1 labeled pDNA 
in serum-reduced media (OptiMEM). MFI (mean fluorescence intensity) normalized to the negative 
control. 10,000 cells in total were quantified by flow cytometry. Values represent the mean ± S.D. (n = 3). 
Buffer capacity (β) and pKa values of the methacrylate-based homopolymers P1 to P3 (B) as well as the 
copolymers P4 to P7 (C) determined by acid-base titration and calculated by the Henderson-Hasselbalch 
equation.[93] (D) Quantification of the endosomal release of selected polyplexes by the calcein release 
assay. The endosomal release of polyplexes was determined after 4 h by fluorescence microscopy and 
imaging analysis. After successful escape from endo-lysosomes calcein diffuses into the cytoplasm 
leading to an increase in the fluorescent area. The ratio of the green fluorescent calcein area in % over the 
number of detected cell nuclei (stained with Hoechst 33324) was determined for quantification.  
 
It is assumed that successful endosomal release is strongly connected to the ability of 
the polyelectrolytes to buffer acidification of the endosomes, indicated by the pKa values 
as well as the buffer capacities (β) of the polymers. The pKa values of the homo- and 
copolymers, determined by acid-base titration, ranges between pH values of 7.45 and 
8.40, and nicely correspond to the basicity of the respective amino functionalities in 
aqueous solution (Figure 3.3 B and C, see tables). Furthermore, the poly(methacrylate)s 
revealed buffer capacities in the range of pH 6.0 to 10.0. As expected, polymers with a 
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high content of primary and secondary amino functionalities (P2, P3, P6 and P7) 
showed buffer capacities at more basic conditions of pH value 8.0 and above. In contrast, 
polymers with an increasing content of tertiary amino groups (P1, P4, P5) tend to show 
buffer capacities from neutral to acidic conditions in agreement with the increase of the 
DMAEMA content. In particular, P1 revealed an increased buffering capacity over the 
whole physiological pH range from pH values 6.0 to 8.0. Despite the high buffering 
capacities of polymers containing tertiary amino functionalities, the transfection ability 
of P1, P4 and P5 remains low. In order to verify the efficacy of the endosomal release 
of the homopolymers P1 and P2 against the best performers P3, P6 and P7, the escape 
was quantified by the calcein release assay. In general, all tested poly(methacrylate)s 
were able to escape from endo-lysosomal compartments as demonstrated in Figure 3.3D. 
A successful endosomal release was demonstrated by the presence of numerous bright 
green fluorescent cell areas (Figure 3.3 D2). In contrast, non-treating control cells 
exhibited mostly punctuate green fluorescence (Figure 3.3 D1), which can be assigned 
to the entrapped calcein within the endo-lysosomes. Polyplexes based on amino 
functionalized poly(methacrylate)s with the highest content of primary amino groups 
(P3 and P6) achieved the fastest and most sufficient endosomal release. P1 revealed the 
lowest calcein fluorescence area per cell and, therefore, seemed to be unable to escape 
from the endo-lysosomes in a time-efficient manner, which might be responsible for its 
poor transfection efficiency. The findings clearly contradict an endosomal release of 
poly(methacrylate)s by the proton sponge effect, in particular for P1. But the findings 
are in agreement with former studies.[92, 94-95] In order to examine the endosomal release 
of these polymers by nano-hole formation due to polymer-membrane interactions, high-
angle annular dark-field scanning transmission electron microscopy (HAADF-STEM) 
was applied (Figure 3.4). This technique provides high resolution to a few nanometer 
with the ability to visualize cellular ultrastructures, thus offering the possibility to track 
polyplexes in their intracellular pathway.[96] Due to the strong chemical affinity of their 
functional groups, i.e., amines and phosphates, to the staining reagents (OsO4 and uranyl 
acetate) polyplexes were observed as black structures within the extra- and intracellular 
environment. Polyplexes prepared with P6 were found to be entrapped within endo-
lysosomal compartments in close vicinity to the inner leaflet of the vesicular membrane 
(Figure 3.4 A and B, red arrows). In some cases, these polymer-membrane interactions 
lead to the alteration and deformation of the membrane (Figure 3.4 B, orange arrows). 
These structural changes were associated with endosomal escape events, as a disturbed 
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membrane integrity of polyplex-containing endo-lysosomes were observed (Figure 
3.4 A, red arrow heads). Furthermore, the polyplex structure seems to penetrate through 
the vesicular membrane to the cytoplasm. These outcomes support the hypothesis of the 
endosomal escape by nano-hole formation due to local destabilization and 
permeabilization events of the endo-lysosomal membrane through the direct polyplex 
interaction as described by literature.[62, 65, 89]  
 
 
Figure 3.4. HAADF-STEM images of P6-polyplex treated HEK-293 cells for 4 h in serum-reduced media 
(A-B). Polyplexes can be observed as electron dense structure (black). Red arrows indicate polyplexes 
entrapped within endo-lysosomal compartments in close vicinity to the exoplasmic vesicle membrane. 
Orange arrows indicate deformed membrane structures of endo-lysosomes caused by polyplex 
interactions. Red arrow heads indicate disturbed membrane integrity of polyplex-containing vesicles and 
potential membrane disruption or hole formation. Polyplex structures (black) seem to penetrate the 
membrane from the interior of endo-lysosomes to the cytoplasm. 
 
The impact of polymer-membrane interactions was further endorsed by a protein 
leakage assay, i.e., a hemoglobin release assay from erythrocytes (data are shown in 
Pub2). This assay revealed an increased cellular membrane damage of erythrocytes after 
treatment with the homo- as well as copolymers. Especially, polymethacrylates with a 
higher content of primary amino groups (P3, P6) demonstrated enhanced membrane 
activity. This outcome is in accordance to the calcein release assay and, thus, might 
explain the superior transfection performance of poly(methacrylate)s bearing primary 
amino groups. However, the high membrane disruptive activity of the 
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poly(methacrylate)s was associated with severe cytotoxic effects (data are shown in 
Pub2). A common strategy to accomplish the reduction of adverse side effects is the 
introduction of stealth polymers like poly(ethylene glycol) (PEG).[21-22] Another suitable 
polymer class with stealth potential is PEtOx representing a promising alternative to 
PEG.[25, 97] PEtOx is considered to be responsible for the reduction of unspecific 
interactions with non-cellular and cellular components, elongated blood circulation, low 
immunogenicity and reduced clearance in vivo.[25-26] However, such stealth polymers 
bear the risk of diminished transfection efficiencies presumably due to weak DNA 
complexation and decreased cell interactions.[98-99] In order to identify the optimal 
balance between the cytotoxicity and the transfection efficiency, a library of graft 
copolymers comprising a PAEMA or PMAEMA backbone with 2-ethyl-2-oxazoline 
(EtOxn) side chains were examined. Since primary and also secondary amino groups 
demonstrated satisfying gene delivery performances, EtOxn macromonomers with a 
degree of polymerization (DP) of 5 and 20 were chosen in order to show whether the 
side chain length of the graft copolymer influences the gene delivery process. 
Furthermore, to examine the impact of the EtOxn density on the transfection process, a 
degree of grafting (DG) of 10% and 30% was aimed. Higher DG were excluded due to 
the fact that studies on PEG graft copolymers with longer side chains demonstrated 
reduced polyplex formation and transfection efficiency.[100] The members of the library 
featured the general structure P(MAEMAm-g-EtOxn(x)), referred as P8 to P11, and 
P(AEMAm-g-EtOxn(x)), referred as P12 to P15 (Figure 3.5). The grafted copolymers P8 
to P15 revealed comparable molar masses to the non-grafted homopolymers (i.e. P2, 
P3) ranging from 13.4 to 22.8 kDa with varying molar fractions of EtOxn moieties (EtOx 
mol%) dependent on the DP and DG. 
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A 
 
B 
Abbr. Polymer nEtOx 
DGx 
[%]a 
Mn  
[g mol-1] b 
Ðb 
Mol% 
EtOxc 
P8 P(MAEMA95-g-EtOx5(10)) 5 17 17,300 1.43 56 
P9 P(MAEMA95-g-EtOx5(30)) 5 40 20,200 1.42 77 
P10 P(MAEMA80-g-EtOx20(10)) 20 16 17,500 1.40 72 
P11 P(MAEMA80-g-EtOx20(30)) 20 31 13,400 1.30 82 
P12 P(AEMA95-g-EtOx5(10)) 5 16 16,700 1.44 53 
P13 P(AEMA95-g-EtOx5(30)) 5 41 18,400 1.49 77 
P14 P(AEMA80-g-EtOx20(10)) 20 10 22,800 1.48 82 
P15 P(AEMA80-g-EtOx20(30)) 20 41 17,300 1.59 88 
 
Figure 3.5. Schematic representation of the chemical structures of the grafted poly(methacrylate)s (A) 
and characterization data of the eight-membered library (B). a The degree of grafting (DG) was determined 
from 1H-NMR spectra. b Molar mass (Mn) was determined by SEC (water, 0.1% trifluoroacetic acid, 0.1 M 
NaCl, RI detection, PVP calibration). c Molar ratio of EtOx (Mol% Ox) was calculated from 1H-NMR 
spectra of the corresponding Boc-protected polymers. 
 
Unshielded poly(methacrylate)s led to severe cytotoxicity as well as harsh but beneficial 
disruptive effects on the cellular membranes, as depicted in Figure 3.6. The grafting of 
AEMA and MAEMA bearing polymers with EtOxn shielding units significantly 
improved the cytocompatibility compared to the unshielded analogues (Figure 3.6 A 
and B). The graft copolymers P8 and P12 bearing EtOxn side chains with a DP of 5 and 
the lowest theoretical DG of 10% revealed cytotoxicity at higher polymer concentrations 
above 300 µg mL-1 or 100 µg mL-1, respectively. Nevertheless, the cytotoxicity of the 
graft polymers could be minimized or even prevented by either the increase of the length 
of EOtxn side chains or the increase of DG. The shielding effect of the EtOxn did not 
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only improve the cytocompatibility of the AEMA and MAEMA containing 
homopolymers by a factor of 10 and above, it also reduced their membrane disruptive 
activity (Figure 3.6 C). All members of the library revealed no to low hemolytic activity 
at the tested conditions, endorsing the utilization of EtOx as stealth polymer.  
 
 
Figure 3.6. Cyto- and hemocompatibility of the grafted poly(methacrylate) library. (A and B) Evaluation 
of the relative viability (%) of L929 mouse fibroblast cells after polymer treatment for 24 h according to 
ISO10993-5. (C) Hemolysis assay of isolated erythrocytes from different blood samples. Erythrocytes 
were incubated with increasing polymer concentrations and the release of hemoglobin was determined. 
Complete hemolysis (100%) was achieved using Triton X-100, which served as positive control. PBS 
served as negative control (data not shown). A value less than 2% hemoglobin release was classified as 
non-hemolytic, 2 to 5% as slightly hemolytic and a value above 5% as hemolytic. Values represent the 
mean ± S.D. (n = 3). 
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Despite the positive impact of the EtOxn on the overall biocompatibility, the shielding 
led to adverse side effects in terms of polyplex uptake and, consequently, on the 
transfection efficiency. As depicted in Figure 3.7 A, polyplexes based on copolymers 
comprising short EtOxn side chains (DP = 5) revealed uptake efficiencies between 
60 and 80% after 4 h. On the other hand, the copolymers P10, P11, P14 and P15 with 
longer EtOxn side chains (DP = 20) showed low uptake rates. Interestingly, the DG did 
not influence the cellular internalization in our study. It can be assumed that the longer 
side chains prevent the interaction of the polyplex with the cellular membrane and, 
consequently, a successful endocytosis. Furthermore, an influence of serum proteins on 
the uptake performance was observed (Figure 3.7 A, see MFI values) as the uptake level 
for almost all copolymers was reduced in serum-containing media. Hence, the shielding 
property of EtOxn did not seem to be sufficient for a complete repellent effect of 
proteins, as an accumulation of proteins to the polyplex can additionally impede the 
internalization by alteration of the polyplex physicochemical characteristics.[27, 101] 
Transfection studies of the grafted copolymers confirmed the influence of the EtOxn 
grafting on the transfection behavior (Figure 3.7 B). As assumed from the missing 
uptake efficiency, copolymers with long EtOxn side chains (P10, P11, P14 and P15) 
failed in the transfection of adherent HEK-293 cells. But also, copolymers with a 
theoretical DG of 30% (P9 and P13) revealed no transfection efficiencies despite high 
uptake rates, thus suggesting an inability to escape endo-lysosomal compartments. An 
explanation could be the decreased polymer interaction with the exoplasmic membrane 
of endo-lysosomal compartments as also demonstrated by the hemolysis assay and live 
cell imaging (data are shown in Pub3). In contrast to the cellular internalization, which 
is affected by the DP of the side chains, the transfection performance seems rather be 
affected by the DG. Merely the polymers with a DP of 5 and a theoretical DG of 10%, 
i.e., P8 and P12, were able to transfect HEK-293 cells with TEs of 15 ± 4.2% and 45 ± 
9.5%, respectively. In particular, P12 revealed gene delivery performances comparable 
to the homopolymers P2 and P3. Hence, this polymer demonstrated not only high 
cytocompatibility but also satisfying transfection efficiencies making the pursued 
strategy a promising concept for the design of safe and powerful gene delivery vectors. 
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Figure 3.7. Gene delivery study of the grafted poly(methacrylate)s. (A) Cellular uptake study of 
polyplexes based on YOYO-1 labeled pDNA (N/P 30) in serum-reduced (plain columns, OptiMEM) and 
serum-containing (dashed columns, RPMI) media for 4 h at 37 °C. (B) Transfection of HEK-293 cells 
with pDNA encoding the enhanced green fluorescein protein (EGFP) in serum-reduced (OpiMEM) media 
at N/P 30 after 24 h. MFI (Mean fluorescence intensity) normalized to the negative control. 10,000 cells 
were quantified by flow cytometry. Values represent the mean ± S.D. (n = 3). 
 
In summary, amino-functionalized poly(methacrylate)s represent versatile non-viral 
gene delivery vectors with excellent transfection efficiencies, since they offer a wide 
range of molar masses, well-defined architectures and various functionalities. It was 
found that the type and content of amino functionalities have a relevant impact on the 
transfection performance including (i) the cyto- and hemocompatibility, (ii) the time-
efficient endosomal release and (iii) the gene expression. In accordance to literature, 
polymers with primary and secondary amino functionalities were beneficial for DNA 
binding and polyplex formation, while polymers with tertiary amino groups 
demonstrated the highest buffering capacities at acidic pH conditions. Nevertheless, 
polymers with a high content of primary amino groups revealed superior transfection 
performances in vitro at selected experimental set-ups, whereas polymers with tertiary 
amino functionalities showed poor transfection efficiencies. Contrary to the current 
opinion, a high buffering capacity do not seem to be a crucial prerequisite for the 
efficient poly(methacrylate)-mediated transfection of mammalian cells. The successful 
escape from endo-lysosomal compartments does not predominantly rely on buffering 
effects as proposed from the “proton sponge” hypothesis but possibly rather on the 
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intense interaction of the polymer or polyplex, respectively, with the vesicular 
membrane as described in Chapter 2. In particular, polymers with primary amino 
functionalities revealed a high membrane activity, which might lead to the formation of 
nano-holes within the membrane of endo-lysosomes and, thus, to a successful escape. 
However, this pronounced membrane affinity causes severe cytotoxic effects, which 
could be overcome by the introduction of shielding moieties. PEtOx represents a suitable 
polymer revealing the favored stealth effect and could be utilized to generate grafted 
poly(methacrylate)s. This strategy significantly improved the overall cell viability and 
was able to minimize or even eliminate cytotoxic side-effects. Nevertheless, an 
appropriate balance between the degree of grafting as well as the length of side chains 
has to be found to obtain powerful gene delivery vectors with high transfection 
efficiencies.   
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3.2 Poly(ethylene imine)-based polymers 
Parts of this chapter have been published in Pub4 T. Bus, C. Englert, M. Reifarth, P. Borchers, 
M. Hartlieb, A. Vollrath, S. Hoeppener, A. Traeger, U. S. Schubert, 3rd generation poly(ethylene imine)s 
for gene delivery, J. Mater. Chem. B 2017, 5, 1258-1274 and in Pub5 C. Englert, A.-K. Trützschler, 
M. Raasch, T. Bus, P. Borchers, A. S. Mosig, A. Traeger, U. S. Schubert, Crossing the blood-brain barrier: 
Glutathione-conjugated poly(ethylene imine) for gene delivery, J. Control. Release 2016, 241, 1-14. 
Since the first report as non-viral gene delivery agent in 1995, poly(ethylene imine) 
(PEI) remains the “gold standard” for gene delivery in vitro up to now.[16-17] Its high 
transfection efficiency is based on its high cationic charge density due to the polyamine 
structure, where every third atom is a protonatable nitrogen atom. The weak-base 
buffering polyelectrolyte PEI reveals a pH-dependent protonation behavior and 
conformational changes.[102] This structure provides optimal conditions for pDNA 
binding and stable polyplex formation but also reduced water solubility, molar mass-
dependent cytotoxicity and non-specific interactions with cellular as well as non-cellular 
components.[18, 103] Various attempts have been made to improve the overall 
biocompatibility of PEI. In particular, the design of novel PEI derivatives comprising 
biodegradable linkers (e.g. disulfide bonds),[104-106] carbohydrates (e.g. dextran or 
fructose),[30, 107] hydroxyl starch[108] or stealth polymer moieties[109-110] have been in the 
focus of previous research. As described in Chapter 3.1, the presence of PEtOx 
functionalities within a polyamine structure represents an effective strategy to overcome 
undesired drawbacks. With regard to the two existing topologies of PEI, the 
modification and optimization of LPEI for the investigations of structure-property 
relationships is often preferred over the branched form, since BPEI suffers from the lack 
of control during synthesis and from well-defined structures.[111] The cationic ring-
opening polymerization (CROP) of polyoxazolines allows the synthesis of well-defined 
polymers, which can be utilized for the acidic or basic hydrolysis resulting in LPEI.[112-
113] Hence, the partial hydrolysis of POx results in the synthesis of premature PEIs or 
concretely in the copolymer P(Ox-stat-EI) and represents a straightforward concept to 
obtain polymers with improved biocompatibility. However, a high degree of stealth 
functionalities might impair the transfection efficiency as revealed for 
poly(methacrylate)s. In order to circumvent this effect, functional groups like amino 
groups or targeting molecules can be attached to the P(Ox-stat-EI) backbone by post-
polymerization functionalization. An alkene functionality was installed in order to 
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introduce various amino groups by thiol-ene addition. To examine the biological activity 
and the transfection potential of such PEI-derivatives a series of different polymers 
based on PEtOx was synthesized (Figure 3.8 and Table 3.2) containing stealth moieties 
(i.e., EtOx), cationic functionalities (e.g., EI) and/or highly specific functional groups 
for DNA binding or targeting (e.g., amino functionalities, ligands). As noted from 
Chapter 3.1 primary amino functionalities achieved superior gene delivery 
performances compared to the other amino groups and were, therefore, chosen as 
functional moieties within the flexible side chain. 
 
 
Figure 3.8. Schematic overview of the functional moieties of novel PEI derivatives providing stealth, 
cationic charge and targeting behavior. Spherical functionality implies a potential targeting molecule. 
Asterisks indicate variable end groups. 
 
The series comprise statistical linear homo- and copolymers with narrow molar mass 
distributions bearing different amounts of secondary and primary amino groups. The 
homopolymer PEtOx (P16) with a DP of 575 was synthesized by CROP according to 
literature reports and served as starting material for the synthesis of the other library 
members.[97] LPEI (P18) was obtained by the full hydrolysis of P16 and was used as the 
transfection standard. The partial hydrolysis of P16 resulted in the copolymer P(EtOx-
stat-EI) (P17) comprising an EtOx content of ~ 54%. This EtOx content was chosen in 
our study since P(Ox-stat-EI) with higher POx concentration were reported to have 
disadvantageous effects on the delivery performances with reduced TEs.[114-115] To 
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examine the effect of stealth monomers and different amino groups on the overall gene 
delivery process, three different statistical copolymers of the general structure 
P(EtOx54%-stat-EIn-stat-AmButOxm) were synthesized by post-polymerization 
functionalization of P17 followed by thiol-ene photoaddition to introduce primary 
amino groups (AmButOx). The copolymers exhibited a constant EtOx content but 
varying ratios of secondary as well as primary amino groups and were named P19, P20 
and P21, respectively (Table 3.2).  
 
Table 3.2. Selected characterization data of the PEI-based copolymers with a DP of 575. 
Abbr. Polymer 
Amino ratio 
secx : primy 
Mna  
[g mol-1] Ð
a 
P16 P(EtOx)100%  57,000 1.3 
P17 P(EtOx54%-stat-EI46%) 1:0 31,300 1.3 
P18 P(EtOx5%-stat-EI95%) 1:0 9,900 1.4 
P19 P(EtOx54%-stat-EI12%-stat-AmButOx34%) 1:2.8 35,300 1.6 
P20 P(EtOx54%-stat-EI17%-stat-AmButOx29%) 1:1.7 43,700 1.6 
P21 P(EtOx54%-stat-EI23%-stat-AmButOx23%) 1:1 30,500 1.5 
 
a Molar mass and dispersity values were determined by AF4 equipped with a MALLS detector and a 
cellulose membrane with a molar-mass cut-off of 10 kDa. 
 
The EtOx content of 54% within the copolymer structures clearly influenced their 
physicochemical properties and biological activity. As expected, the homopolymer P16 
revealed high cytocompatibility without a loss of cell viability at the tested conditions 
(Figure 3.9 A). In contrast, P18 showed severe cytotoxic effects at minimal polymer 
concentrations indicated by the half-maximal cytotoxic concentration (CC50) value of 
4 µg mL-1. The obtained CC50 data from P18 are in accordance with previously 
published reports.[18, 116] However, commercially available LPEI (e.g. 25 kDa from 
Polysciences) revealed higher CC50 values of 25 to 30 µg mL-1, which could be 
attributed to significant amounts of N-acyl residues (≥ 10%) from the manufacturing 
process.[115, 117-118] Interestingly, the introduction of EtOx in the ratio 1:1 was sufficient 
to eliminate cytotoxic effects, as P17 showed no loss of cell viability up to the highest 
tested polymer concentration (1 mg mL-1). Despite their high molar masses, all three 
copolymers bearing primary amino groups in the polymer side chain (P19 to P21) also 
benefit from the EtOx content, as they do not harm the overall viability of cells at the 
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tested conditions. The positive impact of EtOx on the overall hemocompatibility of the 
copolymers was further demonstrated by the assessment of the hemoglobin release and 
agglomeration formation of erythrocytes (Figure 3.9 B and C). In contrast, P18 revealed 
a strong interaction with cellular membranes of blood cells causing the aggregation of 
erythrocytes (Figure 3.9 B), which might cause an increase of the blood viscosity in vivo 
and could hamper the blood flow. Furthermore, higher P18 concentrations (≥ 100 µg 
mL-1) caused the disruption of the erythrocyte membranes indicated by the release of 
hemoglobin. All PEI derivatives P19 to P21 demonstrated neither a hemolytic activity 
nor the aggregation of erythrocytes in a concentration range from 10 to 100 µg mL-1 
indicating ideal prerequisites for potential in vivo applications. 
 
 
Figure 3.9. Cytocompatibility studies PEI-based homo- and copolymers. (A) Evaluation of the relative 
viability of L929 mouse fibroblast cells and polymer’s CC50 after 24 h polymer treatment according to 
ISO10993-5. (B) Selected microscopic images of erythrocytes after polymer treatment. A high membrane 
activity resulted in the clotting of erythrocytes. Scale bar represents 50 µm. (C) Hemolysis assay of 
erythrocytes after polymer incubation at indicated concentrations. Triton X-100 served as positive control 
(98.8% hemoglobin release) and PBS as negative control (0.2% hemoglobin release). A value less than 
2% was classified as non-hemolytic, 2 to 5 as slightly hemolytic and values > 5% as hemolytic. Values 
represent the mean ± S.D. (n = 3). 
 
The stealth behavior of EtOx provided biosafety beneficial for biomedical applications, 
but also bearing the risk for adverse effects on the nucleic acid packaging and the 
polyplex stability. The nucleic acid binding as well as release affinity was investigated 
with pDNA and siRNA, since both are used for gene therapy approaches but differ 
significantly in their characteristics. Most importantly, siRNA is comprised of a few 
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base pairs (< 30 base pairs (bp)) and, therefore, stiff and more rigid compared to the long 
circular pDNA (4.7 kbp). The DNA molecule is condensed and packed into a compact 
structure during the complexation process by interacting with the nitrogen atoms of 
multiple cationic polymer chains, whereas the structure of siRNA remains unaltered 
interacting more likely with a single polymer chain. Hence, the formation of stable 
polyplexes based on siRNA is more challenging. The physicochemical characterization 
of polyplexes based on pDNA and siRNA confirmed an influence of the EtOx on the 
polyplex formation. The polyplex formation of the library was evaluated by the ethidium 
bromide assay (Figure 3.10 A). The homopolymer P18 as well as the copolymers P19 
to P21 revealed a high affinity to both, pDNA and siRNA. With increasing polymer 
concentrations, ethidium bromide was excluded from its binding site within the nucleic 
acid resulting in the decrease of its fluorescence intensity. Moreover, the stable polyplex 
formation was indicated by a low and steady fluorescence plateau. For P18 a low N/P 
ratio (10 to 20) is sufficient to achieve stable polyplexes with a z-average of 80 nm and 
a positive net charge of ζ = 33 mV (Figure 3.10 B). These results are in accordance to 
literature reports and represent ideal characteristics for cellular uptake and trafficking 
processes. The negative charge of the nucleic acid is masked, thus proposing a sufficient 
packaging and protection from degradation as well as a facilitated affinity to negatively 
charged cell membranes followed by endocytosis. Interestingly, P17 failed in the 
formation of appropriate polyplexes as indicated by the formation of polydisperse 
complex fractions (Figure 3.10 A and B). Consequently, this directly affected the 
transfection performance, as seen in the lack of EGFP gene expression in Figure 3.10 C. 
But this in turn, confirm the value of stable polyplex formation for successful gene 
delivery. The EtOx content of 54% might weaken the electrostatic interactions or even 
prevent the binding of DNA to the secondary amino groups of the PEI backbone. 
However, the effect was compensated by the introduction of more flexible side chains 
containing primary amino functionalities as demonstrated for P19, P20 and P21. 
Primary amino groups were shown to be essential for DNA binding and polyplex 
formation. Thus, the copolymers were able to form suitable polyplexes with an overall 
z-average below 180 nm and a positive net charge of ζ = 21 to 27 mV (Figure 3.10 B) 
indicating the successful masking of the nucleic acid charge. With regard to their pDNA 
gene delivery performance, an influence of the polymer composition was obvious. 
Polymers with a more equalized ratio of primary to secondary amino functionalities 
(P20 and P21) achieved high transfection levels of ~ 60% comparable to P18 (Figure 
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3.10 C). P19 comprising a higher ratio of primary amino groups revealed lower 
transfection performances (TE: ~ 45%). To assess the shielding property of the 
copolymers, pDNA transfection was further performed in serum-containing media 
(Figure 3.10 C, plain columns). Adverse effects of serum proteins on the transfection 
efficiency were observed for all three copolymers and P18. However, the highest 
utilized N/P ratio of P21 withstood the inhibitory influence of serum proteins and 
resulted in similar efficiencies as in the absence of serum. At these conditions, the 
polymers P21 showed superior TE over the transfection standard P18. 
 
 
Figure 3.10. (A) Complexation affinity and polyplex formation (ethidium bromide assay) of the polymer 
library at indicated N/P ratios with pDNA (plain columns) and siRNA (dashed columns). (B) Size and 
zeta potential (surface charge) of pDNA- and siRNA-based polyplexes at N/P 30 determined via dynamic 
light scattering and electrophoretic light scattering in a HEPES-based buffer. (C) Transfection efficiency 
of pDNA-based polyplexes for adherent HEK-293 cells in serum-reduced (OptiMEM, dashed columns) 
and serum-containing media (RPMI + 10% FCS, plain columns) at different N/P ratios after 24 h. (D) 
siRNA knockdown mediated by P18, P19, P20 and P21 and jetPRIME (positive control) at N/P 30 after 
72 h. Stable EGFP-expressing CHO cells were transfected with siRNA-based polyplexes using siRNA 
able to knock down EGFP. Statistical analysis (t-test) against control cells, * represents p < 0.05 and # 
represents p < 0.005. Values represent the mean ± S.D. (n ≥ 3). 
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An opposite trend was seen for the delivery of siRNA (Figure 3.10 D). Copolymers with 
a higher content of primary amino groups, namely P19 and P20, revealed an improved 
silencing ability compared to P21. Although P19 and P20 demonstrated adequate 
knockdown levels, their design demonstrated still room for improvements as P18 and 
the positive control jetPEI were more efficient in siRNA delivery. It could be suggested 
that the physicochemical characteristics of the nucleic acids (size, morphology) play an 
essential role for the interaction with the PEI copolymers (Figure 3.11). The large DNA 
molecule appeared to be capable to interact with both, the secondary amino groups 
within the PEI backbone as well as with the primary amino groups in the side chains to 
achieve sufficient condensation in a compact polyplex structure. In particular, the 
secondary amino groups seemed to be beneficial for DNA condensation and delivery. 
In contrast, it was assumed that the short strands of siRNA preferably interact with the 
primary amino groups of the flexible side chain, since they might be easier accessible 
than the EtOx encompassing secondary amino groups.  
 
 
Figure 3.11. Schematic illustration of the influence of polymer composition on nucleic acid binding 
dependent on type and nature of nucleic acids.
 
Besides the sophisticated demands regarding biocompatibility and delivery efficiency 
of various genetic materials, the targeted delivery thereof to cells or the tissue of interest 
represents a further major challenge of modern gene therapy approaches. In particular, 
the blood-brain-barrier (BBB) is the most challenging obstacle regarding the delivery of 
therapeutic nucleic acids or other drugs.[119-121] The passage of macromolecules and 
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small molecules (98% < 400 g mol-1) is strictly limited due to its defined structure: A 
tight cell layer of cerebral microvascular endothelial cells (CMEC) that are in close 
contact with astrocytes and pericytes.[122] There are several strategies to pass the BBB, 
on the one hand the passive diffusion by small molecules and, on the other hand, the 
active transport of macromolecules mainly mediated by carrier proteins or 
transcytosis.[120, 123-124] Thus, the introduction of targeting molecules to the polymeric 
vector enables the passage by receptor-initiated transport or transcytosis. The 
functionalization of polymers with the tripeptide L-Glutathione (GSH) was previously 
proven to be a promising targeting approach.[31-32, 125] Hence, the combination of the 
previously described PEI copolymers in the presence of primary or secondary 
functionalities with an additional GSH-decoration represent a powerful non-viral 
delivery concept to investigate the active targeting ability of the PEI derivatives through 
the BBB. In this context, P18 was directly used as starting materials for the aimed 
copolymers. P18 was modified by post-polymerization functionalization followed by 
thiol-ene photoaddition to install the GSH-targeting functionality with a simultaneous 
presence of either secondary or primary amino groups within the polymer backbone 
(Figure 3.12). The statistical copolymers P(EI73%-stat-GluBuOx27%) stated as P22 
comprising only secondary amino groups in the polymer backbone and GSH in the sides 
chain as well as P(AmButOx82%-stat-ButEnOx10%-stat-GluButOx8%) stated as P23 
containing primary amino groups and GSH in the corresponding side chains were 
investigated regarding their DNA delivery and targeting capabilities. 
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A 
 
B 
Abbr. Polymer Targeting unit 
Mna  
[g mol-1] Ð
a 
P18 P(EtOx5%-stat-EI95%)  9,900 1.4 
P22 P(EI73%-stat-GluButOx27%) GSH 21,000 2.0 
P23 P(AmButOx82%-stat-ButEnOx10%-stat-GluButOx8%) GSH 63,300 1.8 
Figure 3.12. PEI-derivatives with GSH functionalization. (A) Schematic representation of the chemical 
structures of GSH-decorated PEI copolymers P22 and P23. (B) Selected analysis data of the polymers. 
a Molar mass and dispersity values were determined by AF4 with a MALLS detector and a cellulose 
membrane with a molar-mass cut-off of 10 kDa. 
 
Based on the polymer structure the bulky GSH moieties might cause the sterically 
hindrance of the accessibility to primary or secondary amino groups responsible for 
membrane interactions linked to toxicity as well as for DNA binding. In fact, P22 and 
P23 revealed improved cell viabilities compared to P18 (Figure 3.13 A). This effect was 
more pronounced for P22 probably due to the higher amount of GSH (27%) compared 
to P23 (8%). A similar trend was observed for the pDNA binding abilities of the 
polymers (Figure 3.13 B). While P18 showed a fast and stable binding to pDNA with 
increasing N/P ratio, both GSH-functionalized polymers, in particular P22, required 
higher polymer supplementation to achieve efficient polyplex formation. Based on its 
polymer composition, P23 provides primary amino groups within the flexible side chain 
that in fact are easier accessible for the phosphates of the pDNA. Whereas, P22 
comprises solely secondary amino moieties for DNA binding which were presumably 
shielded by the presence of the GSH molecule.  
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Figure 3.13. (A) Evaluation of the relative cell viability of L929 mouse fibroblast cells of GSH-decorated 
copolymers P22 and P23 as well as the non-decorated P18 after 24 h according to ISO10993-5. (B) DNA 
binding affinity and polyplex formation by the ethidium bromide assay. Values represent the mean ± S.D. 
(n = 3). 
 
A perfused microfluidic chip with an endothelial cell layer mimicking the BBB was used 
to investigate the capabilities of the GSH-modified polymers to cross the BBB. For this 
purpose, a human CMEC cell line (hCMEC/D3) resembling the cerebral endothelial cell 
layer of the BBB were cultured on a suspended membrane within a multi-organ-tissue-
flow (MOTiF) biochip until full confluence. Labeled polyplexes (using YOYO-1 iodide 
labeled pDNA) based on P18, P22 and P23 were perfused under physiological 
conditions within the chip and the BBB passage was examined by fluorescence 
microscopy. The chip design allowed both, the investigation of the cellular uptake of 
polyplexes within the endothelial cell layer as well as the quantification of the total 
amount of polyplexes crossing the endothelial barrier. The highest enrichment of 
YOYO-1 labeled pDNA-polyplexes into the hCMEC/D3 cells was observed for P23 as 
depicted in the microscopic images of Figure 3.14 A and the fluorescence intensity 
quantification in Figure 3.14 B. In contrast, P22 revealed the lowest uptake into the 
barrier model system and P18 exhibited moderate enrichment within the cell layer. 
Moreover, the determination of the trans-endothelial movement of the different 
polyplexes confirmed these findings. P22-based polyplexes revealed a time-dependent 
passage through the BBB as an increasing translocation was observed (Figure 3.14 C). 
However, P23 was not able to cross the endothelial cell layer as the YOYO-fluorescence 
intensities remain low within the 60 min of perfusion. The diminished performance of 
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P23 could be explained by its chemical structure. The presence of primary amino 
functionalities as well as the unprotected double bonds lead to high cytotoxic effects and 
cell membrane activity, thus showing high unspecific interactions to cells. As depicted 
in Figure 3.14 A and B, P23 was adhered to and internalized into the hCMEC/D3 cells 
probably followed by cargo release on location instead of translocation through the cell 
layer. The GSH content of P23 of nearly 10% might be insufficient for translocation. 
The increased translocation of P18 could be explained by its severe cytotoxicity causing 
defects in the endothelial layer’s integrity and the disruption of tight junctions 
(immunofluorescence staining, data are shown in Pub5). Hence, the leakage of the 
hCMEC/D3 cell layer facilitate the translocation of P18 but does not make it suitable 
for BBB gene delivery. Polyplexes based on P22 with 27% GSH functionalities 
efficiently pass the BBB model barrier, thus making it a promising candidate as 
therapeutic nanocarrier.  
 
 
Figure 3.14. Perfusion of GSH-conjugated copolymers P22 and P23, as well as P18 in a microfluidically 
supported biochip assay mimicking the BBB. (A) Microscopic images displaying the YOYO-labeled 
polyplex (green) uptake within the hCMEC/D3 cells (cell nucleus stained blue by Hoechst 33342). (B) 
Quantification of polyplex internalization into hCMEC/D3 cells by image analysis. (C) Passage of 
polyplexes through the hCMEC/D3 cell layer over time. * Significances vs. P22, *** p<0.001, n = 3, 
scale bar = 100 nm. 
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To conclude, the presented PEI copolymers revealed several advantages over LPEI. It 
could be demonstrated that an EtOx content of around 50% markedly improved the 
overall cyto- and hemocompatibility. However, the introduction of functional moieties 
containing primary as well as secondary amino groups were required to ensure stable 
polyplex formation and sufficient internalization rates. The impact of the polymer design 
balancing stealth, functional and targeting moieties for efficient delivery was 
demonstrated. The PEI copolymers were able to outperform the gold standard LPEI in 
terms of (targeted) gene delivery with different types of nucleic acids at in vivo 
mimicking conditions. The introduction of L-Glutathione into the copolymer backbone 
resulted in successful targeting abilities. Thus, they represent promising alternatives for 
more complex transfection approaches including hard-to-transfect cells or tissues.  
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4. The delivery of drugs by poly(2-oxazoline)-based polymers 
Parts of this chapter have been published in Pub6 I. Yildirim, T. Bus, M. Sahn, T. Yildirim, D. Kalden, 
S. Hoeppener, A. Traeger, M. Westerhausen, C. Weber, U. S. Schubert, Fluorescent amphiphilic 
heterografted comb polymers comprising biocompatible PLA and PEtOx side chains, Polym. Chem. 2016, 
7, 6064-6074, Pub7 M. Hartlieb, T. Bus, J. Kübel, D. Pretzel, S. Hoeppener, M. N. Leiske, K. Kempe, B. 
Dietzek, U. S. Schubert, Tailoring cellular uptake and fluorescence of poly(2-oxazoline)-based nanogels, 
Bioconjugate Chem. 2017, 28, 1229-1235 and Pub8 D. Hoelzer, M. N. Leiske, M. Hartlieb, T. Bus, D. 
Pretzel, S. Hoeppener, K. Kempe, R. Thierbach, U. S. Schubert, Tumor targeting with pH-responsive 
poly(2-oxazoline)-based nanogels for metronomic doxorubicin treatment, Oncotarget 2018, 9, 22316-
22331. 
Low solubility, diminished bioavailability and high cytotoxicity combined with strong 
immune responses are some of various drawbacks accompanied by the administration 
of pure pharmaceuticals. The utilization of polymeric nanocarriers offers the opportunity 
to deliver drugs to the desired site of action within the body by circumventing these 
drawbacks. Most drug delivery vectors are based on biocompatible and/or biodegradable 
polymers, which accomplish desired demands in terms of safety and controlled drug 
release. Pertinent polymers are polylactic acid (PLA) and poly(lactic-co-glycolic acid) 
(PLGA), which have been successfully approved for the delivery of various therapeutic 
agents.[37-38, 126] As both polymers are hydrophobic the most preferred drug delivery 
strategy is the formulation of nanoparticles by solvent evaporation using 
nanoprecipitation or emulsion techniques. The polymers PEG and POx are also utilized 
for drug delivery due to their stealth behavior, which favor high biocompatibility as well 
as high pharmacokinetics.[127-130] As revealed from Chapter 3, EtOx monomer units 
offer a great variation of compositions and allows the introduction of different side-
chain functionalities. Therefore, PEtOx is well-suited for the formulation of drug-loaded 
polymeric vectors. It can be functionalized with hydrophobic moieties like PLA or 
others to generate amphiphilic molecules, thus facilitating the self-assembly to various 
structures like micelles or vesicles.[126] Due to their small sizes, which is usually below 
100 nm, self-assembled structures are favored for passive targeting strategies, i.e. the 
EPR effect.[41, 131] To examine the potential of modified POx-based polymers for drug 
delivery, two different concepts of self-assembly were utilized and investigated (Figure 
4.1): (i) Self-assembly of amphiphilic heterografted comb polymers comprising 
hydrophilic EtOx moieties as well as hydrophobic polylactide (LA) units and, (ii) core 
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cross-linked assemblies from diblock copolymers consisting of hydrophilic EtOx units 
as well as an amino group containing poly(4-amino-butyl-2-oxazoline) (AmOx) 
moieties.  
 
 
Figure 4.1. Schematic overview of the different moieties of POx-based polymers comprising stealth or 
biodegradation characteristics as well as amino functionalities utilized for drug delivery approaches. 
Asterisks indicate variable end groups. 
 
With regard to the firstly mentioned concept, a series of heterografted comb polymers 
with molar masses ranging from 19.5 to 29 kDa comprising a methacrylate backbone 
with varying ratios of hydrophilic EtOx side chains (DP = 5) and hydrophobic LA side 
chains (DP = 10 or 15) were synthesized by a combination of ROP, CROP and RAFT 
polymerization (Figure 4.2 A and B). The obtained polymers P24 to P28 comprised the 
general structure: P(EtOx5MA-stat-LA10/20MA)n/m, and were investigated according to 
their increasing EtOx and decreasing LA content. Pyrene, which was covalently attached 
to the LA side chain, served as fluorescent drug model and additionally, was used as 
tracer to detect the cellular distribution. As a function of the chemical composition it 
was predicted that the self-assembly of the polymers in aqueous solutions led to 
spherical micelles or vesicles. Hence, it was assumed that the hydrophobic LA side 
chains with the pyrene label should be organized within the core of the self-assembled 
structures encompassed by the methacrylate backbone. Whereas, the hydrophilic EtOx 
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arms should point towards the water phase, thus shaping the outer layer of the self-
assembled structures. 
 
A 
 
B 
Abbr. Polymer EtOx/LAa Mnb [g mol-1] Ðb 
P24 P(EtOx5MA-stat-LA15MA)45/55 45/55 27,500 1.2 
P25 P(EtOx5MA-stat-LA10MA)50/50 50/50 28,200 1.4 
P26 P(EtOx5MA-stat-LA10MA)65/35 65/35 29,000 1.3 
P27 P(EtOx5MA-stat-LA10MA)70/30 70/30 26,300 1.3 
P28 P(EtOx5MA-stat-LA10MA)80/20 80/20 19,500 1.2 
Figure 4.2. (A) Schematic representation of the formation of the heterografted comb polymers consisting 
of EtOxn side chains (DP = 5), LA side chains (DP = 10 or 15) and a poly(methacrylate) backbone. The 
self-assembly of the amphiphilic structures was achieved by the solvent-evaporation method in water, 
which lead to the formation of micellular structures as well as vesicles dependent on the chemical 
composition. (B) Selected characterization data of the heterografted comb polymers. a Molar ratio of EtOx 
and LA repeating units were calculated from suitable signal integrals in the 1H NMR spectra of purified 
polymers. b Molar mass and dispersity values were determined by SEC (CHCl3, RI detection, PMMA 
calibration). 
 
The actual morphology of the heterografted comb polymers were confirmed by dynamic 
light scattering (DLS) and cryogenic transmission electron microscopy (cryo-TEM) 
measurements revealing different self-assembled structures with varying sizes in 
aqueous media (Figure 4.3). The morphology correlated well with the hydrophilic 
character of the polymers. Polymers with a low EtOx content tend to form polydisperse 
mixtures of smaller spherical and worm-like micelles exhibiting sizes between 20 and 
CROP
RAFT
ROP
P(EtOx5MA-stat-LA10/15MA)n/m
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50 nm as well as large vesicles (segmented, distorted, lamellar) up to 400 nm (Figure 
4.3, see cryo-TEM images of P24 and P25). With increasing EtOx content more defined 
spherical structures with sizes around 15 to 50 nm in diameter were obtained. In 
particular, P27 revealed micelles with monomodal size distributions (Figure 4.3). Due 
to the influence of EtOx, it is possible to tune the size and morphology of self-assemblies 
according to requested demands for drug delivery approaches.  
 
 
Figure 4.3. Determination of the size and morphology of heterografted comb polymer assemblies in water 
(5 mg mL-1) by DLS and cryo-TEM measurements. Self-assembly were achieved by the dropping method 
(solvent to non-solvent). 
 
No cytotoxicity for all self-assemblies was expected, as both side chains are known to 
be biocompatible.[37, 97] Indeed, high cell viabilities for all members of the heterografted 
comb polymer library were confirmed at the tested conditions, independent from the 
chemical compositions (Figure 4.4 A). This result furthermore endorsed the suggestion 
of micellar or vesicular structures including the shielding of the hydrophobic pyrene by 
the EtOx side chains. A gradual, but not critical, decrease in the cell viability was 
observed for some polymers at the highest tested concentration (200 µg mL-1), which 
might be attributed to a slight release of pyrene from degraded LA side chains. Based 
on their varying size distribution, which could be prejudice passive or active 
internalization, the cellular entry mechanism was investigated at 37 °C and 4 °C by 
confocal live cell imaging (see exemplary images for P24, Figure 4.4 B and C)). All 
tested polymers revealed the cellular internalization of self-assemblies at physiological 
conditions, as pyrene signals (magenta) were detected in the cell cytoplasm. 
Interestingly, only few pyrene signals were co-localized with endo-lysosomal 
compartments (Figure 4.4 B, co-localization depicted as white signal), thus indicating 
either a rapid endosomal release after endocytosis or an alternate entry mechanism. 
Uptake studies at 4 °C revealed a significant reduction of intracellular pyrene signals 
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(Figure 4.4 C, white arrows), thus imply that a minor fraction of the self-assemblies 
(probably sizes below 20 nm in diameter) was able to enter cells by a passive uptake 
mechanism (e.g., diffusion), whereas the majority was internalized by an energy-driven 
process (e.g., endocytosis). A slow release of thereon attached hydrophobic molecules 
(fluorescent dye or drug) might be feasible due to the degradative nature of LA. 
Furthermore, as the majority of the self-assemblies was localized within the cytoplasm 
no advanced strategy for the endo-lysosomal barrier is required. 
 
 
Figure 4.4. Biological evaluation of the heterografted comb polymer library. (A) Evaluation of the 
relative viability of L929 mouse fibroblasts treated with the comb polymers at indicated concentrations 
for 24 h, according to ISO10993-5. Values represent the mean ± S.D. (n = 3). Uptake study of P24 
(50 µg mL-1 in water) in HEK-293 cells at 37 °C (B) and 4 °C (C) after 4 h by confocal microscopy 
(overlay). Late endosomes or lysosomes were stained with LysoTracker Green (green) and pyrene is 
depicted in magenta. White arrows indicate the presence of pyrene within the cytoplasm. 
Scale bar = 10 µm.  
 
Self-assembly is a dynamic process, which is influenced by various parameters like 
temperature, pH value, ionic strength or monomer/polymer composition.[132-134] Hence, 
the biological activity of self-assembled structures is strongly influenced by these factors 
and keeps the risc for failures in drug delivery. A concept to cirumvent this obstacle is 
the chemical cross-linking of self-assemblies to generate nanogels, revealing stable 
structures and controllable degradation for release purposes. POx-based diblock 
copolymers consisting of a hydrophilic PEtOx and an amino-containing poly(4-amino-
butyl-2-oxazoline) (PAmOx) segment, which have been synthesized via CROP, were 
investigated for drug delivery (Figure 4.5 A and B). The P(EtOx-b-AmOx) was 
dissolved in chloroform to obtain micellar structures. In a next step, the amino moieties 
of the copolymer were further cross-linked by glutaraldehyde resulting in nanogels 
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comprising a hydrophilic PEtOx shell and a cross-linked core, which contained pH 
responsive imine bonds (Schiff base). Furthermore, fluorescein (P29) or doxorubicin 
(DOX, P30) have been covalently attached in a reversible manner to the cross-linked 
core of the nanogel to quench excessive aldehyde functions. By the variation of the 
degree of cross-linking, the size as well as the zeta potential could be adjusted, which 
consequently influenced the biological activity of the nanogels. An increase in the 
degree of cross-linking resulted in increased sizes (nearly two-fold), which might be 
explained by the swelling of the cross-linked part of the micelle. Furthermore, a decrease 
in the cationic zeta potential was observed with the increase in cross-linking. These 
effects resulted in diminished cellular internalization and demonstrated that the cell 
uptake of the nanogels could be fine-tuned according to respective demands for drug 
delivery by varying the cross-linking degree. 
 
A 
B 
Abbr. Composition Loading Mna [g mol-1] Ða 
P29 P(EtOx98-b-AmOx32) Fluorescein 13,900 1.1 
P30 P(EtOx98-b-AmOx32) Doxorubicin 13,900 1.1 
 
Figure 4.5. (A) Schematic illustration of the formation of cross-linked PEtOx-based nanogels with 
covalently immobilized fluorescein (1) or doxorubicin (2). Self-assembly was achieved in chloroform 
leading to micellar structures with a P(AmOx) core. Cross-linking was applied using glutaraldehyde. 
(B) Selected polymer characterization data. a Molar mass and dispersity values were determined by SEC 
(DMAc, poly(styrene) calibration). 
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Although the nanogels exhibited cationic charges, which are known for cytotoxic effects 
and low hemocompatibility, the fluorescein-loaded carrier P29 did not affect the overall 
cytocompatibility (Figure 4.6 A, B and C) probably because of the EtOx shielding. To 
evaluate this kind of nanocarrier for therapeutic approaches in terms of drug delivery, 
fluorescein was replaced by DOX (P30). DOX is the most applied chemotherapeutic 
drug to combat various types of cancer, e.g., hematologic malignancies, breast 
carcinoma or bone sarcoma.[135] Its mode of action can be divided into several 
mechanism including (i) the intercalation into DNA double strands, (ii) the prevention 
of DNA replication and transcription by the inhibition of the topoisomerase II and, (iii) 
the formation of free radicals causing DNA damage and apoptosis.[136-137] Despite its 
effectiveness in the therapeutic treatment, the administration of pure DOX causes 
different severe side effects.[135, 138] The loading of DOX into PEtOx-based nanogels 
could improve the overall biocompatibility and increase the availability at the tumor site. 
It was assumed that due to its small sizes (diameter < 20 nm), the nanogels are delivered 
to cancerous tissue by the EPR effect. The site-specific release of the drug was provoked 
by the pH responsive imine bonds (Schiff base). Stability studies demonstrated that the 
nanogels did not alter in size or polydispersity index (PDI) at physiological pH values 
(pH = 7.4) at 37 °C, whereas a lower pH value of 5.0 and the presence of glycine resulted 
in the increase of both parameters indicating the disassembling of the cross-linking 
connected with the potential release of the drug. Once DOX-loaded nanogels were 
internalized into tumor cells, the release of DOX occur within endo-lysosomal 
compartments exhibiting an acidic pH environment.[139] The efficient release of DOX 
was verified by cytotoxicity studies using a human colorectal carcinoma cell line (HT-
29) (Figure 4.6 A), a well-known in vitro cancer model that was also used in xenograft 
mouse experiments. In contrast to the fluorescein-loaded nanogels P29, DOX-loaded 
nanogels (P30: CC50 = 0.752 µg mL-1) revealed a concentration-dependent cytotoxicity 
profile comparable to free DOX (CC50 = 1.998 µg mL-1). Besides the cytocompatibility, 
the hemocompatibility was evaluated as crucial prerequisite for in vivo applications 
including the absence of blood clotting for prolonged circulation times. Due to the 
stealth properties of the PEtOx blocks, P30 did neither induce severe lysis of 
erythrocytes nor the aggregation thereof (Figure 4.6 B and C), which support the 
suitability of the nanogels for therapeutic administrations. 
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Figure 4.6. Biological investigations of free DOX, fluorescein-loaded (P29) as well as DOX-loaded 
nanogels (P30). (A) Evaluation of the relative viability of HT-29 cells after nanocarrier treatment at 
indicated concentrations for 72 h, according to ISO 10993-5. (B) Hemolysis assay at indicated 
concentrations on isolated erythrocytes from sheep blood samples. Triton X-100 served as positive control 
causing 100% hemoglobin release, while PBS served as negative control (0% hemoglobin release). A 
value < 2% was classified as non-hemolytic, 2 to 5% as slightly hemolytic and a value above 5% as 
hemolytic. (C) Erythrocyte aggregation of isolated erythrocytes from sheep blood samples. PBS served 
as negative control, while BPEI served as positive control. (D) Uptake study of the P30 nanogels and 
DOX (0.01 mg mL-1) on HT-29 cells at 37 °C. Internalization was measured by flow cytometry after 6 h 
(plain column) and 24 h (dashed column). Statistical analysis was performed for the MFI of DOX vs. P30 
nanogels after 6 h and is indicated as * p < 0.05 according to Student’s t-test. Values represent the mean 
± S.D. (n = 3). 
 
To evaluate their biomedical potential, the cellular uptake of P30 was investigated 
against the administration of pure DOX by flow cytometry (Figure 4.6 D) as well as 
CLSM measurements (Figure 4.7) using HT-29 cells. As depicted in Figure 4.6 D both 
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types of supplementation resulted in a rapid cellular internalization as indicated by an 
almost complete uptake (~100% positive cells) within the first 6 h. Nevertheless, P30 
revealed significantly increased MFI values, which increased in time, compared to the 
corresponding free DOX (Figure 4.6 D). These outcomes suggested an increased 
accumulation of the nanogels within the cells, while the reduced uptake of pure DOX 
might be explained by a P-glycoprotein-mediated efflux of DOX, which is a critical 
known phenomenon promoting the multidrug resistance of cancer cells (e.g., breast 
cancer).[140-142] To explore the intracellular fate of the nanogels in more detail, its cellular 
distribution was investigated by live cell imaging. Due to the irreversible labeling of the 
nanogel P30 with Alexafluor 660, the continuous tracking of the drug carrier itself as 
well as the detection of DOX release was possible. Within the first 6 h, P30 were 
primary detected within endo-lysosomal compartments, supporting an energy-
dependent uptake mechanism such as endocytosis (Figure 4.7). In contrast, free DOX 
showed both a diffuse localization within the cytosol but also a co-localization with the 
nucleus. The delayed accumulation of DOX delivered by polymer-based nanocarriers 
within the cell nuclei is in accordance to previous reports and is probably associated to 
its slow release kinetic.[143-144] After 24 h, free DOX is predominantly localized within 
the cell nucleus, thus suggesting either an intercalation into the DNA or a cellular efflux 
of cytoplasmic DOX. P30 revealed DOX fluorescence co-localized with the nucleus 
counterstaining after 24 h, while the nanogel labeling (Alexafluor 660) remained within 
the endo-lysosomes. These findings suggested the partial degradation of the nanogel 
correlated with the gradual release of DOX and the entrance of the drug through the 
nuclear envelope. The weak DOX fluorescence signals of P30 within the nucleus could 
be explained by previous reports describing that the fluorescence of DOX is highly 
dependent on its environment and might be decreased upon intercalation with genetic 
material but could be increased by the incorporation in membranes or micelles.[145-146] 
Nevertheless, both cytotoxicity as well as in vitro uptake studies of P30 confirmed the 
extracellular stability and the intracellular degradation of the nanogels as well as the 
successful release of DOX as prerequisites for in vivo investigations to exploit the EPR 
effect. 
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Figure 4.7. In vitro uptake study of pure DOX and P30 (DOX-loaded nanogels) in HT-29 cells after 6 h 
and 24 h by CLSM. Endo-lysosomal compartments are depicted as green fluorescence signals, cell nuclei 
were counterstained by Hoechst and are depicted in blue. DOX is depicted in red and the nanogel labeling 
(Alexafluor 660) in white.  
 
In vivo studies on male athymic nude mice (Crl:CD1-Foxn1nu) with HT-29 originated 
tumors were performed to test the feasibility of passively targeted nanogels. In 
agreement with the concept of metronomic chemotherapy a relatively low DOX 
concentration (1 mg kg-1) was utilized. In the first stage, the general nanogel 
administration (P30) was verified to be uncritical as no obvious signals of toxicity and 
no adverse effects on the body weight of mice were observed after a single dose 
treatment and a 2-week monitoring. The biodistribution of P30 was investigated at 
different time points including 6, 48 and 72 h after a single dose injection of either P30 
(1 mg kg-1) or a NaCl solution (negative control). Tumor tissue as well as selected 
organs (heart, liver, kidney) were excised and prepared for CLSM investigations (Figure 
4.8). Histological tissue sections of the tumor demonstrated an early accumulation of 
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DOX indicated by an inhomogeneous red fluorescence within the first 6 h that is 
markedly reduced after 48 h and 72 h, respectively. A similar effect, including a high 
accumulation of DOX-containing nanocarriers within tumor tissue followed by a 
clearance within 72 h, was previously reported by Hruby and co-workers.[147] Weak 
traces of DOX were further observed within liver tissue, whereas the fluorescence 
signals increased in time. This indicated an increased accumulation and/or an excretion 
by this organ. Minor traces of DOX were detected in the heart and no DOX signals 
within the kidney, which is in accordance to other studies.[147-149] However, it could be 
assumed that the nanogels predominantly remain within the blood in accordance to 
similar studies.[147] Finally, these outcomes confirmed the concept of passive targeting 
of the nanogels exhibiting average diameters of around 20 nm by the EPR effect. 
 
 
Figure 4.8. Biodistribution of DOX-loaded nanogel P30. Confocal fluorescence images of histological 
tissue sections derived from treated mice at different time points (1 mg kg-1 of P30). The fluorescence of 
DOX is depicted in red.  
 
To investigate the therapeutic approach of P30, xenograft mouse models with HT-29 
originated tumors were treated every third day with specific doses of NaCl (negative 
control), P29, P30 and free DOX according to the metronomic schedule (six doses in 
total within 15 days). As depicted in Figure 4.9 A, P30 was able to delay the tumor 
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growth of nude mice within the time frame of the study compared to the control groups 
(NaCl and P29). These results are supported by the Kaplan-Meier survival plot of the 
HT-29 xenograft models (Figure 4.9 B). The negative controls NaCl and P29 revealed 
the lowest median survival time of 37 days or 24 days, respectively. The median survival 
time of free DOX was marginal higher indicated by 39 days. A reason for this result 
might be the low DOX concentration utilized in the study. However, the administration 
of P30 showed highly promising results indicated by prolonged mice survival time of 
73 days. This superior behavior might be explained by (i) the prolonged blood 
circulation time due the EtOx shielding, (ii) the passive targeting strategy by the EPR 
effect due to the small sizes of spherical structures (diameter < 20 nm) and (iii) the 
effective release within endo-lysosomal compartments leading to a highly effective 
toxicity profile. 
 
 
Figure 4.9. Metronomic treatment of xenograft mouse models with NaCl (negative control), DOX, P29 
(fluorescein-loaded nanogels) as well as P30 (DOX-loaded nanogels). (A) The expansion of the relative 
tumor volume over time after administration. (B) Survival of mice presented as Kaplan-Meier plot. 
Statistical analysis is displayed as *P < 0.05 and **P < 0.01 according to the log-rank test. 
 
In conclusion, the application of self-assembled structures based on grafted comb 
polymers or diblock copolymers represent a promising concept for the efficient delivery 
of various molecules and pharmaceuticals. Dependent on the chemical composition 
nano-sized micelles, vesicular structures and nanogels were obtained by 
nanoprecipitation and/or cross-linking. In particular, the utilization of biodegradable 
(i.e., PLA) as well as stealth polymers (e.g., PEtOx) were shown to be highly suitable 
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for drug delivery confirmed by the high bio- and cytocompatibility in vitro and in vivo. 
Different hydrophobic and hydrophilic molecules were covalently, but reversible, 
attached to the core of the self-assemblies, including fluorescent labels (pyrene, 
fluorescein) as tracer for tracking and imaging purposes as well as drug molecules 
(DOX) for therapeutic approaches. The controlled release of the cargo was triggered by 
pH stimuli within acidic endo-lysosomal compartments either due to degradation 
processes or pH responsiveness. Moreover, the nanocarriers were tunable in size, charge 
and morphology either by the content of PEtOx (micelles) or by the degree of cross-
linking (nanogels), hence determining the cellular internalization.  
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5. Summary 
Polymer-based nanocarriers represent promising tools for the modern nanomedicine as 
they open up new prospects in the diagnosis, prevention and treatment of various 
diseases and disorders. Common drawbacks of conventional medicines, such as poor 
bioavailability, impaired target specificity as well as toxicity and immunogenicity 
issues, can be overcome by the efficient and targeted delivery of therapeutically relevant 
substances by polymeric vectors. Due to the high flexibility in the polymer’s chemical 
composition, the delivery strategy can be tailored individually to the specific demands 
of the substances to be delivered. With regard to the utilization of polymeric 
nanocarriers, a general distinction is made between the delivery of nucleic acids (gene 
delivery) and the delivery of pharmaceutical molecules (drug delivery). Since nucleic 
acids show different physical and chemical characteristics (size, stability, solubility etc.) 
compared to drugs, the type of polymer as well as the delivery and targeting strategy has 
to be customized according to the cargo and the intended purpose. This thesis deals with 
the utilization and evaluation of different polymer classes for the enhanced and targeted 
delivery of different biologically active substances (Figure 5.1).  
 
 
Figure 5.1. Schematic representation of an overview of the investigated polymers for the efficient and 
targeted gene and drug delivery.  
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Besides viral or lipid-based systems, cationic polymers are excellent vectors for the 
delivery of therapeutic nucleic acids. Cationic polymers are favored for the delivery of 
nucleic acids, since they can easily interact with the anionically charged genetic material 
through electrostatic interactions leading to the formation of nano-sized polymer-nucleic 
acid complexes, or so-called polyplexes. In particular, long and circular plasmid DNA 
(pDNA) is efficiently encapsulated by condensation into small and compact structures, 
whereas the complexation of small interfering RNA (siRNA), which only comprise a 
few base pairs, is more challenging due to the intrinsic rigid structure and the low spatial 
charge density. Classical cationic polymers that have successfully been applied for gene 
delivery for several decades are for instance poly(ethylene imine) (PEI) and poly(2-
dimethylamino)ethyl methacrylate (PDMAEMA). Their good delivery performances 
and high transfection efficiencies are attributed to their polyelectrolyte structure 
comprising primary, secondary and/or tertiary amino groups. On the other hand, their 
high charge density is notorious to cause severe cytotoxic effects. This “efficiency-
toxicity” paradox represent a crucial bottleneck and hampers the translation of the 
nanocarrier systems into serious clinical applications. To date, only a few studies 
examined the impact of amino functionalities on the final transfection performance and 
comparative information between such functionalities are still missing. To gain deeper 
knowledge on the polymer’s structure-property relationship on the cellular level, the 
direct comparison of different amino functionalities as well as their influence on the 
overall transfection process was investigated. The reversible addition-fragmentation 
chain-transfer (RAFT) polymerization technique represents an ideal tool for this 
purpose, since it provides the controlled synthesis of well-defined polymers comprising 
primary, secondary and tertiary amino functionalities. A library of linear, well-defined 
homo- and copolymers based on (2-aminoethyl)-methacrylate (AEMA), N-methyl-(2-
aminoethyl)-methacrylate (MAEMA) and N,N-dimethyl-(2-aminoethyl)-methacrylate 
(DMAEMA) monomers was investigated regarding their polyplex formation, cellular 
internalization, endosomal release ability and transfection efficiency. It was found that 
the type and content of the amino functionality clearly determined the gene delivery 
performance of the poly(methacrylate)s. The amino functionalized poly(methacrylate)s 
with a high content of primary amino groups (minimum 40 mol%) revealed superior 
transfection performances over secondary amino groups followed by tertiary amino 
groups. Contrary to the “proton sponge” hypothesis, a high buffer capacity does not 
seem to be the predominant factor for the efficient transfection in vitro. The high 
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efficiency of the poly(methacrylate)s could rather be explained by a strong polymer 
interaction with the vesicular membrane presumably leading to the formation of nano-
holes and, thus, to a successful escape from endosomes. However, this enhanced 
membrane affinity causes severe cytotoxic effects, which could be overcome by the 
introduction of shielding moieties. Beside poly(ethylene glycol) (PEG), poly(2-ethyl-
oxazoline) (PEtOx) reveals the favored stealth behavior and a high biocompatibility as 
well. Hence, PEtOx macromonomers were copolymerized with the methacrylate 
monomers AEMA and MAEMA to generate grafted copolymers. This strategy 
significantly improved the overall cell viability and was able to minimize or even 
eliminate cytotoxic side effects. Nevertheless, the degree of grafting as well as the length 
of PEtOx side chains has to be well balanced to maintain powerful gene delivery vectors, 
since an excessive stealth moiety functionalization bears the risk of impeding the 
transfection efficiency.  
Since this strategy worked well for poly(methacrylate)s, it was decided to extend the 
scope for biocompatible but still highly efficient PEI copolymers. Although PEI remains 
the “gold standard” for transfection so far, major drawbacks like reduced water 
solubility, molar mass-dependent cytotoxicity and non-specific interactions with cellular 
as well as non-cellular components limit its application for biomedical approaches. 
Here, a straightforward strategy is provided to obtain highly functional PEI copolymers 
with beneficial stealth moieties. The partial hydrolysis of PEtOx combined with a post-
polymerization functionalization followed by a thiol-ene photo-addition reaction 
enabled the introduction of functional moieties like primary amino groups or targeting 
ligands within a P(Ox-stat-EI) backbone. A series of copolymers with a constant PEtOx 
content but varying ratios of PEI (secondary amino groups) as well as P(AmButOx) 
(primary amino functionalities) was investigated for non-viral gene delivery. The results 
demonstrate the significance of the polymer design balancing stealth and functional 
moieties to assure high transfection performances. The novel PEI copolymers were able 
to outperform the “gold standard” PEI in terms of pDNA and siRNA delivery under in 
vivo mimicking conditions. With regard to a feasible biomedical application, the 
molecule L-Glutathione was introduced within the structure of PEI copolymers and 
examined as potential candidate for active targeting purposes. The successful passage 
of an artificial blood-brain-barrier (a microfluidically perfused biochip) was 
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demonstrated, which emphasizes the potential of the herein presented polymers for more 
complex transfection approaches including hard-to-transfect cells or tissues. 
In contrast to gene delivery, most drug delivery vectors are composed of biocompatible 
and/or biodegradable polymers, which provide desired demands in terms of biosafety 
and controlled drug release. In particular, polylactic acid (PLA) and poly(lactic-co-
glycolic acid) (PLGA) are the most utilized polymers with these properties. 
Furthermore, PEG and poly(2-oxazoline)s (POx) are utilized to improve the solubility 
of drugs but also to enable a prolongated blood circulation time due to the protein and 
cell repellent effect. Two different concepts of self-assembly were herein demonstrated 
to be highly suitable for the delivery of hydrophobic and hydrophilic molecules: (i) The 
self-assembly of amphiphilic heterografted comb polymers (micelles) comprising 
hydrophilic EtOx moieties and hydrophobic lactic acid (LA) units and, (ii) the core 
cross-linked assembly of diblock copolymers (nanogel) based on a PEtOx and a poly(2-
(4-aminobutyl)-2-oxazoline) (PAmOx) segments. Contrary to gene delivery, the cargo 
was covalently attached to the hydrophobic part of the polymer. In a first approach, 
fluorescent probes including pyrene and fluorescein were successfully loaded into the 
self-assembled structures. The stimuli responsiveness and controlled release of the cargo 
was provoked at acidic pH conditions (e.g., within endosomes) either by the degradation 
of the LA chains or by the pH-responsive imine bonds. The nanocarriers were tunable 
in their size, charge and morphology either by the content of PEtOx (micelles) or by the 
degree of cross-linking (nanogels). Moreover, their small sizes below 30 nm make them 
suitable for passive targeting strategies, in particular for the targeting of tumors by the 
enhanced permeability and retention (EPR) effect. In a proof-of-concept study, PEtOx-
based nanogels were loaded with the chemotherapeutic agent doxorubicin (DOX) and 
evaluated in vitro as well as in vivo in xenograft mice models. The high biocompatibility 
of the drug carrier itself, the specific accumulation of DOX-loaded nanogels within the 
tumor site as well as an efficient drug release demonstrated the safety and feasibility of 
the nanogel for medical application. Noteworthy, the DOX-loaded nanogels 
outperformed the administration of pure DOX in terms of prolonged survival times.  
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In summary, polymer-based drug and gene delivery vectors demonstrate excellent 
prospects for their biomedical utilization. To exploit the full potential of this promising 
technology a fundamental understanding in the chemistry and the structure-property 
relationship of polymers on the molecular as well as cellular level are required. The 
presented work introduced novel multi-component polymers, which represent highly 
versatile systems for both, the delivery of diverse types of nucleic acids as well as 
relevant pharmaceuticals. New insights into polycation-mediated gene delivery were 
gained concerning the influence of amino functionalities and PEtOx stealth properties, 
which could be used to optimize the overall delivery performance. Furthermore, tailor-
made PEtOx-based drug delivery vectors meet critical requirements like biosafety and 
efficacy, thus demonstrating their potential as therapeutic nanomedicines. 
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6. Zusammenfassung 
Polymerbasierte Nanoträgersysteme gelten als vielversprechende Technologie der 
modernen Nanomedizin, da ihre Anwendung neue Perspektiven in der Diagnostik, 
Prävention und Behandlung verschiedenster Erkrankungen schaffen. Gegenüber 
konventionell verabreichten Therapeutika, welche häufig aufgrund einer schlechten 
Bioverfügbarkeit, fehlender Spezifität sowie einer erhöhten Toxizität oder 
Immunogenität nicht den gewünschten Effekt erzielen, sind Polymere in der Lage, 
biologisch aktive Substanzen zuverlässig und zielgerichtet an den gewünschten 
Wirkungsort zu transportieren. Aufgrund der hohen Flexibilität in ihrer chemischen 
Zusammensetzung, können Polymere individuell an die jeweilige zu vermittelnde 
Substanz adaptiert werden. Im Hinblick auf die Anwendung von polymeren 
Nanoträgersystemen wird zwischen dem Transport von Nukleinsäuren (Gentransport) 
und dem Transport von pharmazeutischen Wirkstoffen (Wirkstofftransport) 
unterschieden. Nukleinsäuren weisen im Vergleich zu pharmazeutischen Wirkstoffen 
andere physikalische und chemische Eigenschaften (Größe, Stabilität, Löslichkeit, etc.) 
auf. Daher müssen sowohl das polymerbasierte Trägersystem als auch die 
Transportstrategie auf die jeweilige Zielstellung zugeschnitten werden (Abbildung 6.1). 
 
 
Abbildung 6.1. Schematische Darstellung einer Übersicht der hier untersuchten polymerbasierten 
Nanoträgersysteme für den effizienten und zielgerichteten Transport von therapeutisch relevanten 
Nukleinsäuren und Wirkstoffen. 
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Neben viralen und lipidbasierten Systemen sind kationische Polymere ausgezeichnete 
Trägermaterialien für die Vermittlung von therapeutischen Nukleinsäuren, da sie 
aufgrund von elektrostatischen Wechselwirkungen eine hohe Bindungsaffinität zu dem 
anionisch geladenen, genetischen Material aufweisen. Diese Wechselwirkung führt in 
der Regel zu einer spontanen Bildung von Polymer-Nukleinsäure-Komplexen, den 
sogenannten Polyplexen. Insbesondere Plasmid-DNA (pDNA) kann angesichts ihrer 
Größe und zirkulären Topologie sehr effizient in kleine und kompakte Strukturen 
verpackt werden, wohingegen die Komplexierung von „small interfering“ RNA 
(siRNA) infolge der starren Struktur (< 20 Basenpaare) sowie einer geringeren 
räumlichen Ladungsdichte eine größere Herausforderung darstellt. Poly(ethylenimin) 
(PEI) und Poly(2-dimethylamino)ethylmethacrylat (PDMAEMA) sind klassische 
Beispiele für kationische Polymere, die seit vielen Jahrzehnten erfolgreich für den 
Gentransport in vitro verwendet werden. Die hohe Transfektionseffizienz wird ihren 
Polyelektrolytstrukturen zugeschrieben, welche protonierbare primäre, sekundäre bzw. 
tertiäre Aminofunktionalitäten umfassen. Neben der Bindung und Komplexierung von 
genetischem Material führt die hohe Ladungsdichte zu schweren zytotoxischen 
Nebeneffekten. Das sogenannte „Effizienz-Toxizität“-Paradoxon erschwert die 
Umsetzung dieser polymeren Nanoträgersysteme in potenzielle Medizinprodukte für die 
klinische Anwendung. Bisher gibt es nur wenige Studien, die den Einfluss der 
Aminofunktionalitäten von Polymeren auf deren Transporteffizienz untersuchen oder 
die sich mit dem direkten Vergleich von primären, sekundären und tertiären 
Aminofunktionalitäten befassen. Um die Struktur-Eigenschafts-Beziehung von 
Polymeren auf der zellulären Ebene besser zu verstehen, wurde im Rahmen dieser 
Dissertation der Einfluss verschiedener Aminofunktionalitäten auf den gesamten 
Transfektionsprozess einschließlich Komplexierung, Aufnahme in die Zelle, 
endosomalen Austritt und Genexpression untersucht. Eine Bibliothek aus 
wohldefinierten Homo- und Copolymeren, bestehend aus (2-Aminoethyl)methacrylat 
(AEMA)-, N-Methyl-(2-aminoethyl)methacrylat (MAEMA)-und N,N-Dimethyl-(2-
aminoethyl)methacrylat (DMAEMA)-Monomeren wurde hierzu in vitro getestet. Es 
konnte gezeigt werden, dass eine effiziente und hohe Transfektion entscheidend von der 
Art und Menge der Aminofunktionalität abhängt. Polymethacrylate mit einem hohen 
Anteil an primären Aminogruppen (mindestens 40 Mol-%) erzielten deutlich höhere 
Transfektionsraten als Polymethacrylate mit sekundären oder tertiären Aminogruppen 
in der Seitenkette. Entgegen der gängigen Meinung verdeutlichen diese Ergebnisse, dass 
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eine hohe Pufferkapazität nicht ausschlaggebend für eine hohe Transfektionseffizienz 
von Polymethacrylaten ist. Dies widerspricht zudem der „Protonenschwamm-
Hypothese“, welche häufig als Hauptargument für die erfolgreiche Transfektion von 
kationischen Polymeren vorgebracht wird. Die Ergebnisse lassen die Vermutung zu, 
dass eine starke Wechselwirkung zwischen Polymer und endosomaler Membran für die 
hohe Transfektionseffizienz, insbesondere von Polymethacrylaten mit primären 
Aminofunktionalitäten, verantwortlich ist. Diese ausgeprägten Wechselwirkungen sind 
in der Lage die Membran zu permeabilisieren und den Austritt des Polyplexes aus dem 
Endosom über kleinste Membranöffnungen zu ermöglichen. Diese Membranaktivität 
führte jedoch simultan zu schweren zytotoxischen Effekten. Die Reduzierung solcher 
ungewollten Effekte kann über das Einbringen von biokompatiblen Monomeren mit 
sogenanntem „Stealth“-Effekt in die Polymerstruktur erzielt werden. Neben dem 
bekanntesten Vertreter Poly(ethylenglykol) (PEG) verfügt auch Poly(2-ethyl-oxazolin) 
(PEtOx) über derartige „Stealth“-Eigenschaften. Propfcopolymere, mit einem AEMA- 
bzw. MAEMA-Rückgrat und EtOx-Seitenketten, bestätigten die positive Wirkung der 
„Stealth“-Makromonomere auf die allgemeine Zellviabilität, da zytotoxische Effekte 
stark minimiert oder gänzlich eliminiert werden konnten. Dennoch muss bei 
Anwendung dieser Strategie auf eine angemessene Balance zwischen Kettenlänge und 
Propfgrad der EtOx-Makromonomere geachtet werden. Aufgrund des zell- und 
proteinabweisenden Effekts von „Stealth“-Polymeren kann sowohl die 
Bindungsaffinität zu DNA und Zellmembran als auch der endosomale Austritt 
beeinträchtigt werden und demzufolge zu Einbußen in der Transfektionseffizienz 
führen.  
Die bei Polymethacrylaten erfolgreich eingesetzte Strategie wurde daher auch für PEI 
übertragen, um biokompatible aber dennoch höchst effiziente Copolymere zu erhalten 
und zu untersuchen. Obwohl PEI bis heute als „Goldstandard“ für in vitro 
Transfektionen eingesetzt wird, limitieren wesentliche Nachteile (verringerte 
Wasserlöslichkeit, molmassenabhängige Zytotoxizität, unspezifische 
Wechselwirkungen mit zellulären und nicht-zellulären Bestandteilen) die Anwendung 
als Nanomedizin. In unterschiedlichen Studien wurden bereits eine Reihe von 
Konzepten zur Steigerung der Biokompatibilität von PEI sowie die Herstellung von PEI-
Derivaten vorgestellt. Die partielle Hydrolyse von PEtOx stellt einen besonders 
eleganten Ansatz dar, um funktionelle PEI-Copolymere mit den gewünschten „Stealth“-
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Einheiten zu erhalten. Zudem erlaubt eine weiterführende Post-
Polymerisationsfunktionalisierung inklusive Click-Chemie die Einführung von 
Aminogruppen (primäre Aminogruppen) oder Liganden für den zielgerichteten 
Transport. Die auf Grundlage dieser Synthesestrategie erhaltenen statistischen 
Copolymeren mit einem konstanten Anteil an PEtOx und variierenden Anteilen an PEI 
(sekundäre Amine) sowie PAmButOx (primäre Amine) wurden zellbiologisch 
untersucht. Diese Copolymere zeigten eine sehr gute Wirksamkeit in der Vermittlung 
von pDNA als auch siRNA, und waren in der Lage den „Goldstandard“ PEI unter „in 
vivo“-ähnlichen Bedingungen zu übertreffen. Im Hinblick auf eine mögliche 
biomedizinische Anwendung wurde das Targeting-Molekül L-Glutathion in die Struktur 
von PEI-Copolymeren eingefügt und erfolgreich in einem Blut-Hirn-Schranke-Modell 
(mikrofluidisch perfundierter Biochip) getestet. Die vielversprechenden Ergebnisse des 
zielgerichteten Gentransports unterstreichen das Potenzial dieser Polymere für 
komplexere Fragestellungen, wie beispielsweise schwer zu transfizierenden Zellen oder 
Gewebe.  
Im Gegensatz zum Gentransport werden für den Wirkstofftransport überwiegend 
biokompatible und -abbaubare Polymere verwendet, da diese die gewünschten 
Anforderungen hinsichtlich Biosicherheit und einer kontrollierten Wirkstofffreisetzung 
erfüllen. Zu diesen zählen unter anderem die hydrophoben Polymere Polymilchsäure 
(PLA) und Poly(laktat-co-glykolsäure) (PLGA). Darüber hinaus spielen ebenso 
hydrophile Polymere mit „Stealth“-Eigenschaften, z. B. PEG und Poly(2-oxazoline) 
(POx), eine wichtige Rolle in der Verkapselung von Wirkstoffen. Aufgrund ihrer 
protein- und zellabweisenden Wirkung können u. a. die Bioverfügbarkeit und die 
Pharmakokinetik der Wirkstoffe deutlich verbessert werden. Neben der klassischen 
Verkapselung in Nanopartikeln ist die kovalente Bindung von Wirkstoffen an die 
Polymerstruktur eine effektive Strategie für den Wirkstofftransport. Zwei verschiedene 
Assemblierungskonzepte wurden in dieser Arbeit vorgestellt: (i) Die Assemblierung von 
amphiphilen Kammpolymeren (Mizellen) bestehend aus hydrophilen PEtOx-Einheiten 
und hydrophoben Milchsäureeinheiten, und (ii) die Assemblierung mit anschließender 
kovalenten Vernetzung (Nanogele) eines Diblock-Copolymers bestehend aus einem 
PEtOx- sowie einem Poly(2-(4-aminobutyl)-2-oxazoline) (PAmOx)-Segments. Im 
Gegensatz zu Genträgersystemen, wurde hier der Wirkstoff kovalent, aber dennoch 
reversibel, an das Polymer gebunden. In einem ersten Ansatz wurden 
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Fluoreszenzfarbstoffe (Pyren, Fluorescein) verkapselt. Die Freisetzung der 
Fluoreszenzfarbstoffe erfolgte entweder durch den Abbau der PLA-Ketten oder durch 
Abspaltung der Iminbindungen unter sauren pH-Bedingungen, beispielsweise in 
Endosomen. Weiterhin konnten die Größe, Ladung sowie Morphologie der 
Nanoträgersysteme über den PEtOx-Anteil innerhalb der Mizellen oder durch den 
Vernetzungsgrad der Nanogele angepasst werden. Hinsichtlich der kleinen 
Partikelgröße (Durchmesser kleiner als 30 nm) eignen sich diese Trägersysteme für 
passive Targeting-Strategien, z. B. für das Targeting von Tumoren über den erhöhten 
Permeabilitäts- und Retentionseffekt (EPR). In einer Machbarkeitsstudie („Proof-of-
Concept“) wurden Doxorubicin-beladene (DOX) Nanogele in vitro und in vivo an 
Xenograft-Mausmodellen evaluiert. Die hohe Biokompatibilität des Trägermaterials, 
die spezifische Akkumulation der beladenen Nanogele im Tumorgewebe, die effiziente 
Wirkstofffreisetzung sowie die deutlich verlängerte Überlebensdauer, unterstreichen 
das große Potenzial dieser Systeme für die medizinische Anwendung.  
Zusammenfassend konnte gezeigt werden, dass polymerbasierte Gen- sowie 
Wirkstoffträgersysteme eine vielversprechende Zukunft in der biomedizinischen 
Anwendung bieten. Um das volle Potenzial dieser Technologie auszuschöpfen, ist ein 
grundlegendes Verständnis hinsichtlich der chemischen Komposition und der Struktur-
Eigenschafts-Beziehung des Polymers auf molekularer sowie zellulärer Ebene 
notwendig. In dieser Dissertation wurden neue Mehrkomponenten-Polymere 
vorgestellt, welche alle Voraussetzungen für den Transport von Nukleinsäuren, als auch 
für relevante pharmazeutische Wirkstoffe erfüllen. Es wurden neue Einblicke in den 
Polymer-vermittelten Gentransport hinsichtlich des Einflusses von Amino- und PEtOx-
Funktionalitäten gewonnen, die zur Optimierung der Transfektionseffizienz solcher 
Systeme genutzt werden können. Zudem konnte gezeigt werden, dass maßgeschneiderte 
PEtOx-basierte Wirkstoffträgersysteme die hohen Anforderungen bezüglich 
Biosicherheit und Wirksamkeit erfüllen können. 
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AEMA (2-Aminoethyl)-methacrylate 
AF4  Asymmetric flow field-flow fractionation 
AmOx  2-(4-Aminobutyl)-2-oxazoline 
AmButOx But-3-enyl-2-oxazoline functionalized via thiol-ene click with  
2-aminoethane-1-thiol 
ATRP  Atom transfer radical polymerization 
BBB  Blood-brain barrier 
BPEI  Branched poly(ethylene imine) 
CC50  Half-maximal cytotoxic concentration 
CLSM  Confocal laser scanning microscopy 
CROP  Cationic ring-opening polymerization 
Cryo-TEM Cryogenic transmission electron microscopy 
DG  Degree of grafting 
DLS  Dynamic light scattering 
DMAEMA N,N-Dimethyl-(2-aminoethyl)-methacrylate 
DNA  Deoxyribonucleic acid 
DOX  Doxorubicin 
DP  Degree of polymerization 
EGFP  Enhanced green fluorescence protein 
EI  Ethylene imine 
EMA  European Medicines Agency 
EPR effect Enhanced permeability and retention effect 
EtOx  2-Ethyl-2-oxazoline 
FDA  U. S. Food and Drug Administration 
GSH  L-Glutathione 
HAADF High-angle annular dark-field 
hCMEC Human cerebral microvascular endothelial cells 
HEK-293 Human embryonic kidney 293 
HT-29  Human colorectal adenocarcinoma 
LPEI  Linear poly(ethylene imine) 
MALLS Multi angle laser light scattering 
MAEMA N-Methyl-(2-aminoethyl)-methacrylate 
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MFI  Mean fluorescence intensity 
MOTiF Multi-organ-tissue-flow biochip 
mRNA  Messenger RNA 
NMR  Nuclear magnetic resonance spectroscopy 
N/P ratio Nitrogen (polymer) to phosphate (nucleic acid) ratio 
PAMAM Poly(amidoamine) 
PAEMA Poly(2-amino)ethyl methacrylate 
PCL  Poly(ε-caprolactone) 
PDMAEMA Poly(2-dimethylamino)ethyl methacrylate 
pDNA  Plasmid DNA 
PDI  Polydispersity index 
PEG  Poly(ethylene glycol) 
PEI  Poly(ethylene imine) 
PEtOx  Poly(2-ethyl-2-oxazoline) 
PLA  Poly(lactic acid) 
PLGA  Poly(lactic-co-glycolic acid) 
PLL  Poly(L-lysine) 
PMAEMA Poly(2-methylamino)ethyl methacrylate 
PMeOx Poly(2-methyl-2-oxazoline) 
PMMA Poly(methyl methacrylate) 
POx  Poly(2-oxazoline) 
RAFT  Reversible addition-fragmentation chain-transfer 
RNA  Ribonucleic acid 
ROP  Ring-opening polymerization 
SEC  Size exclusion chromatography 
SIM  Structured illumination microscopy 
siRNA  Small interfering RNA 
STEM  Scanning transmission electron microscopy 
TE  Transfection efficiency 
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The great escape: how cationic polyplexes
overcome the endosomal barrier
Tanja Bus,ab Anja Traeger*ab and Ulrich S. Schubert *ab
The targeted and efficiency-oriented delivery of (therapeutic) nucleic acids raises hope for successful gene
therapy, i.e., for the local and individual treatment of acquired and inherited genetic disorders. Despite
promising achievements in the field of polymer-mediated gene delivery, the efficiency of the non-viral
vectors remains orders of magnitude lower than viral-mediated ones. Several obstacles on the molecular
and cellular level along the gene delivery process were identified, starting from the design and formulation
of the nano-sized carriers up to the targeted release to their site of action. In particular, the efficient
escape from endo-lysosomal compartments was demonstrated to be a major barrier and its exact
mechanism still remains unclear. Different hypotheses and theories of the endosomal escape were
postulated. The most popular one is the so-called ‘‘proton sponge’’ hypothesis, claiming an escape by
rupture of the endosome through osmotic swelling. It was the first effort to explain the excellent
transfection efficiency of poly(ethylene imine). Moreover, it was thought that a unique mechanism based
on the ability to capture protons and to buffer the endosomal pH is the basis of endosomal escape. Recent
theories deal with the direct interaction of the cationic polyplex or free polymer with the exoplasmic lipid
leaflet causing membrane destabilization, permeability or polymer-supported nanoscale hole formation.
Both escape strategies are more related to viral-mediated escape compared to the ‘‘proton sponge’’ effect.
This review addresses the different endosomal release theories and highlights their key mechanism.
Introduction
Non-viral gene delivery based on polymers remains in the focus of
interdisciplinary research activities in macromolecular chemistry,
pharmacy and medicine as well as biotechnology.1–3 Polymers
represent promising delivery vectors as they mimic the gene
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delivery performance of viruses but with additional safety bene-
fits regarding pathogenicity and immunogenicity. Furthermore,
they offer the opportunity for unlimited architecture designs
with high chemical variations, large scale production and simple
storage conditions. The understanding of the vector’s chemistry
as well as their structure–property relationship on the molecular
and cellular level are central issues to evaluate their prospective
biomedical or biotechnological potential. Several strategies or
synthetic approaches for polymer-mediated gene delivery exist
including the chemical conjugation of nucleic acids to the
polymer backbone, electrostatic interactions, encapsulation
and the adsorption onto micro or nano spheres.4 Additionally,
the polymers can be functionalized with targeting ligands, labels
or dyes, shielding domains or endosomolytic units to improve
their biological performance. Depending on the aim of approach
it is possible to target different intracellular localizations, like
the cytoplasm by small interfering RNA (siRNA)5,6 and messenger
RNA (mRNA),7,8 the mitochondria by peptide nucleic acids
(PNA)9–11 or the cell nucleus by plasmid DNA (pDNA).12 Attention
was recently attracted to the power of genome editing systems
(CRISPR/Cas9, zinc-finger nucleases) representing the next
challenge for vector design.13–16 The continuous development
of polymeric structures increases the knowledge of the mecha-
nism of transfection and identify several extra- and intracellular
obstacles.17,18 The most important gene delivery challenges were
defined as (i) nucleic acid packaging and carrier stability to
protect the nucleic acids against enzymatic degradation, (ii) the
internalization mechanism and intracellular pathway, (iii) the
endo-lysosomal escape and the transport to the site of action
and finally, (iv) the release of the cargo from its vector. The
intracellular fate of polyplexes, in particular the endo-lysosomal
pathway, was found to be a critical rate-limiting step determining
the success or failure of gene expression.
The scope of this review comprises the utilization of cationic
polymers for the delivery of nucleic acids by complexation
(polyplexes) with emphasis on the endosomal release as the
main rate-limiting step in gene delivery. The first part covers
a brief historical re´sume´ about the development of cationic
polymers used for nucleic acid delivery and describes the
general delivery process. The main part of this review addresses
the different endosomal release strategies that have been hypo-
thesized and highlights their key mechanism. Finally, the
validity of each theory is discussed in detail based on published
studies and reports.
Cationic polymers in gene delivery
The idea to transport nucleic acids into cells in order to force
the expression of a gene of interest is very ancient.19 Early dis-
coveries in the basics of molecular genetics, the gene transfer
in bacteria and the recombinant DNA technology laid the
foundation for the concept of treating diseases by introducing
therapeutic genes into the organism, the so-called gene therapy.19
Developments in this area have passed severalmilestones, including
early successful transfection of mammalian cells in vitro and in vivo,
the introduction of clinical trials, the completion of the Human
Genome Project, the approval and launch of gene therapy products
such as Glybera, as well as the modern vision of precision nano
medicine.20,21
Historical overview of polymer-based gene delivery
The historical progress in polymer-based gene delivery is depicted
in Fig. 1. The first successful mammalian gene delivery experi-
ments based on polyamines were reported in the early 1960s by
Szybalska and Szybalski using spermine in a phosphate buffer
to transfer DNA.22 Few years later, diethylaminoethyl (DEAE)
dextran was applied for the delivery of viral RNA as well as
DNA.23,24 Due to further progress in mammalian gene delivery
and continuos optimization of transfection protocols, several
other natural and synthetic polycations were investigated in the
following decades including poly(ornithine),25,26 poly(brene),27,28
poly(arginine)25,29 and poly(L-lysine) (PLL).25,30 Thereby, the use
of mammalian DNA and plasmid DNA instead of viral gene
constructs became the focus of research. Due to the high content
of amino groups implicating positive charge densities, poly-
cations were able to bind and condense DNA into small, compact
structures varying in shape and size.31,32 In this context it has
to be mentioned that most of heretofore applied polymers, in
particular PLL, required the supplementation of membrane-
active agents or lysosomotrophic additives within the trans-
fection protocol to promote the endosomal escape of the polyplex
into the cytoplasm and to gain distinguishable gene expressions.
Various substances were successfully utilized including solvents
like DMSO,28,33 weak bases as chloroquine34 and ammonium
chloride33 or glycerol.35 Another strategy to achieve successful
transfection at that date was the conjugation of the polymer with
ligands or fusion peptides.30,36,37 Despite promising results the
transfection efficiency remained relatively low, which led to the
search for alternative polymers with improved performances.
At that time different synthetic polymers with high amino
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group content and pH buffering properties were examined for
gene delivery to avoid the usage of lysosomotrophic additives,
cell targeting or membrane disruptive agents and to simplify
the transfection protocol. In the early 1990s poly(amidoamine)
(PAMAM) dendrimers were successfully applied for pDNA delivery
without the need of additives. The polymer’s performance was
explained by its low pKa values of primary amino groups (pKa = 6.9)
and tertiary amino moieties (pKa = 3.9) responsible for endosomal
buffering properties and lysosomotrophic effects.38 A few years
later, 1995, poly(ethylene imine) (PEI), a polymer applied as
chelating agent or in the paper as well as the paint industry, was
examined for gene delivery.39 As the transfection efficiency of
mammalian cells was markedly improved compared to other
polycations used so far, this contributed largely to today’s ‘‘gold
standard’’ for gene delivery.40,41 Also poly(methacrylate)s with
favorable pH buffering capacities due to different amino
moieties were evaluated. In particular, poly(N,N-dimethyl-
(aminoethyl)methacrylate) (PDMAEMA) revealed enhanced
transfection efficiencies.42–45 Nevertheless, as these systems
suffer from high cytotoxicity, the need for an alternative poly-
mer with improved biocompatibility caused a rise in the design
of new cationic polymers. Over the last 20 years, new generation
of polymer classes were introduced to set a higher standard on
safety and efficiency in gene delivery. The focus was directed
towards biocompatible as well as biodegradable polymers
including modified PEI derivatives,46–48 chitosan and its
derivatives,49–52 cyclodextrins,53–55 poly(amino ester)s,56–58
poly(aspartimide)s59,60 or poly(carbonate)s.61,62 Since 2012,
phosphonium and sulfonium containing macromolecules were
investigated for non-viral gene delivery.63–66 These polymers
revealed DNA binding affinity and low toxicity making them
promising alternatives to nitrogen-based systems. Besides poly-
cations, also zwitterionic-based polymers, including polycarboxy-
betaines (PCB), polyphosphobetaines (PPB) and polysulfobetaines
(PSB), have been investigated in the last years.67–70 Recently,
a zinc coordinated copolymer for non-viral gene delivery was
introduced by Guo and colleagues.71 The non-cationic polymer
demonstrated a high affinity to phosphodiesters in nucleic
acids, mediated by a zinc(II)–dipicolylamine moiety, but also
promising transfection performances due to effective endosomal
release properties as well as GSH triggered DNA release. As shown
in Fig. 1, the development of polymers within the last 50 years
reveals several optimizations, highlights and breakthroughs in
the conception and the chemistry of non-viral gene delivery
vectors. However, the efficiency of such vectors is still moderate
and the search for a new ‘‘gold standard’’ far beyond from being
completed. Continuous efforts and increasing knowledge in this
area will encourage the progress of powerful tools for the delivery
of nucleic acids.
The uptake mechanism of polyplexes
The popularity of cationic polymers for the transfer of nucleic
acids is attributed to the simple formulation of gene carriers.
In general, nucleic acids show a high affinity towards cationic
polymers due to electrostatic interactions. Negatively charged
phosphates within the nucleic acid backbone interact with the
positively charged amino groups within the polymer backbone
or the side chains leading to the spontaneous formation of
polymer–nucleic acid complexes, known as polyplexes. An appro-
priate complexation, in particular the condensation of circular,
large nucleic acids, leads to the formation of nanoscaled struc-
tures masking the charges of the nucleic acids and supporting
the adsorption to the cell membrane followed by internalization.
In principle, the uptake of cationic polyplexes is described by
the process of endocytosis (Fig. 2), whereby the exact pathway
strongly affects the intracellular trafficking of the cargo as well
as the transfection efficiency. Endocytosis depends on various
aspects of the nanocarrier such as its size, the polymer type and
the cell type.72–74 Several studies reported the cellular inter-
nalization of cationic polyplexes by means of clathrin-dependent as
well as independent endocytosis, caveolae-mediated endocytosis
and macropinocytosis.47,75–78
Fig. 1 Polycations and polymers used for gene delivery in the past 50 years.
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The mammalian cell membrane is predominantly composed
of neutral lipids including glyocerophospholipids, sphingolipids
and sterols (mostly cholesterol), which create the typical phos-
pholipid bilayer structure.79 The affinity of cationic polyplexes to
the cell membrane is mostly facilitated by surface glycoproteins,
i.e. anionic proteoglycans, or receptors (if ligands are involved
like transferrin or folate etc.).80,81 After attachment to the plasma
membrane, the invagination of the plasma membrane leads to
the entrapment of the polyplex into membrane-bound vesicles
like coated vesicles, caveosomes or macropinosomes (Fig. 2).
Both, clathrin-dependent as well as clathrin-independent endo-
cytosis will result in the localization of polyplexes within early
endosomes. Within these compartments the pH value quickly
drops from neutral to lower pH values of 6.5 to 6.0 due to
the activity of membrane-incorporated vacuolar-type ATPases
(V-ATPase, proton pump). The early endosomes are directed to
sorting endosomes. From there the content is recycled back
to the extracellular milieu by exocytosis or other intracellular
recycling circuits involving the trans-Golgi network. Apart from
that, the cargo can be directed to the lysosomal pathway for
degradation (Fig. 2). In the latter case, the endosomes will
mature to late endosomes, in which the action of the membrane-
bound V-ATPases will lead to a further decrease in pH value to
approx. 5.5 to 5.0. Late endosomes are, furthermore, able to
fuse with lysosomes, which contain a highly acidic milieu of
pH 5.0 to 4.5 representing optimal conditions for the activity
of degradative enzymes (lysosomal hydrolases). Autophagy is
another lysosomal-mediated degradation pathway, which plays
an important role in the clearance of damaged organelles, mis-
folded proteins as well as invaded foreign substances including
pathogens82,83 or nanomaterials.84–87 Initiated by the formation
of a phagophore, which derived from the endoplasmic reticulum
(ER), maturated autophagosomes fuse with lysosomes to
become an autolysosome responsible for degradation processes.
Autophagy could be induced by nutrient starvation but also by
endosomal membrane damage and, thus, represents a further
barrier against the cytosolic release of polyplexes for successful
gene delivery. However, both events (exocytosis as well as the lyso-
somal pathway) were reported to have a pivotal impact on trans-
fection efficiency and should be overcome by the efficient escape
from these compartments.78,88,89 In contrast to this ‘‘classical’’
pathway, polyplexes that are internalized by caveolae-mediated
Fig. 2 The gene delivery process of cationic polymers including polyplex formation, intracellular uptake via various endocytosis pathways, intracellular
polyplex trafficking, endosomal escape into the cytoplasm, release of the cargo from the polymer and transport to the site of action. Depending on the
type of nucleic acid, the site of action is either located within the cytoplasm or in the nucleus. ER: endoplasmic reticulum; NPC: nuclear pore complex.
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endocytosis are exposed to a neutral pH value within the
caveosomes and, thus, to a less hostile environment (Fig. 2).
By means of microtubules, the caveosomes and their cargo
move on to the Golgi apparatus and the endoplasmic reticulum
(ER).74,90 Nevertheless, caveolae are able to interact with early
endosomes, thus getting involved in acidification processes.91
As the fate of the polyplexes and the related transfection effici-
ency strongly depends on the trafficking route, polyplexes should
escape from endocytic vesicles at an early stage of endocytosis
before intracellular expulsion or enzymatic degradation of the
cargo. After successful endosomal escape, the cargo needs to be
released from its carrier and transported to its site of action
(Fig. 2). However, it is not yet clear if the cargo is completely
released from its vector during the escape process or if the
release occurs in the cytoplasm by means of anionic molecules,
e.g. cytoplasmic RNA and heparin-like glycosaminoglycans,92 or
even in the nucleus. In the case of various RNA types, like siRNA
and miRNA, the release within the cytoplasm is sufficient to
enable interaction with the RNA-induced silencing complex
(RISC) in order to exert their silencing activity. In contrast, pDNA
has to cover a relatively long distance through the cytoplasm to
reach the nucleus. Thereby, a complete release of the nucleic
acid from its vector within the periphery of the cytoplasm leads
to the loss of protection and increases the risk of enzymatic
degradation by nucleases. Furthermore, the motion of the naked
DNA to the nuclear envelope is characterized by Brownian
movement and is thought to be highly inefficient depending
on the site of release as well as the size of DNA. The release of
pDNA or pDNA-based polyplexes in the perinuclear region is
thought to be preferable compared to a release within the outer
cellular regions of dense meshed cytoplasm.93,94 Moreover,
various studies discussed an active motion of dissociated pDNA
or the intact polyplex along microtubules or motor proteins
to the nucleus,94–97 as common for viruses.98,99 Besides the
travelling of pDNA to the nuclear envelope, the nuclear trans-
location represents a further critical barrier towards efficient
gene expression and, is frequently discussed with regard to cell-
division dependency and nuclear pore complex involvement.100–104
Nevertheless, the endosomal release is still seen as the major
bottleneck for the delivery of all types of nucleic acids.105–109
Several reviews outline strategies to overcome the endosomal
entrapment by modifying the vector structure or composition,
including fusogenic ligands, peptides, pH-sensitive polymer
properties or photosensitive agents.37,105,107,110,111 In the following
sections we present and discuss the principles behind the escape
of cationic polymers from endo-lysosomal compartments.
Endosomal escape theories
The proton sponge theory
The ability to act as a ‘‘proton sponge’’ within acidifying endo-
somes was a first attempt to explain the highly efficient trans-
fection performance of PEI.39,40 The original postulated ‘‘proton
sponge’’ hypothesis implies that due to the protonation of the
amino groups within the acidic endosomal lumen, a ‘‘massive
vesicular ATPase-driven proton accumulation followed by passive
chloride influx into endosomes [. . .] should cause osmotic
swelling and subsequent endosome disruption.’’39 To under-
stand this pH-driven release model, one has to understand the
nature of PEI. PEI is a polymers with the highest charge density
due to its polyamine structure consisting of repeating units of
two aliphatic carbons and an amino group, –(CH2–CH2–NH)n–
(43 g mol1). There are two morphologies of PEI, the linear
(lPEI) and the branched (bPEI) form commercially available with a
broad molar mass range from 200 g mol1 to 750000 g mol1
whereas the 25 000 g mol1 PEI is the most utilized one in gene
transfer. Both types are distinguishable by their synthesis and
amino group functionalities.112–116 LPEI bears solely secondary
amino groups in the backbone, while bPEI possess primary,
secondary as well as tertiary amino groups. Based on its
structure, PEI is a weak-base buffering polyelectrolyte revealing
a pH-dependent protonation behavior and charge-driven con-
formational changes.117 Potentiometric titrations and compu-
tational approaches revealed that 50 to 55% of the PEI amino
groups are protonated at physiological conditions independent
of the structure of PEI.118–122 The partially protonation behavior
was explained by the electrostatic repulsion due to the close
vicinity (7 Å distance between two charges) of the amino
groups.17,120,121 According to the pKa value, the highest buffer
capacities of PEI lies between pH 8 and 10, which is attributed
to the secondary amino groups present in both polymer types.
Nevertheless, PEI has a broad buffer capacity from the basic
to the acidic range and show a second maximum at pH 4 to 7
(pKa B 4.5), which explains the buffering capacity in acidic
environments such as within endo-lysosomes.117,120 According
to the ‘‘proton sponge’’ theory (Fig. 3), the remaining amino
functionalities are further able to act as a buffering agent or
so-called ‘‘proton sponge’’ within acidifying endo-lysosomal
compartments. The acidification is achieved by the activity of
the membrane-bound V-ATPase, as described in the section
above. In general, this multi-subunit protein-complex trans-
locate protons across the membrane into the interior of the
vesicle by means of ATP hydrolysis, thus generating a trans-
membrane electrical potential difference.123 Charge compensa-
tion is required to maintain the ATPase pumping activity and
the acidification of the compartments. Counter-ion pathway
like chloride channels (ClC) and transporters mediate the influx
of anions (Cl) or efflux of cations (H+) and, therefore, compen-
sate for the accumulation of protons (see Fig. 2) in the natural
state of the proton pumps.123,124Once, a PEI polyplex is entrapped
within endo-lysosomes, the remaining non-protonated amino
groups are further protonated, thus buffering and delaying the
acidification within the vesicles, which is associated with an
simultaneous influx of chloride ions. Moreover, the volume of
the PEI molecule will be enlarged due to the stronger repulsion
of the intramolecular positively charged amino groups, known
as umbrella effect.40,125 While, the V-ATPases try to maintain the
proton gradient across the membrane as well as the acidification
within the vesicle, the luminal chloride counter-ion concen-
tration rises continuously. The evolving osmotic imbalance is,
consequently, counteracted by the entrance of water. A critical
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membrane tension due to continuous swelling of the endosome
and the expansion of the polymer itself finally results in the
bursting of the endo-lysosomal compartment and the release of
its cargo within the cytoplasm.
The ability of cationic polymers to act as a ‘‘proton sponge’’
was found for several other cationic polymers with high buffer
capacities over a broad pH range (pH 5.0 to 8.0) including
PAMAM38 and PDMAEMA.44 However, the ‘‘proton sponge’’
hypothesis is still highly debated in the scientific community,
as experimental evidence is inconsistent. There are four key
aspects discussed so far: (i) the endosomal buffering effect of
cationic polymers and related to this (ii) the ability to prevent
acidification within endo-lysosomal compartments and to avoid
lysosomal involvement and (iii) the complete rupture or lysis of
endo-lysosomes.
Evidence for the important role of endosomal acidification
and buffering was provided by the study of Kichler et al. using
the V-ATPase inhibitor Bafilomycin A1 that suppresses the
acidification within endosomal compartments and, thus, pre-
vent the protonation of PEI leading to a significant decrease in
gene expression.126 Sonawane and coworkers analyzed the
kinetics of acidification and chloride accumulation in endo-
somes by utilizing dye-labeled cationic polymers sensitive to pH
or chloride ions. They observed a reduced acidification and a
high chloride content within swollen endosomes for the high
buffering polymers PEI and PAMAM.127 Other studies examined
the buffering ability after chemical modification of PEI, e.g. by
quaternization. Quaternized PEI was not able to buffer the
acidification and to escape the endosome before lysosomal
fusion. This clearly demonstrated that buffering is essential
for PEI-mediated transfection.128,129 The poor transfection ability
of PLL was explained by the full protonation of the side chains’
primary amino groups and the absent buffering capacity at a
pH below 8.121,130 Once PLL is entrapped within an endosome
it is unable to buffer the acidification and to escape the hostile
environment in a time-efficient manner to avoid an enzymatic
degradation in the lysosomes. Another reason was associated to
its tight DNA binding and the highly stable polyplex formation,
showing weak polyplex dissociation by intracellular compe-
titors required to release the nucleic acid.130–133 Strategies for
PLL-based delivery were based on the conjugation of functional
moieties to the PLL backbone such as histidine, imidazole,
transferrin or membrane-disruptive peptides providing the
missing buffering capacities or an active membrane lysis
mechanism to gain efficient release.134–137 Besides chemical
modification, the supplementation of chloroquine resulted in a
significant enhancement of PLL’s transfection efficiency as
well.128,138 The mode of action of chloroquine (pKa values of
8.1 and 10.2)139 was discussed to be a multi-step mechanism
characterized by (i) an increased accumulation within acidic
compartments and its entrapment after protonation, (ii) the
buffering of the vesicles to promote escape and to prevent
lysosomal degradation, (iii) the interaction with the endosomal
membrane leading to membrane permeabilization and (iv) the
dissociation of polyplexes and the direct interaction with the
unpacked nucleic acids.34,138,140 Recently, it was also demonstrated
that a chloroquine analogue with a fluorine atom instead of the
7-Cl atom revealed ten times higher transfection efficiencies,
thus making it a powerful alternative to chloroquine.140
The good performances of PAMAM (pKa 3 to 6) and
PDMAEMA (pKaB 7.5) were also referred to the excellent buffer
capacities of tertiary amino groups within the polymer structures.
However, in the direct comparison to PEI, PDMAEMA reveal a
five to ten fold lower endosomal escape as well as transfection
efficiency.141–143 This was explained by the fact that PEI revealed
a higher buffering capacity as well as a stronger interaction with
membranes.141,144 An explanation for a weaker membrane
interaction might be the decrease in size of PDMAEMA-based
Fig. 3 Illustration of the ‘‘proton sponge’’ hypothesis. The cationic polyplex is located within an endo-lysosomes and will be further protonated due to its
buffering capacity in the acidic lumen. Due to the high activity of the membrane-bound V-ATPase the enhanced influx of chloride ions causes an osmotic
imbalance (I). This concentration gradient is counteracted by the entrance of water resulting in the swelling of the endo-lysosomal compartment (II) and
finally to the endosomal burst and release of carrier and cargo (III).
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polyplexes at low pH value, whereas PEI-polyplexes revealed
swollen structures at similar conditions.145 Furthermore, it was
shown that PDMAEMA was unable to physically disrupt the
endosomal membrane.146 Funhoff et al. aimed to enhance
the buffering capacity and, therefore, the endosomal escape
of PDMAEMA by the conjugation of two tertiary amino groups
per monomer unit.147 This polymer had two pKa values, one at
pH 5.5 providing buffering capability at low pH as well as a
second at pH 9.3 providing DNA binding and condensation
properties. Despite its promising structure, the polymer did not
achieve adequate transfection efficiencies and it was concluded
that the ‘‘proton sponge’’ effect was not valid for this kind
of polymer. Since poly(methacrylate)s provides the structural
versatility of different amino moieties, they are preferable model
systems to investigate the influence of primary, secondary and
tertiary amino groups on the delivery performance. There are
several studies dealing with the direct comparison of the differ-
ent amino functionalities.148–151 Interestingly, it was shown that
homo- and copolymers bearing a higher content of primary
amino groups led to the highest transfection efficiency com-
pared to polymers with tertiary amino groups.148,152 Based on
their results the authors challenged a direct correlation between
buffer capacity and transfection efficiency.142,148,152 Despite
tertiary amino groups with pKa values close to endo-lysosomal pH,
also PAMAM dendrimers showed much less proton buffering
capacities as well as reduced transfection efficiencies compared
to PEI.153 Native PAMAM dendrimers of higher generations were
found to be unsuccessful in endosomal release, whereas the
insertion of additional functional groups enhanced the trans-
fection efficiency due to improved buffering capacity.153–155
Based on these outcomes we can conclude that different poly-
mers bearing the same amino type, do not necessarily share
the same H+ absorbing ability. Titration studies demonstrated
different protonation behavior between polymers and its corre-
sponding monomers, as polymers showed slightly lower pKa
values.17,44,148,156 Thus, indicating a strong influence of the
chemical structure (amine spacing) on protonation. Therefore,
the prediction of a polymer’s escape and transfection perfor-
mance based on the type of amino functionalities and the
buffering capacity is not reliable.
Other doubts in the ‘‘proton sponge’’ hypothesis focused
on the ability of polymers to prevent the acidification of endo-
somes and a lysosomal involvement. Previous publications
interpreted this effect as an increase in pH value or almost
neutralization.41,127,157 The pH value of polyplex-containing
endosomal vesicles were analyzed by labeling either the poly-
mer or the nucleic acid with pH-sensitive fluorophores, or
utilizing dyes selective for acidic organelles.97,120,138Most findings
revealed an initial pH value decrease in endocytic vesicles
bearing PEI polyplexes (pH B 6) indicating their localization
within early endosomes.128,138 These findings indicate that PEI
is able to delay the acidification but not to increase the luminal
pH. The intracellular fate of PEI polyplexes evokes the question
whether PEI acts only within endosomes or also within lyso-
somes. Godbey et al. and Akinc et al. reported a lack of lysosomal
involvement in PEI-polyplex trafficking.128,158 On the other side,
subcellular fractioning by Lecocq as well as Klemm and
coworkers revealed the accumulation of the polymer within
lysosomal compartments.159,160 Lysosomal involvement of PEI-
polyplexes was further shown by the research of Kulkarni and
colleagues as well as Benjaminsen et al. using pH-sensitive
fluorophores to track PEI polyplexes within the endocytic path-
ways.120,161 They did not recognize a change in the lysosomal
pH value, thus concluding that the proton sponge might not
be the dominating mechanism for endo-lysosomal release.120
Lazebnik and Pack quantitatively determined the endocytic
trafficking of PEI-siRNA polyplexes by a self-developed method
based on a simple polymerization technique combined with a
subcellular fractioning method.162 The authors observed that
PEI polyplexes initially appeared in early endosomes and moved
further to other compartments, like late endosomes and lyso-
somes within the first 30 min of post-transfection. The largest
amounts of polyplexes were detected in lysosomes one hour post-
transfection. An explanation for the inconsistencies of the final
intracellular distribution of polyplexes (early/late endosomes,
lysosomes) might be explained by the complexity of the uptake
mechanism for cationic gene delivery vehicles. Rejman and
colleagues as well as Van der Aa et al. investigated the uptake
mechanisms of PEI polyplexes and observed that the polyplexes
were mainly internalized by two types of endocytosis. PEI-based
polyplexes that were internalized via clathrin-mediated endo-
cytosis, were mostly found within lysosomes but lead to poor
transfection efficiencies probably due to degradation.75,163
No lysosomal co-localization of polyplexes was observed by
caveolae-mediated endocytosis, which, results in high gene
expression.75,77 It was shown that lysosomes could be involved
in the trafficking of polyplexes but its consequence on trans-
fection performance has to be examined individually for each
polymer to be used. Hence, it has to be kept in mind that the
internalization route of cationic polyplexes or nano-carriers is
highly cell type dependent and may vary between different cell
lines but also polymer type.17,74,78,138,164
The most discussed part of the ‘‘proton sponge’’ hypothesis
is the lysis or the complete rupture of the endo-lysosomal
membrane. It was questioned whether the binding of protons
by PEI within the endosome is sufficient enough to cause an
osmotic gradient against the V-ATPase activity. Thus, a critical
PEI concentration was assessed to be necessary to achieve a
critical membrane tension strong enough for rupture.120,165,166
In mathematical calculations and computational modeling studies
it was shown that the osmotic pressure, generated by the pH
value drop from 7.4 to 5.0 as well as the protonation of the
cationic polymer is insufficient for an endosomal membrane
rupture.17,120 The expansion of membrane during swelling,
which was calculated to be approx. 1 to 2%, do not reach the
critical area expansion of lipid vesicles (2 to 5% strain167) at which
the membrane integrity gets lost.17,120 This result indicated that
a complete physically rupture is highly unlikely. Electron micro-
scopy investigations by Bieber et al. demonstrated the attach-
ment of PEI aggregates with the inner side of the lysosomal
membrane causing partial membrane disruptions.168 Similar
observations were made in other TEM imaging studies analyzing
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the trafficking of polyplexes based on PEI, cyclodextran or
poly(methacrylate)s.152,169,170 They typically showed a close
vicinity of the polyplex to the endo-lysosomal membrane and
local membrane deformations and disruptions. Live cell spinning
disk confocal microscopy was further utilized to capture the
dynamics in endosomal release and observed a release of
nucleic acids within the cytoplasm by a transient local burst
or through nanoscale holes.171 Interestingly, the endosomes
remained intact after the escape event and no complete endo-
somal lysis was observed. Summarizing these results, a local
destabilization of the endosomal membrane integrity, which
lead to a transient nanoscale hole formation, might explain the
endosomal release.171 Although several literature reports describe
this phenomenon as ‘‘pore formation’’, we will continue to speak of
‘‘nanoscale hole formation’’ in order to avoid misunderstandings
regarding protein-formed membrane pores mediating the passage
of small molecules and ions.172
The polyplex-mediated membrane disruption
As a consequence, a new endosomal escape concept was
proposed. In brief, the endosomal escape is mediated by a
direct charge-driven polyplex–membrane interaction leading to
local membrane destabilization, permeability or even nano-
scale hole formation from where the polyplex can be released
into the cytoplasm (Fig. 4).108,168,171,173 A key characteristic is
that the endo-lysosomal compartment is kept intact during and
after escape compared to a complete lysis as suggested in the
‘‘proton sponge’’ hypothesis.
PEI and other amino-containing polymers provoke membrane
damage or at worst cell lysis as indicated by various cytotoxicity
studies.174,175 These disruptive properties of polymers were also
thought to be beneficial for transfection, thus generating an
optimal balance between cytotoxicity and transfection efficiency.
The principles of polymer–membrane interactions were funda-
mentally elucidated by the work of Banaszak Holl.108,176,177 His
group investigated a broad range of cationic polymers including
PEI, PLL and PAMAM dendrimers and evaluated membrane
damages or permeability of artificial lipid bilayers or cellular
membranes by atomic force microscopy (AFM), enzymatic or
protein leakage assays and flow cytometry experiments.177–179
Different degrees of membrane damages like membrane thinning
due to lipid reorientation or lipid removal, and transient mem-
brane hole formation were identified, which was influenced by the
polymer molar mass, charge density and concentration.176,179–181
Interestingly, nanoscale membrane holes induced the leakage of
intracellular molecules or dyes,178,179 but did neither facilitate the
cellular entry of polyplexes nor gene expression.182 Since auto-
phagy can be triggered by endosomal membrane damage,183,184 a
direct evidence for polyplex-mediated membrane disruption or
nanoscale hole formation could be given by the detection of
autophagy markers. Different studies described the utilization
of fluorophore-tagged microtubule-associated protein 1 light
chain 3 (LC3), galectin-8 (Gal8) and galectin-9 (Gal9) markers to
assay endosomal escape and membrane damage, caused by non-
viral gene delivery vectors, in real-time by live cell imaging.85,87,185
The charge-driven polymer–membrane interaction within
membrane vesicles, as a key aspect of this theory, can be
explained by the composition of the inner leaflet of the endo-
lysosomal membrane. The membrane structure of early endo-
somes is rather similar to the plasma membrane and mainly
composed of neutral lipids (sphingolipids, sterols, etc.). During
the maturation to late endosomes the lipid composition changes
Fig. 4 Illustration of the polyplex-mediated escape theory. Once entrapped within an endo-lysosomal compartment, the cationic polyplexes will be
protonated due to the activity of the membrane-bound ATPases. The polyplex with increasing charge density directly interacts with the anionic
(phospho)lipids of the inner membrane leaflet. This interaction leads to membrane destabilization and to a local loss of membrane integrity, thus forming
nanoscale holes within the membrane. The vector is able to escape the endo-lysosomal compartment through these holes. The compartment keeps
intact and complete lysis or rupture does not occur.
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towards anionic lipids as the amount of sterols decreases and
the amount of anionic bis(monocylglycero)phosphate (BMP)
increases.79 Thus, cationic polymers with continuously increasing
charge density will preferably interact with this kind of lipids
due to electrostatically interactions as well as hydrogen bonding
between the amino groups of the polymer and the phosphate
groups of the lipids. Experimental and simulations studies
reported that the interaction of PEI with anionic lipids enabled
the polymer to intercalate into the hydrophobic core of the
membrane bilayer, thus enhancing anionic lipid translocation
(lipid ‘‘flip-flop’’) and facilitating the transport of charged mole-
cules (nucleic acids) across the membrane.186,187
The polymer-mediated membrane disruption
On the basis of the above introduced theory a revised version
was developed, which explains the endosomal escape of
cationic polymeric vectors by the intercalation of free cationic
polymer chains into the endosomal membrane.108 As depicted
in Fig. 5 the free polymer interacts with the membrane in
terms of a ‘‘carpet structure’’ or polymer-supported membrane
holes, thus, causing defects in the lipid layer, which leads to
the leakage of molecules or nanosized particles. It was hypo-
thesized that the dynamic equilibrium between dissociated
polymer chains and polyplexes represents an essential mecha-
nism behind this theory. It is assumed that the free polymer
can already intercalate into the cell plasma membrane before
endocytosis. Additionally, it is thought that the cell is unable
to clear the polymer from the plasma membrane. Hence,
the polymer keeps circulating in the membrane during the
entire endocytosis and endosomal maturation process leading
to membrane disintegration and supporting the subsequent
membrane permeability or nanoscale hole formation through
which the polyplex and/or nucleic acid can escape.108,188 This
model may also explain cytotoxic effects of cationic polymers, in
particular of PEI, which was found to permeabilize lipid mem-
branes of mitochondria or the endoplasmic reticulum.189,190
Evidence for a positive effect of free polymer chains on the
transfection efficiency was previously reported by different
research groups.154,188,191–194 The authors observed that the
addition of uncomplexed PEI, independent of the timing,
significantly increased the transfection efficiency compared to
the standard protocol of polyplex-mediated transfection.154,192
It was also shown that the chain length play a more essential
role for the enhancement of transfection than the chain
topology.195 Wu and colleagues hypothesized that free
polymer chains are able to interfere with signal proteins
(SNARE) on the inner cell membrane before or during endo-
cytosis, thus, disturbing the fusion of endocytic vesicles with
lysosomes.195,196
The excess of polymer during polyplex preparation indicated
by high N/P ratios is thought to be beneficial for high trans-
fection efficiencies. This was explained by the fact that only a
small amount of PEI is sufficient for complex formation,
whereas the majority of PEI (B70 to 80%) stays free in solution
promoting the internalization and intracellular trafficking of the
polyplexes independent of the molar mass.191,197,198 Detailed
studies on RNA-based polyplexes observed a rapid exchange
between polyplexes of different sizes, free polymer and dissociated
nucleic acids. Based on this a model of dynamic equilibrium was
proposed, which describes the interplay of nucleic acid release
and its protection from nuclease degradation as vital issue for
successful escape and transfection.199
Fig. 5 Graphical illustration of the free polymer-mediated escape theory based on the dynamic release and reattachment of polymer chains as well as
nucleic acids to the polyplexes. Free polymer chains intercalate within the membrane of endo-lysosomal compartments, which leads to membrane
destabilization and to a local loss of membrane integrity. The polyplex escape the endo-lysosomal compartment through the polymer-supported holes
within the membrane. The compartment keeps intact and complete lysis or rupture does not occur.
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This theory is further supported by the work of Clark et al.
using a simplified model of monolayers and vesicles consisting
of a mixture of neutral and negative lipids (1,2-dipalmitoyl-
phosphatidylcholine and bis(monoacylglycero)phosphate) to
examine the interactions of PEI.200 The authors observed that
the adsorption of free PEI molecules causes deformation and
permeabilization of vesicles resulting in the transmembranal
diffusion of large molecules (Alexafluor dye) without a rupture
of the vesicle. Quantitative analysis by patch clamp measure-
ments of whole HEK cells elucidated a polymer-supported lipid
intercalation (carpet structure) or nanoscale hole formation
within the plasma membrane caused rather by free polymers
than by polyplexes.201 The behavior of polyelectrolytes, such as
PEI, may provide an adequate explanation during the discussed
progress. Detailed studies on the polyelectrolyte state of PEI in
dependency of different salt and pH conditions revealed con-
formational changes at different protonation states.117,202 At
neutral pH value, PEI exhibits a more coiled or aggregated
structure and predominately settles itself at the bilayer water
interface, which do not cause disruption or hole formation.
With decreasing pH value, PEI becomes elongated due to the
electrostatic repulsion between charges of the protonated amino
groups. Because of multiple cationic moieties within the polymer
chains a polar environment is created, which provides optimal
conditions for water molecules to pass through the lipid bilayer.
Thus, the strong interaction and penetration of polymer chains
through the membrane leads to the formation of (water) channels
or nanoscale holes.203
Summary and concluding remarks
Cationic polymers used for the delivery of nucleic acids have to
overcome several biological barriers to finally achieve their
assignment. In particular, the escape from endo-lysosomal
compartments was found to be a major critical step in this
process. Once entrapped within the endocytosis pathway only
a minority of delivery vectors (r1 to 2% or two to five bursts
per cell) will overcome the endo-lysosomal barrier.171,204,205
Interestingly, this seems to be sufficient for the transfection
to be efficient. The remaining fraction is destined for recycling
pathways (exocytosis) or enzymatic degradation (lysosome).
To exploit the full potential of this promising technology we
have to gain a deeper understanding in the chemistry and the
property-relationship of polyplexes on the molecular as well
as on the cellular level, since several essential information are
Table 1 Summary of endosomal escape strategies of cationic polymers and polyplexes
Endosomal strategy Key aspects of mechanism Studies/methods supporting the theory
‘‘Proton sponge’’ effect39,40 Inhibition of endo-lysosomal acidification by bafilomycin A1treatment significantly decreases transfection efficiency.126,128
(I) Protonation of polymers’ amino groups in acidic
endo-lysosomal compartment leads to enhanced
chloride ion influx.
Quantitatively measurement of chloride ion accumulation and
acidification within endosomes by pH-sensing fluorescent
probes.127
(II) Osmotic imbalance causes water entrance and
swelling of endo-lysosomal compartment.
(III) Endo-lysosomal membrane rupture or lysis.
Chemical modifications of amino functionalities of PEI directly
influenced transfection efficiency due to alterations in the
buffering capacity of the polymer.128,129
Chloroquine treatment enhances transfection efficiency of PLL,
PLL-conjugates and DEAE dextran, but not of PEI.34,128,137,138
Polyplex-mediated membrane permeability and
nanoscale hole formation18,171
Qualitatively and quantitatively polyplex and pH tracking by
confocal laser scanning microscopy and flow cytometry using
pH-sensitive fluorophores.120,138,161
(I) Time-dependent protonation of amino groups in
acidic endo-lysosomal compartment.
Polymer–membrane interaction of lipid bilayers by
AFM.178–180
(II) Charge-driven interaction of polyplex with endo-
lysosomal membrane.
Quantifying endo-lysosomal disruption by calcein
assay.206
(III) Membrane disintegration, permeability and local
hole formation. Endo-lysosomes remain intact.
Assaying endo-lysosomal disruption by LC3- and Gal8-
autophagy markers via live cell imaging.85,87,185
Qualitatively detection of local membrane disruption by
TEM imaging and live cell spinning disk confocal
microscopy.168,169,171
Computational modeling support polymer–membrane
interactions.203,207
Free polymer-mediated membrane permeability and
nanoscale hole formation108
Enhanced gene expression by the supplementation of free
polymer to standard transfection protocol.191–193
(I) Dynamic release and reattachment of polymer
chains and nucleic acid to polyplex.
Quantification of the cell membrane permeability by cationic
polymers via (whole-cell) patch clamp.201
(II) Free polymer chains intercalate in the plasma
membrane or the membrane of endo-lysosomes.
(III) Membrane disintegration by polymer intercalation or
by polymer-supported hole formation. Endo-lysosomes
Quantification of the endo-lysosomal membrane disruption
by calcein assay.194 Membrane disruption through polymer
interaction by dye, LDH and hemolysis leakage
assay.174,175,178,194
remain intact. Feasible mechanism for nuclear entry. Qualitatively tracking of intact and cleaved nucleic acid by
FRET confocal microscopy and FRET flow cytometry.154
Computational modeling support polymer–membrane
interactions.203
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still missing.17 If we know the key parameters for an efficient
release, we can adapt strategies for the design of more powerful
delivery vectors. During the past decades numerous studies were
performed to explore the polyplex release mechanism. Thereby,
a wide range of methods and techniques help to examine the
performance and efficiency of the release.109 The greatest knowl-
edge on the endosomal release of cationic polymers was gained
by the investigations of PEI-based polyplexes. Fewer insights on
the release mechanism of other cationic polymers have been
achieved with PLL, PDMAEMA or PAMAM. The most commonly
discussed escape strategies based on the polymers mentioned
above are summarized in Table 1. The ‘‘proton sponge’’ hypo-
thesis was the first attempt to explain the excellent gene delivery
performance of polymers with a high amino group content.
Based on the protonation of the amino groups within the acidic
endosomal lumen, it was thought that an osmotic imbalance
causes membrane swelling and, finally, the rupture of the vesicle
membrane. Nowadays, this theory is still popular and frequently
used to explain the efficiency of new transfection vectors. Never-
theless, this hypothesis needs to be revised due to the lack of vital
experimental data and various counterevidence. In particular, the
endosomal membrane rupture or lysis was found to be highly
improbable and was more or less disproved so far. Probably all
amino-containing polymers will act as a ‘‘proton sponge’’ by
capturing a high number of protons, but the general endosomal
escape will not be triggered by a complete membrane rupture.
Undoubtedly, pKa values and high buffer capacities in the range
of physiological and lysosomal pH value are important, but
do not seem to be the predominant parameter for an efficient
endosomal escape of polyplexes. It seems more likely that the
charge-driven direct interaction of polyplexes or free polymer
chains with the endosomal membrane leads to membrane
disintegration, permeability or nanoscale hole formation. But
in particular, the dynamic interplay between complexed and free
polymer might be the secret of success for efficient polymer-
mediated gene delivery. Thus, the underlying mechanism rather
resembles a virus-mediated escape due to the similarity in mem-
brane interaction andwould not be as unique as previously thought.
The viral vector escape mechanism was shown to be driven by the
pH-dependent conformational or hydrophobicity change of pep-
tides leading to the piercing of the vesicular membrane followed by
fusion with the viral vector or membrane disruption.
Finally, we can conclude that several aspects have an essential
impact on the overall endosomal escape of polymer-based vectors.
These include (i) the polymer composition with type and content of
amino functionalities, (ii) the cell type-specific internalization path-
way and (iii) the polymer-specific interaction with lipid bilayers.
However, there is no single truth regarding the cellular gene
delivery mechanism covering all types of polymers. Consequently,
the endosomal escape mechanism must be considered separately
for each polymer to optimize its efficiency.
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ABSTRACT: Methacrylate-based polymers represent promising
nonviral gene delivery vectors, since they oﬀer a large variety of
polymer architectures and functionalities, which are beneﬁcial for
speciﬁc demands in gene delivery. In combination with controlled
radical polymerization techniques, such as the reversible addition−
fragmentation chain transfer polymerization, the synthesis of well-
deﬁned polymers is possible. In this study we prepared a library of
deﬁned linear polymers based on (2-aminoethyl)-methacrylate
(AEMA), N-methyl-(2-aminoethyl)-methacrylate (MAEMA), and
N,N-dimethyl-(2-aminoethyl)-methacrylate (DMAEMA) mono-
mers, bearing pendant primary, secondary, and tertiary amino
groups, and investigated the inﬂuence of the substitution pattern on
their gene delivery capability. The polymers and the corresponding
plasmid DNA complexes were investigated regarding their
physicochemical characteristics, cytocompatibility, and transfection performance. The nonviral transfection by methacrylate-
based polyplexes diﬀers signiﬁcantly from poly(ethylene imine)-based polyplexes, as a successful transfection is not aﬀected by
the buﬀer capacity. We observed that polyplexes containing a high content of primary amino groups (AEMA) oﬀered the highest
transfection eﬃciency, whereas polyplexes bearing tertiary amino groups (DMAEMA) exhibited the lowest transfection
eﬃciency. Further insights into the uptake and release mechanisms could be identiﬁed by ﬂuorescence and transmission electron
microscopy, emphasizing the theory of membrane-pore formation for the time-eﬃcient endosomal release of methacrylate-based
vectors.
■ INTRODUCTION
In the last century the intensive research on major human
diseases has shown that a wide variety of diseases originate
from dysfunction in protein expression. With the increasing
knowledge about gene regulation and the role of RNA,
personalized therapies on the basis of nucleic acids became
feasible. Due to the instability of naked nucleic acids against
nucleases and the limited direct cellular uptake,1 the use of
delivery systems, called vectors, is essential for eﬃcient
therapeutic approaches. Besides viral vectors, synthetic systems
gain increasing attention in the ﬁeld of gene delivery. Despite
the high transfection eﬃciency of viral gene delivery vectors,2
the potential immune response on the natural viral proteins, the
limitations in the size of the DNA and the diﬃculties in the
scale-up of these systems make nonviral systems more
favorable.3 In accordance, the structures and eﬃciencies of
polymeric delivery systems have constantly been improved,
since the ﬁrst polycation-mediated transfection in 19654 and
the ﬁrst polymer-targeted gene delivery in the late 1980s were
introduced.5,6 Diﬀerent bottlenecks during the transfection
processes have been described so far.7 Thereby, a high molar
mass, the presence of cationic charges, as well as a buﬀering
capacity at low pH values were discussed to be beneﬁcial for (i)
the formation of the polymer/nucleic acid complex, (ii) the
attachment of this complex to cellular membranes and the
associated uptake by endocytosis, as well as (iii) the endosomal
escape and dissociation of the cargo from the polymer. To date,
linear poly(ethylene imine) (lPEI) represents the most
frequently applied and most eﬃcient polymer for gene delivery.
The secondary amino groups along the backbone are partially
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protonated at physiological conditions, which enable the
binding of nucleic acids and the buﬀering of acidifying
endosomes as postulated by the popular “proton sponge”
hypothesis.8,9 This theory describes a potential escape strategy
from endolysosomes by the increase of the charge density due
to further protonation leading to an enhanced inﬂux of chloride
ions and water. Consequently, the increasing osmotic pressure
causes the rupture of the endosomal membrane and, hence, the
release of the vector within the cytsoplasm. Besides lPEI, which
comprises mainly secondary amino groups, other materials and
amino functionalities have been studied regarding their
transfection performance including polymers like poly(L-lysine)
(PLL, primary amino groups), poly(N,N-dimethyl(aminoethyl)
methacrylate) (PDMAEMA, tertiary amino groups), and
branched PEI (bPEI, primary, secondary, and tertiary amino
groups). To gain deeper insight into the impact of the diﬀerent
amino functionalities it is important to investigate the
transfection performance with deﬁned polymer architectures.
As a consequence, the reversible addition−fragmentation chain
transfer polymerization technique (RAFT), which tolerates a
wide range of functional groups and enables the controlled
synthesis of well-deﬁned structures, represents a promising tool
in polymer-based gene delivery.10,11 In particular, the structural
versatility of methacrylate-based polymers allows the introduc-
tion of all mentioned diﬀerent amino moieties into a similar
polymer structure and, thus, a direct comparison of the impact
of primary, secondary, and tertiary amino groups. So far, only a
few studies investigated the inﬂuence of this degree of
substitution on the ﬁnal transfection eﬃciency. Primary,
secondary, as well as tertiary amino groups were studied
separately on polymer structure and functionality use by groups
such as Reineke and co-workers as well as by Zhu et al.12−14
Palermo et al. revealed that primary and tertiary amino groups
in methacrylate-based copolymers complex the phosphate head
groups of an artiﬁcial lipid bilayer, showing higher membrane
internalization of the primary amino groups.15 This theory is
supported by earlier ﬁndings of disruptive peptides, which
evolve into the membrane to create pathways for other
molecules to escape into the cytosol.16−18 Nevertheless, a
thorough comparison of structurally similar polymers compris-
ing primary, secondary, and tertiary amino groups is still
missing. To the best of our knowledge, previous reports
included either additional functional domains or monomers, or
lack at least one of the structural amino varieties.
Within this study we focused on the controlled RAFT
synthesis of 2-(N,N-dimethylamino)ethyl methacrylate, N-
methyl-N-tert-butyloxycarbonyl-(2-aminoethyl)-methacrylate
(BocMAEMA), and N-tert-butyloxycarbonyl-(2-aminoethyl)-
methacrylate (BocAEMA) to create a library of linear statistical
homo- and copolymers with varying amino functionalities.
Based on this library, we were able to investigate the inﬂuence
of diﬀerent compositions of primary, secondary, and tertiary
amino groups in linear polymers on the transfection perform-
ance and to elucidate an optimal polymer composition. The
polymers were characterized regarding their polyplex for-
mation, cytocompatibility, and their extra- and intracellular fate
focusing on uptake and endosomal release.
■ RESULTS AND DISCUSSION
Polymer Preparation and Characterization. To system-
atically investigate the inﬂuence of secondary amino groups in
combination with primary and tertiary amino groups on the
transfection eﬃciency, a library of linear statistical polymers was
synthesized via RAFT polymerization.10,19 The direct polymer-
ization of AEMA with MAEMA and/or DMAEMA led to
hydrogels during the polymerization process. This side reaction
is probably caused by the basic eﬀect of the amino groups
containing methacrylate monomers, which resulted in the
aminolysis of the esters or the RAFT group. The cycling or
branching reaction induced by the aminolysis of the
methacrylate ester unit was previously described and is
commonly used for cross-linking of polymers.20 Another
possible reason for the gel formation might be the aminolysis
of the RAFT end group causing intermolecular disulﬁde
bridges.21−23 Therefore, BocAEMA and BocMAEMA were
synthesized starting with the Boc-protection of the correspond-
ing ethanolamine according to literature reports.24−27
Due to the Boc-protection of the primary and secondary
amino groups during synthesis, the hydrogel formation can be
avoided during the polymerization process. The polymerization
was performed in DMF at 70 °C for 40 h with a M/CTA feed
of 240, with a CTA/I ratio of 4 and monomer ratios of the
copolymers or terpolymers of 50:50 or 1/3, respectively
(Scheme 1). The kinetics of the co- and terpolymerization
revealed a controlled polymerization with narrow dispersity and
a statistical distribution of the monomers (see SI Figures S1
and S2). For the copolymerization of BocAEMA and
DMAEMA similar reactivity ratios were already described by
Zhu et al.12 The aim for the ﬁnal molar mass of the synthesized
polymers was at least 20 kDa, which represents a compromise
considering the enhancement of the transfection eﬃciency
versus an increasing toxicity with increasing molar mass and the
opportunity for controlled polymer synthesis.28,29
An overview of the synthesized Boc-protected polymer
library (PBM to PBMA) is provided in Table 1. In the
following, the polymers are named using “P” for polymer, “B”
for the presence of Boc-protected AEMA and/or MAEMA
units, and the combination of letters “D”, “M”, and “A” for the
presence of primary (A), secondary (M), or tertiary amino
group containing monomers (D), respectively. All polymers
Scheme 1. Schematic Representation of the RAFT-Polymerization and Deprotection Reaction of the Terpolymer Containing
Boc-Protected Primary (Red), Secondary (Blue), and Tertiary (Green) Amino Groups Containing Monomers
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featured molar masses in the range of 33 to 54 kDa and narrow
distributions (see Figure 1A). In the 1H NMR spectra of the
homo- and copolymers characteristic methylene signals of the
protection group can be observed at 1.43 ppm (see SI Figure
S3). The resulting compositions were calculated from 1H NMR
using the ratio of the speciﬁc signals of the secondary (δ 2.93
ppm) and tertiary amine (δ 2.25 ppm) containing units, which
are assigned to the methyl groups at the amino function. The
ratio of those methyl signals to the methylene signal (δ 4.02
ppm) of all units neighboring the ester function in the
backbone provides the mole fraction of each monomer.
As no Boc-protection is required, the polymerization of the
PDMAEMA homopolymer (PD) was directly performed in
ethanol using 4,4-azobis(4-cyanopentanoic acid) as initiator at
70 °C for 20 h. The other Boc-protected polymers of the library
(PBM to PBDMA) were ﬁnally deprotected using 1 M
hydrochloric acid in methanol. A complete deprotection of the
polymers was conﬁrmed by HSQC-NMR at a polymer
concentration of 200 mg mL−1, which did not show any
residual 1H-signal in the typical range at 1.44 ppm for the
methyl groups of the Boc-protection group and no correspond-
ing 13C signal (see SI Figure S4). The results of the
characterization experiments are summarized in Table 2. The
characterization of the water-soluble deprotected library was
performed by size exclusion chromatography on an Appli-
Chrom ABOA CatPhil system, which revealed only small
interactions with the cationic polymers (Figure 1B). The
determination of the molar masses was conducted by
asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4) coupled with
multiangle laser light scattering (MALLS) detection showing
narrow distributions and molar masses in the range of 21 to 37
kDa. With regard to the missing appropriate size exclusion
standards (dextrane used for aqueous SEC) for cationic
methacrylate systems the determination of the molar masses
and the dispersities is more accurate by utilizing the MALLS
detection.30 However, the AF4 measurement will always tend
to underestimate the values for dispersitiy in comparison with
other MALLS coupled techniques due to the architecture of the
AF4 channel including a membrane with a cutoﬀ of 10 kDa.31
In additional titration experiments, the pKa values of the
homo- and copolymers PD to PDMA were determined to be in
the range from pH 7.45 to 8.40 (Table 2). The later used
physiological ionic strength was mimicked by the addition of
150 mM NaCl. In Figure S5, the titration curves are shown
starting at around pH 2 and plotted against the volume of 0.1
M NaOH solution added to the polymer solution of 10 mg
mL−1. The calulation of the pKa value was performed by ﬁtting
the obtained curves with a FTT ﬁt after smoothing the plot to
avoid artifacts. The turning points were determined by the
diﬀerentiation of the ﬁtted curves and the pKa value was
calculated by the Henderson−Hasselbalch eq 2 (see Exper-
imental Section). For PDMAEMA the pKa was previously
described to be 7.5 by van de Wetering et al., which is in
Table 1. Selected Characterization Data of the Boc-
Protected Polymers
Polymer
Mn
a
[g mol−1] Đ
nb [mol %]
DMAEMA
nb [mol %]
BocMAEMA
nb [mol %]
BocAEMA
PBM 35,600 1.08 - 100 -
PBA 33,800 1.10 - - 100
PBDM 34,400 1.16 60 40 -
PBDA 49,800 1.19 57 - 43
PBMA 54,600 1.14 - 50 50
PBDMA 46,200 1.25 33 33 33
aMolar mass and dispersity were determined by size exclusion
chromatography (DmAc, 0.21% LiCl, PMMA calibration). bMolar
percentage was determined by 1H NMR.
Figure 1. (A) Size exclusion chromatography curves (DmAc, 0.21% LiCl, PMMA calibration) of the Boc-protected polymer library showing narrow
dispersities. (B) SEC curves (water, 0.1% triﬂuoroacetic acid, 0.1 M NaCl, system peak @ 20 mL) of deprotected polymer library showing
monomodal distributions.
Table 2. Selected Characterization Data of the Co- and
Homopolymers
Polymer MnAF4
a
ĐAF4
a MnSEC
b
ĐSEC
b DPd pKa
PD 26,200 1.09 29,000c 1.09c 185 7.45
PM 24,000 1.21 13,400 2.04 167 8.40
PA 21,400 1.10 11,700 1.98 163 8.19
PDM 31,500 1.14 17,900 2.15 208 7.97
PDA 37,000 1.12 16,500 2.19 249 7.83
PMA 46,000 1.28 20,000 2.26 348 8.29
PDMA 36,000 1.27 21,800 2.35 250 8.03
aMolar masses and dispersities were determined by AF4 using the
MALLS detector. bMolar mass was determined by size exclusion
chromatography (0.1% TFA, 0.1 M NaCl, dextran calibration). cMolar
mass was determined by size exclusion chromatography (DmAc,
0.21% LiCl, PMMA calibration). dThe degree of polymerization was
calculated from AF4 results and 1H NMR determining the ratio of
monomers. pKa value was calculated from the titration curves (see SI
Figure S5).
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accordance with our result for the PD polymer (pKa = 7.45).
32
These results conﬁrm that at typical cell culture conditions at a
pH value of 7.2 to 7.4, at least half of the amino functions of the
polymers are in a protonated state and can, therefore, bind and
condense negatively charged nucleic acids, thus forming
polyplexes.
The calculation of the buﬀer capacity was performed for
qualitative comparison from the titration data according to eq 1
and was plotted as a function of the pH value (Figure S6). For
the calculation of β, d(pH) was set to 1 as deﬁned from
IUPAC. Dn(OH−) was calculated from the volume of sodium
hydroxide solution used for the change of 1 pH unit.33
β =
−nd (OH )
d pH (1)
Tested polymers revealed buﬀer capacities in the range of pH
6.0 to 10.0. Homo- or copolymers with a high content of
primary and secondary amino groups (PM, PA, PMA, and
PDMA) exhibited good buﬀer capacities at more basic
conditions of pH 8.0 and above, while polymers with increasing
content of tertiary amino groups (PD, PDM, PDA) tend to
show also buﬀer capacities from neutral to acidic conditions in
agreement with the increase in DMAEMA content. In
particular, for PD, increased buﬀer capacities over the whole
range from pH 6 to pH 8 could be observed. With regard to the
“proton sponge” theory, it can be assumed that the sample PD
most probably possesses the highest potential of enhancing
endosomal release. Therefore, we examined the transfection
potential of the methacrylate-based polymer library with a
particular focus on the inﬂuence of diﬀerent amino
functionalities in the following studies, which includes
cytocompatibility, cellular uptake, and polymer-mediated
escape.
Cytocompatibility. The success of newly designed
synthetic transfection vectors crucially depends on their
interaction with cellular membranes, the ﬁrst biological barrier
along the intracellular uptake process, which correlates with the
overall cell viability. To investigate the cytotoxic potential of the
methacrylate-based homo- and copolymers in vitro, we
performed a resazurin-based cell viability assay with L929
cells, as recommended by ISO10993-5. Due to high cationic
charge densities within the polymer structure, cytotoxic eﬀects,
as known from the literature, can be expected.34,35 As depicted
in Figure 2, a concentration-dependent cytotoxicity of all
polymers was observed after 24 h. The lowest cell viability was
observed for the homo polymers PD, PM, and PA as well as for
the copolymer PDM revealing CC50 values (half-maximal
cytotoxic concentration) of 23 μg mL−1 for PM and 19 μg
mL−1 for the remaining polymers. Whereas, the co- and
terpolymers containing primary amino groups showed
moderate cytotoxicities with CC50 values of 62 μg mL
−1
(PDA), 38 μg mL−1 (PMA), and 31 μg mL−1 (PDMA),
respectively. The CC50 values of the polymers, except PDA, are
within the range of linear polyethylene imine (lPEI 25 kDa,
CC50 = 25 μg mL
−1), which is the most prominent polymer-
based vector used for gene delivery. The molar mass-dependent
cytotoxicity of lPEI can be explained by its high cationic charge
density, but it should be considered that the polymer-mediated
gene delivery mostly correlates with the cytotoxicity of
polyamines, which is the main issue in transfection.
In addition to that, the membrane activity of the polymers
was investigated using erythrocytes suspended in PBS (Figure
3A and B). All polymers revealed a strong interaction with
cellular membranes as indicated by the increased hemolytic
activity (Figure 3A) and erythrocyte aggregation (Figure 3B).
The membrane activity was higher for polymers containing
primary amino groups. As a signiﬁcantly higher erythrocyte
damage was observed at transfection relevant concentration
(see values for 10 μg mL−1). Membrane destabilization and
rupture indicate a strong membrane activity resulting in a
severe cytotoxicity.13,29
Methacrylate-Based Polyplexes. In order to examine the
binding aﬃnity of all polymers to nucleic acids, the ethidium
bromide quenching assay (EBA) was performed using pDNA
(4.8 kb) as genetic material to be transfected.36,37 Diﬀerent
nitrogen (polymer) to phosphate (DNA) ratios (N/P) were
used for the polyplex preparation in order to assess the optimal
conditions for a stable polyplex formation. All tested polymers
revealed the ability to condense pDNA and to form polyplexes
with increasing N/P ratios (Figure 4A). This was indicated by
the decrease in ﬂuorescence intensities, as a result of the
exclusion of ethidium bromide from its binding site within the
pDNA. At higher N/P ratios (10 to 20) a plateau of constant
ﬂuorescence values is formed in all cases, which indicates a
stable polyplex formation. However, the overall ﬂuorescence
intensities vary depending on the type of composition of the
polymers. Homo- and copolymers based on DMAEMA (PD,
PDM, PDA) displayed higher relative ﬂuorescence intensities
between 60% and 45%. Those polymers demonstrated only a
reduced ability for pDNA condensation, which can be related
to the sterically hindered tertiary amino groups. The presence
of primary and secondary amino groups (PM, PA, PMA, and
PDMA) resulted in improved DNA condensation properties
(ﬂuorescence intensities below 40%). These observations
clearly conﬁrmed the trend for an improved DNA complex-
ation by primary and secondary amino groups.13,28,38
Despite diﬀerences in the complexation behavior and the
resulting relative ﬂuorescence intensities, all polyplexes featured
comparable sizes below 200 nm at N/P 20 with a high cationic
surface charge between 35 and 39 mV (Table 3), which is
typical for cationic methacrylates.39−41 Nevertheless, the
prepared polyplexes exhibited a broad size distribution as
indicated by the relatively high PDI values. This fact indicates
the presence of a disperse polyplex population and suggests the
formation of aggregates, which is a consequence of the
preparation method as well as the complexation buﬀer used.
Figure 2. Cytotoxicity evaluation of the methacrylate-based homo-
and copolymers PD to PDMA including lPEI 25 kDa (as control) at
indicated concentrations after 24 h. CC50 values represented in the
table were calculated applying the Boltzman ﬁt (see Figure S7). Values
represent the mean ± SD (n = 3).
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The high dispersity is most likely caused by the preparation of
polyplexes with higher N/P ratios than necessary for
neutralization of the pDNA charges. However, this method
(vigorous mixing of pDNA and polymer) is known to show
improved polyplex stability and transfection performance.42
The dissociation capability of the genetic material from the
polymer was investigated by the heparin dissociation assay
(Figure 4B).43 The previously formed polyplexes were treated
with diﬀerent concentrations of heparin to provoke the release
of pDNA within the polymer complex acting as competitor to
the polymer. Hence, ethidium bromide will be able to
intercalate into the displaced nucleic acid once more, leading
to an increase in ﬂuorescence intensity. The tested
methacrylate-based polymers seem to force a strong con-
densation of pDNA, since very high concentrations of heparin
(50 U mL−1) were required to reach a (almost) full release of
the pDNA from the polyplexes. The swiftest release was
achieved with PD, PDM, and PDA, although such copolymers
comprising DMAEMA units only revealed reduced pDNA
dissociation rates (80% to 85%).
Polyplex Performance. Since various studies reported
good transfection eﬃciencies (TE) of methacrylate-based
polymers or particles,12,44,45 the transfection capability of the
polymer library was evaluated at various conditions. For this
purpose, HEK-293 cells were transfected with pDNA encoding
the enhanced green ﬂuorescence protein (EGFP). The
transfection eﬃciency was determined by ﬂow cytometry
(Figure 5) analyzing all viable cells (counterstaining with
propidium iodide, red) successfully expressing EGFP (green).
Despite the fact that PD possessed the highest buﬀer capacity
at slightly acidic conditions, which is expected to be beneﬁcial
for endosomal release, it demonstrated the lowest transfection
levels (<20% TE) at diﬀerent N/P ratios independent of
serum-reduced or serum-containing cell media. Similar
observations were reported previously.40,46 The best trans-
Figure 3. Hemocompatibility studies of methacrylate-based homo- and copolymers PD to PDMA. (A) Erythrocyte hemolysis assay of polymers at
indicated concentrations. Triton X-100 served as positive control (99,8% hemolysis) and PBS as negative control (0%). A value less than 2%
hemoglobin release was classiﬁed as nonhemolytic and values >5% as hemolytic. t test of the hemolysis values at 10 μg mL−1 in comparison to PMA;
**P ≤ 0.005; # P > 0.05. (B) Aggregation of erythrocytes after polymer treatment at indicated concentrations. PBS was used as negative control and
bPEI (25 kDa) as postitive control. Values represent the mean ± SD (n = 3).
Figure 4. Polyplex stability: (A) Ethidium bromide quenching assay with polyplexes of PD to PDMA prepared at diﬀerent N/P ratios (pDNA). (B)
Dissociation assay of polyplexes PD to PDMA (N/P 20) using heparin at diﬀerent concentrations. Values represent the mean ± SD (n = 3).
Table 3. Size and Zeta Potential of pDNA-Polyplexes
Prepared with PD to PDMA at N/P 20a
polyplexes of Z-average [d.nm] PDI ζ (zeta potential) [mV]
PD 84 0.4 37
PM 97 0.4 37
PA 180 0.4 39
PDM 138 0.3 37
PDA 144 0.4 35
PMA 115 0.4 38
PDMA 148 0.3 39
aPolyplexes were measured in 20 mM 4-(2-hydroxethyl) piperazine-1-
ethanesulfonic acid (HEPES) and 5% (w/v) glucose, at pH 7.2, by
dynamic and electrophoretic light scattering.
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fection eﬃciencies were achieved with PA (66% TE) and PMA
(56% TE) revealing comparable gene expression to lPEI, the
standard of transfection (25 kDa, Polysciences) at a N/P ratio
of 20. The terpolymer PDMA showed also good transfection
levels (43% TE) at N/P 20, while PM, PDM, and PDA
revealed moderate TEs between 20% and 30%. A concen-
tration-dependent impairment of the overall cell viability during
transfection in serum-reduced medium was observed (Figure
S8) and showed similar tendencies compared to the
cytotoxicity proﬁle of the polymers (see Figure 2). It has to
be mentioned, that the assessment of the viability by ﬂow
cytometry (PI staining) is based on membrane leakage and,
therefore, not directly comparable to the alamarBlue assay.
Nevertheless, it is known that polyplexes revealed decreased
cytotoxicity compared to free polymers, as the cationic charge is
partially masked upon complexation with nucleic acids.47 In the
presence of serum proteins, the intracellular level of EGFP
decreases drastically, resulting in maximum TEs below 20% for
all methacrylate-based polymers as well as lPEI. Furthermore,
improved cell viabilities for tested polyplexes at these
conditions were observed (Figure S8). Due to their strong
cationic character, negatively charged proteins may aggregate
with the polyplexes, which causes an alteration in the surface
charges and the sizes of the complex, ﬁnally leading to the
formation of larger structures and the masking of the positive
net charge.48,49 This eﬀect, in turn, may lead to a reduced
aﬃnity to cell membranes (polymer-membrane interaction),
diminished uptake of polyplexes and, consequently, to a
reduction in transfection eﬃciencies.50,51
Based on the results obtained from ﬂow cytometry
experiments, we conclude that polymers with tertiary amino
groups and an average molar mass in the range of 20 kDa are
not beneﬁcial for transfection, whereas primary amino groups
have a substantial impact on the successful delivery of nucleic
acids, as the highest transfection eﬃciency was observed for the
polymer with the highest primary amine content (serum-
reduced conditions). It should be mentioned that the
transfection eﬃciency of PDMAEMA was previously shown
to increase with the increase of the molar mass.52 The best
polymer for transfection was PA, which comprises 100% AEMA
units. Polymers including additional secondary amino groups
(PMA and PDMA) also demonstrated improved outcomes
compared to polymers without any primary amino groups.
Homopolymers with 100 mol % tertiary or secondary amino
groups as well as copolymers consisting of varying ratios of the
corresponding monomers lacked the ability to eﬃciently
transfect HEK-293 cells. Despite the beneﬁcial buﬀer capability
based on the presence of tertiary amino groups, various studies
have been questioning the endosomal escape mechanism of
PDMAEMA by the “proton sponge” eﬀect.16,53,54 Our results
further undermine this theory, since the buﬀer capacities of the
methacrylate-based polymers do not correlate with their ability
for gene expression.55,56
To gain a deeper insight of the diﬀerences in the gene
delivery performance of the methacrylates, we investigated the
uptake behavior of the polyplexes. It has been reported that
Figure 5. Transfection study of adherent HEK-293 cells in serum-
reduced (OptiMEM, light gray) and serum-containing media (RPMI +
10% FCS, black) with all polymers of the library and commercial 25
kDa lPEI as positive control at diﬀerent N/P ratios after 24 h. Values
represent the mean ± SD (n = 3).
Figure 6. (A) Polyplex uptake of adherent HEK-293 cells in serum-reduced media using YOYO-1 labeled pDNA. The uptake eﬃciency (columns)
and the mean ﬂuorescence intensity of all viable cells (dots) measured by ﬂow cytometry after certain time points. Values represent the mean ± SD
(n = 3). (B) Quantiﬁcation of endosomal release by the calcein release assay. HEK-293 cells were treated with PD, PM, PA, PMA, and PDMA
polyplexes and simultaneous supplementation of calcein (25 μM). After 4 and 24 h the endosomal release of polyplexes was evaluated by the release
of calcein from endosomes into the cytoplasm of the cells, leading to high ﬂuorescence signals. Ratio of green ﬂuorescent calcein area in % over the
number of detected Hoechst stained nuclei in HEK-293 cells were detected by ﬂuorescence microscopy and quantiﬁed using ImageJ.
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cationic polyplexes are internalized into cells by endocyto-
sis.57,58 Since we obtained polyplexes with favorable sizes below
200 nm and cationic net charges, their cellular uptake was
investigated by ﬂow cytometry measurements using YOYO-1
labeled pDNA and baﬁlomycin, a vacuolar type H+-ATPase
inhibitor (see SI Figure S9A,B). Uptake studies at 4 °C
conﬁrmed an energy-dependent internalization pathway via
endocytosis, shown by the inhibition of the polyplex uptake
into HEK-293 cells (Figure S9A). Furthermore, results
obtained by the treatment of cells with baﬁlomycin further
support an uptake by endocytosis, since an almost complete
inhibition of EGFP transfection was observed (Figure S9B).
This eﬀect is caused by the inhibition of the acidiﬁcation of
endolysosomal organelles, which prevents the endosomal
release of polyplexes into the cytoplasm, and thus, a successful
transfection. This experiment further supports the requirement
of polymer protonation through acidiﬁcation to achieve
suﬃcient endosomal escape.
In contrast, uptake studies at 37 °C revealed a time-
dependent uptake of YOYO-1 labeled polyplexes, where about
80% of HEK-293 cells presented internalized polyplexes after 4
h (Figure 6A). In particular, the homopolymers PD (MFI =
188) and PA (MFI = 159) followed by PDM (MFI ∼ 150)
revealed the highest amount of YOYO-1 positive cells.
Our results indicate that a high uptake is not the limiting step
for high transfection levels,59 since the endosomal release
represents a further critical hindrance in the gene delivery
process.29,60 Therefore, the endosomal escape of the
homopolymers PD, PM, and PA as well as the best performing
copolymer PMA and terpolymer PDMA was further examined
via a calcein release assay after 4 and 24 h (see Figure 6B and SI
Figures S10 and S11). Calcein is a membrane impermeable
ﬂuorophore, which is not able to enter cells by diﬀusion, but by
ﬂuid-phase endocytosis. As calcein is, therefore, trapped within
the endolysosomes, it can only escape by membrane disruption,
which leads to a bright ﬂuorescence in the cytosol by the
distribution of calcein throughout the whole cell.54,61 Since our
polymers and polyplexes revealed increased interaction with
cellular membranes (see hemolysis and aggregation data), they
may promote the release of calcein from endolysosomes within
the cytoplasm compared to untreated cells. This experimental
setup is designed to model the potential release mechanisms
hypothesized by earlier studies on methacrylates with artiﬁcial
membranes.15 Representative images of HEK-293 cells with
calcein remaining captured within the endolysosomes (control)
as well as images of successfully released calcein (PMA) are
provided within the Supporting Information (Figures S10 and
S11). After endosomal release of the dye into the cytosol, the
ﬂuorescent area of the calcein signal should increase while the
relative ﬂuorescence intensity should decrease in comparison to
the stained cell nuclei. The evaluation of the endosomal release
was conducted by image analysis of the captured ﬂuorescence
pictures using the ImageJ software as described in the
Experimental Section focusing on the increase in the relative
ﬂuorescent area to the number of stained nuclei. The
diﬀerentiation between endosomal and cytosolic ﬂuorescence
was limited using ﬂuorescence microscopy regarding spatial
information and resolution quality. Therefore, the overall
ﬂuorescent area was plotted against the number of Hoechst
stained nuclei. The results revealed an increased ﬂuorescent
area of HEK-293 cells treated with methacrylate-based
polyplexes compared to cells treated only with calcein
(control). The methacrylate-based polyplexes showed an up
to eight-times higher relative ﬂuorescent area after 4 h in
contrast to the control, which provides a hint for an early
endosomal escape by membrane disruptive activity. In
particular, PA, PMA, and PDMA showed the fastest endosomal
release, whereas PD revealed a lower ratio of escape after 4 h.
This trend may relate to its poor transfection performance. PD
seems to be unable to escape the endosomes in a time eﬃcient
manner as, for instance, PA, thus being kept entrapped within
endolysosomes despite its high buﬀer capacity. As mentioned
earlier, various studies have been questioning the endosomal
escape of PDMAEMA by the “proton sponge” eﬀect.16,53,54 For
example, Jones et al. reported the lack of an endosome
disruptive activity of PDMAEMA as an explanation for its
diminished transfection performance.54 After 24 h, the
ﬂuorescence area of PA and PMA treated cells decreases
compared to the other measured polyplexes, which indicates a
fast release within a few hours. A decrease in calcein
ﬂuorescence intensity after 4 h was also reported by others
and explained by the activity of P-glycoprotein pumps, which
might transport calcein out of the cell.62 A rapid endosomal
release of polyplexes within the ﬁrst hours during the
Figure 7. HAADF-STEM images of polyplex treated HEK-293 cells for 4 h in OptiMEM. Polyplexes can be observed as electron dense structures
(black). (A,B) PMA polyplex treated cells: Red arrows indicate polyplex aggregation in the extracellular environment. Yellow arrows indicate
interaction of polyplexes with the membrane of endolysosomal vesicles. Green arrows indicate deformed membrane structures of endolysosomes
caused by polylpex interaction. Red arrowheads indicated disturbed membrane integrity of polyplex-containing vesicles and potential membrane
disruption or pore formation. Polyplex structures (black) seems to pass from endosomes to cytoplasm.
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transfection process seems to correlate with high transfection
eﬃciency, as the highest transfection levels were observed for
PA and PMA.
In order to elucidate the location and membrane interaction
of the polyplexes, high-angle annular dark-ﬁeld scanning
transmission electron microscopy (HAADF-STEM) was
applied. This method provides a resolution down to a few
nanometers and combines it with the capability to reveal the
ultrastructure of the cellular interior. Figure 7 shows
representative images of HEK-293 cells, embedded into an
Epon-based resin, after exposure to polyplexes based on PMA
after 4 h incubation time. In addition to the cellular organelle
structures (i.e., mitochondria, vesicles, nucleus), structures of
high electron density (dark/black) were observed. We attribute
these structures to polymer−DNA complexes, since the
functional groups of the polyplex (amines and phosphates)
exhibit a strong chemical aﬃnity to the standard staining
reagents (OsO4 and uranyl acetate) resulting in an eﬃcient
staining of polyplexes. This staining ability of mentioned
reagents has been observed for a variety of diﬀerent polyplexes
so far.63 In Figure 7A and B, PMA polyplexes are located within
endosomal structures and, partially, a high number of
polyplexes is observed within these structures. In the periphery
of the cells the formation of aggregates is evident (red arrow);
however, smaller aggregates are also observed to approach the
cells. Next to completely ﬁlled endosomal structures, some
intracellular vesicles are ﬁlled with a low number of densely
packed polyplexes next to a large amount of intracellular ﬂuids.
In Figure 7B an increased interaction of the polyplexes with the
endosomal membrane is observed in some cases (yellow
arrows), which can be explained by the electrostatic interaction
between the positively charged polyplexes and the negatively
charged membranes. A close vicinity of the polyplexes to the
endosomal membrane was also observed for PEI-based
polyplexes.64 Moreover, in some cases alterations of the
endosomal membrane structures become evident. Here, the
polyplexes are partially observed in close vicinity to the
endosomal structure, which are associated with deformed
membranes (green arrows). These structural changes can be
attributed to endosomal escape events. An alternative escape
strategy to the “proton sponge” eﬀect might be induced by the
direct interaction of methacrylate-based polyplexes with the
endolysosomal membrane causing a membrane destabilization
and a subsequent release due to pore formation without
complete rupture. This eﬀect was previously reported for
cationic polymers.59,60,65−67 A disturbed membrane integrity of
polyplex-containing vesicles was observed, as parts of the
electron dense structures were detected outside of the vesicular
membrane reaching into the cytoplasm of HEK-293 cells
(indicated by red arrow heads). This observation, as well as our
previous results (hemolysis and calcein assay), support an
endosomal escape by pore formation due to an increased
tension on the membrane rather than a complete osmotic
rupture of the endosome.
■ CONCLUSION
In an eﬀort to understand the inﬂuence of diﬀerent amino
functionalities in methacrylate-based polymers on their trans-
fection eﬃciency, we have synthesized a library of deﬁned linear
homo- and copolymers bearing primary, secondary, and tertiary
amino groups. The polymers were prepared using the RAFT
process and revealed similar molar masses with a DP of 163 to
250 and narrow dispersities (Đ = 1.09 to 1.28) as well as
varying compositions of DMAEMA, MAEMA, and AEMA
monomers. pKa values between 7.45 and 8.40 were observed,
leading to partial protonation of all polymers at physiological
conditions. The buﬀer capacities, in particular, for PD, are in
the pH range of endosomal environments, which is supposed to
be beneﬁcial for transfection. All synthesized polymers were
able to bind and condense pDNA resulting in the formation of
stable, nanosized polyplexes (<200 nm). Furthermore, the
performance of these polymers as gene delivery vehicles was
examined at diﬀerent conditions by microscopic techniques
(ﬂuorescence and scanning transmission electron microscopy)
as well as ﬂow cytometry measurements. It was found that
several parameters (Figure 8) show a relevant impact on the
successful transfection: most importantly, (i) the type and
content of the amino group, (ii) the interaction of the polymer
with the membrane, and (iii) a rapid endosomal release.
However, the size of polyplexes, their uptake rate, and,
interestingly, the buﬀer capacity revealed no direct correlation
with the observed transfection levels. Based on our results, the
transfection eﬃciency of such polymers can be summarized
regarding their amino functionalities as follows: Primary amino
groups > Secondary amino groups > Tertiary amino groups.
High contents of primary amino groups in homo- (PA) and
copolymers (PMA) resulted in an improved transfection
eﬃciency, whereas higher amounts of tertiary amino groups
within the polymer structure seem to hamper the transfection
process (PD and PDM). A primary amino content of at least
∼40 to 50 mol % was found to be necessary for eﬃcient
transfection, since already the copolymer PDA (AEMA30%-
DMAEMA70%) comprising ∼70 mol % of tertiary amino groups
Figure 8. Overview of factors (main polyplex properties) with impact
on the transfection eﬃciency using the Pearson correlation coeﬃcient.
Highest proportional correlation is represented by 1.0, whereas −1.0
means the highest inverse proportional correlation. Values around zero
indicate no correlation. For membrane disruption, the hemoglobin
release at 10 μg mL−1 polymer concentration was used. For
cytotoxicity the half-maximal (50%) cytotoxic concentration (CC50)
was used. The binding aﬃnity represents the measured relative
ﬂuorescence of ethidium bromide at N/P 20. To compare the mean
ﬂuorescence intensity (MFI) of polyplex uptake, the time (min) that
was needed to reach 100 relative MFI (where the control is 1) was
determined. The calcein release represents the ratio of green
ﬂuorescent calcein area in % over the number of detected Hoechst
stained nuclei of the polymers after 4 h.
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showed reduced results. With the addition of 30 mol %
secondary amino groups, the transfection performance of the
terpolymer PDMA (AEMA30%-MAEMA30%-DMAEM40%) in
contrast, signiﬁcantly increased compared to PDA. This eﬀect
was only observed for copolymers of MAEMA, since the
homopolymer PM also demonstrated reduced transfection
levels. The good performance of the presented homo- and
copolymers could furthermore be explained by a strong
polymer−membrane interaction rather than by a rupture
mediated by osmotic swelling, as postulated for the “proton
sponge” eﬀect. However, it is demonstrated that the endosomal
acidiﬁcation is still required for further protonation of the
polymers and therefore for their suﬃcient interaction with the
endolysosomal membrane (see baﬁlomycin treatment). In fact,
all polymers exhibited high hemoglobin release and erythrocyte
aggregation, indicating their ability to destabilize membranes
and to cause a partial rupture. Despite the fact that such a high
membrane interaction leads to an increased cytotoxicity, this
property seemed to be beneﬁcial for a fast endosomal release.
This assumption is in accordance with the results of our calcein
release assay, which revealed a fast endosomal escape, in
particular, for PA and PMA. Based on these investigations, we
conclude that the mechanisms for endosomal escape during
transfection of methacrylate based polymers diﬀer signiﬁcantly
from PEI, as they are unaﬀected by the respective buﬀer
capacity and support the theory of the disruptive formation of
pores.
■ EXPERIMENTAL SECTION
Materials. Unless otherwise stated, the chemicals were used
without further puriﬁcation. 2-(N,N-Dimethylamino)ethyl
methacrylate (DMAEMA), methacryloyl chloride, anhydrous
triethylamine, 4-cyano-4-(phenylcarbonothioylthio) pentanoic
acid (CPDB-COOH), neutral aluminum oxide and 2-
(methylamino)ethanol, propidium iodide, and calcein were
purchased from Sigma-Aldrich (Merck). The inhibitor removal
for DMAEMA was performed using the inhibitor remover from
Sigma-Aldrich. Linear and branched poly(ethylene imine)
(lPEI/bPEI, 25 kDa) was obtained from Polysciences. Di-tert-
butyldicarbonate for the protection was from Alfa Aesar and 2-
aminoethanol was purchased by TCI. 2-Bisazobutyronitile was
received from Acros and recrystallized from methanol prior to
use. Hydrochloric acid, dimethylformamide, and tetrahydrofur-
an were purchased from VWR Chemicals; all other solvents
used were obtained from standard suppliers. Ethidium bromide
solution (1%, 10 mg mL−1) was obtained from Carl Roth.
AlamarBlue, YOYO-1 iodide, and Hoechst 33342 (10 mg mL−1
solution) were obtained from Life Technologies (Thermo
Fisher). If not stated otherwise, cell culture consumables, cell
culture media, and supplements (L-Glutamin, antibiotics) were
obtained from Greiner Bio-One, Lonza, and Biochrom (Merck
Millipore), respectively. Plasmid pEGFP-N1 (4.7 kb, Clontech,
USA) encoding green ﬂuorescent protein (EGFP) was isolated
with the Giga Plasmid Kit provided by Qiagen. Double-
stranded DNA (dsDNA, 23 nucleotides) was purchased from
Jena Bioscience.
Synthesis of N-tert-Butyloxycarbonyl-(2-aminoethyl)-
methacrylate (BocAEMA). N-tert-Butyloxycarbonyl-(2-ami-
noethyl)-methacrylate was synthesized according to a proce-
dure of Kuroda et al.24 10 g of 2-aminoethanol was dissolved in
120 mL THF and 200 mL of a 1 M aqueous sodium hydroxide
solution were added. 35.28 g of di-tert-butyldicarbonate in 80
mL THF was added dropwise while cooling the reaction
mixture in an ice bath and stirred overnight. The mixture was
diluted with ethyl acetate and washed with water, NaHCO3,
and brine and the aqueous phase was reextracted with ethyl
acetate, dried over sodium sulfate, and the solvent removed
under reduced pressure. Without further puriﬁcation 18.5 g of
N-tert-butyloxycarbonyl-2-aminoethanol was diluted with 30
mL dry dichloromethane under Schlenk conditions and 22.6
mL of dry triethylamine was added while cooling the mixture in
an ice bath. Fifteen milliliters of methacryloyl chloride were
added dropwise and the reaction was stirred overnight. The
mixture was washed with water, brine, and sodium hydrogen
carbonate and dried over sodium sulfate. The crude oﬀ-white
product was ﬁnally recrystallized from n-hexane. 1H NMR (300
MHz, CDCl3): δ [ppm] = 1.42 (s, 9H), 1.93 (s, 3H), 3.43 (m,
2H), 4.18 (t, 2H), 4.8 (br. s, 1H), 5.57 (s, 1H), 6.10 (s, 1H).
13C NMR (75 MHz, CDCl3): δ [ppm] = 18.2 (CH3), 28.3
(CH3), 39.6 (CH2), 63.9 (CH2), 79.5 (CH2), 125.8 (Cquart),
136.0 (Cquart), 155.7 (Cquart), 167.2 (Cquart).
Synthesis of N-Methyl-N-tert-butyloxycarbonyl-(2-
aminoethyl)-methacrylate (BocMAEMA). N-Methyl-N-
tert-butyloxycarbonyl-(2-aminoethyl)-methacrylate was synthe-
sized according to a procedure of Sinclair et al.25 Ten grams of
N-methylaminoethanol, dissolved in 80 mL chloroform was
cooled in an ice bath and 29 g di-tert-butylcarbonate in 80 mL
was added dropwise and stirred at room temperature for 1 h.
The solvent was removed under reduced pressure and the
mixture was puriﬁed by distillation (30 mbar, 180 °C). Under
Schlenk conditions 21.4 g of N-methyl-N-tert-butyloxycarbonyl-
2-aminoethanol were diluted with 100 mL dry dichloro-
methane, 49.4 mL triethylamine was added, and the reaction
mixture cooled in an ice bath. 17.7 mL methacryloyl chloride in
100 mL dichloromethane were added dropwise and the
reaction was stirred at room temperature overnight. The
mixture was washed with water and brine and dried over
sodium sulfate. Further puriﬁcation was done by column
chromatography using a mixture of cyclohexane an ethyl acetate
(9:1−3:1). 1H NMR (300 MHz, CDCl3): δ [ppm] = 1.96 (s,
9H), 2.76 (m, 3H), 3.30 (m, 2H), 4.56 (m, 2H), 5.65 (s, 1H),
6.30 (s, 1H). 13C NMR (75 MHz, CDCl3): δ [ppm] = 18.2
(CH3), 28.3 (CH3), 35.2 (CH2), 47.9 (CH3), 62.7 (CH2),
79.7(CH2), 126.0 (Cquart), 136.1 (Cquart), 155.8 (Cquart), 167.1
(Cquart).
Synthesis of Homo- and Copolymers. Homo- and
copolymers of BocAEMA, BocMAEMA and DMAEMA were
prepared by the reversible addition−fragmentation chain
transfer (RAFT) polymerization method.10 In a typical RAFT
copolymerization experiment, 0.735 g of BocAEMA (3.18 ×
10−3 mol), 0,773 g of BocMAEMA (3.18 × 10−3 mol), 0.98 mg
of AIBN initiator (5.96 × 10−5 mol), 5.68 mg of CPDB-COOH
RAFT agent (20.33 × 10−5 mol) and 5.03 mL DMF were
mixed together with anisole as internal standard (0.347 mL) in
a 25 mL reaction vial. The monomer concentration was kept at
1 mol L−1. The reaction mixture was degassed with argon for at
least 30 min and, subsequently, the reaction solution was placed
in a preheated oil bath at 70 °C for 38 h. The copolymer was
puriﬁed by two times precipitation from THF into a minimum
of 10-fold volume of n-hexane and dried under reduced
pressure. Conversion was measured by 1H NMR spectroscopy
using anisole as internal standard.
The RAFT polymerization of the DMAEMA homopolymers
was carried out in ethanol in 1.73 molar solution. 1.572 g
DMAEMA (0.01 mol), 2.8 mg 4,4-azobis(4-cyanovaleric acid)
(0.001 mmol), and 11.1 mg 4-cyano-4-(phenylcarbonothioylth-
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io) pentanoic acid (0.004 mmol) were dissolved in 3.3 mL of
ethanol, and 0.77 mL DMF were added as internal standard.
The reaction mixture was degassed with argon for 10 min and
heated to 70 °C for 10 h. The resulting polymer was puriﬁed
via precipitation from THF in n-hexane twice and dried at high
vacuum. Conversion was measured by 1H NMR.
Deprotection of Boc-Protected Polymers. Boc-pro-
tected homo- and copolymers were deprotected using diluted
hydrochloric acid in methanol. In a typical procedure, 300 mg
polymer was dissolved in 10 mL methanol and 1 mL of
concentrated hydrochloric acid was added dropwise and stirred
at room temperature overnight. The solvent was removed
under reduced pressure, dissolved in water, and freeze-dried.
Asymmetric Flow Field-Flow Fractionation (AF4).
Asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4) was performed
on an AF2000 MT system (Postnova Analytics, Landberg,
Germany) coupled to an UV (PN3211, 260 nm), RI
(PN3150), and MALLS (PN3070, 633 nm) detector. The
eluent is delivered by two diﬀerent pumps (tip and focus-ﬂow)
and the sample is injected by an autosampler (PN5300) into
the channel. The channel has a trapezoidal geometry and an
overall area of 31.6 cm2. The nominal height of the spacer was
500 μm and a regenerated cellulose membrane with a molar
mass cutoﬀ of 10,000 g mol−1 was used as the accumulation
wall. All experiments were carried out at 25 °C and the eluent
was 20 mM NaCl in 25 mM sodium acetate buﬀer at pH 3.5.
The detector ﬂow rate was set to 0.5 mL min−1 for all samples
and a sample volume of 50 μL (10 mg mL−1) was injected with
an injection ﬂow rate of 0.2 mL min−1 for 7 min. For all
samples the cross-ﬂow was set to 2 mL min−1. After the
focusing period and a transition time of 1 min, the cross-ﬂow
was kept constant for 1 min and then decreased under a power
function gradient 0.40 to zero within 15 min. Afterward the
cross-ﬂow was kept constant at zero for 20 min to ensure
complete elution. For calculation of the molar mass a Zimm
plot was used. The refractive index increment (dn/dc) of all
samples was measured by manual injection of a known
concentration directly into the channel without any focusing
or cross-ﬂow. The dn/dc was calculated as the average of at
least three injections from the area under the RI curve.
NMR Spectrometry. NMR spectra were recorded on a
Bruker AC 300 MHz or on a Bruker AC 250 MHz
spectrometer.
Titration. The titration for the detection of the pKa value of
the polymers was performed with the automated titrator 765
Dosimat (Metrohm, Herisau, Swiss) and the pH detector
GMH3530 (GHM Messtechnik GmbH Standort Greisinger,
Regenstauf, Germany). For a typical measurement the polymer
in aqueous 150 mM NaCl solution (10 mg mL−1) was acidiﬁed
by 10 μL hydrochloric acid and stirred while titrated against a
0.1 M sodium hydroxide solution (0.1 mL min−1) to a pH value
of 12. The pKa value was calculated using the Henderson−
Hasselbalch eq 2 by determining the equivalence point from
the titration diagram.
= +
−
ppH K log
[A ]
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Size Exclusion Chromatography (SEC). Size exclusion
chromatography (SEC) was measured on a Agilent 1200 series
system equipped with a PSS degasser, a G1310A pump, a
G1362A refractive index detector, and a PSS GRAM guard
column running with dimethylacetamide (DmAc) with 0.21%
of lithium chloride. The Techlab oven was set to 50 °C and the
molar masses were calculated using a poly(methyl methacry-
late) (PMMA) standard. For the water-soluble polymers a SEC
system of Jasco was used with a DG-980-50 degasser, a PU-980
pump, equipped with a RI-930 RI detector and Jasco oven set
to 50 °C. The column used was AppliChrom ABOA CatPhil,
which is operated with a water solution with 0.1% triﬂuoric acid
and 0.1 M NaCl.
Polyplex Preparation. Polyplexes of plasmid DNA
(pDNA) and polymers were prepared by mixing stock solutions
of 15 μg mL−1 pDNA and diﬀerent amounts of polymers (1 mg
mL−1) to obtain various N/P ratios (nitrogen of polymer to
phosphate of pDNA) in HBG buﬀer (20 mM 4-(2-
hydroxethyl) piperazine-1-ethanesulfonic acid (HEPES) and
5% (w/v) glucose, pH 7.2). The solutions were vortexed for 10
s at maximal speed and incubated at room temperature for 15
min to ensure complex formation.
Ethidium Bromide Quenching Assay. The formation of
polyplexes with pDNA was examined by quenching of the
ethidium bromide ﬂuorescence. Brieﬂy, 15 μg mL−1 pDNA in a
total volume of 100 μL HBG buﬀer were incubated with
ethidium bromide (0.4 μg mL−1) for 10 min at room
temperature. Subsequently, polyplexes with diﬀerent amounts
of polymer (various N/P ratios) were prepared in black 96-well
plates (Nunc Thermo Fisher) and incubated at room
temperature for 15 min before the ﬂuorescence measurements.
The ﬂuorescence of the samples was measured at an excitation
wavelength of 525 nm and an emission wavelength of 605 nm
using a Tecan microplate reader. A sample containing only
pDNA and ethidium bromide was used to calibrate the device
to 100% ﬂuorescence against a background of 0.4 μg mL−1 of
ethidium bromide in HBG solution. The percentage of dye
displaced upon polyplex formation was calculated using eq 3:
=
−
−
×
F F
F F
RFU[%] 100
sample 0
pDNA 0 (3)
Here, RFU is the relative ﬂuorescence and Fsample, F0, and
FpDNA represents the ﬂuorescence intensities of a given sample,
the ethidium bromide in HBG alone, and the ethidium bromide
intercalated into pDNA alone.
Heparin Dissociation Assay. Polyplexes with an N/P ratio
of 20 were prepared as described above in a total volume of 100
μL HBG buﬀer containing ethidium bromide (0.4 μg mL−1).
After incubation in the dark at room temperature for 15 min,
polyplexes were transferred into a black 96-well plate, and
heparin of indicated concentrations was added. The solution
was mixed and incubated for further 30 min at 37 °C in the
dark. The ﬂuorescence of ethidium bromide was measured at
Ex 525 nm/Em 605 nm with a Tecan microplate reader. The
percentage of intercalated ethidium bromide was calculated as
described before.
Dynamic and Electrophoretic Light Scattering. Dy-
namic light scattering (DLS) was performed on a Zetasizer
Nano ZS (Malvern Insturments, Herrenberg) with a He−Ne
laser operating at a wavelength of λ = 633 nm. All
measurements (30 runs, triplicate) were carried out at 25 °C
after an equilibration time of 120 s. The counts were detected
at an angle of 173°. The mean particle size was approximated as
the eﬀective (z-average) diameter and the width of the
distribution as the polydispersity index of the particles (PDI)
obtained by the cumulants method assuming a spherical shape.
Electrophoretic light scattering (ELS) was used to measure the
zeta potential (ζ). The measurement was performed on a
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Zetasizer Nano ZS (Malvern Instruments, Herrenberg,
Germany) by applying laser Doppler velocimetry. For each
measurement, 20 runs were carried out using the slow-ﬁeld
reversal and the fast-ﬁeld reversal mode at 150 V. Each
experiment was performed in triplicate a 25 °C. The zeta
potential was calculated from the electrophoretic mobility (μ)
according to the Henry Equation. Henry coeﬃcient f(ka) was
calculated according to Oshima. For size determination of
polyplexes a pDNA concentration of 15 μg mL−1 was used for
preparation at N/P 20 in HBG buﬀer.
Determination of Cytotoxicity. Cytotoxicity studies were
performed with the mouse ﬁbroblast cell line L929 (CCL-1,
ATCC), as recommended by ISO10993-5. The cells were
cultured in Dulbecco’s modiﬁed eagle’s medium (DMEM,
Biochrom) supplemented with 10% fetal calf serum (FCS), 100
U mL−1 penicillin, and 100 μg mL−1 streptomycin at 37 °C in a
humidiﬁed 5% (v/v) CO2 atmosphere. In detail, cells were
seeded at 104 cells per well in a 96-well plate and incubated for
24 h. Afterward, the testing substances (polymers) at diﬀerent
concentrations, ranging from 1 μg mL−1 to 500 μg mL−1, were
added to the cells and the plates were incubated for further 24
h. Subsequently, the medium was replaced by a mixture of fresh
culture medium and alamarBlue solution, prepared according to
the manufacturer’s instructions. After a further incubation of 4
h at 37 °C, the ﬂuorescence was measured at Ex 570 nm/Em
610 nm, with untreated cells on the same well plate serving as
negative controls. The negative control was standardized as 0%
of metabolism inhibition and referred as 100% viability. Data
are expressed as mean ± SD of three independent
determinations.
Hemolysis Assay. The interaction of polymers with cellular
membranes was examined by analyzing the release of
hemoglobin from erythrocytes. Blood from sheep, collected
in heparinized tubes, were provided by the Institute of Animal
Science and Animal Welfare, Friedrich Schiller University Jena.
The blood was centrifuged at 4500 × g for 5 min, and the pellet
was washed three times with cold 1.5 mM phosphate buﬀered
saline (PBS, pH 7.4). After dilution with PBS in a ratio of 1:7,
aliquots of erythrocyte suspension were mixed 1:1 with the
polymer solution and incubated in a water bath at 37 °C for 60
min. After centrifugation at 2400 × g for 5 min, the hemoglobin
release into the supernatant was determined spectrophoto-
metrically using a microplate reader at 544 nm wavelength.
Complete hemolysis (100%) was achieved using 1% Triton X-
100 serving as positive control. Pure PBS was used as negative
control (0% hemolysis). The hemolytic activity of the
polycations was calculated as follows (eq 4):
= ×
−A A
A
%Hemolysis 100
( )eSampl Negative control
Positive control (4)
A value less than 2% hemolysis rate were classiﬁed as
nonhemolytic, 2 to 5% as slightly hemolytic and values >5% as
hemolytic. Experiments were run in triplicates and were
performed with three diﬀerent blood donors.
Erythrocyte Aggregation. Erythrocytes were isolated as
described above. The erythrocyte suspension was mixed 1:1
with the polymer solutions (100 μL total volume) in a clear ﬂat
bottomed 96-well plate. The cells were incubated at 37 °C for 2
h, and the absorbance was measured at 645 nm in a microplate
reader. Cells which were treated with PBS, which served as
negative control and 25 kDa bPEI (50 μg mL−1, Sigma-Aldrich)
was used as positive control. Absorbance values of the test
solutions lower than the negative control were regarded as
aggregation. Experiments were run in triplicates and were
performed with three diﬀerent donor bloods from sheep.
Polyplex Uptake. HEK-293 cells (CRL-1573, ATCC) were
routinely cultured in RPMI 1640 medium supplemented with
10% FCS, 100 μg mL−1 streptomycin, 100 IU mL−1 penicillin,
and 2 mM L-glutamine at 37 °C in a humidiﬁed 5% (v/v) CO2
atmosphere.
For kinetic uptake studies of polyplexes, cells were seeded at
a density of 105 cells per mL in 24-well plates and cultured for
24 h. One hour prior to the addition of polyplexes, the medium
was changed to OptiMEM (Thermo Fisher). The pDNA was
labeled with YOYO-1 iodide prior to polyplex preparation. For
labeling of 1 μg pDNA, 0.026 μL of 1 M YOYO-1 solution was
mixed with pDNA and incubated for 15 min at 4 °C protected
from light. Afterward HBG buﬀer and polymers were added at
the indicated N/P ratio and polyplexes were formed as
described previously. At least 50 μL polyplexes in solution
were added to the cells. The cells were harvested 0.5, 1, 2, 4,
and 24 h after polyplex addition and 10% trypan blue was
added to quench the outer ﬂuorescence of cells. For energy-
dependent uptake studies, cells were equilibrated in OptiMEM
at 4 °C 30 min prior to polyplex addition. The plates were
further incubated at 4 °C for 4 h. To determine the relative
uptake of polyplexes, 104 cells were measured by ﬂow
cytometry using a Cytomics FC 500 (Beckman Coulter) and
the amount of viable cells (propidium iodide counterstaining,
red) showing YOYO-1 signal (green) were gated.
Calcein Assay. Endosomal escape was evaluated by the
calcein quenching assay, as reported earlier using dsDNA (Jena
Bioscience) for polyplex preparation.61 The calcein solution (25
μM ﬁnal concentration, dissolved in ultrapure water), and
polyplexes (N/P 20, 50 μL) were simultaneously added to
HEK-293 cells supplemented in OptiMEM for 4 h.
Subsequently, cells were washed three times with PBS to
remove remaining calcein and free polyplexes. 250 μL phenol-
free growth medium supplemented with Hoechst 33342
(1:1000) was added to cells for a further incubation period
of 20 min prior to imaging analysis. To examine calcein release
after 24 h, cells were cultured in fresh growth media without
calcein after the washing steps for further 20 h. Imaging was
performed with a ﬂuorescence microscope (Axio Observer Z1,
Carl Zeiss, Jena, Germany) equipped with a mercury arc UV
lamp and the appropriate ﬁlter combinations for excitation and
detection of emission (Hoechst 33342: Ex 405 nm/BP 435−
490 nm; Calcein: Ex 458 nm/BP 510−550 nm). Five images of
random well plate localizations per sample were captured with a
Plan-Apochromat 10 × 0.45 air objective while identical
instrument settings (camera gain, integration time, UV lamp
power). Image analysis was performed with the freely available
ImageJ software. Therefore, the images of Hoechst counter-
stained cell nuclei were processed using the “subtract
background” command (10 pixels, separate colors). Afterward
the “threshold” was set using the “Otsu” method in black and
white (color space HSB, dark background) and the brightness
was set to 5/255. The image type was set to 8-bit and
converted “to Mask” and the “watershed” method was applied
to avoid overlapping of the cell nuclei by an automated manner.
Finally the “analyze particles” option was used (21-inﬁnity pixel
units, circularity 0.5−1.0, show outlines, display results, exclude
edges, and summarize) for particle counting of the cell nuclei.
For the calcein images, the analysis was performed in the same
manner, but instead of the “watershed” method, the “dilate”
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method was used. For determination of ﬂuorescent area the
“analyze particles” protocol (0 to inﬁnity pixels, circularity 0 to
1.0, and no outlines) was applied.
Transfection of Adherent Cells. For transfection studies,
cells were seeded at a density of 105 cells per mL in 24-well
plates and incubated for 24 h at 37 °C, 5% CO2. One hour
prior to transfection, cells were supplemented with 0.5 mL
OptiMEM or fresh serum containing growth medium.
Polyplexes were prepared as described above, and were added
to the cells (50 μL per well). After an incubation time of 4 h at
37 °C, the supernatant was replaced by fresh growth medium
and the cells were further incubated for 20 h. Regarding
Baﬁlomycin experiments, 175 nM Baﬁlomycin was added to the
cells and incubated for 20 min, prior to the polyplex
supplementation. For analysis via ﬂow cytometry (Cytomics
FC 500, Beckman Coulter), cells were harvested by
trypsinization. Dead cells were identiﬁed via counterstaining
with propidium iodide. For determination of transfection
eﬃciency, 104 viable cells expressing EGFP (green) were gated.
The experiments were performed independently three times.
Transmission Electron Microscopy. For electron micros-
copy investigations, HEK-293 cells were seeded on 6-well plates
with a cell density of 2 × 106 cells mL−1 and incubated with the
respective polyplex (N/P 20) in OptiMEM for 4 h.
Subsequently, cells were detached with trypsin and the resulting
cell suspension was centrifuged, washed (PBS 1×), and ﬁxed
for 2 h with glutaraldehyde (2% in PBS 1×, prepared from 8%
EM grade stock solution, purchased from EMS, Hatﬁeld) on
ice. After glutaraldehyde ﬁxation, the cells were again washed
with PBS and post-ﬁxed for 1 h with osmium tetroxide (1% in
PBS, prepared from 4% EM grade stock solution, purchased
from EMS, Hatﬁeld). After washing with pure water, the cell
suspension was stained for 1 h with uranyl actetate solution in
the dark (1% in solution in ultrapure water prepared from
depleted uranyl acetate dihydrate purchased from EMS,
Hatﬁeld). Subsequently, the sample was again washed with
pure water prior to dehydration by an ethanol/water series
(50%, 70%, 90%, 2 × 100% dry EtOH, puriﬁed with a Solvent
Puriﬁcation System, stored over molecular sieves). The
dehydrated samples were then transferred into BEEM capsules
(Plano, Wetzlar). After removal of the ethanol, the cell
suspension was immersed in mixtures of Embed 812 (EMS,
Hatﬁeld) and ethanol (Embed/EtOH = 1:1 v/v for 1 h, 2:1 v/v
for 12 h) and prior to embedding in pure Embed 812 for 4 h.
After a further change of the embedding medium, the resin was
allowed to harden in an oven at 70 °C for 24 h. From the resin
block, ultrathin sections of 80 nm were cut with an
ultramicrotome (PT-XL PowerTome, RMC, Tucson) using a
diamond knife (RMC, Tucson). The ultrathin resin sections
were captured, deposited on a carbon supported copper grid
(400 mesh, Quantifoil, Jena), and imaged with a Technai G2
system (FEI), with 120 kV acceleration voltage in STEM mode
(HAADF detection).
Statistical Analysis. The result values represent the mean
± SD (n ≥ 3). To determine the Pearson correlation, the
PEARSON function in Excel was used. Each parameter was
compared to the transfection eﬃciency at N/P 20. The t test
calculation was done using the t test function in excel. The
hemolysis data of the library at 10 μg mL−1 was compared with
the values of PMA.
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embryonic kidney cells; MFI, Mean ﬂuorescence intensity;
HAADF-STEM, High-angle annular dark-ﬁeld scanning trans-
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&'
Kinetic plot of ln (M0/Mt) over time for the Boc protected copolymers ( (A), ( (B),  (C), 
( (D). 
 
%#
)'
Kinetic plot of the molar mass over the conversion of ( (A), ( (B),  (C) and ( (D). 
  
  
  
  
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%#
*'
+, 1H'NMR spectra of the Boc'protected of ( in CDCl3, +, 1H'NMR spectra deprotection of ( 
with trifluoroacetic acid in D2O, +-, 1H'NMR spectra deprotection of ( with 1M HCl in methanol in D2O.




%#
.'
HSQC'NMR of ( (100 mg) showing no methyl signals of the corresponding Boc'protection group. 
Spectrum on to 1H'NMR, spectrum left 13C'NMR in D2O. 
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%#
 /0 Titration curves of the deprotected polymer library 10 mg mL'1 in 150 mM NaCl in water +,, 
methacrylate monomers DMAEMA, AEMA and MAEMA 10 mg mL'1 in pure water +,, the calculated pKas are 
shown in bold dots. 
 
%#
1'
Buffer capacity of the deprotected polymer library calculated with equation (1) from titration over the pH 
range.  (dark blue) and ( (red) are strongly overlapping. Connecting lines do not represent actual data 
points; for visual support. 
5 
 
 
 
%#
2' Example of dose'response curves of L929 mouse fibroblasts after polymer treatment for 24 h with (. 
CC50 values were calculated with Origin software (Botzman fit) from cytotoxicity data.




%#
3' Viability data of the corresponding transfection experiments (Figure 5) using polymethacrylate library at 
various N/P ratios. Cell viability was determined by propidium iodide staining and flow cytometry. Values represent 
the mean ± S.D. (n=3).
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%#
 4' +, Energy'dependent uptake study on HEK'293 cells. Amount of cells [%], which internalized 
polyplexes (( to () with YOYO'1 labeled pDNA after 4 h at 37 °C and 4 °C. +, Transfection efficiency of 
( to ( (N/P 20) after treatment with bafilomycin (proton pump inhibitor). Cells were analyzed 24 h post'
transfection. Values represent the mean ± S.D. (n=3).



%#
 &5' Fluorescence image of HEK'293 cells treated with  in the calcein quenching assay (see 
experimental part). +, and +-, ImageJ processed images for nucleus count and fluorescence area determination. +, 
and +(, fluorescence images stained with Hoechst or calcein at corresponding wavelength (Hoechst 33342: 
Ex 405 nm/BP 435'490 nm; Calcein: Ex 458 nm/BP 510'550 nm) after background correction. Scale bar black or 
white corresponds to 50µm.  
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%#
 &&. Fluorescence image of HEK'293 cells treated only with calcein serving as control in the calcein 
quenching assay (see experimental part). +, and +-, ImageJ processed images for nucleus count and fluorescence 
area determination. +, and +(, fluorescence images stained with Hoechst or calcein at corresponding wavelength 
(Hoechst 33342: Ex 405 nm/BP 435'490 nm; Calcein: Ex 458 nm/BP 510'550 nm) after background correction. Scale 
bar black or white corresponds to 50µm. 
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ABSTRACT: We show the potential of oligo(2-ethyl-2-oxazoline)
(Oxn)-shielded graft copolymers of (2-aminoethyl)-methacrylate
and N-methyl-(2-aminoethyl)-methacrylate for pDNA delivery in
HEK cells. For the eﬀect of grafting density and side chain length
concerning improved transfection properties through the concept
of shielding to be investigated, copolymers were synthesized via the
macromonomer method using a combination of cationic ring
opening polymerization and reversible addition−fragmentation
chain transfer polymerization to vary the degree of grafting (DG
= 10 and 30%) as well as the side chain degree of polymerization
(DP = 5 and 20). Investigations of the polyplex formation, in vitro
ﬂow cytometry, and confocal laser scanning microscopy measure-
ments on the copolymer library revealed classical shielding
properties of the Ox side chains, including highly reduced
cytotoxicity and a partial decrease in transfection eﬃciency, as also reported for polyethylene glycol shielding. In terms of the
transfection eﬃciency, the best performing copolymers (A-g-Ox5(10) and M-g-Ox5(10)) revealed equal or better performances
compared to those of the corresponding homopolymers. In particular, the graft copolymers with low DG and side chain DP
transfected well with over 10-fold higher IC50 values. In contrast, a DG of 30% resulted in a loss of transfection eﬃciency due to
missing ability for endosomal release, and a side chain DP of 20 hampered the cellular uptake.
■ INTRODUCTION
Vectors for gene delivery can be divided into two major groups:
viral and nonviral carrier systems. Even though the most eﬃcient
vectors are still viral vectors, their small size prohibits the use of
large genetic material. In addition, safety issues cannot be
neglected due to the use of recombinant viruses.1 The group of
nonviral vectors includes liposomes as well as natural and
synthetic polymers. Advantages of polymeric carriers comprise
tailored variation in size and structure, low immunologic
interaction, and straightforward upscaling possibilities.2 How-
ever, nonviral systems still reveal lower transfection eﬃciencies in
comparison to viruses. Despite their fundamentally diﬀerent
structures, liposomes and cationic polymers have to overcome
the same obstacles of transfection: (1) reversible binding of
genetic material, (2) intracellular uptake across the cell
membrane into endosomes, and (3) the endosomal escape and
release of the nucleic acids.2,3
Polymeric carrier systems often consist of cationically charged
monomers providing the possibility to complex the anionically
charged genetic material (e.g., pDNA, siRNA).2 In addition,
cationically charged moieties enable an electrostatic interaction
with the partially anionically charged cell membranes.4,5 This
interaction enables the polymers to enter eukaryotic cells via
endocytosis and might also be beneﬁcial for escape from the
formed endosomes. Diﬀerent theories regarding the endosomal
escape of cationic polymers were hypothesized. The proton
sponge eﬀect is one theory, explaining the escape by a burst of the
endosome due to osmotic pressure.6 However, vectors with a
high buﬀer capacity do not always feature enhanced transfection
performance.7,8
An intercalation of the polymer into the membrane could
provide an alternative explanation: Channels may be formed in
the endosomal membrane through which the genetic material or
the polyplex can escape the endosome.9,10 This theory is
supported by in-depth investigations using disruptive peptides,
highly cationic charged poly(amidoamine) (PAMAM) den-
drimers, and poly(allyl ammonium) derivatives.8,9,11
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Polymethacrylates containing tertiary amines have been used
for gene delivery since 1996.12Despite relatively low transfection
performance, poly(2-(N,N-dimethylamino)ethyl methacrylate
(PDMAEMA) represents the most common polymer in this
respect. The replacement of DMAEMA by N-methyl-(2-
aminoethyl)-methacrylate (MAEMA) or (2-aminoethyl)-meth-
acrylate (AEMA) resulted in higher transfection eﬃciencies but
also higher toxicities of the polymers.13,14 Despite the latter,
PAEMA revealed excellent performance for luciferase expres-
sion, as reported by Ming et al. in 2010.15 Recently, our group
investigated the delivery performance of homo- and statistical
copolymers of all three monomers, demonstrating the essential
need for primary and secondary amines for suﬃcient transfection
performance.16
In general, the ﬁne balance between cytotoxicity and
transfection eﬃciency still remains a critical obstacle for the
application of densely charged polymers for transfection
processes. For all homopolymers bearing primary and secondary
amines (such as PAEMA and PMAEMA), high transfection
eﬃciencies are accompanied by high toxicity on eukaryotic
cells.17 The ability to permeate cellular membranes is closely
connected to the toxic eﬀects from membrane disruption.18 The
incorporation of glucopyranose into PAEMA- and PMAEMA-
based polymers resulted in lowered toxicity maintaining
reasonable transfection eﬃciencies, as reported by Reineke et
al.13,19
Shielding with neutral polymers such as poly(ethylene glycol)
(PEG) is a more classical approach.20 The polymer decreases the
surface charges and sterically hinders access to the functional
groups. In turn, this results in a reduction of cytotoxicity, lower
aggregation rates, reduced unspeciﬁc interaction with phag-
ocytes, and a high circulation time in vivo.20 For this reason, PEG
is well approved, applied in several drugs as well as transfection
vectors, and included in FDA approvals.21,22However, a reduced
transfection eﬃciency is observed for shielded gene carriers
compared to unshielded ones as a side eﬀect.22 For instance,
PDMAEMA-g-PEG did not eﬃciently transfect for a degree of
grafting (DG) higher than 30%.23 For ABA block copolymers, a
minimum degree of polymerization (DP) was beneﬁcial (110 for
PDAEMA and 15 for the PEG blocks).24 An increasing number
of patients showing immunological response to PEG has driven
the search for alternative shielding polymers.25,26 Since the
1980s, the number of untreated patients expressing anti-PEG
antibodies has increased from 0.2 to 25% in 2008.25,27 This
results in earlier blood clearance due to the immune system,
thereby obliterating PEG’s beneﬁts such as prolonged circulation
time.28
Hydrophilic poly(2-oxazoline)s (POx) represent an alter-
native for PEG that has come into focus lately.29,30 In particular,
poly(2-ethyl-2-oxazoline)s (PEtOx) feature a high biocompati-
bility (up to 20 g L−1 in vitro and up to 2 g kg−1 in rats).31 POx
can be synthesized by living cationic ring-opening polymer-
ization (CROP), providing a multitude of possibilities for
obtaining building blocks suitable for incorporation into
polymeric gene vectors.32 In 2014, Correia et al. combined
PEtOx with poly(D,L-lactic acid) and polyethylene imine (PEI)
to form micelles for microcircle DNA delivery, representing an
exemplary use of the shielding properties of PEtOx for linear
polymeric vectors.33,34 In 2011, Erlach et al. showed a strong
dependency of the transfection eﬃciency on the DG and DP of
shielding side chains for graft copolymers with a poly(L-lysine)
backbone, which were synthesized via a grafting-onto ap-
proach.35,23
In particular, POx macromonomers with a methacrylate
functionality represent valuable components for the design of
cationic polymers synthesized by reversible addition−fragmen-
tation chain transfer (RAFT) polymerization.36 The macro-
monomers oﬀer the opportunity to incorporate shielding
moieties into cationic vectors to potentially improve viability as
well as transfection eﬃciency. In this study, we exploit a library of
graft copolymers for pDNA delivery. For this purpose, the
primary and secondary amino group bearing monomers AEMA
and MAEMA were copolymerized with PEtOx-based macro-
monomers via RAFT polymerization to shield the cationic graft
copolymer backbone (Scheme 1). For the optimum copolymer
composition to be identiﬁed, the side chain DP was varied, and
DG values from 10 to 30%were targeted. In comparison with the
PAEMA and PMAEMA homopolymers, the masking regarding
biocompatibility and transfection was investigated in vitro
supported bymeans of ﬂow cytometry and CLSMmeasurements
on HEK cells.
■ EXPERIMENTAL SECTION
Materials. Unless stated otherwise, all chemicals were used without
further puriﬁcation and purchased from standard suppliers. Meth-
acryloyl chloride, anhydrous triethylamine (NEt3), 2-cyano-2-propyl
benzodithioate (CPDB), neutral aluminum oxide, and 2-
(methylamino)ethanol were purchased from Sigma-Aldrich. Di-tert-
butyldicarbonate was obtained fromAlfa Aesar, and 2-aminoethanol was
purchased from TCI. 2,2-Azobis(2-methylpropionitrile) (AIBN) was
received from Acros and recrystallized from methanol prior to use. 2-
Ethyl-2-oxazoline (EtOx, Acros Organics) and methyl p-toluenesulfo-
nate (MeOTs, Sigma-Aldrich) were dried over barium oxide, distilled,
and stored under an argon atmosphere. Acetonitrile (ACN, Sigma-
Aldrich) was dried in a solvent puriﬁcation system (Pure Solv EN,
Scheme 1. Schematic Representation of the RAFT Copolymerization of the Boc-Protected Monomers BocA and BocM with the
OEtOxMAMacromonomers Ox5 (DP = 5) andOx20 (DP = 20) to Obtain the Boc-Protected Graft Copolymers BocA-g-Ox5/20(10/
30) and BocM-g-Ox5/20(10/30), Respectively, and Subsequent Deprotection Yielded the Graft Copolymers with a Cationic
Backbone A-g-Ox5/20(10/30) and M-g-Ox5/20(10/30)
a
aNumbers in brackets indicate the degree of grafting, i.e., 10 or 30, respectively.
Biomacromolecules Article
DOI: 10.1021/acs.biomac.8b00362
Biomacromolecules 2018, 19, 2759−2771
2760
InnovativeTechnology) before used as a polymerization solvent.
Hydrochloric acid (HCl), N,N-dimethylformamide (DMF), and
tetrahydrofuran (THF) were purchased from VWR Chemicals. Linear
poly(ethylene imine) (lPEI, 25 kDa) and branched PEI (bPEI, 25 kDa)
were obtained from Polysciences. Ethidium bromide solution (1%,
10 mg mL−1) was purchased from Carl Roth (Karlsruhe, Germany).
AlamarBlue, YOYO-1 iodide, Hoechst 33342 (10 mg mL−1 solution) as
well as LysoTracker Red DND-99 were obtained from Life
Technologies (Thermo Fisher, Germany). If not stated otherwise, cell
culture media and supplements (antibiotics) were obtained from
Biochrom (Merck Millipore, Germany) and Thermo Fischer
(Germany). Plasmid pEGFP-N1 (4.7 kb, Clontech, USA) encoding
green ﬂuorescent protein (EGFP) was isolated with the Giga Plasmid
Kit provided by Qiagen (Hilden, Germany).
Instruments. The polymerization of EtOx was performed in a
Biotage Initiator Sixty microwave synthesizer.
NMR spectra were recorded on a Bruker AC 300MHz or on a Bruker
AC 250 MHz spectrometer in CDCl3 or D2O at room temperature.
Size exclusion chromatography (SEC) was measured on an Agilent
1200 series system equipped with a PSS degasser, a G1310A pump, a
G1362A refractive index detector, and a PSS GRAM guard/30/10 Å
column series running with N,N-dimethylacetamide (DMAc) with
0.21% of lithium chloride. The Techlab oven was set to 50 °C, and the
molar masses were calculated using a poly(methyl methacrylate)
(PMMA) standard (505−981,000 g mol−1). For the water-soluble
polymers, a Jasco SEC system was used comprising a DG-980-50
degasser, a PU-980 pump, a RI-930 RI detector, and a column oven set
to 50 °C. The system was equipped with AppliChrom ABOA CatPhil
guard/200/350 Å column set and run with an aqueous eluent containing
0.1% triﬂuoroacetic acid and 0.1MNaCl. Poly(2-vinylpyridine) (P2VP)
(1,300−81,000 g mol−1) calibration was used for the graft copolymers.
The PAEMA and PMAEMA homopolymers were analyzed using
dextran calibration (180−277,000 g mol−1) as previously published.16
The macromonomers were analyzed on a Shimadzu SEC system
equipped with an SCL-10A VP system controller, a LC-10ADVP pump,
and an RID-10A refractive index detector using a solvent mixture
containing chloroform, triethylamine, and isopropanol (94:4:2) at a ﬂow
rate of 1 mL min−1 on a PSS-SDV-linear S 5 μm column (PSS GmbH
Mainz, Germany) at 40 °C. The system was calibrated with polystyrene
standards (370−128,000 g mol−1).
Batch dynamic light scattering (DLS) was performed on a Zetasizer
Nano ZS (Malvern Instruments, Herrenberg, Germany). All measure-
ments were performed in folded capillary cells (DTS1070, Malvern
Instruments, Herrenberg, Germany). After an equilibration time of
120 s, 3 × 15 s runs were carried out at 25 °C (λEx = 633 nm). Scattered
light was detected at an angle of 173°. Eachmeasurement was performed
in triplicate. Electrophoretic light scattering (ELS) was used to measure
the zeta potential (ζ). The measurement was also performed on the
Zetasizer Nano ZS by applying laser Doppler velocimetry. For each
measurement, 3 runs were carried out using the slow-ﬁeld reversal and
the fast-ﬁeld reversal mode at 150 V. Each experiment was performed in
triplicate at 25 °C. The zeta potential was calculated from the
electrophoretic mobility (l) according to the Henry equation. Henry
coeﬃcients f(ka) were calculated according to Ohshima.37
Titration.The titration for the determination of the pKa values of the
polymers was performed with an automated titrator 765 Dosimat
(Metrohm, Herisau, Swiss) and a pH detector GMH3530 (GHM
Messtechnik GmbH Standort Greisinger, Regenstauf, Germany). For a
typical measurement, the polymer in ultrapure water (10 mg mL−1) was
acidiﬁed by addition of 10 μL of 6 M hydrochloric acid and stirred while
titrated against a 0.1 M sodium hydroxide solution (0.1 mL min−1) to a
pH value of 12. The titration curves were analyzed via an FTT ﬁt using a
20 points smoothing. The pKa values were estimated using the
Henderson−Hasselbalch equation (eq 1) by determining the
equivalence point from the titration diagram.
= +
−
K
A
HA
pH p log
[ ]
[ ]
a
(1)
Monomer Synthesis. N-tert-Butyloxycarbonyl-(2-aminoethyl)-
methacrylate (BocAEMA, BocA). BocAEMA was synthesized according
to a procedure by Kuroda et al.38 Ten grams (0.162 mol) of 2-
aminoethanol was dissolved in 120 mL of THF and 200 mL of a 1 M
sodium hydroxide solution were added. Then, 35.28 g (0.162 mol) of di-
tert-butyldicarbonate in 80 mL of THF was added dropwise while
cooling the reaction mixture in an ice bath. Subsequent to stirring
overnight at room temperature, the mixture was diluted with ethyl
acetate and washed with water, aqueous sodium bicarbonate solution,
and brine. The aqueous phase was re-extracted with ethyl acetate and
dried over sodium sulfate, and the solvent was removed under reduced
pressure. Without further puriﬁcation, 18.5 g (0.114 mol) of N-tert-
butyloxycarbonyl-2-aminoethanol was diluted with 30 mL of dry
dichloromethane under Schlenk conditions, and 22.6 mL (0.167 mol) of
dry NEt3 was added while cooling the mixture in an ice bath. Fifteen
milliliters (0.155mol) of methacryloyl chloride was added dropwise, and
the reaction was stirred overnight. The mixture was washed with water,
brine, and aqueous sodium bicarbonate solution and dried over sodium
sulfate. The crude oﬀ white product was ﬁnally recrystallized from n-
hexane.
1H NMR (300 MHz, CDCl3): δ [ppm] 1.42 (s, 9H), 1.93 (s, 3H),
3.43 (m, 2H), 4.18 (t, J2= 5.33 Hz 2H), 4.8 (br. s, 1H), 5.57 (s, 1H), 6.10
(s, 1H). 13CNMR (75MHz, CDCl3): δ [ppm] 18.2 (CH3), 28.3 (CH3),
39.6 (CH2), 63.9 (CH2), 79.5 (CH2), 125.8 (Cquart), 136.0 (Cquart),
155.7 (Cquart), 167.2 (Cquart). Yield: 60%, 15.67 g.
N-Methyl-N-tert-butyloxycarbonyl-(2-aminoethyl)-methacrylate
(BocMAEMA, BocM). BocMAEMA was synthesized according to a
procedure by Sinclair et al.39 Ten grams (0.133 mol) of N-
methylaminoethanol was dissolved in 80 mL of chloroform and cooled
in an ice bath. Twenty-nine grams (0.113 mol) of di-tert-butylcarbonate
in 80 mL of chloroform was added dropwise and stirred at room
temperature for 1 h. The solvent was removed under reduced pressure,
and the mixture was puriﬁed by distillation (30 mbar, 180 °C). Under
Schlenk conditions, 21.4 g (0.122 mol) of N-methyl-N-tert-butylox-
ycarbonyl-2-aminoethanol was diluted in 100 mL of dry dichloro-
methane. Then, 49.4 mL (0.366 mol) of triethylamine was added, and
the reaction mixture was cooled in an ice bath. Then, 17.7 mL (0.183
mol) of methacryloyl chloride in 100 mL of dichloromethane was added
dropwise. Subsequent to stirring at room temperature overnight, the
mixture was washed with water as well as brine and dried over sodium
sulfate. Further puriﬁcation was performed by column chromatography
using a mixture of cyclohexane and ethyl acetate (9:1−3:1; v/v, Rf =
0.18, 10:1).
1H NMR (300 MHz, CDCl3): δ [ppm] 1.96 (s, 9H), 2.76 (m, 3H),
3.30 (m, 2H), 4.56 (m, 2H), 5.65 (s, 1H), 6.30 (s, 1H). 13C NMR (75
MHz, CDCl3): δ [ppm] 18.2 (CH3), 28.3 (CH3), 35.2 (CH2), 47.9
(CH3), 62.7 (CH2), 79.7 (CH2), 126.0 (Cquart), 136.1 (Cquart), 155.8
(Cquart), 167.1 (Cquart). Yield: 77%, 22.84 g.
Oligo(2-ethyl-2-oxazoline)methacrylate. The oligo(2-ethyl-2-
oxazoline) methacrylatesOx5 andOx20were synthesized as described in
the literature.40
According to a [M]/[I] of 20 for Ox20 and an initial monomer
concentration of 4 mol L−1, 0.559 g (3 mmol) of MeTos, 5.954 g (60
mmol) of EtOx, and 9 mL of acetonitrile were transferred to a predried
microwave vial under an argon atmosphere. The closed vial was
transferred to the autosampler of the microwave. After a prestirring
period of 30 s, the solution was heated to a temperature of 140 °C for
2 min. The reaction vessel was cooled to room temperature by
pressurized air. The living polymer chains were quenched by addition of
0.34 mL (4.5 mmol) of methacrylic acid and 0.84 mL (6 mmol) of NEt3.
The reaction solution was heated at 50 °C for 20 h. After cooling to
room temperature, 300 mL of dichloromethane was added. The organic
phase was washed with saturated aqueous sodium bicarbonate solution
and brine. The organic layers were dried over sodium sulfate and ﬁltered,
and the solvent was evaporated under reduced pressure (T ≤ 26 °C).
The degree of polymerization was calculated from 1H NMR
spectroscopy by comparison of the proton signal of the initiating
methyl group at 2.95 to 3.05 ppm to the backbone signal from 3.51 to
4.28 ppm (see Figure S1) and the dispersity was determined via SEC
(see Figure S2) using polystyrene calibration.
The resulting polymers were stored at −18 °C.
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1H NMR (300 MHz, CDCl3): δ [ppm] 1.11 (s, 15H), 1.91 (s, 3H),
2.38 (m, 10H), 3.01 (m, 3H), 3.48 (m, 18H), 4.28 (s, 2H), 5.60 (s, 1H),
6.06 (s, 1H).
Ox20: Mn (NMR) 2,100 g mol
−1, Mn (SEC): 2,800 g mol
−1 (PS
calibration), DF 96%, Đ = 1.08. For the synthesis of Ox5, MeTos (12
mmol, 2.234 g), EtOx (60 mmol, 5.966 g), and 9 mL of acetonitrile were
reacted in the microwave for 30 s as described above. The
functionalization was performed as described above using 1.550 mL
(18 mmol) of methacrylic acid and 3.4 mL (24 mmol) of NEt3.Ox5:Mn
(NMR): 600 g mol−1,Mn (SEC): 900 gmol
−1 (PS calibration), DF 94%,
Đ = 1.20.
RAFT Copolymerization. Copolymers of BocAEMA or BocMAE-
MA and Ox5 or Ox20 were obtained by RAFT polymerization. In a
typical RAFT copolymerization experiment for BocA-g-Ox5(30), 1.00 g
of Ox5 (1.08 mmol), 0.586 g of BocAEMA (2.53 mmol), 0.74 mg of
AIBN (4.51 μmol), 3.99 mg of CPDB (18.00 μmol), and 3.61 mL DMF
were mixed with anisole as internal standard (0.118 mL) in a 10 mL
reaction vial. The monomer concentration was kept at 1 mol L−1. The
reaction mixture was degassed with argon for at least 10 min, a t0 sample
was taken, and subsequently, the reaction solution was placed in a
preheated oil bath at 70 °C for 21 h. A te sample for determination of
monomer conversion was taken. Conversion was measured by 1HNMR
spectroscopy in CDCl3 using anisole as an internal standard. The
copolymer was precipitated from THF into a large volume of n-hexane
twice, and size exclusion chromatography on Biobeads SX1 column in
THF was performed. Afterward, the clean product was dried under
reduced pressure. The reaction time was 16.5 h for BocA-g-Ox20(30),
BocA-g-Ox5(10), and BocA-g-Ox20(10) and 15.25 h for the
BocMAEMA copolymers (BocM-g-Ox5/20(10/30)). Additional dialysis
was performed against ultrapure water for 4 weeks using a regenerated
cellulose membrane with a cutoﬀ of 3.5 kg mol−1 for BocA-g-Ox20(30),
BocA-g-Ox20(10), and BocM-g-Ox5/20(10/30). The feed ratios of the
copolymers can be found in Table 1.
BocA-g-Ox5/20(10/30).
1H NMR (300 MHz, CDCl3): δ [ppm] 0.87
(Ha), 1.44 (Hb), 1.82−2.09 (Hc), 2.31−2.40 (Hd), 3.04 (He, 3H), 3.37−
3.45 (Hf), 3.99 (Hg), see Figure S3.
Mn (SEC, DMAc with 0.21% of lithium chloride, PMMA calibration):
BocA-g-Ox5(30), 74,200 g mol
−1 (Đ = 1.27); BocA-g-Ox20(30), 75,000
g mol−1 (Đ = 1.23); BocA-g-Ox5(10), 56,000 g mol
−1 (Đ = 1.26);
BocA-g-Ox20(10), 81,900 g mol
−1 (Đ = 1.36).
BocM-g-Ox5/20(10/30).
1HNMR (300 MHz, CDCl3): δ [ppm] 0.87
(Ha), 1.44 (Hb), 1.91 (Hc), 2.30−2.40 (Hd), 2.92−3.03 (He), 3.45 (Hf),
4.02 (Hg), see Figure S4.
Mn (SEC, DMAc with 0.21% of lithium chloride, PMMA calibration):
BocM-g-Ox5(30), 66,100 g mol
−1 (Đ = 1.33); BocM-g-Ox20(30),
80,000 g mol−1 (Đ = 1.24); BocM-g-Ox5(10), 42,400g mol
−1 (Đ =
1.38); BocM-g-Ox20(10)PB8, 65,100 g mol
−1 (Đ = 1.25).
Deprotection of the Boc-Protected Graft Copolymers. The
Boc-protected copolymers were deprotected using diluted hydrochloric
acid in methanol. In a typical procedure, 300 mg of the polymer was
dissolved in 10 mL of methanol, and 1 mL of hydrochloric acid was
added dropwise. The reaction mixture was stirred at room temperature
overnight. The volatiles were removed under reduced pressure, and the
polymer was dissolved in water and freeze-dried.
A-g-Ox5/20(10/30).
1H NMR (300 MHz, D2O): δ [ppm] 1.05 (CH3
backbone + CH3 side chain EtOx), 1.50−2.09 (CH2 backbone), 2.31−
2.40 (CH2 side chain EtOx), 2.91 (CH3 EtOx initiator), 3.37−3.52
(CH2−N side chain), 4.28 (CH2−O side chain), see Figure S6.
Mn (SEC, H2O, 0.1% triﬂuoric acid and 0.1 M NaCl, P2VP
calibration): A-g-Ox5(30), 18,400 g mol
−1 (Đ = 1.49); A-g-Ox20(30),
17,300 g mol−1 (Đ = 1.54); A-g-Ox5(10), 16,700 g mol
−1 (Đ = 1.44); A-
g-Ox20(10), 22,800 g mol
−1 (Đ = 1.48).
Table 1. Synthesis and Characterization Data of the Boc-Protected Graft Copolymers BocA-g-Ox5/20(10/30) and BocM-g-
Ox5/20(10/30) with the Overall [M]/[CTA] Ratio Kept as 200 for All RAFT Polymerizations
nEtOx feed MA/Oxn [%] conv.NMR
a [%] DPbTheo MA/Oxn
c
NMR [%] MnTheo
d [g mol−1] MnSEC
e [g mol−1] Đe
BocA-g-Ox5(30) 5 70:30 >98 196 55:45 105,300 74,200 1.27
BocA-g-Ox20(30) 20 70:30 >90 180 70:30 121,900 75,000 1.23
BocA-g-Ox5(10) 5 90:10 >90 180 83:17 112,800 56,000 1.26
BocA-g-Ox20(10) 20 90:10 >90 180 85:15 114,600 81,900 1.36
BocM-g-Ox5(30) 5 70:30 >90 184 59:41 103,700 66,100 1.33
BocM-g-Ox20(30) 20 70:30 97 198 69:31 128,900 80,000 1.24
BocM-g-Ox5(10) 5 90:10 90 180 86:14 116,400 42,400 1.38
BocM-g-Ox20(10) 20 90:10 93 186 90:10 125,700 65,100 1.25
aDetermined by 1H NMR spectroscopy from the reaction mixtures. bCalculated from the initial [M]/[CTA] ratio and overall monomer conversion.
cDetermined by 1H NMR spectroscopy of the puriﬁed polymers. dCalculated from conversion and copolymer composition (amino group-containing
monomer MA/macromonomer Oxn).
eDetermined by SEC (DMAc, 0.21% LiCl, PMMA calibration).
Figure 1. (A) Size exclusion chromatograms of the Boc-protected MAEMA-based graft copolymers BocM-g-Ox5/20(10/30) (top, DMAc, 0.21% LiCl,
RI detection) and of the unprotected MAEMA-based graft copolymersM-g-Ox5/20(10/30) (bottom, water, 0.1% triﬂuoroacetic acid, 0.1 MNaCl). (B)
1H NMR spectra of the protected graft copolymer BocM-g-Ox5(10) (black, in CDCl3) and the respective deprotected graft copolymer M-g-Ox5(10)
(red in D2O) including assignment of the peaks to the schematic representation of the structure of BocM-g-Ox5(10).
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M-g-Ox5/20(10/30).
1H NMR (300 MHz, CDCl3): δ [ppm] 1.05
(CH3 backbone + CH3 side chain EtOx), 1.50−2.09 (CH2 backbone),
2.31−2.40 (CH2 side chain EtOx), 2.70−2.91(CH3 EtOx initiator + N−
CH3), 3.37−3.52 (CH2−N side chain), 4.28 (CH2−O side chain), see
Figure 1.
Mn (SEC, H2O, 0.1% triﬂuoric acid and 0.1 M NaCl, P2VP
calibration): M-g-Ox5(30), 20,200 g mol
−1 (Đ = 1.42); M-g-Ox20(30),
13,400 g mol−1 (Đ = 1.30); M-g-Ox5(10), 17,300 g mol
−1 (Đ = 1.43);
M-g-Ox20(10), 17,500 g mol
−1 (Đ = 1.40).
SEC and NMR results are also summarized in Table 2.
PAEMAand PMAEMAHomopolymers.The synthesis of PAEMA
(PA) and PMAEMA (PM) is described in an earlier publication.16
Polyplex Preparation. Following an adjusted method by Pezzoli et
al.,41 polyplexes of pDNA and polymers were prepared by mixing stock
solutions of 15 μg mL−1 of pDNA and diﬀerent amounts of polymers
(1mgmL−1) to obtain various N*/P ratios in HBG buﬀer (20mM4-(2-
hydroxethyl) piperazine-1-ethanesulfonic acid (HEPES) and 5% (w/v)
glucose, pH 7.2). N* is referred to the number of transfection-relevant
potentially protonatable nitrogen atoms (i.e., amine nitrogen atoms) to
exclude amide nitrogen atoms within the polymer structure and P the
number of phosphates from the pDNA in mixture. The solutions were
vortexed for 10 s at maximal speed and incubated at room temperature
for 15 min to ensure complex formation.
Ethidium Bromide Quenching Assay. The formation of
polyplexes with pDNA was examined by quenching of the ethidium
bromide ﬂuorescence. Brieﬂy, 15 μg mL−1 of pDNA in a total volume of
100 μL of HBG buﬀer was incubated with ethidium bromide (0.4 μg
mL−1) for 10 min at room temperature. Subsequently, polyplexes with
diﬀerent amounts of polymer (various N*/P ratios) were prepared in
black 96-well plates (Nunc Thermo Fisher) and incubated at room
temperature for 15 min before the ﬂuorescence measurements. The
ﬂuorescence of the samples was measured at an excitation wavelength of
λ = 525 nm and an emission wavelength of λ = 605 nm using a Tecan
microplate reader. A sample containing only pDNA and ethidium
bromide was utilized to calibrate the device to 100% ﬂuorescence against
a background of 0.4 μgmL−1 of ethidium bromide inHBG solution. The
percentage of dye displaced upon polyplex formation was calculated
using eq 2
=
−
−
*
F F
F F
RFU [%] 100
sample 0
pDNA 0 (2)
where RFU is the relative ﬂuorescence and Fsample, F0, and FpDNA are the
ﬂuorescence intensities of a given sample, the ethidium bromide in HBG
alone, and the ethidium bromide intercalated into pDNA alone.
Heparin Dissociation Assay. Polyplexes with an N*/P ratio of 30
were prepared as described above in a total volume of 100 μL of HBG
buﬀer containing ethidium bromide (0.4 μg mL−1). After incubation in
the dark at room temperature for 15 min, the polyplexes were
transferred into a black 96-well plate, and heparin of indicated
concentrations was added. The solution was mixed and incubated for
a further 30 min at 37 °C in the dark. The ﬂuorescence of ethidium
bromide was measured at λEx = 525 nm/λEm = 605 nm with a Tecan
microplate reader. The percentage of intercalated ethidium bromide was
calculated as described before.
Determination of Cytotoxicity. Cytotoxicity studies were
performed with the mouse ﬁbroblast cell line L929 (CCL-1, ATCC)
as recommended by ISO10993-5. The cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM, Biochrom) supplemented with 10%
fetal calf serum (FCS), 100 U mL−1 penicillin, and 100 μg mL−1 of
streptomycin at 37 °C in a humidiﬁed 5% (v/v) CO2 atmosphere. In
detail, cells were seeded at 104 cells per well in a 96-well plate and
incubated for 24 h. Afterward, the polymers at diﬀerent concentrations,
ranging from 5 to 330 μg mL−1, were added to the cells, and the plates
were incubated for additional 24 h. Subsequently, the medium was
replaced by a mixture of fresh culture medium and alamarBlue solution
(Life Technologies, Germany) prepared according to the manufac-
turer’s instructions. After a further incubation of 4 h at 37 °C, the
ﬂuorescence was measured at λEx = 570/λEm = 610 nm with untreated
cells on the same well plate serving as negative controls. The negative
control was standardized as 0% of metabolism inhibition and referred to
as 100% viability. Data are expressed asmean± SD of three independent
determinations.
Hemolysis Assay. The interaction of polymers with cellular
membranes was examined by analyzing the release of hemoglobin
from erythrocytes. Blood from sheep, collected in heparinized tubes, was
provided by the Institute of Animal Science and Animal Welfare,
Friedrich Schiller University Jena. The blood was centrifuged at 4,500 g
for 5 min, and the pellet was washed three times with cold 1.5 mM
phosphate-buﬀered saline (PBS, pH 7.4). After dilution with PBS in a
ratio of 1:7, aliquots of erythrocyte suspension were mixed 1:1 with the
polymer solution and incubated in a water bath at 37 °C for 60 min.
After centrifugation at 2,400 g for 5 min, the hemoglobin release into the
supernatant was determined spectrophotometrically using a microplate
reader at 544 nmwavelength. Complete hemolysis (100%) was achieved
using 1% Triton X-100 serving as positive control. Pure PBS was used as
negative control (0% hemolysis). The hemolytic activity of the
polycations was calculated as follows (eq 3)
= *
−A A
A
%hemolysis 100
( )sample negative control
positive control (3)
A value less than 2% hemolysis rate was classiﬁed as nonhemolytic,
2−5% as slightly hemolytic, and values >5% as hemolytic. Experiments
were run in triplicate and were performed with three diﬀerent blood
donors.
Erythrocyte Aggregation. Erythrocytes were isolated as described
above. The erythrocyte suspension was mixed 1:1 with the polymer
solutions (100 μL total volume) in a clear ﬂat-bottomed 96-well plate.
The cells were incubated at 37 °C for 2 h, and the absorbance was
measured at λ = 645 nm in a microplate reader. Cells, which were treated
with PBS, served as negative control, and 25 kDa bPEI (50 μg mL−1,
Polysciences) was used as positive control. Absorbance values of the test
Table 2. Characterization of Deprotected Polymers A-g-
Ox5/20(10/30) and M-g-Ox5/20(10/30)
polymer nEtOx
DGa
[%]
Mn
b
[g mol−1] Đd pKa
c
mol%
Oxe DPfTheo
A-g-
Ox5(30)
5 41 18,400 1.49 7.60 77 196
A-g-
Ox20(30)
20 41 17,300 1.54 7.36 88 180
A-g-
Ox5(10)
5 16 16,700 1.44 7.42 53 180
A-g-
Ox20(10)
20 10 22,800 1.48 7.41 82 180
M-g-
Ox5(30)
5 40 20,200 1.42 7.60 77 184
M-g-
Ox20(30)
20 31 13,400 1.30 7.42 82 198
M-g-
Ox5(10)
5 17 17,300 1.43 7.91 56 180
M-g-
Ox20(10)
20 16 17,500 1.40 7.56 72 186
PAd 0 0 11,700 1.98 7.71 0 163
PMd 0 0 13,400 2.04 7.01 0 167
aDegree of grafting determined from the 1H NMR spectra.
bDetermined by SEC (water, 0.1% triﬂuoroacetic acid, 0.1 M NaCl,
RI detection, P2VP calibration). cCalculated from the titration curve of
the acidiﬁed polymers (10 mg mL−1 in water) against 0.1 M NaOH
solution. dPAEMA and PMAEMA data previously published, DPAF4
163/167.16 Dextran calibration was used for SEC. eCalculated from
the 1H NMR spectra of the corresponding Boc-protected copolymers.
fCalculated from the initial [M]/[CTA] ratio and overall monomer
conversion.
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solutions lower than the negative control were regarded as aggregation.
Experiments were run in triplicate and were performed with three
diﬀerent donor bloods from sheep.
Polyplex Uptake. HEK-293 cells (CRL-1573, ATCC) were
routinely cultured in DMEM medium (1 g L−1 glucose) supplemented
with 10% FCS, 100 μg mL−1 of streptomycin, 100 IU mL−1 of penicillin,
and at 37 °C in a humidiﬁed 5% (v/v) CO2 atmosphere.
For kinetic studies of polyplexes, cells were seeded at a density of 105
cells per mL in 24-well plates and cultured for 24 h. One hour prior to
the addition of polyplexes, the medium was changed to serum-reduced
OptiMEM or replaced by fresh growth medium (DMEM). The pDNA
was labeled with YOYO-1 iodide prior to polyplex preparation in HBG
buﬀer. For labeling of 1 μg pDNA, 0.026 μL of 1 M YOYO-1 solution
was mixed with pDNA and incubated for 15 min at 4 °C protected from
light. Subsequently, the polymers were added at the indicated N*/P
ratio, and polyplexes were formed as described previously. At least 50 μL
of polyplexes in solution were added to the cells. The cells were
harvested 4 h after polyplex addition. For the relative uptake of
polyplexes to be determined, 104 cells were measured by ﬂow cytometry
using a Cytomics FC 500 (Beckman Coulter), and the amount of viable
cells showing YOYO-1 signal (green) were gated.
Regarding the uptake studies via confocal laser scanning microscopy,
HEK-293 cells were seeded and cultured as described above in glass-
bottomed microscopy dishes (CELLSTAR FourWell Plate, Greiner
BioOne, Germany). Prior to polyplex addition, medium was replaced by
fresh DMEM. Polyplexes containing YOYO-1-labeled pDNA was
incubated for 4 h at 37 °C. Afterward, medium was replaced by fresh
DMEM supplemented with Hoechst 3342 for nucleus staining and
LysoTracker Red DND-99 for lysosomal staining. Additionally, 10%
trypan blue solution was added to quench the ﬂuorescence of not
completely internalized polyplexes. Imaging was performed with
LSM880, Elyra PS.1 system (Zeiss, Germany) applying a 63× 1.4 NA
plan apochromat oil objective. Colocalization studies were analyzed
using the ZEN software (Zeiss, Germany) of ﬁve images per experiment.
The experiments were performed independently at least three times.
Transfection of Adherent Cells. For transfection studies, HEK-
293 cells were seeded at a density of 105 cells per mL in 24-well plates
and incubated for 24 h at 37 °C in 5% CO2. One hour prior to
transfection, medium was replaced by 0.5 mL of OptiMEM. Polyplexes
were prepared as described above and were added to the cells (50 μL per
well). After an incubation time of 4 h at 37 °C, the supernatant was
replaced by fresh growth medium, and the cells were further incubated
for 20 h. For analysis via ﬂow cytometry (Cytomics FC 500, Beckman
Coulter), cells were harvested at least 24 h post-transfection by
trypsinization. Dead cells were identiﬁed via counterstaining with
propidium iodide. For determination of transfection eﬃciency, 104
viable cells were measured and cells expressing EGFP (green) were
gated. The experiments were performed independently three times.
■ RESULTS AND DISCUSSION
Polymer Synthesis and Characterization. Within this
study, the potential shielding eﬀect of hydrophilic PEtOx side
chains in methacrylate-based cationic graft copolymers and their
reduction of cytotoxic eﬀects was investigated. As long side
chains may hinder the polyplex formation, we selected to
investigate graft copolymers with side chain DPs of 5 and 20,
respectively. The corresponding Oxn macromonomers Ox5 with
a DP of 5 and Ox20 with a DP of 20 were synthesized via CROP
as described previously.42 Therefore, the living polymer chains
were quenched using methacrylic acid and triethylamine to
introduce the methacrylate functionality at the ω-chain ends.40
The degree of functionalization was found to be nearly
quantitatively as determined by 1H NMR spectroscopy (see
Supporting Information).
Primary as well as secondary amino moieties are suitable for
the complexation of nucleic acids. As a direct comparison for
graft copolymer architectures is missing to date, we included
both into the graft copolymer backbone. For aminolysis-induced
gelation reaction during RAFT polymerization to be avoided, the
amino group containing methacrylates were polymerized as Boc-
protected monomers BocA and BocM according to the
literature.38,39
It is known from the literature that the transfection eﬃciency
of linear PDMAEMA is negligible up to a molar mass of
∼60 kDa.43 Comparable studies on the inﬂuence of other
functionalities in copolymer vectors revealed improved trans-
fection eﬃciencies using molar masses in the range of
10−40 kDa.3,23,44,45 Therefore, the overall [monomer] to
[chain transfer agent] ratio was set to 200 for all RAFT
polymerizations to reach reasonable molar masses. In particular,
the balance between eﬃcient transfection and cytotoxicity seems
to be one of the major issues in vector synthesis. We therefore
aimed at graft copolymers featuring DGs of 10 and 30%,
respectively. Hence, the ratio of amino group-functionalized
monomer and macromonomer was kept 7:3 or 9:1 for both Oxn
macromonomers (DP 5, 20). The combination of the four
comonomers ratios resulted in a library of eight copolymers
covering a broad range of ratios of transfection amine units to
shielding units (Oxn) (Table 1).
The copolymerizations were performed at 70 °C in DMF.
After a reaction time between 15 and 21 h, monomer conversions
above 90% were achieved, resulting in theoretical DP values in
the range of 180−196 as intended. Residual macromonomer was
completely removed by a combination of precipitation, size
exclusion chromatography on a Biobeads SX1 column, and
dialysis against water (see Experimental Section for details).
Accordingly, the SEC elugrams of the puriﬁed graft copolymers
revealed monomodal molar mass distributions with Đ values
between 1.23 and 1.38 (Figure 1A and Figure S5). Molar masses
between 42 and 81 kDa were estimated using PMMA calibration,
which are, however, of little signiﬁcance due to the graft
architecture of the polymers.
The composition of the graft copolymers was determined by
means of 1H NMR spectroscopy using isolated characteristic
signals of the repeating units (see Figure 1B and Figure S6). For
the graft copolymers containing the protected primary amino
moieties BocA-g-Ox5/20(10/30), the methyl signal integral of
the Boc protection group at 1.45 ppm and the methyl end group
of the Ox5/20 side chains at 3.0 ppm were well suited (signals “b”
and “e” in Figure S6). Because of the overlapping methyl signal of
the secondary amino moiety with signal “e”, the composition of
BocM-g-Ox5/20(10/30) was calculated from the ratio of the Boc
signal and the methylene signal of the Ox5/20 side chains at
2.42 ppm (signals “b” and “d” in Figure 1B). The composition of
the graft copolymers comprising Ox20 (i.e., with a side chain DP
of 20) is in good agreement with the comonomer feed ratio. In
contrast, the graft copolymers with a side chain DP of 5 featured a
slightly decreased molar fraction of Boc-protected amino
methacrylate compared to the feed ratio.
The whole library of Boc-protected polymers was deprotected
using 1Mhydrochloric acid inmethanol. Complete deprotection
was proven by the disappearance of the methyl signals at 1.44
ppm in 1H NMR spectra that are assigned to the Boc protection
group (see Figure 1B and Figure S6, Table 2). The composition
of all deprotected graft copolymers was again evaluated from
suitable signals in the 1H NMR spectra and found to be in
reasonable agreement with that of the deprotected polymers
(signals “e” and “g” in Figure 1 were used for this purpose). In
addition, the SEC elugrams of all deprotected graft copolymers
revealed monomodal molar mass distributions. It is thus to be
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expected that no undesired degradation occurred during the
deprotection step, and the initial DG was maintained. In
conclusion, our experimental setup provided a series of eight
graft copolymers with tailored variation and arrangement of
building blocks to introduce shielding of cytotoxic segments
within the polymer architectures. For the comparison of the graft
copolymers with the homopolymers of AEMA (PA) and
MAEMA (PM), homopolymers with comparable DPs of 163
and 167, respectively, were used (see Table 2).16
As the endosomal release is usually inﬂuenced by the pH value
change in the endosome, the pKa values of the amine-functional
graft copolymers were determined by half-automated titration
from acidic to alkaline conditions using 0.1 M NaOH solution
(see Table 2, Figure S7). For this purpose, the turning points
were determined by diﬀerentiation of the ﬁtted titration curves.
Afterward, the pKa values were calculated by the Henderson−
Hasselbalch equation (eq 1). The pKa values between 7.36 and
7.91 are in a comparable range to those of the homopolymers PM
(pKa = 7.01) and PA (pKa = 7.71) (Table 2). These results
conﬁrmed that at least half of the amino moieties of the polymers
are in a protonated state at pH values between 7.2 and 7.4, as
typical for cell culture. As a general trend, the pKa values of the
graft copolymer series comprising secondary amino moietiesM-
g-Oxn are slightly higher than those of the graft copolymers
comprising primary amino groups A-g-Oxn.
Although it is not commonly believed anymore that the
proton-sponge eﬀect is the only reason for eﬃcient gene delivery,
the buﬀering ability still seems to severely impact the
performance of vectors.6 In other studies, we experienced a
trend of the buﬀer capacity linked to the endosomal escape
performance of polymeric vectors from which we would assume
that the polymers with the highest buﬀer capacities show the
highest potential in transfection performance. Therefore, the
buﬀer capacities were calculated from the FTT-smoothed curves
of the titration using eq 4. The titration of HCl against NaOH
solution as reference for low buﬀer capacity of maximum of 0.7 ×
10−4 mol can be found in the literature.46
β =
−
nd (OH )
d pH (4)
The buﬀer capacities are plotted as a function of the pH value
in the pH range from 4 to 10 in Figure 2. In particular, the graft
copolymers featuring a low DG and side chain DP revealed high
buﬀer capacities in the relevant pH range from 7.4 to 5. The
buﬀer capacity decreased with increasing side chain DP.
Biocompatibility and Polyplex Properties. The aim of
the combination of PEtOx-based and cationic building blocks in
graft copolymer architectures was to increase the biocompati-
bility of the corresponding cationic homopolymers with high
charge density, i.e., PAEMA (PA) and PMAEMA (PM). For the
cytotoxicity of the copolymers to be examined, an alamarBlue
assay was performed with polymer concentrations up to
330 μg mL−1 for 24 h (Figure 3A). Furthermore, the polymers
were incubated with erythrocytes obtained from sheep blood to
test membrane destabilization and aggregation of the blood cells
to obtain further information about the polymers’ biocompat-
Figure 2. Buﬀer capacity of the deprotected graft copolymers calculated with eq 4 from titration over pH range for copolymers containing (A) AEMA
and (B) MAEMA.
Figure 3. Bio- and hemocompatibility of the library. (A) Relative
viability of L929 cells after 24 h incubation with the amino-functional
graft copolymers and the homopolymers PM and PA at indicated
concentrations as recommended by ISO10993-5. (B) Hemolysis assay
of erythrocytes after incubation with the polymers at indicated
concentrations. Triton X-100 was used as positive and phosphate-
buﬀered saline (PBS) as negative controls. A value less than 2%
hemolysis is classiﬁed as nonhemolytic, 2 to 5% as slightly hemolytic,
and values >5% as hemolytic. Values represent the mean ± SD (n = 3).
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ibility (Figure 3B). For all experiments, the homopolymers PA
and PM are included as unshielded references (red or black,
Figure 3A).
As known from the literature, primary and secondary amino
groups show disruptive eﬀects on cellular membranes, which
support the endosomal escape but in turn can lead to harsh
membrane damage.47,48 Surprisingly, the six graft copolymers
comprising Oxn side chains with a DP of 20 or featuring a DG of
30% showed no toxic eﬀects at all in the concentration range
from 5 to 330 μg mL−1, yielding viabilities of around 100%.
M-g-Ox5(10) revealed only slightly toxic eﬀects decreasing the
viability to 80%, whereas the viability of cells incubated with
A-g-Ox5(10) decreased to 41% at 330 μg mL
−1, i.e., the highest
concentration tested. Apparently, a DG of 10% in combination
with the rather short Ox5 side chains is not suﬃcient to
completely shield the high amount of primary and secondary
amino groups. In addition, the toxicity of polymers containing
MAEMA (IC50 = 23 μg mL
−1) is slightly lower than for AEMA-
based polymers (IC50 = 19 μg mL
−1).16 The same trend can also
be seen in Figure 3A for the homopolymers PA and PM showing
an exponential decrease of the viability at low concentrations (c <
50 μg mL−1). The fact that the viability of the copolymers was
improved by a factor of 10 and higher points toward the shielding
eﬀect of the oligomeric oxazoline side chains, as known from
PEG shielding.21,49 In the case of erythrocyte hemolysis, no to
low hemolytic activity was detected up to 2% with PBS as
negative control at 0% and Triton X-100 as positive control. In
comparison with the homopolymers PA and PM, a signiﬁcant
reduction of the hemolysis at 100 μg mL−1 can be seen. It is
known that a high charge density can result in high erythrocyte
aggregation and membrane disruption.17,50 A high rate of
aggregation occurred (see Figure S8) for all copolymers, slightly
lower or comparable to commercial bPEI 25 kDa. These results
lead to the conclusion that the membrane activity is still potent
for aggregation but that the graft copolymers do not induce
membrane disruption.
In the next step, polyplex formation and DNA dissociation
were investigated via a competitive assay using ethidium bromide
as intercalation dye into the pDNA (Figure 4A) and heparin as
competitor for the pDNA in the release study (see Figure 4B).
Therefore, polyplexes of all graft copolymers were prepared by
mixing polymer and pDNA at certain N*/P ratios at room
temperature (N* is the number of transfection relevant amines,
and P is the number of phosphates from the pDNA in the
mixture).
All polymers revealed a good binding aﬃnity, in particular at
higher N*/P ratios, indicated by the reduction of ethidium
ﬂuorescence intensity from 100 to 40%. The complex formation
is almost entirely reversible up to a ﬂuorescence intensity of
100% (Figure 4B). In contrast to the homopolymers, an eﬀective
pDNA dissociation from the copolymers was only observed at
very high heparin concentrations starting at 30 μg mL−1.
Apparently, the Oxn side chains of the graft copolymers impede
the displacement by heparin and thus protect the nucleic acid. In
particular, the copolymers A-g-Ox20(10) and M-g-Ox20(10)
revealed high polyplex stability against anionic competitor
molecules because they required more than 4-times higher
heparin supplementation compared to the homopolymers to
achieve 100% release. An explanation for the delayed dissociation
could be the increased DP of the side chains, hampering the
action of heparin as a competitor for the pDNA. Nevertheless,
the reason for the enhanced dissociation properties of the
polymers comprising a DG of 30% remains unclear. DLS
measurements of the copolymers in aqueous 0.1 MNaCl and 0.1
M HCl solution revealed hydrodynamic diameters from 8 to 14
nm (number weighted values, see Figures S9−11).51 The
unexpectedly small number-weighted size average of some of the
polyplexes is potentially due to the overestimation of small
uncomplexed polymer chains in the polyplex solution. The zeta
potential and size distribution of the polyplexes weremeasured in
HBG buﬀer, revealing positively charged complexes (9−21 mV)
of increased size and dispersity (see Table S1). This further
indicates the successful masking (and condensation) of the
anionically charged pDNA within the polyplex at N*/P 30,
which is beneﬁcial for the aﬃnity to the cell plasma membrane
and the intracellular uptake process.
Uptake and Transfection. After successful polyplex
formation, the properties concerning uptake and transfection
eﬃciency were the focus of further studies. For this purpose,
uptake experiments using YOYO-1-labeled pDNA were
performed at 37 °C for 4 h with HEK cells. The repellent
properties of PEG-shielded vectors reported so far reveal no
inﬂuence of serum proteins, showing the same eﬃciencies in
reduced as well as serum-containing medium.52 Such eﬀects have
been reported also for the more hydrophilic poly(2-methyl-
oxazoline).53 For investigating if PEtOx exhibits a similar eﬀect in
our graft copolymers, the uptake experiments were performed in
Figure 4. Polyplex formation and stability studies with pDNA using the graft copolymers A-g-Ox5/20(10/30) and M-g-Ox5/20(10/30) and the
homopolymers PM and PA. (A) Complexation aﬃnity (ethidium bromide quenching assay) of respective polymers at indicated N*/P ratios. N* is the
number of amines, and P is the number of phosphate groups of the pDNA. (B) Dissociation assay of polyplexes formed at N*/P 30 using heparin
(0−40 U mL−1). Values represent the mean ± SD (n = 3).
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serum-reduced OptiMEM and media or serum-containing
growth medium (Figure 5).
In comparison to commercial PEI, stated as the gold standard
for non-viral transfection, the four polymers comprising PEtOx
side chains with a DP of 5 showed comparable uptake eﬃciencies
to PEI, reaching levels from≈ 60 to over 80% after 4 h according
to transfection standard protocol. Polyplexes formed from graft
copolymers with longer PEtOx side chains (Ox20) revealed no or
only low uptake eﬃciencies. In contrast, the degree of grafting
did not inﬂuence the uptake. Presumably, the longer Ox20 chains
hamper the interaction of the amines with the cellular membrane.
Furthermore, an inﬂuence of serum proteins on the uptake
performance could be observed (in particular for MFI values).
The shielding property of PEtOx does not seem to be suﬃcient
for a complete repellent eﬀect of proteins, as an accumulation of
proteins to the polyplex can hinder the internalization. After
successful uptake studies, transfection experiments in HEK cells
were also performed in OptiMEM. Figure 6 shows the
transfection eﬃciency (TE, bars) as well as the mean
ﬂuorescence intensity (MFI, dots).
Surprisingly, the transfection performance diﬀered from the
uptake eﬃciency of pDNA-based polyplexes. As expected from
the previous experiments, copolymers containing side chains
with a DP of 20 (Ox20) showed no transfection eﬃciencies. In
contrast to the cellular uptake, the transfection eﬃciency is
inﬂuenced by the degree of grafting: A-g-Ox5(30) and M-g-
Ox5(30) revealed no transfection eﬃciency. Those copolymers
with a DG of ∼30% seem to be unable to escape the endosomes
even though they have been internalized with high eﬃciencies.
This might be because the higher amount of side chains decreases
the polymer-membrane interaction inside the endosomes and
thereby limits the endosomal escape. The hemocompatibility
tested before (Figure 3B) supports this assumption. The highest
membrane interaction was found for the copolymers A-g-
Ox5(10) andM-g-Ox5(10). Copolymers A-g-Ox5(10) andM-g-
Ox5(10) showed maximum buﬀer capacities of 11.05 and 8.60
mmol between pH values 5 and 9 in contrast to the other
copolymers featuring reduced buﬀer capacities in the range of
6.61 to 2.59 mmol. The maximum buﬀer capacity range of the
best performer A-g-Ox5(10) is shifted to lower pH values
compared to M-g-Ox5(10). The improved TE of the AEMA-
based graft copolymer leads to the assumption that the buﬀer
capacity may inﬂuence the endosomal escape. CLSM measure-
ments conducted on HEK cells transfected using the graft
copolymers with a side chain DP of 5 further supported this
hypothesis (Figure 7).
Images of YOYO-1-stained pDNA complexed with the
indicated polymers revealed localization within HEK cells. For
proving whether the endosomal escape of polymersA-g-Ox5(10)
and M-g-Ox5(10), showing transfection, diﬀers from A-g-
Ox5(30) and M-g-Ox5(30), showing no transfection but good
uptake, a colocalization experiment was performed. Therefore,
the polyplexes, including the references PA, PM, and lPEI
(YOYO-1-labeled), and LysoTracker Red-labeled endolyso-
somes were investigated regarding their colocalization after
4 h. A colocalization of both signals (yellow signals) indicates
that the pDNA is located inside the endolysosomes. Green
signals (YOYO-1) refer to pDNA located outside the
endolysosomes and might indicate an eﬃcient release from the
endosome. Polyplexes of A-g-Ox5(10) and M-g-Ox5(10)
revealed a reduced correlation factor of 0.25 to 0.26 compared
to the polyplexes formed with A-g-Ox5(30) and M-g-Ox5(30)
(0.41 and 0.35). This correlates well with the observed
transfection eﬃciency of A-g-Ox5(10) and M-g-Ox5(10) and
might be linked to amore eﬃcient endosomal release, mandatory
for a successful transfection. In comparison to lPEI (R = 0.17),
both best performers showed slightly higher correlation factors,
which is in agreement with the transfection eﬃciencies obtained.
The homopolymers PA and PM exhibited low correlation
factors, indicating a superior release capability, which is in
accordance with the previously reported data.16
Structure Correlation. Up to this point, the polymers’
properties have only been discussed concerning their DG or side
chain DP. By increasing both, the fraction of shielding units is
increased. For further investigating if simply the overall molar
Figure 5. Cellular uptake study of A-g-Ox5/20(10/30) and M-g-
Ox5/20(10/30) polyplexes (N*/P 30) using YOYO-1-labeled pDNA.
HEK cells were treated with polyplexes for 4 h at 37 °C, and uptake was
analyzed via ﬂow cytometry showing the uptake eﬃciency (bars) in
serum-reduced (plane) and full growth medium (striped) and the MFI
(dots) in serum-reduced (red) and full growth medium (black). Values
represents the mean± SD (n = 3). Data for PA and PM polyplexes at an
N*/P value of 20 are taken from ref 16.
Figure 6. Transfection eﬃciency (black y-axis, bars) and MFI over all
cells (red y-axis, dots) regarding tested graft copolymers in comparison
to the homopolymers PA and PM for adherent HEK cells in OptiMEM
at N*/P 30 after 24 h. The control represents untreated HEK; lPEI
25 kDa was purchased from Polysciences, and lPEI DP 600 was self-
synthesized lPEI with a DP of 600. Values represent the mean± SD (n =
3). Data for PA and PM polyplexes at N*/P value of 20 are taken from
ref 16, and the data for PEI DP 600 are taken from Bus et al.54
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fraction of Ox moieties is directly inﬂuencing the tranfection-
related properties such as buﬀer capacity, hemolysis activity,
viability, and uptake eﬃciency, those properties were plotted
against the Ox mol% in Figure 8. The buﬀer capacity at pH 7
decreases with increasing molar fraction of Ox (Figure 8A). This
is expected as the graft copolymers with higher Ox content
feature fewer amino moieties. The hemolysis rate, and thereby
the strong membrane interaction, is increasing with decreasing
Ox content (Figure 8B). This is in good agreement with the
results obtained for the viability, as we often observe a
Figure 7. Imaging of HEK cells transfected with the indicated polymers in growth media for 4 h and stained with Hoechst (blue) for the cell nuclei,
LysoTracker Red (red) for endolysosomes, and YOYO-1-labeled pDNA (green). Outer ﬂuorescence was quenched with trypan blue. (A) Correlation
factor of LysoTracker Red and YOYO-1 for polyplexes in endolysosomes. (B−E) Representative images of polyplexes formed withA-g-Ox5(10) (B),A-
g-Ox5(30) (C),M-g-Ox5(10) (D), andM-g-Ox5(30) (E). Scale bar represents 20 μm. Data represent mean ± SEM of ﬁve technical and at least three
biological replicates. White arrows indicate examples of colocalized pDNA polymer complexes in endolysosomes.
Figure 8. Structure−property relation of (A) the buﬀer capacity at pH 6, (B) uptakeMFI, (C) viability at 500 μgmL−1, and (D) hemolysis rate at 100 μg
mL−1 against the mol% of 2-oxazoline moieties (see Table 2). Graft copolymers based on AEMA are depicted in red, and MAEMA-based polymers are
depicted in gray.
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dependency of the biocompatibility on the hemolytic properties.
Indeed, the viability is increasing with the molar Ox fraction, i.e.,
with decreasing number of amino moieties (Figure 8C).
Furthermore, the uptake is directly dependent on the molar
fraction of Ox: It is increasing with decreasing Ox content. In
general, it can be summarized that these poperties of the graft
copolymers are independent from the DG or the side chain DP
and only dependent on the overall number of shielding repeating
units, i.e., the molar Ox fraction.
■ SUMMARY AND CONCLUSIONS
An eight membered library of graft copolymers comprising
PAEMA as well as PMAEMA backbones and PEtOx side chains
with a DP of 5 or 20 was successfully obtained. They were fully
characterized using SEC and NMR spectroscopy and featured
pKa values between 7.39 and 7.9. Biocompatibility tests revealed
that already a DG of 10 and a side chain DP of 5 led to a
signiﬁcant reduction of cytotoxic eﬀects with regards to viability
and hemolytic activity with the PEARSON correlation
(calculation model for the signiﬁcance of correlations between
two factors; correlation 0.6 < x > −0.6) of 0.88 and −0.91,
respectively (see Table S2). All graft copolymers were able to
complex pDNA in a suﬃcient and reversible manner. Polyplexes
formed from graft copolymers with a side chain DP of 5 were
eﬃciently internalized into HEK cells. The uptake of these graft
copolymers was dependent on the use of serum-enriched
medium with regards to the MFI after 4 h. This is in contrast
to the shielding properties reported for PEG, which is known for
serum-independent uptake and transfection.29 However, only
the copolymers A-g-Ox5(10) and M-g-Ox5(10) with low side
chain DP and low DG achieved reasonable transfection
eﬃciencies. This leads to the hypothesis that the degree of
shielding (DG of 30 and side chain DP of 20) was too high for the
endosomal escape and, as a consequence, for eﬃcient trans-
fection. Although PEG shielding is usually reported to reduce the
transfection eﬃciency in comparison to the unshielded polymers,
the transfection eﬃciency of PA (45%) was retained in the graft
copolymer A-g-Ox5(10) (Figure 9). Even though a reduction of
the transfection eﬃciency ofM-g-Ox5(10) compared to PM was
observed, a strong improvement in the biocompatibility was
revealed. In comparison to the shielded methacrylate copoly-
mers, the transfection standard lPEI revealed high transfection
eﬃciency but results simultaneously in signiﬁcantly reduced cell
viability.
In fact, the commercial gold standard lPEI includes ∼11%
unhydrolized EtOx units, serving as shielding moieties,55,56
which is obvious from the comparison with the previously
published data for self-synthesized lPEI 600 with a hydrolysis
degree of >98%.57 Figure 9 clearly demonstrates the strong
reduction of the cytotoxic eﬀects of A-g-Ox5(10) and M-g-
Ox5(10) while the transfection eﬃciency of the primary amine-
bearing polymer A-g-Ox5(10) improved against the homopol-
ymer PA.
Our future research will concentrate on further decreasing the
PEtOx content of the graft copolymers to explore if the
transfection eﬃciency can be further improved while maintaining
the beneﬁcial signiﬁcantly reduced cytotoxicity that is induced by
the PEtOx side chains.
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Figure S1: 1H-NMR spectrum (300 MHz, CDCl3) of the macromonomer Ox5 (DP = 5). The 
spectrum was calibrated to the initiating methyl group signal at 3.01 ppm. The unmarked signals 
belong to solvent residues of acetonitrile and dichlorormethane, respectively. 
 
 3 
 
Figure S2: Size exclusion chromatograms of the macromonomers Ox5 and Ox20 (CHCl3, 
triethylamine, isopropanol (94:4:2)), system signal at 12 min. 
 4 
Figure S3: 1H-NMR spectrum (300 MHz, CDCl3) of the protected graft copolymer 
BocA-g-Ox5(10) and assignment of the signals to the polymer structure. 
 5 
Figure S4: 1H-NMR spectrum (300 MHz, CDCl3) of the protected graft copolymer 
M-g-Ox5(10) and assignment of the signals to the polymer structure.  
 6 
 
Figure S5: Top: Size exclusion chromatogram of the Boc-protected AEMA based graft-
copolymers (DMAc, 0.21% LiCl, RI detection). Bottom: SEC elugrams of the deprotected 
AEMA based graft copolymers (water, 0.1% trifluoroacetic acid, 0.1 M NaCl). Solvent signal at 
10 mL and system peak at 11 mL.  
 7 
 
Figure S6: 1H-NMR spectra of BocA-g-Ox5(10) (black in CDCl3) and A-g-Ox5(10) (red in D2O) 
and assignment of the peaks to the structure of the polymers. 
 8 
 
Figure S7: Titration curves of the deprotected graft copolymers (10 mg mL-1 in water) against 
0.1 M NaOH solution. Calculated pKa values are highlighted by a filled circle. 
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Figure S8: Erythrocyte aggregation assay of A-g-Ox5/20(10/30) and M-g-Ox5/20(10/30) at 
indicated concentrations. BPEI with a molar mass of 25 kDa served as positive control and PBS 
as negative control. 
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Figure S9: Intensity-weighted (A, C) and number-weighted (B, D) size distributions of A-g-
Ox20(30) (A-B) and A-g-Ox5(10) (C-D) observed by DLS measurements in 0.1M NaCl solution 
(c(polymer) = 2 mg mL
-1
). All measurements were conducted n = 3. 
 11 
 
Figure S10: Intensity-weighted (A, C) and number-weighted (B, D) size distribution of A-g-
Ox20(30) (A-B) and A-g-Ox5(10) (C-D) observed by DLS measurements in 0.1M HCl solution. 
(c(polymer) = 2 mg mL
-1
). All measurements were conducted n = 3. 
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Figure S11: Intensity-weighted (A, C) and number-weighted (B, D) size distribution of 
polyplexes of A-g-Ox20(30) (A-B) and A-g-Ox5(10) (C-D)  at N*/P 30 observed by DLS 
measurements in 20 mM 4-(2-hydroxethyl) piperazine-1-ethanesulfonic acid (HEPES) and 5% (w/v) 
glucose, pH 7.2. All measurements were conducted n = 3. 
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Table S1: Zeta potentials of the pDNA complexes with A-g-Ox5/20(10/30) and M-g-Ox5/20(10/30) at 
N*/P 30 measured by electrophoretic mobility measurements (20 mM 4-(2-hydroxethyl) piperazine-1-
ethanesulfonic acid (HEPES) and 5% (w/v) glucose, pH 7.2). All measurements were conducted n = 3 
separately (15 measurements each). 
  
Polymer sample 
Number weighted 
size polymer, 
(0.1M NaCl)  
d [nm] 
Number weighted 
size polymer, 
(0.1M HCl) 
 d [nm] 
Zeta potential 
[mV] 
Number 
weighted size 
polyplex,  
d [nm] 
A-g-Ox5(30) 11 12 17.6 51 
A-g-Ox20(30) 15 14 19.1 18 
A-g-Ox5(10) 8 8 15.7 52 
A-g-Ox20(10) 11 12 21.3 50 
M-g-Ox5(30) 10 11 19.5 71 
M-g-Ox20(30) 12 11 13.2 20 
M-g-Ox5(10) 11 10 10.4 59 
M-g-Ox20(10) 11 11 15.2 55 
 14 
Table S2: PEARSON correlation factor, where 0.4 to 0.59 indicates moderate correlation, 0.6 to 
0.79 strong correlation and 0.8 to 1 very strong correlation. 
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3rd generation poly(ethylene imine)s for gene
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Matthias Hartlieb,§ab Antje Vollrath,ab Stephanie Hoeppener,ab Anja Traeger*ab and
Ulrich S. Schubert*ab
Cationic polymers play a crucial role within the field of gene delivery offering the possibility to
circumvent (biological) barriers in an elegant way. However, polymers are accompanied either by a high
cytotoxicity or low efficiency. In this study, a series of high molar mass poly(2-oxazoline)-based
copolymers was synthesized introducing 2-ethyl-2-oxazoline, ethylene imine, and primary amine bearing
monomer units representing a new generation of poly(ethylene imine) (PEI). The potential of these
modified PEIs as non-viral gene delivery agents was assessed and compared to linear PEI by studying the
cytotoxicity, the polyplex characteristics, the transfection efficiency, and the cellular uptake using plasmid
DNA (pDNA) as well as small interfering RNA (siRNA). High transfection efficiencies, even in serum
containing media, were achieved using pDNA without revealing any cytotoxic effects on the cell viability at
concentrations up to 1 mg mL1. The delivery potential for siRNA was further investigated showing the
importance of polymer composition for different genetic materials. To elucidate the origins for this superior
performance, super-resolution and electron microscopy of transfected cells were used, identifying the
endosomal release of the polymers as well as a reduced protein interaction as the main difference to
PEI-based transfection processes. In this respect, the investigated copolymers represent remarkable
alternatives as non-viral gene delivery agents.
Introduction
Within the last decades synthetic polymers emerged as versatile
tools in the field of gene delivery.1 They represent promising
alternatives to viral vectors or lipid-based, non-viral transfection
agents, since they combine the advantages of large scale produc-
tion, simple storage conditions, and the availability of a variety
of architectures with tailored properties, e.g. defined molar
masses, end groups, and functionalities.2 The most prominent
representative of synthetic, cationic polymers utilized for nucleic
acid delivery is the gold standard poly(ethylene imine) (PEI).3,4
Subdivided into a linear (lPEI) and a branched (bPEI) topology,
it reveals one of the highest cationic-charge-densities of all
organic macromolecules.5 Under physiological conditions,
every sixth nitrogen (N) is protonated6 and able to interact with
the phosphate groups (P) of deoxyribonucleic acid (DNA) as well
as ribonucleic acid (RNA) to form nanoscale interelectrolyte
complexes, so-called polyplexes.7–9
lPEI offers the benefit to be synthesized by hydrolysis of
poly(2-alkyl-2-oxazoline)s (POx) using a living polymerization
process resulting in well-defined structures.10 However, these
advantages are accompanied by a severe cytotoxicity and undesired
non-specific interactions with cellular and non-cellular components,
both in vitro and in vivo.11–13 Various attempts have been made to
optimize PEI by focusing on the design of biodegradable14–16 and
biocompatible17,18 derivatives, which represent the 2nd generation
of PEI-based polymers. Carbohydrates, e.g. dextran19 or hydroxyethyl
starch (HES),20 as well as stealth polymers like poly(ethylene glycol)
(PEG)21,22 are extensively studied.23 Approaches as the introduc-
tion of biodegradable linkers, such as disulfide bonds,24–26 the
combination with liposomes27,28 or the utilization of micelles
or nanoparticles in combination with PEI29,30 are further con-
cepts partially fulfilling the complex requirements. Besides the
post-modification of the PEI backbone, the partial hydrolysis
of POx, resulting in P(Ox-stat-EI) copolymers, represents a
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promising approach.31,32 The ‘‘stealth behavior’’ of POx, compar-
able to PEG, facilitates a reduction of cytotoxicity.32,33 Although
the cytotoxicity problem might be solved, the modifications
often result in inefficient gene delivery presumably due to weak
DNA complexation and decreased cell interaction.34 Hence, the
design criteria for a perfect polymeric vector are still unknown and
other polymer characteristics, i.e. the degree of hydrophobicity
or synergistic effects of different polycationic species within
one polymeric vector, have to be considered.17,35
The present contribution focusses on the synthesis of high
molar mass copolymers of lPEI and POx. A combination of
primary and secondary amines as well as non-charged 2-ethyl-2-
oxazoline (EtOx) units was aspired. While different amine
species were used to support the polyplex formation, biocom-
patibility is achieved via the integration of EtOx. To realize the
synthesis of the targeted polymer structure, a post-polymerization
functionalization of partially hydrolyzed high molar mass poly(2-
ethyl-2-oxazoline) (PEtOx) was used. The insertion of alkenes is
followed by the functionalization via thiol–ene click chemistry.
This extraordinary combination of modification techniques offers
a new platform of copolymers which marks the beginning of a
new generation – the 3rd generation of PEI (see Fig. 1).
The designed copolymers were investigated concerning their
in vitro transfection potential including polyplex characterization,
competitor/serum interaction and the cellular uptake mechanism
using plasmid DNA as well as siRNA. For a detailed understanding
of themechanism during the gene delivery process super-resolution
fluorescence as well as electron microscopy were utilized.
Materials and methods
Materials
2-Ethyl-2-oxazoline (EtOx) and methyl tosylate were obtained
from Acros Organics, distilled to dryness (over barium oxide
in the case of EtOx), and stored under argon atmosphere.
Pyridine, methanol, dichloromethane, 4-N,N-dimethylamino-
pyridine (DMAP), 2-(boc-amino)ethanethiol, 2,2-dimethoxy-2-phenyl-
acetophenone (DMPA), trifluoroacetic acid and Amberlysts A21
(free base) were obtained from Sigma Aldrich (Steinhausen,
Germany) and are of analytical grade and were used without
further purification. Acetonitrile was purified on aMBraun solvent
purification system (MB SPS-800). The dye Cy5 was purchased
from Lumiprobe GmbH (Hannover, Germany). N-Succinimidyl-4-
pentenate was prepared according to literature procedures.36 The
commercially available poly(ethylene imine)s, both the branched
(bPEI) as well as the linear (lPEI) type, were purchased from
Polysciences (USA). Poly(methacrylic acid) (PMAA, DP = 200) was
synthesized according to literature procedures.37 The transfection
reagent jetPRIME, used as positive control for siRNA delivery,
was obtained from Polyplus (Polyplus transfection SA, USA).
5-(N-Ethyl-N-isopropyl)amiloride (EIPA) was purchased from
Sigma-Aldrich (Merck, Darmstadt). Ethidium bromide solution
(1%, 10 mg mL1) was purchased from Carl Roth (Karlsruhe,
Germany). AlamarBlue, YOYO-1 iodide, Hoechst 33342 trihydro-
chloride as well as all other indicated CLSM dyes were obtained
from Life Technologies (Thermo Fisher Scientific, Germany). If not
stated otherwise, cell culture media and solutions (L-glutamine,
antibiotics) were obtained from Biochrom (Berlin, Germany).
Plasmid pEGFP-N1 (4.7 kb, Clontech, USA) encoding green
fluorescent protein (EGFP) was isolated with the Giga Plasmid
Kit provided by Qiagen (Hilden, Germany). The siRNA negative
controls (scrambled siRNA, 21 nucleotides, double-stranded) and
the siRNA against egfp (sense 50-GCAAGCTGACCCTGAAGTTCAT-30,
antisense 50-ATGAACTTCAGGGTCAGCTTGC-30) were purchased
from Eurogentech (Seraing, Belgium).
General methods and instrumentation
An Initiator Sixty single-mode microwave synthesizer from Biotage,
equipped with a noninvasive IR sensor (accuracy: 2%), was used for
polymerizations and hydrolyses under microwave irradiation.
Proton (1H) nuclear magnetic resonance (NMR) spectra were
acquired in deuterated methanol, at room temperature using
a Bruker AC 300 MHz spectrometer; chemical shifts (d) are
expressed in parts per million relative to TMS.
Size exclusion chromatography (SEC) was performed using an
Agilent Technologies 1200 Series gel permeation chromatography
system equipped with a G1329A auto sampler, a G131A isocratic
pump, a G1362A refractive index detector, and both a PSS Gram
30 and a PSS Gram 1000 column placed in series. As eluent a
0.21% LiCl solution in N,N-dimethylacetamide (DMAc) was used
at 1 mL min1 flow rate and a column oven temperature of 40 1C.
Molar masses were calculated using a poly(styrene) calibration.
Fig. 1 Overview of different generations of linear poly(ethylene imine) (lPEI). Compared to the original lPEI (1st generation), which has been established
over the last decades, the 2nd generation lPEI contains functional monomer units (black or orange) besides the present ethylene imine units (blue). The
3rd generation lPEI describes the presence of multiple functional units comprising cationic functionalities (blue), functional groups to increase cell
viability (black) as well as a third group of functionalities (orange, e.g. primary amine functionalities or targeting molecules).
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Asymmetric flow field-flow fractionation (AF4) was performed on
an AF2000 MT System (Postnova Analytics, Landsberg, Germany)
coupled to an UV (PN3211, 260 nm (Postnova)), RI (PN3150), multi-
angle light scattering (MALLS, PN3070, 633 nm (Postnova)) and DLS
(ZetaSizer Nano ZS; Malvern) detector. The eluent was delivered by
three different pumps (tip, focus, cross-flow) and the sample was
injected by an autosampler (PN5300) into the channel. The channel
has a trapezoidal geometry and an overall area of 31.6 cm2. The
nominal height of the spacer was 500 mm. A regenerated cellulose
membrane with a molar mass cut-off of 10 kDa served as
accumulation wall. All experiments were carried out at 25 1C with
pure water as eluent. A sample of 10 mL (1 mg mL1) was injected
with an injection flow rate of 0.2 mL min1 and a cross-flow rate
of 1.2 mL min1 for 7 min (detector flow rate 0.5 ml min1, focus
flow rate 1.5 mL min1). After the focusing step, the cross-flow
rate was reduced under an exponential gradient (0.4) within 10 min
to 0 mL min1. The cross-flow was kept constant at 0 mL min1
for 40 min to ensure complete elution. All measurements were
in triplicate.
For the acid/base titration the copolymers P1 to P3 (mB 20mg)
were dissolved in 4 mL deionized water, and 20 mL conc. hydro-
chloric acid were added (0.06 M). The titration was performed
against 0.1 M aqueous sodium hydroxide solution using a 765
Dosimat fromMetrohm, a digital pH/mV-thermometer GMH 3530
from Greisinger electronic, and the EBS9 M Recorder software.
Synthesis of poly(2-ethyl-2-oxazoline) (PEtOx)
The monomer 2-ethyl-2-oxazoline (3.965 g) and the initiator
methyl tosylate (12.42 mg, 0.067 mmol) were dissolved in dry
acetonitrile (6.0 mL) in a microwave vial within a glovebox
under nitrogen atmosphere. After stirring for 2 minutes the
vessel was transferred to a microwave synthesizer and heated for
128min at 140 1C. After cooling to room temperature, a sample was
taken to determine the chain length by 1H NMR. The polymeriza-
tion mixture was diluted with 5 mL of dichloromethane, followed
by precipitation in 250 mL ice-cold diethyl ether. The precipitate
was filtered off, dissolved in deionized water and lyophilized
(yield: 3.720 g, 94%).
PEtOx. DP = 575. 1H NMR (300 MHz, D2O): d 3.70–3.20
(–NR–CH2–CH2), 2.41–2.08 (CH2–CH3), 1.09–0.79 (CH2–CH3)
ppm. SEC (DMAc, LiCl): Mn = 69 000 g mol
1, Ð = 1.3. AF4:
Mn = 57 000 g mol
1, Ð = 1.23.
Synthesis of poly(2-ethyl-2-oxazoline-stat-ethylene imine)
(P(EtOx-stat-EI))
To obtain a specific degree of hydrolysis of P(EtOx-stat-EI),
kinetic studies were performed previously according to litera-
ture procedures.38 The results were used to synthesize PEtOx
with defined degree of hydrolysis in larger scale. Accordingly,
PEtOx (3.510 g, 0.062 mmol) was dissolved in 6 M hydrochloric
acid (36 mL). The reaction mixture was heated in a microwave
synthesizer at 100 1C for 100 min. Subsequently, the excess of
HCl and the resulting propionic acid were distilled off and the
residue was dissolved in 15 mL water. The obtained solution
was neutralized with 3 M aqueous NaOH to a pH value48, and
the remaining solvent was removed under reduced pressure. The
residue was dissolved in DMF and the filtered polymer solution
was precipitated two times in 500 mL cold diethyl ether. The
obtained product was dried at 85 1C under reduced pressure.
1H NMR spectroscopy was used to determine the conversion
of the PEtOx to lPEI. Therefore, the signals from the released
lPEI backbone and the signals from the remaining CH3 group in
the side chain of PEtOx were used (yield: 2.350 g, 91%).
P(EtOx-stat-EI). EtOx : EI [%] = 54 : 46. 1H NMR (300 MHz,
MeOD): d 3.69–3.41 (NR–CH2–CH2), 2.93–2.63 (NH–CH2–CH2),
2.55–2.31 (CH2–CH3), 1.19–1.03 (CH2–CH3) ppm. SEC (DMAc,
LiCl): Mn = 48 000 g mol
1, Ð = 1.28. AF4: Mn = 31 300 g mol
1,
Ð = 1.03.
Synthesis of P(EtOx-stat-EI-stat-ButEnOx) (preP1 to preP3)
The partially hydrolyzed PEtOx, P(EtOx-stat-EI) (1: 659 mg, 2:
654 mg, 3: 647 mg), and the catalyst 4-N,N-dimethylamino-
pyridine (DMAP, 100 mg, 0.82 mmol) were dissolved in a
microwave vial in pyridine (V = 8 mL) at 80 1C. In a second
vial, a defined quantity of N-succinimidyl-4-pentenate (645 mg,
483 mg, 318 mg) was dissolved in the same solvent (4 mL) and
heated up to 80 1C. The two solutions were combined and solvent
was added (3 mL) to yield a 4 wt%mixture of P(EtOx-stat-EI). The
reaction mixture was stirred for 20 h at 80 1C. After cooling to
room temperature the sample was filtered and precipitated into
400 mL ice-cold diethyl ether. The copolymer was filtered off
and washed with 40 mL of diethyl ether. Due to the negligible
effect of the side product N-hydroxysuccinimide on subsequent
reaction steps, no further purification steps were required. The
residue was dried under reduced pressure to constant weight
(yield: 1: 619 mg, 68%, 2: 650 mg, 75%, 3: 625 mg, 77%).
preP1. EtOx : EI : ButEnOx = 54 : 12 : 34%. 1H NMR (300 MHz,
MeOD): d 6.00–5.77 (HCQCH2), 5.18–4.95 (HCQCH2), 3.81–3.40
(NR–CH2–CH2), 3.00–2.74 (NH–CH2–CH2), 2.67 (NHS), 2.60–2.20
(CH2–CH3, CH2–CH2–C2H3), 1.20–0.97 (CH2–CH3) ppm. SEC (DMAc,
LiCl): Mn = 36 000 g mol
1, Ð = 2.12. AF4: Mn = 25 500 g mol
1,
Ð = 1.41.
preP2. EtOx : EI : ButEnOx = 54 : 17 : 29%. 1H NMR (300 MHz,
MeOD): d 6.00–5.78 (HCQCH2), 5.17–4.95 (HCQCH2), 3.81–3.40
(NR–CH2–CH2), 2.95–2.68 (NH–CH2–CH2), 2.59 (NHS), 2.57–2.21
(CH2–CH3, CH2–CH2–C2H3), 1.21–1.00 (CH2–CH3) ppm. SEC (DMAc,
LiCl): Mn = 34 500 g mol
1, Ð = 1.63. AF4: Mn = 30 900 g mol
1,
Ð = 1.33.
preP3. EtOx : EI : ButEnOx = 54 : 23 : 23%. 1H NMR (300 MHz,
MeOD): d 5.99–5.76 (HCQCH2), 5.19–4.96 (HCQCH2), 3.81–3.40
(NR–CH2–CH2), 2.94–2.66 (NH–CH2–CH2), 2.57 (NHS), 2.55–2.25
(CH2–CH3, CH2–CH2–C2H3), 1.22–0.99 (CH2–CH3) ppm. SEC (DMAc,
LiCl): Mn = 36 000 g mol
1, Ð = 1.55. AF4: Mn = 30 400 g mol
1,
Ð = 1.33.
Synthesis of P(EtOx-stat-EI-stat-bocAmButOx) via thiol–ene
functionalization (bocP1 to bocP3)
In a microwave vial, P(EtOx-stat-EI-stat-ButEnOx) (preP1: 253 mg,
preP2: 351 mg, preP3: 360 mg) was dissolved in methanol (2 mL).
In a second vial, the photoinitiator 2,2-dimethoxy-2-phenylaceto-
phenone (DMPA, 49 0.5mg, 0.19 mmol) and a 1.3-fold excess per
double bond of 2-(boc-amino)ethanethiol (193 mL, 239 mL, 205 mL)
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were dissolved in methanol (2 mL), likewise. The combined
solutions (10 wt%) were degassed with nitrogen for 20 min and
the clear solution was stirred in a UV chamber (l = 365 nm)
overnight. Subsequently, the copolymer was precipitated in
200 mL ice-cold diethyl ether. After filtration, the copolymer was
dried under reduced pressure for two days (yield: bocP1: 361 mg,
89%, bocP2: 493 mg, 92%, bocP3: 476 mg, 92%).
bocP1. EtOx :EI :bocAmButOx = 54 :12 :34%. 1HNMR (300MHz,
MeOD): d 3.81–3.40 (NR–CH2–CH2), 3.27–3.16 (S–CH2–CH2),
3.00–2.74 (NH–CH2–CH2), 2.64 (NHS), 2.63–2.55 (S–CH2–CH2),
2.54–2.27 (CH2–CH3, CH2–C2H4–CH2), 1.82–1.57 (CH2–C2H4–CH2),
1.55–1.39 (C(CH3)3), 1.21–1.00 (CH2–CH3) ppm.
bocP2. EtOx :EI :bocAmButOx = 54 :17 :29%. 1HNMR (300MHz,
MeOD): d 3.81–3.41 (NR–CH2–CH2), 3.28–3.16 (S–CH2–CH2),
2.92–2.72 (NH–CH2–CH2), 2.69–2.59 (S–CH2–CH2), 2.58 (NHS),
2.54–2.29 (CH2–CH3, CH2–C2H4–CH2), 1.82–1.56 (CH2–C2H4–CH2),
1.55–1.39 (C(CH3)3), 1.21–1.03 (CH2–CH3) ppm.
bocP3. EtOx : EI : bocAmButOx = 54 : 23 : 23%. 1H NMR
(300 MHz, MeOD): d 3.79–3.41 (NR–CH2–CH2), 3.27–3.17
(S–CH2–CH2), 2.91–2.71 (NH–CH2–CH2), 2.67–2.59 (S–CH2–CH2),
2.58 (NHS), 2.54–2.29 (CH2–CH3, CH2–C2H4–CH2), 1.80–1.56
(CH2–C2H4–CH2), 1.55–1.39 (C(CH3)3), 1.20–1.02 (CH2–CH3) ppm.
Synthesis of P(EtOx-stat-EI-stat-AmButOx) via deprotection
(P1 to P3)
The copolymer P(EtOx-stat-EI-stat-bocAmButOx) (bocP1: 321 mg,
bocP2: 402 mg, bocP3: 420 mg) was dissolved in dichloromethane
(3 mL). Trifluoroacetic acid was added (5 mL) and the reaction
mixture was stirred overnight at room temperature. The copolymer
was precipitated in 400 mL ice-cold diethyl ether. The precipitate
was filtered, washed with 40 mL diethyl ether, dissolved in
methanol and shaken overnight with Amberlyst A21 (free base)
(B0.5 g). The solvent was removed and the copolymer lyophilized
(yield: P1: 240 mg, 95%, P2: 293 mg, 91%, P3: 330 mg, 95%).
P1. EtOx :EI : bocAmButOx = 54 : 12 : 34%. 1H NMR (300 MHz,
MeOD): d 3.76–3.29 (NR–CH2–CH2), 3.11–2.98 (S–CH2–CH2),
2.84–2.65 (NH–CH2–CH2), 2.58 (NHS), 2.57–2.46 (S–CH2–CH2),
2.45–2.16 (CH2–CH3, CH2–C2H4–CH2), 1.83–1.44 (CH2–C2H4–CH2),
1.10–0.89 (CH2–CH3) ppm. SEC (DMAc, LiCl):Mn = 30500 g mol
1,
Ð = 1.60. AF4: Mn = 35300 g mol
1, Ð = 1.74.
P2. EtOx : EI : bocAmButOx = 54 : 17 : 29%. 1H NMR (300 MHz,
MeOD): d 3.68–3.21 (NR–CH2–CH2), 3.01–2.87 (S–CH2–CH2),
2.72–2.56 (NH–CH2–CH2), 2.50 (NHS), 2.48–2.37 (S–CH2–CH2),
2.37–2.08 (CH2–CH3, CH2–C2H4–CH2), 1.70–1.36 (CH2–C2H4–CH2),
1.03–0.82 (CH2–CH3) ppm. SEC (DMAc, LiCl):Mn = 39000 g mol
1,
Ð = 1.58. AF4: Mn = 43700 g mol
1, Ð = 1.72.
P3. EtOx : EI : bocAmButOx = 54 : 23 : 23%. 1H NMR (300 MHz,
MeOD): d 3.87–3.40 (NR–CH2–CH2), 3.23–3.03 (S–CH2–CH2),
2.97–2.75 (NH–CH2–CH2), 2.74–2.57 (S–CH2–CH2), 2.56–2.28
(CH2–CH3, CH2–C2H4–CH2), 1.88–1.56 (CH2–C2H4–CH2), 1.22–0.98
(CH2–CH3) ppm. SEC (DMAc, LiCl): Mn = 31500 g mol
1, Ð = 1.45.
AF4: Mn = 30500 g mol
1, Ð = 1.62.
Copolymer labeling with Cy5
Copolymer P3 (40 mg) and triethylamine (150 mL) were dissolved
in DMF (10 mL). After addition of the cyanine-5-NHS-ester
(0.4 mg) the reaction was stirred at room temperature over-
night. The labeled copolymer was precipitated in 500 mL ice-
cold diethyl ether, filtered and re-dissolved in H2O (15 mL).
Further purification was performed by dialysis against water
using a Spectra/Por 3 dialysis membrane (3500 g mol1 cut-off).
Finally, the product was lyophilized and obtained as a blue
powder. The calculated labeling efficiency (via UV-Vis) for
conjugation was 65% for P3–Cy5 (yield: 27 mg, 67%). lPEI
was treated likewise but dialyzed against a water/methanol
mixture and dried under reduced pressure, subsequently (yield:
2.6 mg, 26%; labeling efficiency: 2%).
Synthesis of linear poly(ethylene imine) (lPEI)
The synthesized copolymer P(EtOx-stat-EI) (DP = 575, 100 mg)
was treated with an excess of 6 M aqueous hydrochloric acid
(1.5 mL) for 2 hours at 100 1C in a microwave synthesizer
to yield a hydrolyzed linear poly(ethylene imine) (DP = 575).
Neutralization and purification via precipitation were per-
formed analogous to the described synthesis of P(EtOx-stat-EI)
(see above). The product lPEI was dried at 85 1C under high
vacuum for 2 days and the degree of hydrolysis was determined
by 1H NMR by correlating the integrals of the PEI backbone and
the remaining methyl group of the PEtOx side chain (yield:
51 mg, 87%).
lPEI. EtOx :EI [%] = 5 :95. 1HNMR (300MHz,MeOD): d 3.58–3.41
(NR–CH2–CH2), 2.91–2.61 (NH–CH2–CH2), 2.56–2.36 (CH2–CH3),
1.18–1.06 (CH2–CH3) ppm.
Polyplex preparation
Polyplexes of pDNA and polymers were prepared by mixing
stock solutions of 15 mg mL1 pDNA and different amounts of
polymers (1 mg mL1) to obtain various N/P ratios (nitrogen
of polymer to phosphate of pDNA) in HBG buffer (20 mM
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) and
5% (w/v) glucose, pH 7.2). The solutions were vortexed for 10 s
at maximal speed and incubated at room temperature for
20 min to ensure complex formation. For the preparation of
polyplexes with siRNA, 1 mM siRNA (final concentration) was
used as described above.
Ethidium bromide quenching assay
The formation of polyplexes with pDNA as well as siRNA was
examined by quenching of the ethidium bromide fluorescence.
Briefly, pDNA (15 mg mL1) or siRNA (1 mM) in a total volume
of 100 mL HBG buffer were incubated with ethidium bromide
(0.4 mg mL1) for 10 min at room temperature. Subsequently,
polyplexes with different amounts of polymer (various N/P ratios)
were prepared in black 96-well plates (Nunc Thermo Fisher).
The samples were incubated at room temperature for 15 min.
The fluorescence of the samples was measured at an excitation
wavelength of 525 nm and an emission wavelength of 605 nm
using a microplate reader (TECAN Infinite M200 Pro, Crailsheim,
Germany). A sample containing only pDNA and ethidium
bromide was used to calibrate the device to 100% fluorescence
against a background of 0.4 mg mL1 of ethidium bromide in
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HBG solution. The percentage of dye displaced upon polyplex
formation was calculated using eqn (1):
RFU½% ¼
Fsample  F0
FpDNA  F0
 100 (1)
Here, RFU is the relative fluorescence and Fsample, F0, and FpDNA
are the fluorescence intensities of a given sample, the ethidium
bromide in HBG alone, and the ethidium bromide intercalated
into pDNA alone.
Heparin dissociation assay
To investigate the release of pDNA from polyplexes, the heparin
dissociation assay was performed. Polyplexes with an N/P ratio
of 30 were prepared as described above in a total volume of
100 mL HBG buffer containing ethidium bromide (0.4 mg mL1).
After incubation in the dark at room temperature for 15 min,
the polyplexes were transferred into a black 96-well plate, and
heparin of indicated concentrations was added. The solution
was mixed and incubated for further 30 min at 37 1C in the
dark. The fluorescence of ethidium bromide was measured
at Ex 525 nm/Em 605 nm with a Tecan microplate reader. The
percentage of intercalated ethidium bromide was calculated as
described before.
Dynamic and electrophoretic light scattering
Dynamic light scattering (DLS) was performed on a Zetasizer
Nano ZS (Malvern Instruments, Herrenberg) with a He–Ne laser
operating at a wavelength of l = 633 nm. All measurements
(30 runs, triplicate) were carried out at 25 1C after an equili-
bration time of 120 s. The counts were detected at an angle of
1731. The mean particle size was approximated as the effective
(z-average) diameter and the width of the distribution as the
polydispersity index of the particles (PDI) obtained by the
cumulants method assuming a spherical shape. Electrophoretic
light scattering (ELS) was used to measure the zeta potential (z).
The measurement was performed on a Zetasizer Nano ZS
(Malvern Instruments, Herrenberg, Germany) by applying laser
Doppler velocimetry. For each measurement, 20 runs were
carried out using the slow-field reversal and the fast-field
reversal mode at 150 V. Each experiment was performed in
triplicate a 25 1C. The zeta potential was calculated from the
electrophoretic mobility (m) according to the Henry equation.
Henry coefficient f (ka) was calculated according to Oshima.
Determination of the cytotoxicity
Cytotoxicity studies were performed with the mouse fibroblast
cell line L929 (CCL-1, ATCC), as recommended by ISO10993-5.
The cells were routinely cultured in Dulbecco’s modified eagle’s
medium (DMEM, Lonza, Basel) supplemented with 10% fetal calf
serum (FCS), 100 UmL1 penicillin and 100 mgmL1 streptomycin
at 37 1C in a humidified 5% (v/v) CO2 atmosphere.
In detail, cells were seeded at 104 cells per well in a 96-well
plate and incubated for 24 h, whereas no cells were seeded in the
outer wells. Subsequently, the testing substances (polymers) at
indicated concentrations (from 0.25 mg mL1 to 1 mgmL1) were
added to the cells and the plates were incubated for further 24 h.
Control cells were incubated with fresh culture medium.
Subsequently, the medium was replaced by a mixture of fresh
culture medium and Alamar-Blue solution (Life technologies,
Darmstadt, Germany), prepared according to the manufacturer’s
instructions. After a further incubation of 4 h at 37 1C, the
fluorescence wasmeasured at Ex 570/Em 610 nm, with untreated
cells on the same well plate serving as negative controls. The
negative control was standardized as 0% of metabolism inhibi-
tion and referred as 100% viability. Cell viability below 70%
was considered indicative of cytotoxicity. Data are expressed as
mean  SD of three determinations.
Hemolysis assay
The interaction of polymers with cellular membranes was investi-
gated by analyzing the release of hemoglobin from erythrocytes.
Blood from sheep, collected in heparinized tubes, was provided by
the Institute of Laboratory Animal Science and Animal Welfare,
Friedrich-Schiller University Jena. The blood was centrifuged at
4500  g for 5 min, and the pellet was washed three times with
cold 1.5 mM phosphate buffered saline (PBS, pH 7.4). After
dilution with PBS in a ratio of 1 : 7, aliquots of erythrocyte suspen-
sion were mixed 1 : 1 with the polymer solution and incubated in a
water bath at 37 1C for 60 min. After centrifugation at 2400  g
for 5 min, the hemoglobin release into the supernatant was
determined spectrophotometrically using a microplate reader
(TECAN Infinite M200 Pro, Crailsheim, Germany) at a wave-
length of 544 nm. Complete hemolysis (100%) was achieved
using 1% Triton X-100 serving as positive control. Pure PBS
was used as negative control (0% hemolysis). The haemolytic
activity of the polycations was calculated as follow (2):
% Hemolysis ¼ 100
ASample  ANegative control
 
APositive control
(2)
A value less than 2% hemolysis rate were classified as non-
hemolytic, 2 to 5% as slightly haemolytic and values 45%
as hemolytic. Experiments were run in triplicates and were
performed with three different batches of donor blood.
Erythrocyte aggregation
Erythrocytes were isolated as described above. The erythrocyte
suspension were mixed 1 : 1 with the polymer solutions (100 mL
total volume) in a clear flat bottomed 96-well plate. The cells
were incubated at 37 1C for 2 h, and the absorbance was
measured at 645 nm in a microplate reader. Cells, which were
treated with PBS served as negative control and 25 kDa bPEI
(50 mgmL1, Polysciences) was used as positive control. Absorbance
values of the test solutions lower than the negative control were
regarded as aggregation. Experiments were run in triplicates and
were performed with three different batches of donor blood.
Polyplex uptake
HEK-293 cells (CRL-1573, ATCC) were cultured in RPMI 1640
medium (Lonza, Basel) supplemented with 10% FCS, 100 mg mL1
streptomycin, 100 U mL1 penicillin and 2 mM L-glutamine at
37 1C in a humidified 5% CO2 (v/v) atmosphere.
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For uptake studies, cells were seeded at a density of 105 cells
per mL in 24-well plates and cultured for 24 h. One hour prior
to the addition of the polyplexes, the medium was changed to
OptiMEM (Life Technologies, Darmstadt, Germany). The poly-
plexes were prepared as described above and at least 50 mL
polyplexes in solution were added to the cells. The plates were
incubated for 4 h at 37 1C, 5% CO2.
For kinetic studies of the polyplex uptake within 4 h, pDNA
was labeled with YOYO-1 iodide prior to the polyplex prepara-
tion. For labeling of 1 mg pDNA, 0.026 mL of 1 M YOYO-1
solution was mixed with pDNA and incubated for 20 min at 4 1C
protected from light. Afterwards, HBG buffer and polymers
were added at the indicated N/P ratio and the polyplexes were
formed as described previously. The cells were harvested 0.5, 1,
2 and 4 h after polyplex addition and 10% trypan blue was
added to quench the outer fluorescence of the cells. For energy-
dependent uptake studies, cells were equilibrated in OptiMEM
at 4 1C 1 h prior polyplex addition. The plates were incubated at
4 1C for 4 h. To determine the relative uptake of the polyplexes,
104 cells were measured by flow cytometry using a Cytomics FC
500 (Beckman Coulter) and the amount of viable cells showing
YOYO-1 signal were gated. Dead cells were identified via counter-
staining with propidium iodide (PI). The experiments were
performed at least three times independently.
For inhibition experiments, cells were treated with 100 mM
5-(N-ethyl-N-isopropyl)amiloride (EIPA) in standard culture media
30 min prior to polyplex addition. Subsequently, P3 and lPEI
polyplexes were added to the cells and incubated for further
4 h. Afterwards, the cells were harvested and analyzed as
described above via flow cytometry or were further prepared
for STEM imaging.
Transfection of adherent cells
For transfection of adherent HEK-293 cells, the cells were
seeded at a density of 105 cells per mL in 24-well plates and
incubated for 24 h at 37 1C, 5% CO2. One hour prior to
transfection, the cells were washed with PBS and supplemented
with 0.5 mL OptiMEM or fresh serum containing growth
medium (RPMI 1640). The polyplexes were prepared as
described above, and were added to the cells (50 mL per well).
After an incubation time of 4 h at 37 1C, the supernatant was
replaced by fresh growth medium and the cells were incubated
for further 20 h. For analysis via flow cytometry (Cytomics FC
500, Beckman Coulter), cells were harvested by trypsinization.
For determination of the viability during flow cytometry, dead
cells were identified via counterstaining with propidium iodide.
For determination of the transfection efficiency, 104 viable cells
expressing EGFP were gated. The experiments were performed
three times independently. Regarding the Bafilomycin experi-
ments, 175 nM Bafilomycin was added to the cells in OptiMEM
and incubated for 20 min, prior to the polyplex addition. The
knockdown studies were performed with stable EGFP expressing
CHO cells (CCL-61, ATCC, stable transfected with pEGFP-N1) and
the corresponding siRNA (against egfp, riboxx, Germany). The
polyplexes were incubated in OptiMEM for 6 h and measured
after 72 h via flow cytometry.
Electron microscopy
Scanning transmission electron microscopy with high-angle
annular dark-field detection (STEM-HAADF) was carried out using
a Technai G2 system (FEI), with 120 kV or 200 kV acceleration
voltage on ultrathin slices of resin-embedded cell samples.
For cell preparation, HEK-293 cells (105 cells mL1) were
seeded on 6-well plates and incubated for 4 h at 37 1C with the
respective polyplex samples (N/P 30). The cells were harvested,
washed with PBS and fixed for 2 h with glutaraldehyde (2% in
PBS, prepared from 8% EM grade stock solution) on ice.
Subsequent to aldehyde fixation, the cells were washed with
PBS prior to the fixation with OsO4 for 1 h (1% in PBS, prepared
from 4% EM grade stock solution, both purchased from EMS,
Hatfield). After this, the cells were washed with MilliQ water
and staining with uranyl acetate solution was carried out for
1 h and protected from light (1% in solution in MilliQ water
prepared from depleted uranyl acetate dihydrate purchased
from EMS, Hatfield). Subsequently, the sample was washed
with pure water prior to dehydration by an ethanol/water series
(50%, 70%, 90%, 2  100% dry EtOH, purified with a Solvent
Purification System and stored over molecular sieves). Thereafter,
the cells were transferred into BEEM capsules (Plano, Wetzlar),
in which the cell suspension was immersed in mixtures of
Embed 812 (EMS, Hatfield) and ethanol (Embed/EtOH = 1 : 1 v/v
for 1 hour, 2 : 1 v/v for 12 h, pure Embed 812 for 4 h).
Subsequent to a further exchange of the embedding medium,
the resin was allowed to harden at 70 1C for 24 h. From the
resin block, ultrathin sections with a thickness of 80 nm were
cut with an ultramicrotome (PT-XL PowerTome, RMC, Tucson)
using a diamond knife (RMC, Tucson). The ultrathin resin
sections were applied on a carbon supported copper grid
(400 mesh, Quantifoil, Jena).
Confocal microscopy and structured illumination microscopy
Live cell imaging was performed for uptake studies. In detail,
HEK cells (105 cells mL1) were seeded on glass-bottomed dishes
(ibidi, Germany, thickness 170  5 mm for high-resolution fluores-
cence microscopy) and cultivated for 24 h in a humidified atmo-
sphere. One hour prior to the polymer addition, the cells were
rinsed with phosphate buffered saline (PBS) and the medium
was changed to OptiMEM. The polyplexes were formed with
Cy5-labeled P3 and YOYO-labeled pDNA or Cy3-labeled siRNA,
added to the cells and incubated for further 4 h. Subsequently,
medium was replaced by fresh culture medium or PBS supple-
mented with Hoechst 33342 for nucleus staining, LysoTracker
Red DND-99 or LysoTracker Green DND-26 (all from Thermo
Fisher Scientific) for lysosome staining.
Imaging was performed with LSM880, Elyra PS.1 system (Zeiss,
Oberkochen, Germany) applying a 63 1.4 NA plan apochromat
oil objective. For SIM imaging, cells were grown on high precision
cover glasses (Marienfeld-Superior, 18  18 mm, 170  5 mm
certified thickness) at a density of 5  104 cells mL1, fixed with
paraformaldehyde (2% in PBS) and embedded in prolong
gold antifading reagent (Thermo Fisher Scientific). Regarding
the SIM performance, excitation wavelengths of 405 nm
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(exc. grating 28.0 mm), 488 nm (exc. grating 34.0 mm), 561 nm
(exc. grating 42.0 mm) and 642 nm (exc. grating 42.0 mm resp.
51.0 mm) were used. The following four color channels were
used for both microscopy techniques: Nucleus (Hoechst 33342
staining, excitation wavelength 405 nm, BP 420–480 + LP 750,
grey), pDNA (YOYO-1 Iodide, excitation wavelength 488 nm,
BP 495–550 + LP 750, green), polymer P3 (Cy-5 labeling, excitation
wavelength 642 nm, LP 655, blue) and lysosome (CellLight
Lysosomes-RFP BacMam 2.0, excitation wavelength 561 nm,
BP 570–620 + LP 750, red). The grating position and axial
position of the sample table were controlled by piezo controllers.
Images were recorded with a sCMOS camera (pco.edge, Kehlheim,
German), cooled to 5 1C. Reconstructions and deconvolution
were performed with the commercial ZEN2 software installed
on the system (Zeiss, Oberkochen, Germany).
Statistical analysis
The values represent the mean  SD. For the calculation of
the standard derivation of two or more different groups, the
two sample t-test (student’s t-test) or the ANOVA was used.
Statistical significance was defined as * for p-values of o0.05
and # for p-values o0.005.
Results and discussion
Polymer synthesis
As chain transfer reactions are more likely to occur during poly-
merization of 2-methyl-2-oxazoline,39 2-ethyl-2-oxazoline was used
as monomer for the polymerization of the precursor homopolymer,
being able to decrease cytotoxicity of aspired copolymers.40
PEtOx was synthesized according to a literature procedure by
microwave supported cationic ring-opening polymerization
(CROP).41 The degree of polymerization of 575 was calculated
from the tosylate 1HNMR signals of MeOTos before purification.
In order to ensure the absence of water, the polymerization
solutions were prepared in a glove box under nitrogen atmo-
sphere yielding PEtOx with a dispersity Ð of 1.3 (SEC: DMAc,
0.21% LiCl, standard: PS, Table 1). This homopolymer served as
precursor for the subsequent copolymer synthesis.
PEtOx was hydrolyzed in a microwave synthesizer (Scheme 1a)
to yield the copolymer poly(2-ethyl-2-oxazoline-stat-ethylene
imine) (P(EtOx-stat-EI)) with an EtOx content of 54% (calc.
from 1H NMR).38
To introduce primary amines to the polymers, a fraction of
the ethyleneimine units was functionalized with N-succinimidyl-
4-pentenate to introduce alkene functionalities (Scheme 1b).42
While the synthesis of poly(2-butenyl-2-oxazoline) is possible via
the polymerization of the respective monomers,36 these units
do not withstand the conditions of the acidic hydrolysis of
PEtOx. Three different copolymers of P(EtOx-stat-EI-stat-ButEnOx)
(preP1 to preP3) with varying ratios of secondary amines and
2-(3-butenyl-2-oxazoline)s (1 : 3, 1 : 2, 1 : 1) were synthesized
while maintaining a constant EtOx content of 54% (Table 1). The
introduction of primary amines was performed by thiol–ene photo-
addition. Hence, the copolymers P(EtOx-stat-EI-stat-AmButOx)
(P1 to P3) were synthesized by reaction of the corresponding
precursor copolymers (preP1 to preP3) with a protected aminothiol
under UV irradiation and subsequent deprotection to yield the
primary amine group (Scheme 1c and d).
Characterization by 1H NMR spectroscopy confirms the
presence of 2-ethyl-2-oxazoline (EtOx) as well as ethylene imine
(EI) units (Fig. 2, PEtOx and P(EtOx-stat-EI)). The integrals of
the signals of the EtOx side chain (A, B) as well as the signals of
the backbone (C) remain constant during further reactions and
are, therefore, used as reference.
The successful functionalization with the activated acid
N-succinimidyl-4-pentenate is exemplified by the proton signals
of the double bond (ButEnOx) that appear at 5.9 ppm (–HCQCH2,
H) and 5.1 ppm (–HCQCH2, I) for the copolymer preP3. The
first signal is used to calculate the composition of the formed
copolymer by comparing the signals of the ethylene imine
backbone (between 3.00 to 2.66, NH–CH2–CH2, D) and the methyl
protons of the EtOx side chain (between 1.22 to 0.97, CH2–CH3, A).
The successful functionalization of preP1 to preP3 with the thiol
is shown by the disappearance of the double bond signals after
the photoaddition (bocP3). The signals of the newly formed CH2
groups appear at 2.40 (I0) and 1.70 ppm (H0), respectively.
Furthermore, a singlet of the tert-butyloxycarbonyl (boc) pro-
tecting group is obtained at 1.50 ppm (L). After treatment with
Table 1 Composition and molar masses for PEtOx, P(EtOx-stat-EI), preP1 to preP3 and P1 to P3
Compositiona Amine ratio NMRb AF4 SEC
Abbr. Name X [%] Y [%] secX : primY Mn [g mol
1] Mn [g mol
1] Ð Mn [g mol
1] Ð
PEtOx PEtOx575 — — — 57000 57 000 1.2 69 000 1.3
P(EtOx-stat-EI) P(EtOx54%-stat-EIX) 46 — — 42100 31 300 1.3 48 000 1.3
preP1 P(EtOx54%-stat-EIX-ButEnOxY) 12 34 — 58100 25 500 1.4 36 000 2.1
preP2 P(EtOx54%-stat-EIX-ButEnOxY) 17 29 — 55800 30 900 1.3 34 500 1.6
preP3 P(EtOx54%-stat-EIX-ButEnOxY) 23 23 — 53000 30 400 1.3 36 000 1.6
P1 P(EtOx54%-stat-EIX-AmButOxY) 12 34 1 : 2.8 73 200 35 300 1.7 30 500 1.6
P2 P(EtOx54%-stat-EIX-AmButOxY) 17 29 1 : 1.7 68 600 43 700 1.7 39 000 1.6
P3 P(EtOx54%-stat-EIX-AmButOxY) 23 23 1 : 1 63 100 30 500 1.6 31 500 1.5
a Determined by 1HNMR (calculated from the ratio of EtOx, ButEnOx signals and EI backbone). b Determined by 1H NMR (calculated from tosylate
signals of MeOTos before purification).
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trifluoroacetic acid (TFA) and precipitation into diethyl ether,
the signal of the protecting group disappears, indicating the
successful deprotection of bocP1 to bocP3 and, consequently,
the synthesis of P(EtOx-stat-EI-stat-AmButOx) (P1 to P3).
A comparison of the composition and molar masses of
the prepared copolymers obtained by asymmetric flow field-
flow fractionation (AF4) and size exclusion chromatography
(SEC) is shown in Table 1. Although a trend is clearly visible,
the obtained values should be handled with care due to the
fact that the introduction of double bond containing ButEnOx
units as well as the cationic amine units (primary and secondary)
could lead to undesired column and membrane interactions
and, hence, to a change in the elution behavior. SEC traces,
exemplified for the synthesis of P2, are depicted in the ESI†
(Fig. S1).
To enable in vitro imaging, copolymer P3 was labeled using
one equivalent of Cy5–NHS per polymer chain. Successful dye
functionalization and purification via dialysis (3500 g mol1
cut-off) was verified by size exclusion chromatography (SEC),
revealing no trace of unbound dye (ESI,† Fig. S2).
Bio- and hemocompatibility
Biocompatibility represents a critical parameter for PEI based
polymers. One option to reduce the known cytotoxicity of PEI12,13,43
Scheme 1 Schematic representation of the synthesis of cationic copolymers. (a) Partial hydrolysis of poly(2-ethyl-2-oxazoline) in a microwave
synthesizer, (b) post-polymerization functionalization with N-succinimidyl-4-pentenate, (c) thiol–ene photo-addition of 2-(boc-amino)ethanethiol at
365 nm and (d) deprotection using trifluoroacetic acid.
Fig. 2 Comparison of 1H NMR spectra of PEtOx, P(EtOx-stat-EI), preP3, bocP3 and the final product P3 (* side product N-hydroxysuccinimide)
(300 MHz, MeOD).
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is the introduction of EtOx units.31 The copolymers introduced
here (P1 to P3) possess an oxazoline content of 54%, expected to
decrease severe cytotoxic effects. The cytotoxicity of P1 to P3 was
investigated in comparison to lPEI (Fig. 3A), obtained by full
hydrolysis of P(EtOx-stat-EI). Besides lPEI, commercial available
linear poly(ethylene imine) (comlPEI, 25 kDa, Polyscience) was
used as internal control. The results of the following in vitro
experiments performed with comlPEI are summarized in the
ESI† (Fig. S18–S20).
As assumed, lPEI leads to a significant reduction of cell
viability at low concentrations (IC50 of 3.6 mg mL
1), which is
in accordance to literature data.3 Despite a high molar mass
(425 kDa), P(EtOx-stat-EI) as well as P1 to P3 showed no
cytotoxicity after 24 h using polymer concentrations up to
1 mg mL1 (IC50 4 1 mg mL
1, Fig. 3A). This improvement
on cell viability is attributed to the introduced EtOx content of
54% within the copolymers and is consistent with literature
reports on partially hydrolyzed POx.32
The blood compatibility of the copolymers was further
investigated by assessment of the hemolytic activity (Fig. 3B)
as well as the aggregation of erythrocytes. The treatment of
P(EtOx-stat-EI) and P1 to P3 did not show any hemolytic activity in
a concentration range from 10 to 50 mg mL1. A slight hemolysis
(B1% hemoglobin release) could be revealed at higher concen-
trations of P(EtOx-stat-EI) and P1 (100 mg mL1). In contrast, lPEI
revealed an increased interaction with the cellular membranes
of the blood cells resulting in hemoglobin releases above 2%
(100 mg mL1) and, moreover, in a strong agglomeration of
erythrocytes (see ESI,† Fig. S3 and S4). The later was not
observed with EtOx containing copolymers (P(EtOx-stat-EI),
P1 to P3) indicating a good hemo- and biocompatibility.
Characterization of the polyplexes
Despite the beneficial impact of EtOx on the biocompatibility
of the polymers, their impact on the polyplex formation was
investigated. For this purpose, the ethidium bromide quenching
assay (EBA) was used to investigate the condensation of plasmid
DNA (pDNA) by P1 to P3 as well as P(EtOx-stat-EI), at different
nitrogen (polymer) to phosphate (DNA) ratios (N/P). Ethidium
bromide is excluded from its binding sites within the oligo-
nucleotides because of the electrostatic and hydrophobic inter-
actions between polymer and the nucleic acid, leading to a
reduction in fluorescence that can be correlated to the affinity
of the complexation.44,45 All copolymers (P1 to P3) revealed
decreasing fluorescence intensities below 40% relative fluores-
cence units (RFU, Fig. 4A). Stable polyplexes indicated by a
plateau were reached at higher N/P ratios 5 to 40, whereby no
significant differences between P1, P2, P3 and lPEI were
observed. In contrast, the precursors PEtOx (data not shown)
and P(EtOx-stat-EI) did not form appropriate polyplexes. It can
be assumed that the EtOx units prevent a strong binding
of the DNA to the secondary amines of the PEI backbone.
This reduced complexation affinity is compensated by the
introduction of the more flexible side chains consisting of
AmButOx (primary amines) within P1 to P3, which apparently
are essential for the polyplex formation. Interestingly, the combi-
nation of EI and AmButOx seems to be beneficial, since a
comparable copolymer P(MeOx-stat-AmButOx) without ethylene
imine units revealed reduced pDNA complexation around 60% RFU
in a previous study.17 A synergistic effect between both, primary
amines in the side chain and secondary amines in the backbone,
leads to an improved binding of DNA despite an EtOx content of
54%. The following studies of P1 to P3 were performed with
polyplexes formed at N/P 30 as this guarantees stable polyplex
formation.
To analyze the stability and the dissociation properties
of the formed polyplexes, the heparin dissociation assay was
performed.46–48 Heparin, a sulfated glycosaminoglycan, has
an anionic character and competes with the nucleic acid of
the polyplex. With increasing amount of heparin, the pDNA
dissociates from the polymer and the polyplex dissolves. As
indicated in Fig. 4B, polyplexes formed with partially hydro-
lyzed PEtOx (P(EtOx-stat-EI)) as well as P2 and P3 polymers
revealed a reversible binding, achieving 80% dissociation at
5 U mL1 heparin. A higher heparin concentration (20 U mL1)
was required for P1 reaching 80% dissociation. One reason for
Fig. 3 Determination of bio- and hemocompatibility. (A) Relative viability of L929 cells after 24 h incubation with the polymers at different
concentrations according to ISO10993-5. (B) Hemolysis assay of erythrocytes after incubation with polymers at the indicated concentrations. Triton
X-100 served as positive control (98.8% hemolysis) and PBS as negative control (0.2%). A value less than 2% hemolysis rate was classified as non-
hemolytic, 2 to 5% as slightly hemolytic and values 45% as hemolytic. Values represent the mean  S.D. (n = 3).
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this might be the higher amount of AmButOx, responsible for
an enhanced binding to the genetic material. However, a full
release from the copolymers P1 to P3 could not be achieved using
heparin. Therefore, another polyanion, namely poly(methacrylic
acid) (PMAA, DP = 200), was successfully used as competitor
(Fig. S5, ESI†). lPEI required an increased amount of heparin
(40 U mL1) as compared to the copolymers. These results
confirm the weakening of the electrostatic interactions caused
by the presence of EtOx units, which are beneficial for a fast
release of the genetic material.
As polyplexes are usually internalized into cells via endocytic
pathways, the size as well as the charge of the complexes is of
crucial importance. For efficient delivery, critical sizes of poly-
meric nanocarriers up to 200 nm are recommended.33,49
As depicted in Table 2, the polyplexes formed with P1 to P3 at
N/P 30 exhibit a favorable size of approximately 150 nm with a
positive net charge, as determined by dynamic and electro-
phoretic light scattering. P(EtOx-stat-EI) formed complexes
with a z-average of 242  73.4 nm and high polydispersity
(0.46) supporting the inefficient polyplex formation as observed
by EBA.50 Polyplexes formed with lPEI revealed a smaller
complex size of 80 nm with a positive net charge comparable
to previous studies.46 These results support our assumption that
the EtOx units impede the compact packaging of the genetic
material into small polyplexes. This can be compensated by the
presence of AmButOx units resulting in polyplex sizes between
lPEI and loosely bound P(EtOx-stat-EI) polyplexes. Therefore,
the tailored combination of EtOx and AmButOx units within
the copolymer structure can be used to design polyplexes with
required properties.
Transfection efficiency
Based on the previous results, the polymers P1 to P3 appear
to be promising candidates as non-viral gene delivery agents
and were, therefore, analyzed regarding their transfection
efficiency (TE) using human embryonic kidney (HEK) cells
and pDNA containing a enhanced green fluorescence protein
reporter gene (egfp). The TE was determined by flow cytometry
analyzing all viable cells (PI staining) which successfully
express EGFP (see ESI,† Fig. S6 and S7). To investigate
the interaction with serum proteins, a side effect of cationic
polymers, the cells were transfected in serum reduced media
(OptiMEM) and in serum containing media (RPMI1640 supple-
mented with 10% FCS) (Fig. 5). The use of serum offers
test conditions more comparable to an in vivo situation and
represents a known challenge for the performance of the
polymers due to the inhibitory effect of serum proteins on
the cellular uptake process.51,52
It should be noted that higher N/P ratios were required for
the copolymers as all nitrogen atoms were taken into account
for the N/P calculations. This includes also the amide function-
alities of EtOx and AmButOx although they are not capable to
interact with the pDNA. P1-based polyplexes were less efficient
as indicated by a TE below 50%. High TEs over 60% were
achieved in serum reduced conditions for P2 and P3 polyplexes
at N/P 30 to 50. Comparable TEs were obtained for lPEI at
N/P20. Compared to the transfection in OptiMEM, the EGFP
transfection level of P1 to P3 at N/P 50 in serum containing
media did not change considerably. Due to the cytotoxic effect
of lPEI and the influence of serum proteins the cell viability as
well as the TE decreased rapidly with increasing N/P ratios.
The combination of high cell viability (no cyto-/hemotoxicity)
and formidable transfection performance even in the presence
of proteins underlines the potential of P2 and, in particular, P3
as preferable gene delivery vectors. Moreover, P3 also withstands
Fig. 4 Polyplex formation and stability with pDNA using the polymers P(EtOx-stat-EI), P1, P2, P3 as well as lPEI, which was used as positive control.
(A) Complexation affinity (ethidium bromide quenching assay) of all polymers at the indicated N/P ratios. (B) Dissociation assay of polyplexes formed at
N/P 30 using heparin. Values represent the mean  S.D. (n = 3).
Table 2 Size and surface charge (zeta potential) of pDNA complexes at
N/P 30measured via dynamic light as well as electrophoretic light scattering
Polymeric system z-Average [d, nm] PDI Zeta potential [mV]
P(EtOx-stat-PEI) 242  73.4 0.46 20  0.44
P1 158  1.0 0.23 27  0.25
P2 143  1.4 0.21 23  0.11
P3 154  1.4 0.23 23  0.12
lPEI 80  2.3 0.17 33  4.23
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a comparison to lPEI and the literature known ‘gold standard for
transfection’, comlPEI (see ESI,† Fig. S18).
Uptake mechanism
For cationic polyplexes, the internalization into cells by endo-
cytosis followed by the endosomal release of the pDNA into
the cytosol and the subsequent transport into the nucleus
is reported.53,54 To clarify this process and to understand
the excellent transfection performance of the copolymers,
the uptake mechanism was investigated. An uptake kinetic
using polyplexes formed with YOYO-1 labeled pDNA was
performed to detect the internalization within cells by flow
cytometry (Fig. 6). All tested polymers exhibited a fast and time-
dependent cellular uptake. In detail, almost 90% of measured
cells internalized polyplexes after 4 h when medium is changed
Fig. 5 Transfection efficiency of copolymers P1 to P3 and lPEI for adherent HEK cells in serum reduced (OptiMEM, light grey) and serum containing
media (RPMI + 10% FCS, dark grey) at different N/P ratios after 24 h. Values represent the mean  S.D. (n = 3).
Fig. 6 Uptake study. Polyplexes formed with YOYO-1 labeled pDNA were incubated with HEK cells in OptiMEM for indicated time points using the
copolymers P1 to P3 and lPEI (N/P ratio 30) as control. Statistical analysis (t-test) was used to compare the MFI after 4 h of P1 with P3 and lPEI,
* represents p o 0.05 and # p o 0.005 of MFI values using student’s t-test. Values represent the mean  S.D. (n = 3).
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according to standard transfection protocol. In particular, P1 as
well as lPEI showed an enhanced uptake efficiency after 30 min
(B60%) compared to P2 and P3 (40%). Although most of the
cells internalized polyplexes, the quantities (mean fluorescence
intensities, MFI) differ significantly after 4 h (Fig. 6). Higher
internalized polyplex concentrations were detected in cells
using P2, P3 (twofold) and P1 (threefold) compared to lPEI.
An explanation might be the introduction of AmButOx to
the copolymers for enhanced complexation with the genetic
material and cellular uptake, while the EtOx content possessing
reduced membrane disruption.
To preclude an uptake by passive membrane diffusion, the
uptake of YOYO-1 stained polyplexes was performed at 4 1C and
37 1C, respectively (Fig. S8B, ESI†). Polyplexes of all tested
polymers were internalized into cells at 37 1C with approxi-
mately 90% efficiency. In contrast, the uptake efficiency was
significantly decreased to approximately 10% at 4 1C for all
samples. This indicates an energy-dependent uptake (endocytotic
process). Furthermore, bafilomycin, a proton pump (H+-ATPase)
inhibitor, was used to prevent endosomal release caused by
acidification (Fig. S8A, ESI†). The inhibition of an endosomal
escape prevents the release of pDNA into the cytoplasm, the
transfer into the nucleus and the EGFP expression. As expected,
the TE significantly decreased after treatment with bafilomycin
for all tested polymers too5%. This indicates the involvement
of the endosomal uptake and release as critical steps during the
transfection mechanism, as it is reported for PEI.43,55
High resolution microscopy of polyplex–cell interactions
Deeper insights into the uptake mechanism and the fate of
polyplexes within the cells were obtained with microscopic studies
including confocal microscopy, structured illuminationmicroscopy
(SIM) and high-angular annular dark-field scanning transmission
electron microscopy (HAADF-STEM).
Confocal microscopy as well as SIM studies were performed
with HEK cells and polyplexes based on YOYO-1 labeled pDNA
and Cy5-labeled P3 representing the polymer with the overall
highest transfection efficiency compared to lPEI. Fluorescence
imaging of cells, in particular SIM images, revealed a co-localization
of pDNA-bound P3 polyplexes (blue) within the lysosomes/late
endosomes (red, RFP labeling, Fig. 7 and Fig. S9 and S10, ESI†).
The detection of the YOYO-signal within the cytoplasm that was
not co-localized with lysosomal structures reveals that pDNA
is released from the polyplex itself. Considering the low con-
centration of heparin required to destabilize the polyplex, an
efficient release of pDNA into the cytoplasm can be assumed. As
SIM provides a resolution of approx. 100 nm, a more detailed
insight into the polyplex behavior within the lysosomes/late
endosomes was obtained compared to conventional confocal
imaging. A non-centrically localization of P3 polyplexes
Fig. 7 High resolution imaging. (A) Structured illumination image of P3-based polyplexes within cells (deconvolved data). White arrows indicate
co-localization of P3-pDNA polyplexes within lysosomes. (B and C) Magnified view of the yellow and red, dash-lined frame in (A): P3-Cy5 polyplex within
the endosome. 63 Oil Obj. 1.4 NA. Grey: Hoechst 33342. Red: lysosomal membrane (RFP). Green: plasmid DNA labeling (YOYO-1). Blue: polymer
labeling (Cy-5). (D–F) HAADF-STEM images of P3-based polyplexes taken up by HEK cells. The following letters correspond to cell organelles: N = cell
nucleus, M = mitochondria, E = endosomal compartment, P = polyplex.
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(Cy5 and YOYO-1 signal) within the endosome (red) was
observed, being in close vicinity to the endosomal membrane
(Fig. 7A and zoom-in Fig. 7B and C, single channel splitting:
Fig. S11, ESI†). This could be attributed to a strong interaction
between the polyplex and the cytoplasmic membrane at the time
of the cellular uptake or a strong interaction of the polyplex with
the endosomal membrane caused by acidification. However, also
lPEI polyplexes (Cy5 and YOYO-1 signal) were localized in close
vicinity to the endosomal membrane (Fig. 8A and zoom-in Fig. 8B
and C, single channel splitting: Fig. S12, ESI†). Interestingly, a
higher number of larger endosomes bearing polyplex signals
with an apparent larger spatial dimension was found for lPEI
in contrast to P3. To study the interaction of both polymers
with the endosomal membrane in more detail, STEM on
embedded sections was carried out to confirm this assumption.
STEM provides a resolution in the low nanometer range,
elucidating the subcellular ultrastructural context, and particularly,
highlighting membrane structures. EM images revealed an uptake
of single P3 polyplexes into vesicles with sizes of 200 to 500 nm
(n 4 10 vesicles of different sections were analyzed, Fig. S13,
ESI†). Although, the polyplexes themselves provide only poor
electron contrast, their structures were highlighted efficiently
within the cellular environment (Fig. 7D–F) in the sample by
sample staining. This can be explained by the strong affinity
of the amines of the polymer and phosphates of the DNA to
the heavy metal stains (OsO4 and uranylacetate, respectively).
The close vicinity between P3 polyplex and the endosomal
membrane was confirmed. We attribute this observation to a
preceding active cell membrane-driven uptake event, initiated
by strong interaction of a single polyplex with the membrane.
We observed an uptake event involved by membrane ruffles
and lamellipodia-like structures (Fig. 7E and F), supporting our
previous findings concerning an energy-dependent uptake,
such as by macropinocytosis. We therefore investigated cells after
incubation with P3 polyplexes in the presence of the inhibitor,
5-(N-ethyl-N-isopropyl)amiloride (EIPA, 100 mM). Our experiments
support the assumption, since only 25% of the cells internalized
P3 polyplexes after 4 h (see ESI,† Fig. S14). Performing STEM
imaging, we observed no P3 polyplexes within the cytoplasm
(see ESI,† Fig. S15A and B). This underlines an uptake mechanism
via macropinocytosis.
STEM images of lPEI polyplexes revealed larger endosomes
with sizes of 500 to 1500 nm (n 4 10 vesicles of different
sections were analyzed, Fig. S16, ESI†) bearing more than a
single polyplex as well as increased cellular membrane rupture
(Fig. 8D–F). The presence of multiple polyplexes within large
endosomes explains the large spatial dimension of the polyplex
signals as being found in SIM images (Fig. 8F). STEM images
of cells, which were incubated with lPEI polyplexes in the
presence of a macropinocytosis inhibitor (EIPA), revealed indeed
a cellular internalization (see ESI,† Fig. S15C and D). However,
the uptake efficiency was apparently lower compared to the
Fig. 8 High resolution imaging. (A) Structured illumination image of lPEI-based polyplexes within HEK cell, white arrows indicates full co-localization
(deconvolved data). (B and C) Magnified zoom of yellow and red, dash-lined frame in (A): lPEI-Cy5 polyplex within the endosome. 63 oil obj. 1.4 NA.
Grey: Hoechst 33342. Red: lysosomal membrane (RFP). Green: plasmid DNA labeling (YOYO-1). Blue: polymer labeling (Cy-5). (D–F) HAADF-STEM
images of lPEI-based polyplex taken up by HEK-293 cell. The following letters correspond to cellular structures: N = cell nucleus, M = mitochondria,
E = endosomal compartment, P = polyplex.
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standard uptake protocol (B65% YOYO-positive cells after 4 h)
and hints towards alternative uptake mechanisms in addition
to macropinocytosis. It was already demonstrated that lPEI
possesses a high membrane activity (see erythrocyte aggrega-
tion, Fig. S3 and S4, ESI†), which is in association with polymer
aggregation in serum containingmedia5 and could lead to enhanced
uptake of multiple polyplexes within single endosomes. Aggregated
polyplexes could be also responsible for a reduced uptake
because of a size-limited uptake mechanism, e.g. endocytosis.
The presence of EtOx subunits within P3 shields the formed
polyplexes from aggregation caused by protein interaction prior
to uptake. This might be a reason for a more efficient cellular
uptake and the high transfection efficiency of the respective
copolymer. Based on this data, the efficient endosomal release of
single P3 polyplexes is impressive compared to agglomerated
lPEI polyplexes. Due to the high buffer capacity of lPEI, an
enhanced protonation of amines followed by the swelling of
the endosomesmight occur, as it is hypothesized for the ‘‘proton
sponge’’ effect.6,51,53,54,56 In case of P3, the full protonation of the
primary/secondary amines could lead to a destabilization of the
membrane indicating a membrane rupture and the subsequent
release of the cargo into the cytosol. A previous study of Zuhorn
and co-workers describes a similar process for PEI polyplexes
supporting these findings.52 Additionally, the authors showed
that the release did not come along with a complete rupture
of the endosome. As the polymers P1 to P3 possess a content of
12 to 23% secondary amines and a content of primary amines of
34 to 23%, they do not show such a severe swelling of endosomal
compartments like lPEI polyplexes. Nevertheless, it can be assumed
that a protonation of the primary amines in the side chain
within the endosomal compartments forces the interaction of
the polymers with the endosomal membrane leading to an
efficient endosomal release. These results indicate that not only
the buffer capacity and the swelling of endosomal compartments
but also the interaction of the polymer with the endosomal
membrane facilitate the escape from the endosome, which is in
accordance to literature data and visualized in detail.51,52
siRNA delivery
To further investigate the potential of the modified PEI
copolymers, the delivery efficiency for siRNA was determined.
Although DNA and siDNA represent genetic material they differ
in certain characteristics. Most importantly, siRNA is smaller
(o30 base pairs (bp) compared to 4700 bp pDNA) and more
rigid. From a biological point of view, pDNA has to be trans-
ferred across the nuclear barrier to the cell nuclei, whereas
siRNA has to be released from the polyplex in the cytoplasm to
form the RNA-induced silencing complex (RISC).57
The copolymers P1 to P3 were further investigated regarding
the influence of primary and secondary amines for siRNA delivery.
High binding affinity to siRNA (o40%) of all tested polymers was
observed by EBA (Fig. 9A). Positively charged polyplexes with a size
of o200 nm were formed, whereas lPEI polyplexes exhibited
a compact size of around 83 nm (Table 3). This trend was also
observed for the pDNA based polyplexes (see Table 2).
A GFP-expressing CHO cell line was used to estimate the
knockdown efficiency (Fig. 9B). Interestingly, P1 showed superior
knockdown efficiency for siRNA (244  50.3 MFI), compared
to P3 (317  19.3 MFI), which was identified as best performer
for pDNA transfection. Both, P1 and P2, led to a significant
reduction of around 40% of the fluorescence intensity of
EGFP-expressing cells. In contrast, P3 showed only 10 to 20%
reduction of MFI. Interestingly, lPEI as well as branched PEI
Fig. 9 Investigations of the siRNA delivery. (A) Binding affinity of siRNA to P1 to P3 and lPEI at different N/P ratios measured by the fluorescence
quenching of ethidium bromide. The fluorescence of pure siRNA represents 100% RFU. (B) siRNA knockdown mediated by P1 to P3, lPEI and jetPRIME
polyplexes at N/P 30 after 72 h. Stable EGFP-expressing CHO cells were transfected with polyplexes formed using siRNA able to knock down egfp.
Statistical analysis (t-test) was used to compare the mean fluorescence intensity (MFI) of the control with P1 to P3 and lPEI, * represents p o 0.05 and
# p o 0.005. The values represent the mean  S.D. (n Z 3).
Table 3 Size and surface charge (zeta potential) of the siRNA complexes
at N/P 30 measured via dynamic light as well as electrophoretic light
scattering in water-based HBG buffer
Polymeric system z-Average [d, nm] PDI Zeta potential [mV]
P1 102  1.2 0.15 21  1.2
P2 124  1.5 0.13 25  1.0
P3a 149  12.6 0.49 22  0.1
lPEI 83  2.3 0.23 33  1.6
a Intensity weighted size distribution revealed a mean peak of 257 nm
(68%).
Paper Journal of Materials Chemistry B
Pu
bl
ish
ed
 o
n 
21
 D
ec
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
by
 T
hu
er
in
ge
r U
ni
ve
rs
ita
ts 
La
nd
es
bi
bl
io
th
ek
 Je
na
 o
n 
28
/0
3/
20
18
 1
3:
26
:4
6.
 
View Article Online
1272 | J. Mater. Chem. B, 2017, 5, 1258--1274 This journal is©The Royal Society of Chemistry 2017
(bPEI) revealed high knockdown potentials of around 60%
(Fig. 9B). ComlPEI was less efficient and exhibited comparable
efficiencies to the copolymers P1 and P2 (Fig. S20, ESI†). However,
the highest knockdown (480%,B68 3.9MFI) was achieved with
the positive control jetPRIME (cationic, polymeric transfection
reagent, Polyplus). The fluorescence intensities were not reduced
when using scrambled siRNA (negative control, see ESI,† Fig. S17).
The polymers P1 and P2 revealed adequate knockdown levels, but
are not as effective as commercially available siRNA transfection
agents. Nevertheless, the promising performance and high bio-
compatibility of these 3rd generation PEIs could be developed in
future studies by optimizing the polymeric design and composition
as a higher AmOx content shows improved performance.
To understand the different performances of the copolymers
depending on the genetic material, the endosomal release has
to be considered. For successful delivery of siRNA a fast and
efficient release from the endosome into the cytosol is bene-
ficial, whereas the transfection efficiency of pDNA is increased,
when it is transported to the perinuclear region inside endo-
somal compartments.58
From the titration of the polymers P1 to P3 (Fig. 10A) the
buffer capacities of the respective copolymers were calculated
(b = dn(OH)/dpH) and expressed as a function of the pH value
(Fig. 10B). The copolymers show considerable higher buffer
capacities with increasing EI content for pH values between
5 and 7 (endosomal release environment). As P3 revealed the
Fig. 10 (A) Acid–base titration curves of an acidified solution of the cationic copolymers P1 to P3 (B5 mg mL1) dissolved in 4 mL hydrogen chloride
(HCl, 0.06 M) and neutralized with sodium hydroxide (0.1 M). For comparison, 0.06 M HCl was titrated accordingly. Precipitation of lPEI at pH 7 prevents
the interpretation of the respective titration curve. (B) The buffer capacities of the cationic copolymers P1 to P3 were calculated from A utilizing the
relation b = dn(OH)/dpH and presented as a function of the pH value. For comparison, the buffer capacity of HCl is included.
Fig. 11 Schematic representation of the polyplex formation illustrating the interaction of 3rd generation poly(ethylene imine) with pDNA or siRNA.
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highest buffer capacity at acidic conditions, this could be an
explanation for the diminished performance for siRNA delivery
due to a delayed endosomal escape. In contrast, P1 showed
the highest degree of protonation at endosomal pH values
facilitating a faster endosomal release into the cytosol by inter-
action of the charged amines with the endosomal membrane. It
should be kept in mind, that P1 and P2 revealed also a high
buffer capacity at a pH value around 9, in contrast to P3, which
could be a hint for different performances.
Moreover, it could be assumed that the different physico-
chemical parameters of the genetic material (size, topology)
play a crucial role for the interaction with the 3rd generation
PEIs (Fig. 11). siRNA is small and stiff preferentially interacting
with the primary amines in the polymer side chain. In contrast
to that, the large pDNA requires the interaction with the primary
amines (flexible side chains) as well as the secondary amines
(backbone). This enabled an tremendous enhancement of
pDNA delivery compared to literature reported polymer systems,
e.g. P(EtOx-stat-MeOx).17
Conclusion
The introduced 3rd generation PEI copolymers has shown to
present several advantages in contrast to 1st (PEI) and 2nd
(single PEI modifications) generation approaches in terms of
efficient polymeric gene delivery. Starting from high molar
mass PEtOx, partially hydrolyzed P(EtOx-stat-EI) copolymers were
synthesized. Subsequently, different amounts of the ethylene
imine subunits were functionalized, introducing alkene groups
which, in turn, could be used to attach primary amine groups
in the side chains using thiol–ene chemistry. While the EtOx
content of these polymers remained constant, the ratio between
primary and secondary amine groups was varied to obtain a
series of copolymers. It should be highlighted that no adverse
effects on the cell viability was observed for polymer concentra-
tions up to 1 mg mL1 in contrast to lPEI (IC50 = 3.6 mg mL
1).
Remarkably, these 3rd generation PEIs were, in contrast to the
2nd generation P(EtOx-stat-EI), able to form well-defined com-
plexes with various genetic materials, in detail pDNA and siRNA.
Besides a fast uptake, the delivery of pDNA revealed comparable
transfection efficiencies to lPEI. In serum containing media,
the performance of copolymer-based polyplexes could even
exceed the efficiency of lPEI. Furthermore, the copolymers (in
particular P1 and P2) revealed siRNA delivery capability as well.
Nevertheless, an optimization of this approach should be further
pursued in future studies. Noteworthy, a different ratio of
primary to secondary amines is required to form appropriate
polyplexes with siRNA emphasizing the multivalence and potential
of the presented polymeric system.
Using live cell confocal microscopy, super-resolution micro-
scopy as well as transmission electron microscopy of ultrathin
sections of embedded cell samples, the transfection mechanism
was elucidated in more detail. In contrast to lPEI, where endo-
somes contained multiple polyplexes in swollen endosomes,
copolymer based polyplexes present themselves individually
within the endosomal compartments. This was attributed to a
lower protein interaction of PEtOx containing vectors, preventing
agglomeration in serum containingmedia prior to uptake as well
as to a diminished membrane interaction. This feature also
leads to a release process based on membrane interactions of
the described polyplexes in contrast to the ‘‘proton sponge’’
effect hypothesized for PEI. The 3rd generation PEI outperforms
PEI of former generations (1st and 2nd) concerning an overall
concept in terms of toxicity as well as transfection efficiency for a
wide range of genetic materials. Thus, it represents a promising
alternative for more complex transfection approaches including
hard-to-transfect cells or in vivo studies.
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Figure S1. Size exclusion chromatography traces of the starting homopolymer PEtOx and the copolymers 
P(EtOx-stat-EI), preP2 and P2 (N,N-dimethylacetamide, 0.21% LiCl, calibration: polystyrene).
Figure S2. Size exclusion chromatography elugrams of the labeled copolymer P3 (P3-Cy5) in comparison to the 
unlabeled starting material (P3) (N,N-dimethylacetamide, 0.21% LiCl, calibration: polystyrene).
Hemocompatibility of PEI-based polyplexes
The erythrocyte aggregation of the PEI copolymers was performed in parallel with high molar 
mass lPEI polymers as positive controls. lPEI show membrane-perturbing activity at high 
concentrations (100 µg mL-1) leading to the aggregation of erythrocytes as indicated in the 
photospectrometrically measurement and by light microscopy. This effect was not seen with 
the copoly mers P1 to P3.
Figure S3. Erythrocyte aggregation of the tested polymers at indicated concentrations. bPEI (25 kDa) served as 
positive control resulting in high aggregation formation and PBS as negative control. Values represent the mean 
± S.D. (n=3).
Figure S4. Light microscopy of erythrocyte aggregation of the polymers P1 to P3, PEtOx and both lPEI 
polymers. PBS served as negative control, while bPEI (25kDa) was served as positive control. Scale bar = 50 µm.
Interaction of polymers with genetic material
The polyplex dissociation assay was performed aside from heparin with poly(methacrylic acid) 
(PMAA) (DP = 200) as competing factor. To keep equal conditions, same PMAA 
concentrations as for heparin were used during the measurement. 
Figure S5. Dissociation assay of polyplexes formed with pDNA at N/P 30 and with increasing PMAA 
concentrations, which correlates to heparin concentrations.
Analysis of polyplex uptake and transfection of cells
The uptake and transfection studies were performed with HEK cells and pDNA encoding the 
EGFP (enhanced green fluorescence protein) or with YOYO-labeled pDNA. Transfection 
efficiency was determined by measuring the amount of viable cells (PI stained) expressing 
EGFP after 24 h via flow cytometry, whereas non-transfected cells served as negative control. 
To determine the amount of EGFP expressing cells, the histogramm of control cells was used 
and the percentage of cells within the gated area was defined as transfection efficiency in 
percentage.
Figure S6. Flow cytometry measurements. A) Dot-plot of PI stained HEK cells for determining cell viability. 
FL2 Log represents red fluorescence of PI stained cells. All cells within the specified area G represent all measured 
viable cells. B) Histogramm of non-transfected cells served as control. FL1 Log represents green fluorescence by 
EGFP expression.
Figure S7. Histograms of flow cytometry measurements determining positive EGFP-expressing HEK cells after 
24 h post-transfection with P1 to P3 and lPEI (N/P 30). Only viable HEK cells (PI staining) were gated. FL1 Log 
represents green fluorescence by EGFP expression.
To investigate the uptake mechanism in detail, cells were treated at different conditions with 
bafilomycin (proton pump inhibitor) or at 4 °C and 37 °C.
Figure S8. A) Uptake study: amount of cells taken up YOYO-1 labeled pDNA after 4 h at different temperatures 
(4 °C and 37 °C) using the copolymers P1 to P3 and lPEI (N/P ratio 30) as controls. Values represent the mean 
(n = 3). B) Comparison of the transfection efficiency of P1 to P3 and lPEI for adherent HEK cells in serum 
reduced (OptiMEM) and serum containing media (RPMI + 10% FCS) as well as after bafilomycin treatment at 
N/P 30. Values represent the mean (n = 3).
Live cell imaging
Confocal as well as structured illumination microscopy were used to investigate the uptake 
process of polyplexes in more detail and for visualization purposes. Therefore, non-treated 
control HEK cells as well as P3 polyplexes added to HEK cells in serum reduced media were 
analyzed.
Control: pDNA transfection
Figure S9. Uptake studies: HEK cells in serum reduced media without polyplexes served as negative controls. 
The cells were analyzed after 4 h via confocal laser scanning microscopy. The cell nucleus was stained with 
Hoechst 33342, the lysosomes with LysoTracker Red.
P3-Cy5: pDNA transfection
Figure S10. Uptake studies: Pure YOYO-labeled pDNA was added to HEK cells in serum reduced media. The 
cells were analyzed after 4 h via confocal laser scanning microscopy. The cell nucleus was stained with 
Hoechst 33342, the lysosomes with LysoTracker Red.
Structured illumination microscopy (SIM)
Figure S11. Magnified SIM images of endosome bearing polyplexes formed with P3 in the presence of DNA 
(SIM data, deconvolved, acquired with 63x Oil Obj. 1.4 NA). Red; Lysosomal membrane (RFP). Green: pDNA 
labeling (YOYO-1). Blue: Polymer labeling (Cy5). A and E: Merged channels. B-D, F-H: split channels. Scale 
bars = 1 µm,
Figure S12. Magnified SIM images of endosome bearing polyplexes formed with lPEI in the presence of DNA 
(SIM data, deconvolved, acquired with 63x Oil Obj. 1.4 NA). Red; Lysosomal membrane (RFP). Green: pDNA 
labeling (YOYO-1). Blue: Polymer labeling (Cy5). A and E: Merged channels. B-D, F-H: split channels. Scale 
bars = 1 µm,
Scanning transmission electron microscopy (STEM)
To obtain deeper insights into the uptake mechanism and the fate of polyplexes inside the cell 
as well as the endosomal environment, scanning transmission electron microscopy (STEM) 
were performed. The images display a section (thickness of the resin slice: 80 nm) through the 
cell and sizes are determined by a two-dimensional section through the cell. This can only 
conditionally make a statement of the actual size of the three-dimensional vesicle. More than 
5 sections (and ~ 10 vesicles) of different cells were analyzed to evaluate our findings.
Figure S13. STEM images of polyplex uptake in HEK cells at standard conditions. Polyplexes were formed with 
P3 and pDNA. Cells were harvested after 4 h.
Macropinocytosis inhibitor
For inhibition experiments, cells were treated with 100 µM 5-(N-ethyl-N-isopropyl)amiloride 
(EIPA) in standard culture media 30 min prior to polyplex addition. Subsequently, P3 and lPEI 
polyplexes were added to the cells and incubated for further 4 h. Afterwards, the cells were 
harvested and analyzed as described above via flow cytometry or were further prepared for 
STEM imaging. 
 Figure S14. Polyplex uptake (YOYO-labeled pDNA) in HEK cells after treatment with EIPA (macropinocytosis 
inhibitor). 
Figure S15. STEM images of polyplex uptake in HEK cells after treatment with EIPA (macropinocytosis 
inhibitor). A-B) Uptake of P3 polyplexes. C-D) Uptake of lPEI polyplexes. White arrows indicate vesicles with 
polyplexes.
 Figure S16. STEM images polyplex uptake in HEK cells at standard conditions. Polyplexes were formed with 
lPEI and pDNA. Cells were harvested after 4 h.
siRNA delivery
A stable GFP-expressing CHO cell line was transfected with the polymers P1 to P3 as well as 
PEI using scrambled siRNA as negative control. The knockdown of EGFP was analyzed via 
flow cytometry by measuring the MFI of all viable cells (PI staining).
Figure S17. siRNA transfection efficiency mediated by P1 to P3 as well as PEI polyplexes at N/P 30 after 72 h. 
Stable EGFP-expressing CHO cells were transfected with scrambled siRNA served as negative control. The 
values represent the mean ± S.D., n ≥ 3.
Comparison of lPEI and commercial lPEI25k (comlPEI, Sigma Aldrich)
The cytotoxicity tests of the PEI copolymers were performed in parallel with high molar mass 
lPEI polymers as positive controls. Fully hydrolyzed PEtOx, thus lPEI as well as the 
commercially available lPEI (25 kDa, comlPEI) obtained from Polysciences were used. The 
synthesized lPEI shows a higher cytotoxicity (IC50 at ~ 4 µg mL-1), whereas the commercial 
PEI reaches 50% cell viability at 25 µg mL-1. The reduced cytotoxicity could be attributed to 
residual, N-acyl groups from polymerization, which is also stated by the supplier.[39] 
Furthermore, the hemolysis and the erythrocyte aggregation assay were performed with both 
PEIs. Both polymers show membrane-perturbing activity at high concentrations (100 µg mL-1) 
leading to hemoglobin release and the aggregation of erythrocytes. This effect was not seen 
with the copolymers P1 to P3.
Figure S18. Comparison of lPEI and commercially available PEI (comlPEI, Polysciences). A) Cytotoxicity assay 
treating L929 cells with the synthesized lPEI as well as comlPEI at indicated concentrations. B) Hemolysis assay 
of erythrocytes after incubation with polymers at indicated concentrations. Triton X-100 served as positive control 
(100% hemolysis) and PBS as negative control. C) Erythrocyte aggregation of the tested polymers at indicated 
concentrations. bPEI (25 kDa) served as negative control resulting in high aggregation formation and PBS as 
negative control. Values represent the mean ± S.D. (n=3).  
Figure S19. Comparison of lPEI and commercially available PEI (comlPEI, Polysciences). A) Complexation 
affinity (EBA) of mentioned polymers using pDNA at the indicated N/P ratios. B) Dissociation assay with heparin 
of polyplexes formed with pDNA at N/P 30. C-D) Transfection efficiency of both PEI polymers for adherent HEK 
cells in serum reduced (C) as well as serum containing (D) media at different N/P ratios after 24 h. Values 
represent the mean ± S.D. (n=3).
Besides the synthesized lPEI, comlPEI was used as control for the ethidium bromide quenching 
assay (Figure S18A). Both polymers show a high complexation affinity with pDNA, while a 
faster polyplex formation of lPEI could be detected at N/P 5. Regarding the heparin dissociation 
assay, comlPEI achieved a full decomplexation of genetic material at a heparin concentration 
of 10 U mL-1 (Figure S19B). For the complete release of pDNA (100% RFU) from lPEI 
polyplexes, 40 U mL-1 heparin was required. The uptake and transfection studies were 
performed with HEK cells and pDNA encoding the EGFP (enhanced green fluorescence 
protein). Transfection efficiency was determined by measuring the amount of cells expressing 
EGFP after 24 h via flow cytometry. ComlPEI shows high TE > 80% at N/P ratios of 20 to 50 
in serum reduced media, which is comparable to other studies. It has to be mentioned that with 
increasing N/P ratio, i.e. the polyplex concentration, the cell viability is reduced. This effect 
could be prevented using serum containing media for transfection, whereas a significant 
reduction of up to 70% (at N/P 20) of TE is occured. 
Figure S20. siRNA transfection efficiency mediated by PEI polyplexes at N/P 30 after 72 h. Stable EGFP-
expressing CHO cells were transfected with polyplexes formed using siRNA able to knock down egfp. Statistical 
analysis (t-test) was used to compare the MFI of the control with PEI, * represents p < 0.05 and # p < 0.005. The 
values represent the mean ± S.D., n ≥
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The targeted drug delivery to the central nervous system represents one of the major challenges in pharmaceu-
tical formulations since it is strictly limited through the highly selective blood-brain barrier (BBB). L-Glutathione
(GSH), a tripeptide and well-known antioxidant, has been studied in the last years as potential candidate to fa-
cilitate the receptor-mediated transcytosis of nanocarriers.We thus testedwhether GSH decoration of a positive-
ly charged polymer, poly(ethylene imine), with this vector enables the transport of genetic material and,
simultaneously, the passage through the BBB. In this study, we report the synthesis of GSH conjugated cationic
poly(ethylene imine)s via ecologically desirable thiol-ene photo-addition. The copolymers, containing 80% pri-
mary or secondary amine groups, respectively, were investigated concerning their bio- and hemocompatibility
as well as their ability to cross a hCMEC/D3 endothelial cell layer mimicking the BBB within microﬂuidically per-
fused biochips. We demonstrate that BBB passage depends on the used amino-groups and on the GSH ratio.
Thereby the copolymer containing secondary amines showed an enhanced performance. We thus conclude
that GSH-coupling represents a feasible and promising approach for the functionalization of nanocarriers
intended to cross the BBB for the delivery of drugs to the central nervous system.
© 2016 Elsevier B.V. All rights reserved.
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1. Introduction
Discovered by Paul Ehrlich in 1885 and named by Max
Lewandowsky in 1900, the blood-brain barrier (BBB) is known as one
of the most challenging obstacles concerning the delivery of drugs and
therapeutic nucleic acids [1,2]. Within the BBB, specialized endothelial
cells of the cerebral vasculature (cerebral microvascular endothelial
cell, CMEC) form an endothelial layer that strictly regulates the passage
of small molecules. The tightness of the BBB is furthermore regulated by
astrocytes and pericytes that are in direct contact with the CMECs [3].
The BBB passage ofmolecules depends on several parameters, including
themolecular size, lipid solubility, hydrophilicity, and the degree of dis-
sociation. The passage of macromolecules as well as of 98% of small
molecules (b400 g mol−1) is prevented under physiological conditions
[4]. Besides the passive transport, which comprises the diffusion of
small molecules [5], the active transport of amino acids and macromol-
ecules such as transferrin is described to bemediated by carrier proteins
or transcytosis [6]. While the transport of different amino acids is well-
investigated [7], the transport of L-glutathione (GSH), a tripeptide
which is known as antioxidant that lowers the oxidative stress level
within the brain, is currently under investigation [8–10].
In order to circumvent the BBB, several methods including the inva-
sive direct injection into the central nervous system (CNS) and the non-
invasive nasal delivery of nanoparticular and liposomal carriers as well
as of covalently targeted small molecules have been investigated [11,
12]. However, nasal delivery possesses the difﬁculty to adjust the ther-
apeutic delivery due to individually varying absorption proﬁles, limited
volume and long term side effects [11].
Introducing targetingmolecules to nanocarriers is the key to beneﬁt
from the active transporting systems and to enable also the passage of
larger drugs. Non-viral receptor- and adsorptive-initiated transcytosis,
as well as carrier-mediated transport can be used for an active transcel-
lular vector-based drug delivery. By using larger biomolecules like anti-
bodies and peptides [13,14], additional surface modiﬁcations like
PEGylation and polysorbate 80 (“Tween 80” or polyoxyethylene(20)
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sorbitanmonooleate) [15] or smallmolecule conjugation (such asGSH),
BBB passage could be revealed successfully [16–19]. The latter has been
successfully used to modify nanoparticles for drug delivery resulting in
an enhanced passaging ability of the BBB [20,21]. Recently, Grover et al.
combined two known techniques to create a novel nanoparticle system
(PEGylation andGSH coating), while Gaillard et al. showed the improve-
ment of the BBB passage using liposomal carrier systems [20,21]. The 2-
BBB company has already startedwith two clinical trials regarding lipo-
somal based PEGylated and GSH decorated particles bearing doxorubi-
cin and methylprednisolone [22]. At the end of 2014 positive results
from phase 1 were announced showing a BBB passage and anti-tumor
properties. This reveals that the decoration with GSH seems to be a
promising targeting approach also for other carrier systems. While the
choice of targeting molecules inﬂuences the transcytosis efﬁciency, the
nanocarrier material should be adopted to the transported drug. There-
fore, synthetic as well as natural polymers (e.g. polysaccharides, pro-
teins) have been used for the transport of drugs and genetic material
[23]. Among others, polybutylacrylate (polysorbate 80) [24] and PLA/
PGA or PLGA (TAT [25] or polysorbate 80 [26]) have been successfully
established in in vivo tests for the encapsulation of hydrophobic drugs.
In order to enable nucleic acid delivery to the central nervous system
(as novel treatment option of neuronal-related diseases), there is an ur-
gent need for appropriate binding nanocarriers. Cationic polymers, in
particular poly(ethylene imine) (PEI), represent a class of suitable can-
didates for the complexation of geneticmaterial by electrostatic interac-
tions [27]. Due to its superior buffering ability enabling endosomal
escape, PEI is known as the gold standard of polymeric carriers for
gene delivery in vitro [28]. However, its potential is accompanied with
high cytotoxicity and non-biodegradability [29]. The functionalization
of the linear PEI backbone [30] and the addition of side chains, creating
copolymers, represent a powerful strategy to overcome these limita-
tions and have been extensively studied attaching various carbohy-
drates [31–33] or polymers like poly(ethylene glycol) [34].
However, these in vitro studies were based on standard cell culture
techniques under static culture conditions. Shear forces as observed in
vivo and their impact on endothelial cells [35] as ﬁrst cells to come in
contactwith administereddrugs have not been addressed.Microﬂuidics
can serve as a tool to reduce this transferability gap. Recently, we report-
ed a microﬂuidically supported biochip model of the BBB with the
proof-of-concept of the modulation of the BBB permeability by inﬂam-
matory cytokines [36]. To mimic the cerebral endothelial cell layer of
the BBB, hCMEC/D3 cell layers have been used that speciﬁcally express
cerebral endothelial marker proteins including cell adhesion and tight
junction proteins as well as CNS related transporter proteins. In vitro
the cell line forms a tight endothelial cell layer that shows similarities
with the BBB even in the absence of astrocytes or pericytes [37–39].
Thus HCEMC/D3 cells were already used in various BBB models [40,
41] for mechanistically studies on leukocyte transmigration [42], nano-
particle uptake and transcytosis [43,44].
In this study, we describe for the ﬁrst time a nanocarrier design that
combines vector as well as charge optimized properties for crossing the
BBB and that enables complexation of nucleic acids. We focused on the
installation of GSH moieties on the backbone of high molar mass linear
PEI. A post-polymerization functionalization process was applied to ob-
tain double bond functionalities and deﬁned quantities of cationic ethyl-
ene imine units. Since reduced GSH provides a free thiol end group,
thiol-ene photo-additionwas used tomodify the PEI backbone avoiding
potentially hazardous metal catalysts. Comparable amounts of primary
amine groups in the polymer side chain were installed in a second ap-
proach on the PEI backbone for an enhanced polyplex stability. The co-
polymers were characterized concerning their polyplex formation,
toxicity, hemocompatibility and their potential to deliver nucleic acids
across the BBB. We want to demonstrate that polyplexes, formed by
GSH-modiﬁed PEI-based polymers and plasmid DNA, are able to cross
an endothelial cell model of the BBB under physiological shear stress
of 4 dyn cm−2.
2. Results and discussion
To conjugate GSH to a cationic polymer backbone (using a poly(eth-
ylene imine)-derivative), the thiol-ene photo-addition reactionwas uti-
lized. It can be performed undermild conditions (no thermal energy, no
toxic metal catalysts) without generating harmful side products. The
solubility properties of GSH limits the click reaction to water. To inves-
tigate the inﬂuence of different amine functionalities on the balance be-
tween stable polyplex formation and BBB passage, materials either
containing solely secondary amines or bearing additional primary
amines were synthesized.
2.1. Polymer synthesis
The homopolymer poly(2-ethyl-2-oxazoline) (PEtOx) was synthe-
sized according to literature procedure [9]. For this purpose, the cationic
ring-opening polymerization (CROP) of the monomer 2-ethyl-2-
oxazoline was performed in a microwave reactor. The precursor re-
vealed a degree of polymerization of 575 (calculated from the tosylate
1H-NMR signal integrals ofMeOTos before puriﬁcation) and a dispersity
of 1.3 (SEC: DMAc, 0.21% LiCl, calibration: polystyrene). PEtOx was fur-
ther treated with half-concentrated hydrochloric acid and heated to re-
ﬂux overnight [45]. The resulting linear poly(ethylene imine) (P1)
exhibited a degree of hydrolysis of N 95% (calculated from 1H-NMR).
P1 served as the main polymer for the installation of all functionalities
including the GSHmoieties. To investigate the inﬂuence of different cat-
ionic charges on the biocompatibility and the DNA binding afﬁnity, pri-
mary as well as secondary amine functionalities were introduced to the
polymer backbone besides the GSH functionalities [46]. This versatile
approach required two different synthesis pathways (see Scheme 1).
The ﬁrst one comprises of the partial functionalization of linear
poly(ethylene imine) (P1) with N-succinimidyl-4-pentenate to intro-
duce double bond functionalities yielding the P(EI-stat-ButEnOx) copol-
ymer (P2) (see Scheme 1a, strategy I) [47]. Since the homopolymer
poly(2-butenyl-2-oxazoline) (which can be synthesized by a CROP of
the respective monomers) does not withstand the conditions of acidic
or basic hydrolysis, the mentioned post-polymerization modiﬁcation
strategy was applied. Preliminary studies of copolymers consisting of
varying contents of ethylene imine (EI) and 2-butenyl-2-oxazoline
units (ButEnOx) resulted in a critical amount of EI units required for
the formation of stable polyplexes [47]. Therefore, a ButEnOx content
of 27% was installed onto the backbone of P1, resulting in an EI content
of 78% (2) (see Table 1). The introduction of GSH (reduced state, for the
schematic representation of the structure see Scheme 1)was performed
by a thiol-ene photoaddition while maintaining a constant EI content of
78% (Scheme 1c). Since GSH shows only limited solubility properties,
the click reaction was performed in water utilizing the photoinitiator
Irgacure® 2959. The full conversion resulted in the copolymer P(EI73%-
stat-GluButOx27%) (3).
In a second approach primary amine moieties were installed on the
polymer backbone to investigate their inﬂuence on the interaction with
DNA.While primary amine groups are known to promote superior com-
plexation of nucleic acids [48,49], secondary amines reveal an enhanced
buffer capacity resulting in a fast endosomal release [50]. The previously
mentioned modiﬁcation strategy was used (Scheme 1a, strategy II) to
synthesize a fully functionalized poly(2-butenyl-2-oxazoline) (P4).
Subsequently, the protected aminothiol was added to P4 under UV irra-
diation (Scheme 1b) to yield the copolymer P(bocAmButOx82%-stat-
ButEnOx18%) (P5) (Table 1). In a second photo-addition step, reduced
GSH was introduced to the backbone of P5 analog to the previously de-
scribed ﬁrst synthesis route (Scheme 1c, strategy II). Under these condi-
tions, the conversion of the double bonds was incomplete (56% of the
origin double bond functionalities remained), even after an additional
functionalization step. Almost certainly, the content of ﬂexible side
chains containing sterically demanding protection groups hinders the
full modiﬁcation. Furthermore, the introduction of a deﬁned amount
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of bulkyGSH (~8%) could result in an additional hindrance, which limits
the degree of functionalization. The deprotection of bocP6 (Scheme 1d)
resulted in the ﬁnal polymer P(AmButOx82%-stat-ButEnOx10%-stat-
GluButOx8%) (P6). Focusing on the amount of amine groups within
the copolymers, a comparison of P3 and P6 concerning this point is
part of further investigations.
Characterization by 1H-NMR spectroscopy (Fig. 1) conﬁrmed the al-
most complete hydrolysis of PEtOx revealing one main signal for the
backbone of P1 between 3.70 and 3.20 ppm (NR\\CH2\\CH2, A). In ad-
dition, 5% remaining 2-ethyl-2-oxazoline units can be found. The ap-
pearance of the double bond signals for P2 at 5.81 ppm (CH2_CH\\,
E) and 4.95 ppm (CH2_CH\\, F) conﬁrm the successful
functionalization with N-succinimidyl-4-pentenate. The former signal
is compared to the unaffected ethylene imine backbone to determine
the composition of the formed copolymer P2 (degree of
functionalization: 27%). The disappearance of the double bond signals
after the thiol-ene photoaddition conﬁrmed the complete
functionalization with GSH. Besides the additional protons observed
after the click reaction (E′ and F′), the signals of GSH can be assigned
to the respective protons (see Fig. 1). The very speciﬁc GSH signal for
the CH group of the cysteine unit appears at 4.54 ppm
(NR\\CH\\CH2\\S, H).
The complete functionalization of P1 resulted in polymer P4, indi-
cated by the disappearance of the signals assigned to the ethylene
imine backbone (between 3.70 and 3.20 ppm) (see Fig. 2). Instead, the
signals assigned to the double bonds at 5.8 ppm (CH2_CH\\, D) and
4.96 ppm (CH2_CH\\, E) as well as to the backbone (3.45–3.53,
NR\\CH2\\CH2, A) could be observed. The successful attachment of
side chains bearing primary amine groups and GSH moieties is shown
by the CH2 signals nearby the amine group around 2.8 ppm
(NH2\\CH2\\CH2), the signal of the boc-protecting group which disap-
pears after deprotection (1.4 ppm, CH3 boc) and the speciﬁc GSH pro-
tons of P6.
The composition of the prepared polymers (and respective interme-
diates) is depicted in Table 1. Asymmetric ﬂow ﬁeld-ﬂow fractionation
(AF4) was utilized to determine the molar masses of the starting poly-
mer P1 and the ﬁnal products P3 and P6. Since the intermediates reveal
different solubility behaviors, another characterization method had to
be chosen. Therefore, size exclusion chromatography (SEC) was used
to determine the molar masses of P2, P4, P5 and bocP6. However, in
both cases the presence of cationic amine units (primary or secondary)
and/or double bond functionalities resulted in undesired column and
membrane interactions and, therefore, a change in the elution behavior
(increased dispersities) [51,52]. Although the obtained values indicate
lowermolarmasses compared to the calculated values, a trend is visible.
To conﬁrm the successful photo-addition of GSH and the formation
of a single (polymeric) species (P3, P6), diffusion-ordered NMR spec-
troscopy (DOSY NMR) was performed. GSH clearly revealed a higher
diffusion coefﬁcient compared to the polymeric species. The decreasing
values for the GSH decorated P2 indicate an increase of the hydrody-
namic radius of P3 in solution (Fig. 3A). This can be explained by the
bulky GSH moiety. Comparable results are obtained for P6 (Fig. 3B).
2.2. Bio- and hemocompatibility
Biocompatibility represents a critical parameter for potential non-
viral vectors in biomedical applications. In vitro studies were performed
using the precursor P2 and the ﬁnal GSH-conjugated polymers P3 and
P6 in comparison to the linear PEI (P1) to evaluate their bio- and
hemocompatibility (Fig. 4A and Supporting information Fig. S1). P4
and P5were excluded due to their insolubility in aqueousmedia. P1 ex-
hibited a high cytotoxicity at low polymer concentrations (IC50 of
~4 μgmL−1) because of its highmolarmass and cationic charge density
(leading to membrane damages followed by the possible initiation of
apoptosis [53,54]). Interestingly, the attachment of 27% GSH resulted
in a strong reduction of the cytotoxicity. P3 revealed an IC50 value of
Scheme 1. Schematic representation of the synthesis of I) P(EI-stat-GluButOx) (P3) and II) P(AmButOx-stat-ButEnOx-stat-GluButOx) (P6), respectively. a) Functionalization of linear
poly(ethylene imine) (P1). b) Thiol-ene photo-addition of tert-butyl-(2-mercaptoethyl)carbamate to the copolymer backbone. c) Thiol-ene photo-addition of L-glutathione to the
copolymer backbone. d) Deprotection of primary amine side chains.
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~270 μg mL−1 and even polymer concentrations up to 150 μg mL−1 re-
vealed nearly no cytotoxic effects (relative viability ≥ 85%). The precur-
sor P2 also exhibited a lower cytotoxicity compared to P1 (see
Supporting information Fig. S1A). The replacement of the ethylene
imine units by ﬂexible primary amine containing side chains for P6
led to an increased cytotoxicity (IC50 value of ~44 μg mL
−1) compared
to P3. Furthermore, the incomplete thiol-ene photoaddition resulted
in a lower content of GSH and, likewise, unmodiﬁed double bond func-
tionalities, which could both inﬂuence the biocompatibility. However,
Table 1
Composition and molar masses for (co-)polymers P1 to P6.
Abr. Name
Compositiona NMRb AF4 SECc,d
X
[%]
Y 
[%]
Z
[%]
Mn
[gmol–1]
Mn Ð Ð
[gmol–1]
Mn
[gmol–1]
P1 LPEIx >98 0 0 24,800 9900 1.4 n.d. n.d.
P2 P(EIx–stat–ButEnOxy) 73 27 0 37,500 n.d. n.d. 31,400
c 1.2
P3 P(EIx–stat–GluButOxz) 73 0 27 85,200 21,000 2.0 n.d. n.d.
P4 PButEnOxy 0 >98 0 71,900 n.d. n.d. 44,000
c 1.5
P5 P(bocAmButOxx–stat–ButEnOxy) 82 18 0 155,300 n.d. n.d. 23,400
d 1.9
bocP6 P(bocAmButOxx–stat–ButEnOxy–stat–GluButOxz) 82 10 8 169,500 n.d. n.d. 38,400
d 1.7
P6 P(AmButOxx–stat–ButEnOxy–stat–GluButOxz) 82 10 8 122,300 63,300 1.8 n.d. n.d.
a Determined by 1H NMR (calculated from the ratio of x, y and z signals)
b Determined by 1H NMR (calculated from tosylate signals of MeOTos before purification)
c SEC 1: CHCl3/iPrOH/NEt3 94:2:4, polystyrene calibration
d SEC 2: DMAc, 0.21% LiCl, polystyrene calibration
n.d. – not determined. All polymers soluble in aqueous media and /or insoluble in organic solvents were measured at 
AF4 – MALS system.
Fig. 1. Comparison of 1H-NMR spectra of P1 to P3 (# side productN-hydroxysuccinimide)
(400 MHz, D2O/MeOD). Fig. 2. Comparison of
1H-NMR spectra of P4 and P6 (400 MHz, D2O/MeOD and D2O).
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polymer concentrations of P3 and P6 from 2 to 5 μgmL−1were used for
the preparation of polyplexes, which are in an acceptable range beyond
the cytotoxicity-inducing concentrations. The cytotoxicity test was not
only performed with L292 cells according to the ISO protocol 10993-5
but the assay was also performed with HEK as well as hCMEC/3D cells
for a detailed determination of the causal relation of toxicity and related
interactions (see Supporting information Fig. S2 A). In static culture the
hCMEC revealed a different performance during cytotoxicity tests and
showed only 10% relative viability for P1 at a concentration of
2 μg mL−1 and also a decreased viability for P6 whereas P3 revealed
no cytotoxic effects up to 500 μg mL−1. While the IC50 values of P1
and P6 decreased up to a 2-fold higher concentration,P3 showed no cy-
totoxic effect at all independent of the used cell line (Fig. S2B).
To investigate the blood compatibility ofP2, P3 and P6, the hemolyt-
ic activity as well as the aggregation of erythrocytes was assessed (Fig.
4B, Supporting information Figs. S3 and S4). All investigated copolymers
did not show any hemolytic activity in a concentration range from 10 to
100 μgmL−1. P1 aswell as P2 (SI Fig. S1B) revealed a slightly hemolytic
activity at higher concentrations (50 to 100 μgmL−1) indicated by a he-
moglobin releases of 2% aswell as strong agglomeration of erythrocytes
(see Supporting information, Fig. S3). While no agglomeration for P3
was observed, indicating a good hemocompatibility, P6 showed distinct
interactions with cellular membranes of erythrocytes leading to aggre-
gation. Obviously, the type of amineswithin the polymer side chain rep-
resents a crucial factor for the interaction with cells, in particular with
the plasma membrane, and is therefore linked to the biocompatibility
properties. This fact was also assumed by Dekie et al. concluding this
from glutamic acid derivatives [55]. However, Fischer et al. mentioned
that these effects have to be mentioned relative to the polymer class
and can also be inﬂuenced by factors like charge density (number of
amines and three dimensional arrangements) [54].
As reported earlier, primary amines revealed an increased afﬁnity to
cellular membranes compared to secondary amines, indicated by a
higher toxicity [56]. Tripathi et al. demonstrated the successful reduc-
tion of the cytotoxicity by pyridoxyl derivatization of primary amines
of branched PEI [57]. This behavior supports the ﬁndings observed for
P3 and P6.
2.3. Characterization of the polyplexes
An efﬁcient delivery of nucleic acids, like plasmid DNA, into cells de-
pends on several parameters. They comprise of the compact condensa-
tion of the genetic material, the masking of negative charges, the
prevention of degradation and the efﬁcient dissociation from the vector
after transfer into the cellular cytoplasm or nucleus. PEI derivatives, in
particular PEI disulﬁde linked rabies virus glycoprotein, have been
shown to enable the delivery of neurogenic microRNA into the brain
[58]. To investigate the binding afﬁnity of P1, P2 (SI Fig. S1C), P3 as
Fig. 3. Diffusion ordered NMR spectra of: A) P2, P3 and L-glutathione and B) P6 and L-
glutathione (400 MHz, D2O).
Fig. 4. Bio- & hemocompatibility. A) Relative viability of L929 cells after 24 h incubationwith the respective polymers at indicated concentrations. B) Hemolysis assay of erythrocytes after
incubationwith polymers at indicated concentrations. Triton X-100was used as positive and PBS as negative control. A value b 2%hemolysis is classiﬁed as non-hemolytic, 2–5% as slightly
hemolytic and values N 5% as hemolytic. Values represent the mean ± S.D. (n = 3).
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well as P6 with plasmid DNA as model system, the ethidium bromide
quenching assay (EBA) was utilized. Polyplexes were formed at different
nitrogen (polymer) to phosphate (DNA) ratios (N/P). Due to the electro-
static and hydrophobic interactions between the polymer and the pDNA,
ethidiumbromide is excluded from its binding siteswithin the oligonucle-
otides resulting in a reduction of ﬂuorescence intensity [59,60].
All polymers revealed a decreasing ﬂuorescence intensity with in-
creasing N/P ratios that resulted in a plateau, indicating stable polyplex for-
mation (Fig. 5A and Supporting information Fig. S1D). While the positive
control P1 exhibited a fast polyplex formation starting at N/P 5, P2, P3
and P6 revealed a stable polyplex formation at higher N/Ps from 20 to 40
reaching 60%, 45% and 30% relative ﬂuorescence units (RFU), respectively.
A possible explanation for the slightly lower binding afﬁnity could be the
ethylene imine units which are shielded by the bulky GSH moieties as
well as a lower zeta potential of P3 (4.06 mV) compared to P6 (28.4 mV)
(see Table S5). For P6, primary amine groups are attached through ﬂexible
side chains, which are easier accessible for the pDNA. Additionally primary
amines are known to promote pDNA compensation [61].
The heparin dissociation assaywas used to analyze the stability and the
dissociation behavior of the formedpolyplexes [62,63]. Heparin is a natural
polyanion with one of the highest density of negative charges and can ef-
fectively bind to the positive charged polymers P3 and P6. It competes
with the pDNA within the polyplex and forces the release of the nucleic
acid. The free nucleic acid is able to rebind free ethidium bromide (added
in the same concentration as for the EBA) causing an increase of the ﬂuo-
rescence intensity (Fig. 5B). In the case of the P3 and P6 polyplexes, the
pDNA was released very fast at low heparin concentrations. While P3 re-
vealed a reversible binding, reaching 90% dissociation at 10 UmL−1 hepa-
rin, P6 showed full dissociation (~100% RFU at 10 UmL−1). In contrast, P1
required higher concentrations of heparin (40 UmL−1) for almost full re-
lease (~95% RFU), which underlines the stability of P1/pDNA polyplexes
and is in accordance to literature data [46].
An efﬁcient delivery, comprising of the internalization of polyplexes
into cells via endocytic pathways, requires deﬁned sizes and charges of
the complexes. Therefore, critical sizes of polymeric carriers up to
200 nm are recommended [64]. As shown in Table 2, the formed
polyplexes of P3 and P6 revealed z-averages of 282 nm and 117 nm at
a N/P ratio of 20, respectively, which are calculated from the correlation
function. Since the intensity of the particle scattering is proportional to
the sixth power of its diameter (Rayleigh approximation), larger parti-
cles or agglomerates of free polymer chains result in comparatively
more light scattering and higher intensity than smaller ones. Therefore,
the intensity-weighted diameters (z-averages) determined by dynamic
light scattering are supplemented by the number-weighted sizes re-
vealing a calculated number percentage over 95. Although the calculat-
ed sizes can only be seen as informative basis, they are in good
agreement with the favorable size of polyplexes. The zeta potential
changes during the synthesis from well-known positive charged P1
(28.4 mV) to the GSH bearing conjugate P3 (−6.9 mV). In this case, a
potential explanation could be that the positive charge of the former
PEI backbone is complexing the DNA meanwhile the GSH carboxylic
acid moieties are present at the outside of the polyplex resulting in a
negative value of−6.9 mV while the precursor P2 showed comparable
size and zeta potential as P1. The results of P2 can be found in the
Supporting information, Table S6. The change in charge cannot be ob-
served in the case of P6. Here, the lower content of GSH and the side
chains with more ﬂexible primary amines reduce the effect of the GSH
functionalities.
2.4. Uptake efﬁciency
To investigate the potential of the different polymers to deliver
nucleic acids, cellular uptake studies were performed with adherent
human embryonic kidney (HEK) cells as well as hCMEC/3D in OptiMEM
and EndoGro media (see Supporting information, Figs. S7 and S8). For
this purpose, YOYO-1 labeled pDNA was used for the polyplex forma-
tion at N/P 20 to detect the time-depended cellular internalization by
ﬂow cytometry. A fast polyplex uptake in HEK cells was revealed for
P6 polyplexes exhibiting ~50% internalization after 15 min, N80% inter-
nalization after 1 h, and a nearly complete uptake of polyplexes after 2
to 4 h similar to P1. Taking the aggregation data of P6 into account,
the strong interaction with the cellular membrane, led to enhanced up-
take efﬁciency. In contrast, P3polyplexes exhibited only poor uptake ef-
ﬁciencies with b10% of HEK cells positive for internalized P3 polyplexes
(Fig. 6A). These results were also conﬁrmed by life cell imaging after 1 h
(Fig. 6B). Interestingly, the precursor of P3without GSH, P2, exhibited
Fig. 5.Polyplex formation and stabilitywith pDNAusing thepolymersP1,P3 andP6. A) Complexation afﬁnity (ethidiumbromidequenching assay) of respective polymers at indicatedN/P
ratios. B) Dissociation assay of polyplexes formed at N/P 40 using heparin (0 to 60 U mL−1). Values represent the mean ± S.D. (n = 3).
Table 2
Size and zeta potential measured in 20 mM 4-(2-hydroxethyl) piperazine-1-
ethanesulfonic acid (HEPES) and 5% (w/v) glucose, pH 7.2 of pDNA complexes of P1, P3
and P6 at N/P 20 measured by dynamic light scattering.
Polymeric
system
z-Average
[d/nm]
PDI Number-weighted size
[d/nm]
Zeta potential
[mV]
P1 132 ± 28 0.24 61 ± 18 28.4 ± 2.7
P3 282 ± 5 0.38 109 ± 18 −6.9 ± 0.1
P6 117 ± 1 0.31 61 ± 16 33.2 ± 1.5
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an enhanced polyplex uptake comparable to P6 (see Supporting infor-
mation, Fig. S1E). Compared to HEK cell experiments the uptake of P6
decreased in hCMEC/3D cells independently from the culture media
used to 20 to 40%. In contrast, the results of P1 and P3 uptake did not
changed signiﬁcantly.
Taking the MFI of uptaken pDNA into account, comparable results
were also obtained for the transfection efﬁciencies of the polymers P1,
P3 and P6 in HEK cells. A transfection efﬁciency of over 60% of HEK
cells was achieved for P1, whereas reduced transfection efﬁciencies
were found for P3 and P6 of around 30% and 5%, respectively (see
Supporting information, Fig. S9).
2.5. Blood-brain barrier passaging performance within the biochip
approach
The GSH modiﬁed polyplexes were subsequently investigated to-
wards their ability to cross the endothelial layer of the BBB. HCMEC/
D3 cells resembling the cerebral endothelial cell layer of the BBB were
cultured on a suspended membrane within MOTiF biochips that were
recently shown to enable an improved culture of endothelial cells
under physiological perfusion conditions [65]. Here, the membrane
serves as a cell substrate that is perfused from the apical side of the en-
dothelial cell layer. The cells were grown until full conﬂuence to form a
densely packed layer (see Supporting information, Fig. S10). Additional-
ly, immunoﬂuorescence staining for characteristic adherens and tight
junction proteins was performed to conﬁrm the integrity of the
microvascular endothelial layer before perfusion (see Fig. 7, ﬁrst row).
HCMEC exhibit prominent staining of VE-Cadherin, a key component
of adherens endothelial junction and mediator of Claudin-5 expression
[66]. Claudin-5 is themain claudin-class protein expressed in BBB endo-
thelial cells and a key regulator of its permeability [67]. Another VE-
Cadherin regulated protein is β-Catenin, which plays an important
role in maintenance of the BBB integrity and related signaling [68,69].
In addition,we investigated thedistributionof occludin, another protein
important for tight junction formation and for regulating paracellular
permeability [70]. Occludin is associated with cytoplasmic scaffolding
and regulatory protein ZO-1 [3]. Claudin-5, β-Catenin, ZO-1 and
occludin were found all expressed and localized to intercellular junc-
tions formed by hCMEC. Perfusion with precursor polymer P1 resulted
in a signiﬁcant loss of endothelial junctionalmarkers (see Fig. 7). Arrow-
heads indicate a reduced staining of the proteins at the intercellular
contacts. This observation is in accordance to the results obtained for
the biocompatibility of P1 on L929 cells (see Fig. 4A) as well as on
hCMEC (see Supporting information S2). In ﬂow experiments hCMEC
seem to be renderedmore susceptible to PEI uptake since already a con-
centration of 0.1 μg mL−1 revealed a strong impact on the cell viability
(see Fig. 4A). In 2006Mennesson et al. already showed that an increase
in the polyplex-cell membrane interaction and binding capabilities
under ﬂow conditions is altered by shear and sedimentation velocity
forces [71]. As demonstrated in hemocompatibility tests, P1 leads to
erythrocyte aggregation and, therefore, to strong membrane interac-
tions. We speculate that in the presence of ﬂow this interaction could
Fig. 6. Cellular uptake study of P1, P3 and P6 polyplexes (N/P 20) using YOYO-1 labeled pDNA. A) HEK cells were treated with polyplexes for 15 min to 4 h and uptake was analyzed via
ﬂow cytometry (MFI –mean ﬂuorescence intensity). Values represents the mean ± S.D. (n = 3). B) Confocal microscopy of HEK cells, which were incubated for 1 h with polyplexes
(green). Cell nuclei were stained with Hoechst (blue), lysosomes with LysoTracker Red (red). Scale bar = 10 µm.
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be promoted which results in a disruption of tight junctions and in-
creased cytotoxicity. In contrast, perfusion with polyplex P3 as well as
free pDNA, serving as control, revealed no impact on adherens or tight
junction formation (see Fig. 7). We thus conclude that under ﬂow con-
ditions the tightness of the hCMEC layers is not impaired by the
polyplexes, except for polyplex P1.
The biochip design allows the quantiﬁcation of nanoparticles taken
up by the endothelial layer through ﬂuorescence measurements as
well as the exact determination of the total amount of polyplexes that
crossed the endothelial barrier. The imperviousness of the model sys-
tem, in particular for the endothelial cell layer, was proven for YOYO-1
labeled pDNA without nanocarrier (see Supporting information, Fig.
S11). In order to demonstrate the need of glutathionemoieties for a suc-
cessful passage, the precursor P2was investigated for comparison rea-
sons. For the polyplex P6, we observed the highest uptake into the
endothelial cell layer that was associated with a polyplex aggregation
(Fig. 8A; see also Supporting information Fig. S3), which was also ob-
served in kinetic studies using HEK cells. In contrast, polyplexes P1
and P2 show a lower enrichment at the endothelial layer. P3 exhibited
theweakest enrichmentwithin the endothelial layer compared to other
polymers. An image analysis of the quantitative uptake revealed that
the internalization of the polyplex P6 within the endothelial barrier
was signiﬁcantly higher compared to the internalization of the
polyplexes P1 and P2, respectively (Fig. 8B). Interestingly, the highest
difference in the endothelial uptake of all polyplexes tested was ob-
served for P3, even with a signiﬁcant difference regarding the GSH
free precursor P2 (see Fig. S12).
To further elucidate the trans-endothelial transport of the different
polyplexes, we measured its enrichment in the lower chamber under-
neath the endothelial barrier of the biochip (Fig. 8C). GSH was reported
to facilitate a crossing of the nanocarriers through the BBB [21].We thus
testedwhether pDNAbound toP3 could be delivered through the endo-
thelial barrier more efﬁciently than polyplexes P1, P2 or P6 (high up-
take efﬁciency and strong interaction with endothelial layer). After
30 min of perfusion we observed a signiﬁcant increase of polyplex P1
translocation through the endothelial that remained at this level up to
60 min of perfusion. A viability test revealed that P1was toxic already
at low concentrations (Fig. 4A). A similar effect was further conﬁrmed
by immunoﬂuorescence staining of several endothelial adherens and
tight junction proteins involved in maintenance of barrier integrity. Ac-
cordingly, P1 induced a leakage of hCMEC/D3 cell layers under ﬂow
conditions. The difference in our observations under ﬂow conditions
compared to static culture conditions, where the ﬁnal concentration of
0.5 μg mL−1 was still in an acceptable range, can likely be explained
by a signiﬁcantly increased total amount of polyplexes presented to
the cells within the similar incubation time compared to the static cell
culture. This could be an explanation to the unexpected polyplex pas-
sage after 30 min. In contrast, we observed a continuously increasing
transport of the polyplex P3 through the endothelial layer reaching a
maximum at 60min. Indeed, a signiﬁcantly difference is observed com-
pared to the non-passaging precursor polyplex P2without glutathione
modiﬁcation. Taking the results of the uptake studies into account, a
highly “active” polymer like P6within HEK cells can perform in a differ-
ent way compared to microvascular endothelial cell interactions. It is
not beneﬁcial for a passage through the BBB due to its strong interaction
with any kind of cells, independent of proper uptake or not. These re-
sults indicate that in vivo P6 would probably adhere to and might be
partly internalized by endothelial blood vessel cells, followed by cargo
release instead of passing the cell layer. Importantly, the pure pDNA, the
precursor polyplex using P2 without GSH and P6 containing only 8%
Fig. 7. Expression of BBB relevant junctionalmarker proteins before and after polyplexperfusion. pDNA served as control group. Arrowheads showbreakdown or diminished expression of
adherens (VE-Cadherin) and tight junction components evoked by polyplex P1. Nuclei are stained in blue (scale bar 20 nm, n = 3).
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coupled GSHwere virtually prevented from crossing the endothelial layer.
Only P3 showed no interaction neitherwith HEK cells nor endothelia cells,
but was able to pass the BBB and, therefore, was identiﬁed as a promising
candidate as BBB nanocarrier. These results further indicate the strong in-
ﬂuence of the polymer design/composition for a BBB carrier balancing the
GSH content, DNA binding potential and cellular interactions.
3. Conclusion
In this study, the synthesis of L-glutathione (GSH) bearing cationic
polymers is described. To enable the transport of genetic material,
~80% amine functionalities of different nature (primary amines in side
chains and secondary amine groups in polymer backbones) were
installed within a poly(ethylene imine) derivative. A post-polymeriza-
tion modiﬁcation technique followed by a thiol-ene photo-addition in
water was used to attach the GSH moieties. The cationic polymers in-
vestigated in this study exhibited cytotoxic side effects. The insertion
of different types of amines in combination with GSH improved the
cell viability compared to poly(ethylene imine). While the presence of
primary amines in P6 still revealed adverse effects on the cell viability
combinedwith a strong interactionwith cellular membranes, P3 exhib-
ited a superior cell viability as well as a good hemocompatibility. De-
spite the functionalization with negatively charged GSH, the
copolymers were able to bind and release plasmid DNA. These features
supported the potential application as attractive gene delivery agents
for the passage of the BBB.
Studies with biochip embedded cerebral microvascular endothelial
cell layers perfused under physiological shear stress conditions revealed
a signiﬁcantly enhanced passage of the BBB for the GSHmodiﬁed candi-
date containing secondary amine functionalities. Interestingly, the pri-
mary amines led to strong interactions with cells combined with
remarkable high uptake efﬁciency independent of the utilized cell
types. However, this functionalization likely mediates an intracellular
incorporation within the BBB and, thus, renders the nanocarriers (P6)
unsuitable to efﬁciently cross the endothelial layer of the BBB. While
P1 showed an unexpected cell layer passaging effect which is probably
due to a reduced tightness of the cell layer, the nanocarrier precursor
(P2) as well as the uncomplexed plasmid DNA nanocarriers revealed
signiﬁcantly reduced ability to cross the endothelial BBB compared to
GSH-coupled nanocarriers with higher GSH amounts (P3). The GSH-
coupling of nanocarriers thus represents a promising approach to efﬁ-
ciently cross the BBB while avoiding cellular toxicity as shown in this
ﬁrst proof-of-concept study in vitro. However, follow-up studies are re-
quired to further characterize trans-endothelial transport across the
BBB. To proof the feasibility of GSH-coupled nanocarriers as novel ther-
apeutic option for drug-delivery to the CNS also more complex in vivo
models will be investigated in the future.
4. Experimental part
4.1. Materials
Unless otherwise stated, the chemicals were used without further
puriﬁcation. Triﬂuoroacetic acid, ethanol, methanol, Irgacure® 2959,
tert-butyl-(2-mercaptoethyl)carbamate and reduced L-glutathione
were purchased from Sigma Aldrich. The following chemicals were or-
dered from the suppliers in brackets: 2-Ethylen-2-oxazoline (Acros Or-
ganics), 4-dimethylaminopyridine (Merck Millipore), 2,2-dimethoxy-
1,2-diphenylethan-1-one (TCI America), hydrochloric acid (VWR
Chemicals). N-succinimidyl-4-pentenate was synthesized according to
literature procedures [72]. AlamarBlue, YOYO-1 iodide, Hoechst 33342
trihydrochloride (10 mg mL−1 solution) as well as LysoTracker Red
Fig. 8. Performance of the GSH-conjugated polyplexes P1, P2, P3 and P6 in a microﬂuidically supported biochip assay mimicking permeability of the BBB. A) Microscopic images display
polyplexuptake (green)with thehCMEC/D3 cells (nuclei stainedwithDAPI (blue)) under a physiologic shear stress of 4 dyn cm−2. B) Quantiﬁcational analysis of polyplexes at the cellular
barrier. C) Passage of polyplexes P1, P2, P3 and P6 through BBB-like hCMEC/D3 cell layer over time. * signiﬁcances vs. P3; ***p b 0.001; n = 3; scale bar 100 nm.
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DND-99were obtained from Life Technologies (Thermo Fisher, Germany).
If not stated otherwise, cell culture media and supplements (L-glutamine,
antibiotics) were obtained from Lonza (Basel, Switzerland) and Biochrom
(Merck Millipore, Germany), respectively. All other chemicals were pur-
chased from standard suppliers and used without further puriﬁcation.
4.2. General methods and instrumentation
An Initiator Sixty single-mode microwave synthesizer from Biotage,
equipped with a noninvasive IR sensor (accuracy: 2%), was used for po-
lymerization under microwave irradiation.
Proton (1H) nuclear magnetic resonance (NMR) spectra were re-
corded in deuterated water or methanol, at room temperature using a
Bruker Advance I (300 MHz) or a Bruker Advance III HD (400 MHz)
spectrometer; chemical shifts (δ) are expressed in parts per million rel-
ative to TMS. Size exclusion chromatography (SEC) was measured on a
Agilent 1200 series system equipped with a PSS degasser, a G1310A
pump, a G1362A refractive index detector and a PSS GRAM guard col-
umn running with dimethylacetamide (DmAc) with 0.21% of lithium
chloride. For further measurements a Shimadzu system using a SCL-
10A VP controller equipped with a DGU-14A degasser, a LC-10AD VP
pump, a RID-10A refractive index detector and a PSS SDV guard and lin-
ear S column running with chloroform/iso-propanol/triethylamine
(94:2:4) was utilized. The Techlab oven used for both systems was set
to 40 °C and the molar masses were calculated using polystyrene (PS)
standards. Asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4) was per-
formed on an AF2000 MT system (Postnova Analytics, Landberg, Ger-
many) coupled to an UV (PN3211, 260 nm), RI (PN3150), MALS
(PN3070, 633 nm) detector. The eluent is delivered by two different
pumps (tip and focus-ﬂow) and the sample is injected by an
autosampler (PN5300) into the channel. The channel has a trapezoidal
geometry and an overall area of 31.6 cm2. The nominal height of the
spacer was 500 μm and a regenerated cellulose membrane with a
molar mass cut-off of 10,000 g mol−1 (Mn) was used as the accumula-
tion wall. All experiments were carried out at 25 °C and the eluent
was 20mMNaCl in 25mMsodiumacetate buffer at pH3.5. The detector
ﬂow rate was set to 0.5 mL min−1 for all samples and 50 μL
(10 mg mL−1) were injected with an injection ﬂow rate of
0.2 mL min−1 for 7 min. For all samples the cross-ﬂow was set to
2 mL min−1. After the focusing period and a transition time of 1 min,
the cross ﬂow was kept constant for 1 min and was then decreased
under a power function gradient 0.40 to zerowithin 15min. Afterwards
the cross-ﬂowwas kept constant at zero for 20 min to ensure complete
elution. For the calculation of themolarmass a Zimmplot was used. The
refractive index increment (dn/dc) of all samples was measured by
manual injection of a known concentration directly into the channel
without any focusing or cross-ﬂow. The dn/dcwas calculated as the av-
erage of at least three injections from the area under the RI curve. The
cytotoxicity studies as well as ethidium bromide and heparin assays
were performed using a microplate reader (Tecan Inﬁnite M200 Pro,
Crailsheim, Germany). For the uptake studies of HEK-293 and hCMEC/
D3 cells a ﬂow cytometer, Cytomics FC 500 (Beckman Coulter, Krefeld,
Germany) and a confocal laser scanning microscope LSM880 (Carl
Zeiss, Jena, Germany) were used (see below).
4.3. Synthesis of linear poly(ethylene imine) (P1)
The polymerization of the monomer 2-ethyl-2-oxazoline using the
initiator methyl tosylate was performed in a microwave synthesizer ac-
cording to literature procedures [9]. The resulting poly(2-ethyl-2-
oxazoline) (PEtOx, DP= 575, 5.0 g) was further hydrolyzed in 6 M hy-
drochloric acid (HCl) at 100 °C for 16 h under heating to reﬂux [73]. The
excess of HCl and formed propionic acid was removed under reduced
pressure. After dissolving in water, the solution was neutralized by the
addition of 3 M sodium hydroxide (pH N 8). The precipitated linear
poly(ethylene imine) was ﬁltered off and, subsequently, redissolved in
15mLN,N-dimethylformamide to remove the formed salt. After repeat-
ed precipitation in 400 mL ice-cold diethyl ether, the obtained product
was dried under reduced pressure at 85 °C for three days. 1H-NMR
was used to determine the degree of hydrolysis of the resulting polymer
1 (yield: 1.85 g, 85%).
PEtOx: DP = 575. 1H-NMR (300 MHz, D2O): δ 3.70–3.20
(\\NR\\CH2\\CH2), 2.41–2.08 (CH2\\CH3), 1.09–0.79 (CH2\\CH3)
ppm.
P1: EtOx:EI [%] = 5:95. 1H-NMR (300 MHz, MeOD): δ 3.58–3.41
(NR\\CH2\\CH2), 2.91–2.61 (NH\\CH2\\CH2), 2.56–2.36
(CH2\\CH3), 1.18–1.06 (CH2\\CH3) ppm. AF4: Mn =
9900 g mol−1, Ð = 1.4.
4.4. Synthesis of P(EI-stat-ButEnOx) (P2, P4)
Double bond functionalities were installed on the backbone of P1 by
a post-polymerization modiﬁcation process. For this purpose, P1 (for
P2: 751 mg, for P4: 765 mg) and the catalyst 4-N,N-dimethylamino-
pyridine (DMAP, for P2: 120 mg, 0.98 mmol, for P4: 360 mg,
2.95 mmol) were dissolved in pyridine (V= 5mL) at 80 °C. In a second
vial, N-succinimidyl-4-pentenate (for P2: 707 mg, for P4: 4.012 g) was
dissolved in pyridine (V=5mL) and heated to 80 °C. The two solutions
were combined to a 5 wt% mixture (5 mL pyridine were added) of P1.
The reactionmixture was stirred for 21 h at 80 °C. The polymer solution
was precipitated in 500 mL ice-cold diethyl ether. The ﬁltered product
waswashedwith 50mLdiethyl ether and dried under reduced pressure
to constant weight (yield: P2: 0.83 g, 73%, P4: 1.29 g, 58%).
P2: EI:ButEnOx [%] = 73:27. 1H-NMR (400 MHz, D2O): δ 2.28–2.46
(m, CH2 ButEnOx), 2.63–2.85 (m, NH\\CH2\\CH2), 3.35–3.62 (m,
NR\\CH2\\CH2), 4.9–5.0 (dd, CH2_CH\\), 5.76–5.86 (m,
CH2_CH\\) ppm. SEC (CHCl3/iPrOH/NEt3): Mn = 31,400 g mol
−1,
Ð = 1.20.
P4: EI:ButEnOx [%] = 0:100. 1H-NMR (400 MHz, D2O): δ 2.27–2.44
(m, CH2 ButEnOx), 3.45–3.53 (m, NR\\CH2\\CH2), 4.92–5.04 (dd,
CH2_CH), 5.76–5.84 (m, CH2_CH) ppm. SEC (CHCl3/iPrOH/NEt3):
Mn = 44,000 g mol
−1, Ð = 1.53.
4.5. Synthesis of P(EI-stat-GluButOx) via thiol-ene photo-addition (P3)
In a microwave vial, P(EI73%-stat-ButEnOx27%) (P2: 740 mg) and a
1.2-fold excess per double bond of reduced L-glutathione (1.11 g,
3.6 mmol) were dissolved in 15 mL Milli-Q water (5 wt% of P2).
The radical photoinitiator Irgacure® 2959 (100 mg, 0.45 mmol)
was added and the reaction mixture was degassed with argon for
30 min. The clear solution was stirred in a UV-chamber (λ= 365 nm)
for 17 h and, subsequently, dialyzed against water using Spectra/Por 1
dialysis membrane (6000 to 8000 g mol−1 cut-off). The product P3
was lyophilized and obtained as a yellowish powder (yield: 770mg, 44%).
P3: EI:GluButOx [%] = 73:27. 1H-NMR (400MHz, D2O): δ 1.60–1.71
(m, CH2\\CH2\\S\\), 2.12 (q, NCH\\CH2\\CH2\\C_O), 2.45–2.64
(m, NCH\\CH2\\CH2\\C_O, CH2 ButOx), 2.87–3.30 (m,
CH2\\S\\CH2\\CH2, NH\\CH2\\CH2), 3.63–3.95 (m, NR\\CH2\\CH2,
NR\\CH2\\COOH, NH2\\CH), 4.54 (m, NR\\CH\\CH2\\S) ppm. AF4:
Mn = 21,000 g mol
−1, Ð = 2.0.
4.6. Synthesis of P(bocAmButOx-stat-ButEnOx) via thiol-ene photo-addi-
tion (P5)
In a similar procedure, PButEnOx (P4, 1.13 g) and 2-(boc-
amino)ethanethiol (1.19 g, 6.7 mmol) were dissolved in 15 mL metha-
nol (7.5 wt% of P4). 2,2-Dimethoxy-2-phenylacetophenone (DMPA,
88 mg, 0.40 mmol) was added as photoinitiator and the reaction
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mixturewasdegassedwith argon for 30min. Subsequently, the solution
was stirred in a UV-chamber (λ = 365 nm) for 17 h. Precipitation in
400 mL ice-cold diethyl ether, washing with 50 mL of diethyl ether
and drying under reduced pressure for three days resulted in a yellow-
ish powder P5 (yield: 1.94 g, 80%).
P5: bocAmButOx:ButEnOx [%]= 82:18. 1H-NMR (300MHz,MeOD):
δ 1.42 (s, CH3 boc), 1.65 (s, CH2\\S\\CH2\\CH2\\NR), 2.37–2.63 (m,
m, CH2 ButEnOx, S\\CH2\\CH2\\NR), 3.50 (m, NR\\CH2\\CH2,
S\\CH2\\CH2\\NR), 4.96–5.09 (dd, CH2_CH), 5.84 (m, CH2_CH)
ppm. SEC (DMAc, 0.21% LiCl): Mn = 23,400 g mol
−1, Ð = 1.86.
4.7. Synthesis of P(bocAmButOx-stat-ButEnOx-stat-GluButOx) via thiol-
ene photo-addition (bocP6)
The conjugation of reduced L-glutathione (GSH) to the copolymerP5
was performed similar to the conjugation to P3. For this purpose, P5
(1.01 g) was dissolved in 17 mL ethanol (6 wt% of P5). The
photoinitiator Irgacure® 2959 (321 mg, 1.4 mol) and a 1.2-fold excess
per double bond of GSH (252 mg, 0.82 mmol) was added, the reaction
mixture was degassed with argon for 30min and stirred in a UV-cham-
ber (λ=365 nm) for 48 h. An aliquot of 50 μL was taken and character-
ized via 1H-NMR. Due to still incomplete photo-addition, additional GSH
(150 mg, 0.49 mmol) was added to the reaction mixture and irradiated
for further 48 h. The copolymer was puriﬁed by dialysis against ethanol
using Spectra/Por 1 dialysis membrane (6000 to 8000 g mol−1 cut-off)
and dried under reduced pressure for four days (yield: 735 mg, 67%).
bocP6: bocAmButOx:ButEnOx:GluButOx [%] = 82:10:8. 1H-NMR
(300 MHz, MeOD): δ 1.32–1.48 (s, CH3 boc), 1.67 (m,
CH2\\S\\CH2\\CH2\\NR), 2.20 (m, NCH\\CH2\\CH2\\C_O),
2.17–2.60 (m, NCH\\CH2\\CH2\\C_O, CH2 ButOx), 3.08–3.91 (m,
CH2\\S\\CH2\\CH2, NR\\CH2\\CH2, NR\\CH2\\COOH, NH2\\CH),
4.58 (m, NR\\CH\\CH2\\S), 5.02 (CH2_CH), 5.34 (CH2_CH) ppm.
SEC (DMAc, 0.21% LiCl): Mn = 38,400 g mol
−1, Ð = 1.74.
4.8. Synthesis of P(AmButOx-stat-ButEnOx-stat-GluButOx) via
deprotection (P6)
The protected copolymer bocP6 (615mg)was dissolved in dichloro-
methane (24mL) and triﬂuoroacetic acid (40mL) was added. The reac-
tion mixture was stirred for 20 h at room temperature and,
subsequently, precipitated in 300mL ice-cold diethyl ether. The residue
was ﬁltered off, washedwith 30mL diethyl ether, re-dissolved inmeth-
anol and shaken overnight with Amberlyst® A21 (free base) (~0.5 mg).
After ﬁltration, the solvent was removed and the copolymer P6
lyophilized.
P6: AmButOx:ButEnOx:GluButOx [%] = 82:10:8. 1H-NMR
(400 MHz, D2O): δ 1.60 (CH2\\S\\CH2\\CH2\\NR), 2.05
(NCH\\CH2\\CH2\\C_O), 2.32–3.73 (NCH\\CH2\\CH2\\C_O,
CH2 ButOx, CH2\\S\\CH2\\CH2, NR\\CH2\\CH2, NR\\CH2\\COOH,
NH2\\CH2\\CH2), 4.38 (NR\\CH\\CH2\\S), 5.06 (CH2_CH), 5.84
(CH2_CH) ppm. AF4: Mn = 63,300 g mol
−1, Ð = 1.82.
4.9. Determination of the cytotoxicity
Cytotoxicity studies were performed with the mouse ﬁbroblast cell
line L929 (CCL-1, ATCC), as recommended by ISO10993-5 as well as
with HEK-293 and hCMECs/D3 cells. The cells were routinely cultured
in Dulbecco's modiﬁed eagle's medium (DMEM, Lonza) supplemented
with 10% fetal calf serum (FCS), 100 U mL−1 penicillin and
100 μg mL−1 streptomycin at 37 °C in a humidiﬁed 5% (v/v) CO2 atmo-
sphere. In detail, cellswere seeded at 104 cells perwell in a 96-well plate
and incubated for 24 h, whereas no cells were seeded in the outer wells.
Afterwards, the substances to be tested (polymers) at indicated concen-
trations (from 10 μg mL−1 to 500 μg mL−1) were added to the cells and
the plates were incubated for further 24 h. Control cells were incubated
with fresh culture medium. Subsequently, themediumwas replaced by
a mixture of fresh culture medium and Alamar-Blue solution, prepared
according to themanufacturer's instructions. After an additional incuba-
tion of 4 h at 37 °C, the ﬂuorescence was measured at Ex 570/Em
610 nm, with untreated cells on the samewell plate serving as negative
controls. The negative control was standardized as 0% ofmetabolism in-
hibition and referred as 100% viability. Cell viability below 70%was con-
sidered indicative of cytotoxicity. Data are expressed as mean ± S.D. of
three determinations.
4.10. Hemolysis assay
The interaction of polymers with cellularmembranes was examined
by analyzing the release of hemoglobin from erythrocytes. Blood from
sheep, collected in heparinized tubes, were provided by the Institute
of Laboratory Animal Science and Animal Welfare, Friedrich Schiller
University Jena. The blood was centrifuged at 4500 ×g for 5 min, and
the pellet was washed three times with cold 1.5 mM phosphate buff-
ered saline (PBS, pH 7.4). After dilution with PBS in a ratio of 1:7, ali-
quots of erythrocyte suspension were mixed 1:1 with the polymer
solution and incubated in a water bath at 37 °C for 60 min. After centri-
fugation at 2400 ×g for 5min, the hemoglobin release into the superna-
tant was determined spectrophotometrically using a microplate reader
at 544 nmwavelength. Complete hemolysis (100%) was achieved using
1% Triton X-100 serving as positive control. Pure PBS was used as nega-
tive control (0% hemolysis). The hemolytic activity of the polycations
was calculated as follow (Eq. (1)):
%Hemolysis ¼ 100 
ASample−ANegative control
 
APositive control
ð1Þ
A value b 2% hemolysis rate was considered as non-hemolytic, 2 to
5% as slightly hemolytic and values N 5% as hemolytic. Experiments
were run in triplicates andwere performedwith three different batches
of donor blood.
4.11. Erythrocyte aggregation
The erythrocyte suspension was mixed 1:1 with the polymer solu-
tions (100 μL total volume) in a clear ﬂat bottomed 96-well plate. The
cells were incubated at 37 °C for 2 h, and the absorbance wasmeasured
at 645 nm in a microplate reader. Cells, which were treated with PBS
served as negative control and 25 kDa bPEI (50 μg mL−1, Polyscience)
was used as positive control. Absorbance values of the test solutions
lower than the negative control were regarded as aggregation. Experi-
ments were run in triplicates and were performed with three different
charges of donor blood from sheep.
4.12. Polyplex preparation
Polyplexes of pDNA and polymers were prepared by mixing stock
solutions of 15 μg mL−1 pDNA and different amounts of polymers
(1mgmL−1) to obtain various N/P ratios (nitrogen of polymer to phos-
phate of pDNA) in HBG buffer (20mM4-(2-hydroxethyl) piperazine-1-
ethanesulfonic acid (HEPES) and 5% (w/v) glucose, pH 7.2). The solu-
tions were vortexed for 10 s at maximal speed and incubated at room
temperature for 20 min to ensure complex formation.
4.13. Ethidium bromide quenching assay
The formation of polyplexes with pDNA was examined by
quenching of the ethidium bromideﬂuorescence as described previous-
ly [56]. Brieﬂy, 15 μgmL−1 pDNA in a total volume of 100 μL HBG buffer
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(HEPES buffered glucose) were incubated with ethidium bromide
(0.4 μg mL−1) for 10 min at room temperature. Afterwards, polyplexes
with increasing amounts of indicated polymers (regarding N/P ratio)
were prepared in black 96-well plates (Nunc Thermo Fisher). The sam-
ples were incubated at room temperature for 15 min before ﬂuores-
cence measurements. The ﬂuorescence of the samples was measured
at an excitation wavelength of 525 nm and an emission wavelength of
605 nm using a microplate reader. A sample solely containing pDNA
and EtBr was used to calibrate the device to 100% ﬂuorescence against
a background of 0.4 μg mL−1 of EtBr in HBG solution. The percentage
of dye displaced upon polyplex formation was calculated using Eq. (2):
RFU %½  ¼
Fsample−F0
FpDNA−F0
 100 ð2Þ
RFU is deﬁned as the relative ﬂuorescence and Fsample, F0, and FpDNA
are theﬂuorescence intensities of a given sample, the ethidiumbromide
in HBG alone, and the ethidium bromide intercalated into pDNA alone.
4.14. Heparin dissociation assay
To investigate the release of pDNA from the polyplexes, the heparin
dissociation assay was performed. Polyplexes with a N/P ratio of 40
were prepared as described above in a total volumeof 100 μLHBGbuffer
containing ethidium bromide (0.4 μg mL−1). After incubation in the
dark at room temperature for 15 min, the polyplexes were transferred
into a black 96-well plate, and heparin of indicated concentrations
was added. The solution was mixed and incubated for further 30 min
at 37 °C in the dark. The ﬂuorescence of ethidium bromide was mea-
sured at Ex 525 nm/Em 605 nm with a Tecan microplate reader. The
percentage of intercalated ethidium bromide was calculated as de-
scribed before.
4.15. Dynamic and electrophoretic light scattering
Dynamic light scattering (DLS) was performed on a Zetasizer Nano
ZS (Malvern Instruments, Herrenberg) with a He-Ne laser operating at
a wavelength of λ = 633 nm. All measurements (30 runs, triplicate)
were carried out at 25 °C after an equilibration time of 120 s. The counts
were detected at an angle of 173°. The mean particle size was approxi-
mated as the effective (z-average) diameter and thewidth of the distri-
bution as the polydispersity index of the particles (PDI) obtained by the
cumulants method assuming a spherical shape. Electrophoretic light
scattering (ELS) was used to measure the zeta potential (ζ). The mea-
surement was performed on a Zetasizer Nano ZS (Malvern Instruments,
Herrenberg, Germany) by applying laser Doppler velocimetry. For each
measurement, 20 runs were carried out using the slow-ﬁeld reversal
and the fast-ﬁeld reversal mode at 150 V. Each experiment was per-
formed in triplicate a 25 °C. The zeta potential was calculated from the
electrophoretic mobility (μ) according to the Henry Equation. Henry co-
efﬁcient f(ka) was calculated according to Oshima.
4.16. Polyplex uptake
HEK-293 cells (CRL-1573, ATCC) were cultured in RPMI 1640 medi-
um supplemented with 10% FCS, 100 μg mL−1 streptomycin,
100 IU mL−1 penicillin and 2 mM L-glutamine at 37 °C in a humidiﬁed
5% (v/v) CO2 atmosphere. For uptake studies, cellswere seeded at a den-
sity of 105 cells per mL in 24-well plates and cultured for 24 h. One hour
prior to the addition of the polyplexes, the medium was changed to
OptiMEM (Thermo Fisher, Germany). For the uptake kinetic studywith-
in 4 h, pDNAwas labeledwithYOYO-1 iodide prior to thepolyplex prep-
aration. For labeling of 1 μg pDNA, 0.026 μL of 1 M YOYO-1 solution was
mixedwith pDNA and incubated for 20min at 4 °C protected from light.
Afterwards, HBG buffer and the polymers were added at the indicated
N/P ratio and the polyplexes were formed as described previously. The
cells were harvested 15 min, 30 min, 1 h, 2 h and 4 h after polyplex ad-
dition and 10% trypan blue was added to quench the outer ﬂuorescence
of the cells. To determine the relative uptake of the polyplexes, 10,000
cells were measured by ﬂow cytometry using a Cytomics FC 500
(Beckman Coulter) and the amount of viable cells showing YOYO-1 sig-
nal were gated. Dead cells were identiﬁed via counterstaining with
propidium iodide. The experiments were performed at least three
times independently. The uptake studies of hCMECs were performed
in OptiMEM and EndoGro media, respectively. For live cell imaging
HEK cells (105 cells mL−1) were seeded in glass-bottomed, 4-chamber
dishes (CELLVIEW, Greiner Bio-One, Germany) and cultured for 24 h.
One hour prior to polymer addition, the cells were rinsed with phos-
phate buffered saline (PBS) and the media were changed to OptiMEM.
Polyplexes were prepared at N/P 20 as described above and incubated
for further 1 h. Afterwards, the media were replaced with fresh culture
media supplementedwith LysoTracker Red DND-99 andHoechst 33342
for lysosome and nucleus staining, respectively. The living cells were
imaged with a LSM880 using the following excitation wavelengths/
laser lines 405 nm (for Hoechst), 488 nm (for YOYO-1) and 561 nm
(for LysoTracker Red).
4.17. Transfection of adherent cells
For transfection of adherent HEK-293 cells, the cells were seeded at a
density of 105 cellsmL−1 in 24-well plates and incubated for 24 h at 37 °
C, 5% (v/v) CO2. One hour prior to transfection, the cells were washed
with PBS and supplemented with serum-reduced media (OptiMEM).
Polyplexes were prepared as described above, and were added to the
cells (50 μL per well). After an incubation time of 4 h at 37 °C, the super-
natant was replaced by fresh growthmedium and the cells were further
incubated for 20 h. For analysis via ﬂow cytometry (Cytomics FC 500,
Beckman Coulter), the cells were harvested by trypsinization and 104
cells were analyzed. For determination of the viability during ﬂow cy-
tometry, dead cells were identiﬁed via counterstaining with propidium
iodide. For determination of the transfection efﬁciency, viable cells ex-
pressing EGFP were gated. The experiments were performed indepen-
dently three times.
4.18. Immunoﬂuorescence microscopy.
Cells were ﬁxed with ice cold methanol for 10 min at −20 °C,
permeabilized with 0.1% Saponin and blocking was done with 3% nor-
mal donkey serum. Antibody staining was performed using mouse-
anti-human VE-Cadherin, mouse-anti-human β-Catenin (both BD Bio-
sciences, Heidelberg, Germany), mouse-anti-human Claudin-5, rabbit-
anti-human ZO-1 and rabbit-anti-human Occludin (all Life Technolo-
gies, Karlsruhe, Germany) overnight. Secondary antibodies donkey-
anti-rabbit Cy3 (Dianova, Hamburg, Germany) and donkey-anti-
mouse AlexaFluor647 (Life Technologies) as well as DAPI (Life Technol-
ogies) were applied for 1 h at room temperature. Samples were embed-
ded in ﬂuorescencemountingmedium (Dako, Hamburg, Germany) and
imaged on an Axio Observer.Z1 ﬂuorescencemicroscope (Carl Zeiss AG,
Jena, Germany). Image analysis was performed using ImageJ2 software
(Fiji).
4.19. Dynamic cell culture assay
MOTiF biochips were made by injection moulding of polystyrene
and manufactured by microﬂuidic Chip Shop (Jena, Germany) as de-
scribed previously [65]. Chip geometry and embedded structures are
shown in Supporting information, Fig. S10. The human cerebral micro-
vascular endothelial cell line hCMEC/D3 (BIOZOL, Eching, Germany)
was cultured in EndoGRO-MV Basal Medium supplemented with 5%
(v/v) FCS, 0.2% (v/v) EndoGRO-LS supplement, 5 ng/mL recombinant
human epidermal growth factor, 10mM L-glutamine, 1 μgmL−1 hydro-
cortisone-hemisuccinate, 0.75 U mL−1 heparin-sulfate, 50 μg mL−1
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ascorbic acid (all additives were obtained fromMerck-Millipore, Darm-
stadt, Germany), and 100 U mL−1 penicillin and 100 μg mL−1 strepto-
mycin at 37 °C in a humidiﬁed 5% (v/v) CO2 atmosphere. The
membrane within the biochip was coated with 150 μg mL−1 collagen A
(Biochrom, Berlin, Germany) for at least 1 h prior to cell seeding. hCMEC/
D3 were seeded at a density of 0.75 × 105 cm−2 in the upper channel to
grow on top of the membrane. Cells were cultured until fully conﬂuent
after four to ﬁve days. Afterwards, biochips were connected to an Ismatec
peristaltic pump (Cole Parmer,Wertheim,Germany) via gas permeable sil-
icon tubing (Cole Parmer andmicroﬂuidic Chip Shop) at 37 °C in a humid-
iﬁed 5% (v/v) CO2 atmosphere and accustomed to ﬂow conditions with a
ﬂow rate of 175 μL min−1 (corresponding shear stress of 2 dyn cm2) for
30min.Meanwhile polyplex formation at a N/P ratio of 20was performed
in hCMEC/D3 cell culturemediumas stated abovewith additionally apply-
ing YOYO-1 as reporter dye. As corresponding controls polyplex solutions
without dye were used. Subsequently shear stress was increased to
4 dyn cm2 and polyplex solutions were applied for 1 h. For sampling
30 μL from the lower channel system were taken whereas the ﬁrst 15 μL
were discarded to ensure sampling from under the membrane and not
just from the microchannels. Samples were taken every 15 min. After-
wards, cells were washed gently by ﬂushing the upper and lower
microchannels three times with PBS. Nuclei were stained with Hoechst
33342. Membranes and supernatants were analyzed using an Axio
Observer.Z1 ﬂuorescence microscope (Carl Zeiss AG, Jena, Germany) ap-
plying a ﬁlter with 470 nm excitation and 525 nm emission wave
lengths. At least three images per sample were taken. Fluorescence im-
ages were analyzed with the ImageJ2 software whereas controls were
subtracted for quantiﬁcation.
4.20. Statistical analysis
The values represent the mean± S.D. Direct comparison of two dif-
ferent groups was done with two-tailed, non-paired student's test. For
multiple comparisons analysis by two-way ANOVA was performed
using Turkey's multiple testing as post-test. Statistical signiﬁcant was
deﬁned with p-values of b0.05.
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Figure S1. A) Cytotoxicity assay of P2 using alarmaBlue. Non-treated cells served as 100% relative viability. B) 
Erythrocyte aggregation assay of P2 at indicated concentrations. BPEI served as positive control and PBS as negative 
control. C) Hemolysis assay of erythrocytes after incubation with P2 at indicated concentrations. Triton X-100 served 
as positive control (100% hemolysis) and PBS as negative control (1.99%). A value less than 2% hemolysis rate was 
classified as non-hemolytic, 2 to 5% as slightly hemolytic and values > 5% as hemolytic. Values represent the mean ± 
S.D. (n=3). D) Complexation affinity of P2 with plasmid DNA at indicated N/P ratios (ethidium bromide quenching 
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assay). E) Dissociation assay of P2 polyplexes formed at N/P 20 using heparin (0 to 60 U mL-1). Values represent the 
mean ± S.D. (n=3).  
 
 
Figure S2. Biocompatibility. A) Relative viability of hCMEC cells after 24 h incubation with the respective polymers 
at indicated concentrations. B) Relative viability of HEK cells after 24 h incubation with the respective polymers at 
indicated concentrations. 
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Figure S3. Light microscopy of erythrocyte aggregation of the polymers P1, P3 and P6. PBS served as negative 
control, while bPEI (25kDa) was served as positive control. Scale bar = 20 µm. 
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Figure S4. A) Hemolysis assay of erythrocytes after incubation with polymers at the indicated concentrations. 
Triton X-100 served as positive control and PBS as negative control. A value less than 2% hemolysis rate was classified 
as non-hemolytic, 2 to 5% as slightly hemolytic and values >5% as hemolytic. Values represent the mean ± S.D. (n=3). 
B) Erythrocyte aggregation of the tested polymers at indicated concentrations. bPEI (25 kDa) served as positive control 
resulting in high aggregation formation and PBS as negative control. Values represent the mean ± S.D. (n=3). 
 
Table S5. Size and zeta potential of polymer P1, P2, P3 and P6 in HBG buffer measured by dynamic and 
electrophoretic light scattering. 
Polymeric system 
z-Average 
[d/nm] 
PDI 
Number-weighted size  
[d/nm] 
Zeta potential [mV] 
P1 450 ± 7 0.51 < 1 10.4 ± 0.5 
P2 328 ± 27 0.66 < 1 4.9 ± 0.4 
P3 233 ± 11 0.40 < 1 4.0 ± 1.4 
P6 140 ± 23 0.58 26 28.4 ± 0.6 
 
 
6 
 
Table S6. Size and zeta potential of pDNA complexes of P2 at N/P 20 in HBG buffer measured by dynamic and 
electrophoretic light scattering. 
Polymeric system 
z-Average 
[d/nm] 
PDI 
Number-weighted size  
[d/nm] 
Zeta potential [mV] 
P2 264 ± 11 0.35 109 ± 33 24.3 ± 1.1 
 
 
 
Figure S7. Cellular uptake study of P1, P3 and P6 polyplexes (N/P 20) using YOYO-1abeled pDNA. hCMEC cells 
were treated in EndoGro media with polyplexes for 4 h and uptake was analyzed via flow cytometry (MFI – Mean 
fluorescence intensity). Values represents the mean ± S.D. (n=3). 
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Figure S8. Cellular uptake study of P1, P3 and P6 polyplexes (N/P 20) using YOYO-1abeled pDNA. hCMEC cells 
were treated in OptiMEM with polyplexes for 4 h and uptake was analyzed via flow cytometry (MFI – Mean 
fluorescence intensity). Values represents the mean ± S.D. (n=3). 
 
 
Figure S9. Transfection efficiency of copolymers P1 to P3 and P6 for adherent HEK cells in OptiMEM at different 
N/P ratios after 24 h. Values represent the mean ± S.D. (n = 3). 
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Figure S10. Chip geometry and dynamic cell culture setting. A) Schematic illustration of hCMEC/D3 cultured on top 
of a porous membrane within the chip. GSH-coupled nanocarriers are perfused on the apical side and passage through 
the cell layer was investigated basolateral. B) Microscopic image of confluent and tight hCMEC/D3 layer cultured 
within the chip. Membrane pores appear as bright round spots shining through the cell layer (scale bar 100 nm). 
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Figure S11. Negative control without polymer induced polyplex formation. A) Fluorescence images of YOYO-1 
residues (green) on hCMEC/D3 (nuclei in blue). Only slight interaction can be observed. B) Quantification of YOYO 1 
residues on hCMEC/D3 layer. C) Analysis of possible passage through hCMEC/D3 layer over time. No markable 
fluorescence was detectable. (scale 100 nm; n=3) 
 
 
Figure S12. Three dimensional projection of z-stack images showing polyplex uptake (green) through localization at 
same levels as cell nuclei (blue) can be observed. 
Publications Pub1 to Pub8 
 
 
Publication Pub6 
 
Fluorescent amphiphilic heterografted comb polymers comprising 
biocompatible PLA and PEtOx side chains  
I. Yildirim, T. Bus, M. Sahn, T. Yildirim, D. Kalden, S. Hoeppener, A. Traeger,  
M. Westerhausen, C. Weber, U. S. Schubert  
Polym. Chem. 2016, 7, 6064-6074. 
 
 
Polymer
Chemistry
PAPER
Cite this: Polym. Chem., 2016, 7,
6064
Received 29th June 2016,
Accepted 4th September 2016
DOI: 10.1039/c6py01130f
www.rsc.org/polymers
Fluorescent amphiphilic heterografted comb
polymers comprising biocompatible PLA and
PEtOx side chains†
Ilknur Yildirim,a,b Tanja Bus,a,b Martin Sahn,a,b Turgay Yildirim,a,b Diana Kalden,c
Stephanie Hoeppener,a,b Anja Traeger,a,b Matthias Westerhausen,c
Christine Webera,b and Ulrich S. Schubert*a,b
A series of amphiphilic heterografted comb polymers comprising various ratios of oligomeric polylactide
(PLA) and poly(2-ethyl-2-oxazoline) (PEtOx) side chains was synthesized via the grafting-through method
employing the reversible addition–fragmentation chain transfer copolymerization. Two well-deﬁned PLA
macromonomers were prepared via ring opening polymerization (ROP) of L-lactide using a calcium-
based pre-catalyst, pyrenebutanol as an initiator and methacryloyl chloride as an end-capping agent. The
PEtOx macromonomer was obtained from the cationic ROP of EtOx and end-capping with methacrylic
acid. The amphiphilic comb polymers self-assembled in aqueous solution to form spherical and worm-
like micelles, vesicles and more complex morphologies as a function of the composition, as is evident
from dynamic light scattering and cryo-transmission electron microscopy studies. All polymers were
found to be non-toxic to L929 cells up to a concentration of 200 µg mL−1. Cellular uptake studies with
HEK-293 cells by live cell confocal ﬂuorescence microscopy revealed localization in the cytosol after 4 h
and suggest an energy-driven cellular uptake mechanism.
Introduction
Certain polymer classes are often associated with distinct pro-
perties, such as biodegradability, hydrophilicity, charge or
crystallinity. Although such properties can mostly be adjusted
by the use of appropriate monomer types, the combination of
several polymer classes that are obtained via completely
diﬀerent synthetic routes is advantageous, in particular when
rather conservative application fields are in focus. As an
example, the polyester polylactide (PLA) is the current gold
standard as a biodegradable polymer from renewable
resources to serve for encapsulation of hydrophobic guest
molecules or many other applications in the bio-medical
field.1,2 PLA is obtained by the ring-opening polymerization
(ROP) of lactide, however monomers which would add hydro-
philic properties to a polyester are not commercially available.
Hence, poly(ethylene glycol) (PEG) is often applied as a macro-
initiator for the ROP due to its hydrophilic nature and stealth
eﬀect.3
Modern polymer chemistry oﬀers a rich set of other hydro-
philic polymers to prepare amphiphilic PLA-based macro-
molecules, taking into account the prerequisite that they can
be obtained with well-defined end groups. This is the case for
poly(2-oxazoline)s (POx)4,5 since they can be polymerized by a
living cationic ROP mechanism. POx that feature ethyl- and
methyl-substituents are hydrophilic, and are candidates to
replace PEG since they exhibit similar properties in biological
systems: biocompatibility, protein repellency and prolonged
blood circulation, i.e. the “stealth eﬀect”.6
Besides using hydroxyl end-functional macroinitiators to
prepare linear block copolymers comprising PLA,7,8 polymers
with more sophisticated topologies endow further synthetic
possibilities to the structural design.9,10 Among these, comb-
shaped and graft copolymers open avenues for further vari-
ations, taking into account additional factors such as main
chain topology, grafting density, and the chemical compo-
sition of the backbone and the side chains. These additional
factors oﬀer the possibility to include further functionalities,
but can also result in altered physicochemical properties since
†Electronic supplementary information (ESI) available: Additional UV-vis
absorption and fluorescence emission spectra, 1H NMR spectra, hydrodynamic
radii obtained from DLS measurements, and images from confocal microscopy.
See DOI: 10.1039/c6py01130f
aLaboratory of Organic and Macromolecular Chemistry (IOMC), Friedrich Schiller
University Jena, Humboldtstr. 10, 07743 Jena, Germany.
E-mail: ulrich.schubert@uni-jena.de
bJena Center for Soft Matter (JCSM), Friedrich Schiller University Jena,
Philosophenweg 7, 07743 Jena, Germany
cInstitute of Inorganic and Analytical Chemistry (IAAC), Friedrich Schiller University
Jena, Humboldtstr. 8, 07743 Jena, Germany
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excluded volume interactions between grafted side chains11,12
may lead to morphology diversification in self-assembled
aggregates.13
A heterografted comb polymer is a special type of comb
polymer11–13 that contains two diﬀerent side chain types, thus,
representing a flexible means to combine the properties of dis-
tinct polymer types by an appropriate selection of polymer
backbones and side chains. However, examples of hetero-
grafted comb polymers remain scarce to date, mostly due to
demanding synthetic approaches as a result of the several con-
secutive reactions to be performed on the same polymer back-
bone, which is required in many synthetic approaches.14–17 As
an alternative, the copolymerization of macromonomers via
the grafting through method comprises three independent
steps: the synthesis of the two macromonomers and sub-
sequent copolymerization.12,13
Aside from ring opening metathesis polymerization,18 free
radical19–22 and controlled radical polymerization23,24 are the
most commonly utilized techniques for the polymerization of
macromonomers. However, at least one macromonomer is
often based on a linear polymer without substituents (such as
PEG or PCL),19–21,23 thereby decreasing the steric demand
during the backbone formation. In fact, the copolymerization of
PLA macromonomers with a diﬀerent type of macromonomer
(i.e. PEG,25 poly(dimethylsiloxane)26 and poly(n-butylacrylate)18)
yielding heterografted copolymers has been rarely reported.
Herein, we present the copolymerization of a methacrylate
ω-end-functional hydrophobic PLA macromonomer with a
corresponding methacrylate functional macromonomer based
on hydrophilic poly(2-ethyl-2-oxazoline) (PEtOx)24,27 via revers-
ible addition fragmentation chain transfer (RAFT) polymeriz-
ation in order to obtain a series of amphiphilic heterografted
comb polymers (Scheme 1). The hydrophilic/hydrophobic
balance of the comb polymers was changed by altering the feed
ratio of both macromonomers as well as the degree of polymeriz-
ation (DP) of the PLA-based macromonomer to study the self-
assembly behavior in water by means of dynamic light scattering
(DLS) and cryo-transmission electron microscopy (cryo-TEM).
Scheme 1 Schematic representation of the synthesis of (A) the PLA macromonomer via ROP of L-lactide and in situ end capping with methacryloyl
chloride, (B) the POx macromonomer via microwave assisted CROP of 2-ethyl-2-oxazoline, and (C) the heterografted comb polymers via RAFT
polymerization.
Polymer Chemistry Paper
This journal is © The Royal Society of Chemistry 2016 Polym. Chem., 2016, 7, 6064–6074 | 6065
Pu
bl
ish
ed
 o
n 
15
 S
ep
te
m
be
r 2
01
6.
 D
ow
nl
oa
de
d 
by
 T
hu
er
in
ge
r U
ni
ve
rs
ita
ts 
La
nd
es
bi
bl
io
th
ek
 Je
na
 o
n 
28
/0
3/
20
18
 1
3:
21
:1
1.
 
View Article Online
Since both components represent biocompatible polymers,
pyrene was attached as a fluorescent probe28 to enable detailed
studies regarding the cytotoxicity as well as the cellular uptake
behavior. For this purpose, 1-pyrenebutanol was applied as an
initiator during the calcium alkoxide initiated ROP of
L-lactide,29 which was converted to a macromonomer via end-
capping with methacryloyl chloride.30
Experimental section
Materials
L-Lactide (98%) was purchased from Sigma-Aldrich and puri-
fied by recrystallization from dry toluene and dried under
vacuum. Bis(tetrahydrofuran)calcium bis[bis(trimethylsilyl)
amide] (Ca[N(SiMe3)2]2(THF)2) was synthesized according
to previously reported procedures that are valued in several
reviews.31–34 1-Pyrenebutanol (99%) and methacryloyl chloride
(97%) were purchased from Sigma-Aldrich and used without
further purification. Tetrahydrofuran (THF) was dried by
refluxing over sodium/benzophenone. 2-Ethyl-2-oxazoline
(99%, Acros, EtOx) was dried over barium oxide and distilled
under argon prior to use. Methyl tosylate (98%, Aldrich) was
distilled under reduced pressure and stored under argon.
Acetonitrile (extra dry, Acros) was stored under argon.
Methacrylic acid (99%, Aldrich) was used as received.
Triethylamine was dried over potassium hydroxide and dis-
tilled under argon. 2,2′-Azobis(2-methylpropionitrile) (98%,
Acros, AIBN) was recrystallized from methanol, and the chain
transfer agent 2-cyanoprop-2-yl dithiobenzoate (CPDB) was
purchased from Strem Chemicals. AlamarBlue, YOYO-1 iodide,
NucRed Live 647 as well as LysoTracker Green DND-26 were
obtained from Life Technologies (Thermo Fisher, Germany).
Consumables for cell culture, like pipettes and cell culture
plates (96 well), were obtained from Corning (USA) and
Greiner Bio-one (Austria/Germany). If not stated otherwise,
cell culture media and supplements (L-glutamin, antibiotics)
were obtained from Biochrom (Merck Millipore, Germany).
All other chemicals were purchased from standard suppliers
and used without further purification. For the purification
of the comb polymers a column filled with BioBeads S-X1
(exclusion limit 14 000 Da) with THF or toluene as an eluent
was used.
Instruments
The ROP of L-lactide was carried out under nitrogen in an
MBraun UNILab glove box workstation. The polymerization of
EtOx was performed in a Biotage Initiator Sixty microwave
synthesizer. Proton nuclear magnetic resonance (1H NMR)
spectra were recorded at room temperature in CDCl3 on a
Bruker Avance 300 MHz using the residual solvent resonance
as an internal standard. The chemical shifts are given in ppm
relative to tetramethylsilane (TMS). Size-exclusion chromato-
graphy (SEC) measurements were performed on two diﬀerent
setups. SEC in CHCl3: Shimadzu system equipped with an
SCL-10A system controller, an LC-10AD pump, a RID-10A
refractive index detector, an SPD-10AD VP UV detector, and a
PSSSDV-linear S column (5 mm particle size; Polymer
Standards Service (PSS) GmbH, Mainz, Germany) at 40 °C
using a chloroform, triethylamine, and 2-propanol (94 : 4 : 2)
mixture as an eluent at a flow rate of 1 mL min−1. The system
was calibrated with PMMA standards (410 to 88 000 g mol−1);
SEC in THF: a Shimadzu system equipped with an SCL-10A
system controller, an LC-10AD pump, an RID-10A refractive
index detector, an SPD-10AD UV detector and an SDV linear M
column from PSS at 40 °C using THF as an eluent at a flow
rate of 1 mL min−1. The system was calibrated against PLA
standards (144 to 101 000 g mol−1), which were purchased
from PSS. For the measurements of the matrix-assisted laser
desorption/ionization (MALDI) spectra, an Ultraflex III ToF/
ToF instrument (Bruker Daltonics, Bremen, Germany) was
used. The instrument is equipped with a Nd-YAG laser. All
spectra were measured in the positive reflector mode. The
instrument was calibrated prior to each measurement with an
external PMMA standard from PSS. For the MALDI-ToF-MS
sample preparation, separate solutions of polymer (10 mg
mL−1 in THF), 2-(4′-hydroxybenzeneazo)benzoic acid (HABA,
30 mg mL−1 in THF), and doping of sodium chloride (NaCl,
100 mg mL−1 in acetone) were prepared and mixed following
the dried droplet spotting technique. 1 µL of the mixture was
spotted onto the target plate. For the ESI-Q-ToF-MS measure-
ments, samples were analyzed by a microToF Q-II (Bruker
Daltonics) mass spectrometer equipped with an automatic
syringe pump from KD Scientific for sample injection. The
ESI-Q-ToF mass spectrometer was operated at 4.5 kV, at a de-
solvation temperature of 180 °C. The mass spectrometer was
operated in the positive ion mode. Nitrogen was used as the
nebulizer and drying gas. The ESI-Q-ToF-MS instrument was
calibrated in the m/z range from 50 to 3000 using a calibration
standard (Tunemix solution) supplied from Agilent. All data
were processed via Bruker Data Analysis software version 4.2.
UV-Vis absorption measurements were performed using an
Analytik Jena SPECORD 250 spectrometer (Analytik Jena, Jena,
Germany). The fluorescence spectra were recorded on a Jasco
FP-6500 spectrofluorometer. Dynamic light scattering was per-
formed on a Zetasizer Nano ZS (Malvern Instruments,
Herrenberg, Germany). After an equilibration time of 120 s,
3 × 12 runs were carried out at 25 °C (λ = 633 nm). The counts
were detected at an angle of 173°. Each measurement was per-
formed in triplicate. The size distribution of the particles was
calculated applying the non-linear least squares fitting
method. The mean particle size was approximated as the
eﬀective (Z-average) diameter and the width of the distribution
as the polydispersity index (PDI) of the particles obtained by
the cumulants method assuming a spherical shape of the par-
ticles. Cryo-transmission electron microscopy (cryo-TEM)
investigations were performed on a Tecnai G2 20 (FEI)
equipped with an Olympus Soft Imaging Solutions MegaView
and a 4 × 4k Eagle CCD camera system. Quantifoil grids (R2/2
Quantifoil, Germany) were cleaned by plasma treatment prior
to use. Cryo sample preparation was conducted utilizing a FEI
Vitrobot Mark IV system. 6 μL of the sample solution was de-
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posited onto the grid, equilibrated shortly, and blotted for 1 s.
The grids were immediately plunged into liquid ethane to
obtain vitrification, and samples were stored at liquid nitrogen
temperature until being transferred to the TEM utilizing a
Gatan cryo transfer system.
For cytotoxicity and cellular uptake studies, a microplate
reader (Tecan Infinite M200 Pro, Switzerland) and a confocal
laser scanning microscope LSM880 (Carl Zeiss, Germany) were
used (see below).
Synthesis
Cationic ring-opening polymerization. Oligo(2-ethyl-2-oxazo-
line) methacrylate (EtOx5MA) was synthesized as reported pre-
viously.27 Briefly, 1.383 g (7.44 mmol) of MeTos and 3.60 g
(36.31 mmol) of EtOx were dissolved in 5.41 mL of acetonitrile
and polymerized in a microwave synthesizer for 1 minute at
140 °C. 1.84 mL (21.8 mmol) of MAA and 6.04 mL (46.6 mmol)
of triethyl amine were added. Subsequent to heating at 50 °C
overnight, the macromonomer was dissolved in chloroform
and purified by extraction with aqueous sodium bicarbonate
solution and brine. The volatiles were removed under reduced
pressure. Mn, NMR = 600 g mol
−1, Mn, SEC = 500 g mol
−1, Đ =
1.17 (SEC in CHCl3, PMMA calibration), DP = 5, DF = 96%.
ROP of L-lactide. The ROP of L-lactide was carried out in a
glove box, at room temperature under a nitrogen atmosphere
(<1 ppm H2O, <1 ppm O2), using THF as the solvent.
LA15MA 1: Ca[N(SiMe3)2]2(THF)2 (0.23 mmol, 116 mg) was
dissolved in 1.0 mL of THF. This solution was added under vig-
orous stirring to a solution of L-lactide (1.0 g, 6.94 mmol) and
1-pyrene butanol (126.2 mg, 0.46 mmol) in 5.94 mL of THF in
a microwave vial. This corresponds to a molar ratio of
[L-lactide]/[1-pyrenebutanol]/[Ca] of 15/1/0.5 and an initial
monomer concentration of [L-lactide]0 of 1 mol L
−1. After
10 minutes, a sample was taken from the mixture and analyzed
by 1H NMR spectroscopy in order to determine the monomer
conversion. The vial was capped, taken out of the glove box,
and immersed in an ice bath. Subsequently, methacryloyl
chloride (223 µL, 2.30 mmol) was added dropwise into the
polymerization mixture through the septum of the vial. After
10 minutes, the ice bath was removed and the mixture was
kept at room temperature for 24 hours under vigorous stirring.
The excess of acid chloride was removed via precipitation in
methanol and the purified product was dried under reduced
pressure until a constant weight (yield: 0.8 g, 80%). 1H NMR
(300 MHz, CDCl3): δ/ppm = 1.57 (d, –C(O)CH(CH3)O–), 1.96 (s,
–C(O)CH(CH3)OC(CH3)CH2), 3.37 (t, C16H9CH2C3H6OC(O)–),
4.21 (t, C16H9C3H6CH2OC(O)–), 5.16 (q, –C(O)CH(CH3)O–),
5.63 (s, –C(O)C(CH3)CH2), 6.20 (s, –C(O)C(CH3)CH2)
7.80–8.30 (m, C16H9C4H8OC(O)–). The macromonomer was
characterized by means of SEC (THF, RI detection, PLA
calibration), MALDI-ToF-MS, and ESI-ToF-MS (see Results and
discussion).
LA10MA 2 was obtained in an analogous fashion. 1.0 g of
L-lactide (6.94 mmol), 175 mg of Ca[N(SiMe3)2]2(THF)2
(0.34 mmol), 190 mg of 1-pyrene butanol (0.69 mmol), 338 µL
of methacryloyl chloride (3.40 mmol) and 5.94 mL of THF
were used.
RAFT polymerization. Five diﬀerent comb polymers were
prepared by changing the ratios of the EtOx and PLA macro-
monomers. The [M]total/[CPDB]/[AIBN] ratio was kept at 60/1/
0.25 with an overall monomer concentration of 0.3 mol L−1. In
a representative RAFT copolymerization for P1, LA15MA
(0.590 g, 0.19 mmol), EtOx5MA (0.562 g, 0.94 mmol), CPDB
(4.2 mg, 0.019 mmol), and AIBN (0.77 mg, 0.0047 mmol) were
dissolved in 3.8 mL of THF. After gently purging with argon
for 30 minutes to remove the oxygen from the reaction
mixture, the t0 sample was taken for the determination of the
monomer conversions. The polymerization was conducted in a
pre-heated oil bath at 70 °C for 24 hours. The polymerization
was stopped by cooling to room temperature and exposing the
solution to air. The macromonomer conversions were calcu-
lated by comparing the integral values of the vinylic peaks in
1H NMR spectra of the samples taken before and after
polymerization. The comb polymers were purified by precipi-
tation in methanol and subsequent preparative SEC on a
BioBeads-SX-1 column, respectively. THF or toluene was used
as the eluent based on the solubility of the comb polymers.
Fractions (ca. 2 mL) were collected and analyzed by SEC with
UV and RI detection. The desired fractions were combined and
the volatiles were removed under reduced pressure.
Sample preparation for DLS and Cryo-TEM analysis
5 mg of comb polymer were dissolved in 500 µL of THF. The
solution was dropped into 1 mL of deionized water in aliquots
of 5 µL under vigorous stirring. THF was evaporated by stirring
the open vial for at least two days to yield aqueous suspensions
with a final polymer concentration of 5 mg mL−1.
Determination of cytotoxicity
Cytotoxicity studies were performed with the mouse fibroblast
cell line L929 (CCL-1, ATCC), as recommended by ISO10993-5.
The cells were routinely cultured in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum
(FCS, Capricorn Scientific, Germany), 100 U mL−1 penicillin
and 100 µg mL−1 streptomycin at 37 °C in a humidified 5%
(v/v) CO2 atmosphere. In detail, cells were seeded at 10
4 cells
per well in a 96-well plate and incubated for 24 hours. No cells
were seeded in the outer wells. Afterwards, the testing sub-
stances (polymers) were added to the cells at the indicated
concentrations (from 5 µg mL−1 to 200 µg mL−1) and the
plates were incubated for additional 24 hours. Subsequently,
the medium was replaced by a mixture of fresh culture
medium and the assay reagent alamarBlue (resazurin based
solution, Thermo Fisher, Germany, prepared according to
manufacturer’s instructions). After a further incubation of
4 hours at 37 °C in a humidified 5% (v/v) CO2 atmosphere, the
fluorescence was measured at Ex 570/Em 610 nm, with
untreated cells on the same well plate serving as negative con-
trols. The negative control was standardized as 0% of metab-
olism inhibition and referred to as 100% viability. Cell viability
below 70% was considered indicative of cytotoxicity. Data are
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expressed as mean ± standard deviation (SD) of three indepen-
dent determinations.
Cellular uptake
Live cell imaging was performed using HEK-293 cells
(CRL-1573, ATCC) for analyzing the cellular uptake of the
comb polymers. For this purpose, HEK cells (105 cells per mL)
were seeded in glass-bottomed, 4-chamber dishes (CELLVIEW,
Greiner Bio-One, Germany) and cultured for 24 hours in RPMI
1640 medium (Lonza, Switzerland) supplemented with 10%
FCS, 100 µg mL−1 streptomycin, 100 U mL−1 penicillin and
2 mM L-glutamine at 37 °C in a humidified 5% CO2 atmo-
sphere. One hour prior to polymer addition, the cells were
rinsed with phosphate buﬀered saline (PBS) and the media
were changed to OptiMEM (Gibco, Thermo Fisher, USA). The
polymers were added to cells with a final concentration of
50 µg mL−1 and incubated for an additional 4 hours.
Afterwards, the media were replaced with fresh culture media
supplemented with LysoTracker Green DND-26 and NucRed
Live 647 for lysosome and nucleus staining, respectively.
The living cells were imaged with a LSM880 (Carl Zeiss,
Germany) using the following excitation wavelengths/laser
lines 405 nm (for pyrene), 488 nm (for lysosomes) and 633 nm
(for nucleus).
Results and discussion
Macromonomer syntheses
In order to prepare heterografted comb polymers comprising
hydrophilic and hydrophobic side chains, macromonomers
based on PEtOx and PLA had to be prepared with methacrylate
end groups. To facilitate reasonable conversions during the
subsequent RAFT polymerization, the degree of polymerization
(DP) of both macromonomers was kept low (DP = 5 to 15).
Since several RAFT (co)polymerizations of EtOx5MA have been
successfully established in our laboratories,24,27,35 a DP of 5
was selected for the hydrophilic macromonomer. Hence,
EtOx5MA was obtained by CROP of EtOx using MeTos as an
initiator and subsequent end-capping with methacrylic acid
using triethyl amine as a base to produce methacrylate anions
in situ. For detailed information about the synthesis and
characterization of EtOx5MA, the reader is referred to the
literature.27
So far, the catalyst Ca[N(SiMe3)2]2(THF)2 has proven power-
ful for the preparation of well-defined α-end-functional PLAs
using various alcohols as initiators for the ROP of L-lactide at
room temperature.29 However, direct ω-end-functionalization
of the resulting anionic PLA species has not been attempted
yet. An electrophile such as methacryloyl chloride is necess-
ary30 to introduce a methacrylate end functionality via this
direct end-capping route. Among the multitude of suitable
alcohols that can be used as initiators for the ROP, 1-pyrene-
butanol was selected for this study because of its fluorescence
that makes it a suitable label for cellular uptake studies. To
facilitate a similar reactivity of both macromonomer types
during the subsequent RAFT copolymerization, the DP of the
hydrophobic PLA macromonomers was kept low as well. Both
polymerizations were driven to quantitative conversion prior to
end-capping with a 10-fold excess of methacryloyl chloride.
Hence, two diﬀerent α,ω-end functional PLA macromonomers
with a DP of 10 and 15, respectively, were prepared by ROP of
L-lactide in a one-pot procedure. Table 1 summarizes the
characterization results of the fluorescent PLA-based hydro-
phobic macromonomers LA15MA and LA10MA by means of
SEC, 1H NMR spectroscopy and mass spectrometry.
Due to the absorbance of the pyrene moieties at 340 nm,
SEC analysis with UV detection provides a simple tool to
confirm the covalent attachment of the initiator at the macro-
monomers. As is evident from the overlapping RI and UV
signals in the elugrams of both macromonomers, the pyrene
functionality is distributed evenly throughout the resulting
PLA’s, hinting at the absence of chain transfer reactions
during the ROP (Fig. SI 1†). Moreover, the monomodal SEC
traces and narrow molar mass distributions indicate that the
quenching of the polymerization with methacryloyl chloride
did not induce chain coupling or even autopolymerization of
the methacrylate ω-end functionalities, neither during the
course of the reaction nor during the purification.
SEC alone is incapable of providing a structural proof for a
successful end-capping of the PLA chains. However, the 1H
NMR spectra of the resultant PLA macromonomers clearly
reveal the presence of both pyrene and methacrylate moieties
(Fig. 1). The fact that the separate integration of these signals
was possible enabled the estimation of the degree of polymer-
ization (DP) and the degree of functionalization at the ω-chain
end (DF). For the former, the peak integrals corresponding to
pyrene moieties (peak “g” in Fig. 1) and the methine proton of
the lactide repeating units (peak “a” in Fig. 1) were used. The
resulting molar masses are in good agreement with the values
obtained from SEC analysis with PLA calibration as well as
with the targeted molar mass for both macromonomers.
Table 1 Characterization data of the PLA macromonomersa
M/I Conv.b [%] DPc DFc [%] Mn, theo
d [g mol−1] Mn, NMR
c [g mol−1] Mn, SEC
e [g mol−1] ĐSEC
e Mn, MALDI[g mol
−1] ĐMALDI
LA15MA 15 100 15 93 2500 2500 2300 1.24 2200 1.09
LA10MA 10 100 10 90 1800 1800 1500 1.32 2000 1.13
a [1-Pyrenebutanol]0/[Ca]0/[methacryloyl chloride] = 1/0.5/5, [L-lactide]0 = 1 M in THF, tpol = 10 min, T = 25 °C.
bDetermined by 1H NMR spec-
troscopy from the polymerization mixtures. cDegree of polymerization (DP) and degree of functionalization (DF) obtained from 1H NMR spectra
of the purified macromonomers. dCalculated from M/I and conversion. eDetermined by SEC (THF, RI detection, PLA calibration).
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By comparison of the signals derived from both end groups,
the DF was calculated. Therefore, the vinylic protons of the
methacrylate moiety (peak “d”) and either the pyrene signals
in the aromatic region (peaks “g”) or the benzylic methylene
protons (peak “e”) were used. The resulting DF varies between
84% and quantitative functionalization, based on the selected
peak for integration due to the small intensity of the end
group peaks. Hence, average values from four diﬀerent inte-
grations are reported in Table 1.
The excellent end group fidelity of the PLA macro-
monomers was further confirmed by mass spectrometric
measurements. Fig. 2 shows the MALDI-ToF and ESI-Q-ToF MS
of the PLA macromonomer LA15MA. Both spectra reveal a
single distribution of peaks at regular intervals spaced by
Δm/z = 72 between two neighboring peaks. The experimental
isotopic patterns exactly overlap with the corresponding pat-
terns calculated for the pyrene butanol α- and methacrylate
ω-end functional PLA chains, which are ionized with a sodium
cation. As often observed for ESI-Q-TOF analysis of polymers,
this singly charged m/z distribution is overlaid with a second
(doubly charged) m/z distribution, which corresponds to the
same species ionized with two sodium cations. Although a
Δm/z = 72 (instead of Δm/z = 144) in the mass spectra of PLA is
often attributed to the presence of transesterification reactions
in the literature,30 it should be clearly stated that an intra-
molecular rearrangement at the active catalyst center is the
reason for this observation in our case. This statement is based
on our detailed previous research on this calcium alkoxide
initiator system,29 and sophisticated mechanistic studies are
currently ongoing in our laboratories.
Grafting-through via RAFT copolymerization
Using both macromonomer types, i.e. hydrophilic EtOx5MA
and hydrophobic LAnMA, a series of heterografted comb poly-
mers was prepared by RAFT copolymerization via the grafting
through method. Thereby, the overall [monomer] to [CTA] ratio
was kept constant at 60 using AIBN as an initiator and CPDB
as a chain transfer agent in THF at 70 °C. In order to obtain
comb polymers with varying hydrophilicity, the feed ratio of
the EtOx5MA and LA10MA macromonomer was changed,
however keeping a high molar fraction of the hydrophilic
EtOx5MA throughout the series P2–P5 because of the doubled
DP of the hydrophobic LA10MA. To elucidate the influence of
the DP of the hydrophobic side chains, P1 was synthesized
using LA15MA while keeping the same feed ratio as for P2. As
is often observed for grafting-through approaches, the macro-
monomer conversions were lower in this case due to the
increased steric hindrance induced by the longer side
chains.27 For all comb polymers, complete removal of residual
macromonomers was ensured by successive precipitation in
methanol and preparative SEC using a BioBeads column.
Table 2 summarizes the polymerization conditions and the
characterization results of all purified comb polymers
obtained by 1H NMR spectroscopy and SEC analysis.
Fig. 3 shows an overlay of the SEC traces obtained from the
comb polymers and the macromonomers with RI and UV
detection at 340 nm. As can be clearly seen, all comb polymers
elute earlier than the corresponding macromonomers due to
the increased hydrodynamic volume of P1 to P5. The fact that
unimodal SEC traces are obtained confirms the complete
removal of residual macromonomers during the purification
process. The molar masses determined by SEC are similar for
P1 to P4, which is reasonable because the same [M]/[CTA] ratio
was kept throughout the complete polymer series, and the con-
versions from all RAFT polymerizations were in a comparable
Fig. 1 1H NMR spectrum (300 MHz, CDCl3) of the PLA macromonomer
LA15MA and structural assignment of the observed peaks. Fig. 2 Mass spectra of the PLA macromonomer LA15MA and the overlay
of the isotopic patterns for the structural assignment of the peaks.
(A) MALDI-ToF (HABA, NaCl) and (B) ESI-Q-ToF. Both spectra show an
overlapping m/z series of the same PLA species that are either ionized
with one (z = 1) or two (z = 2) sodium cations, respectively.
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range (see Table 2). However, it has to be considered that SEC
represents a relative method for molar mass determination
and relies on the calibration with linear standard polymers,
whose hydrodynamic volume strongly diﬀers from that of
comb-shaped polymers in general. Hence, SEC underestimates
the molar masses of P1 to P5. All comb polymers elute at
similar retention times, revealing that the hydrodynamic
volume of the polymeric architectures is not influenced by the
side chain composition in chloroform, which represents a
good solvent for both side chain types, i.e. PLA as well as
PEtOx. In addition, the signals from UV and RI detection
overlap for all polymers, confirming the incorporation of the
respective PLA-based macromonomers, since EtOx5MA does
not absorb at the wavelength selected for the UV detector.
Analysis of the purified comb polymers by means of 1H
NMR spectroscopy clearly reveals that both PLA and POx
macromonomers were incorporated into the comb polymers as
the signals derived from both polymer types can be clearly
distinguished (Fig. 4). The signal corresponding to the methyl
end groups of the PEtOx side chains (peak “B” in Fig. 4) was
used to calculate the copolymer composition. Therefore, its
integral was compared with the integral value of the methine
proton peak of the PLA side chains (peak “a” in Fig. 4). The
ratio of the two side chain types in the comb polymers is in
excellent agreement with the feed ratio of both macro-
monomers, showing that LAnMA was successfully incorporated
during the RAFT copolymerization, despite its higher DP in
comparison with EtOx5MA (compare Table 2). In addition, the
aromatic protons of the pyrene unit (peak “c” in Fig. 4), which
represent the end groups of the PLA side chains, are clearly
visible, confirming the observations from SEC with UV detec-
tion (see above).
Fig. SI 3† depicts an overlay of the 1H NMR spectra of P1 to
P5 together with the structural assignment of the observed
peaks used to estimate the copolymer composition. All spectra
were normalized according to the peak maxima of the methine
protons of the PLA side chains to underline the increasing
PEtOx content throughout the polymer series from P1 to P5. As
the PEtOx content in the copolymer increases, so does the
intensity of the respective signals assigned to this type of side
chain. Although the ratio of the distinct side chain types was
apparently not widely varied, the copolymer composition covers
a broader range when the ratio of the EtOx and lactide repeating
units is taken into account. This is due to the increased DP of
the PLA-based side chains (DP = 10 and 15) compared with the
DP of the PEtOx-based side chains (DP = 5).
Table 2 Characterization results of the comb polymers P1 to P5
LAnMA
EtOx5MA/
LAnMA/CTA/AIBN
[EtOx5MA]/
[LAnMA] (feed)
Conv.a [%]
Mn, theo
b
[g mol−1]
Mn, SEC
c
[g mol−1] ĐSEC
c
[EtOx5MA]/
[LAnMA] (NMR)
d
EtOx/LA
(NMR)eEtOx5MA LAnMA
P1 LA15MA 42/18/1/0.25 71/29 32 25 20 600 27 500 1.17 70/30 45/55
P2 LA10MA 42/18/1/0.25 71/29 90 85 50 000 28 200 1.37 65/35 50/50
P3 LA10MA 50/10/1/0.25 83/17 75 73 35 600 29 000 1.25 80/20 65/35
P4 LA10MA 53/7/1/0.25 88/12 95 90 41 000 26 300 1.25 85/15 70/30
P5 LA10MA 54/6/1/0.25 90/10 85 75 36 800 19 500 1.23 90/10 80/20
a Conversion values determined by 1H NMR spectroscopy from the polymerization mixtures. b Calculated from feed and conversion. cDetermined
by SEC (CHCl3, RI detection, PMMA calibration).
dMacromonomer molar ratio calculated from suitable signal integrals in the 1H NMR spectra of
the purified polymers. eMolar ratio of EtOx and LA repeating units calculated from suitable signal integrals in the 1H NMR spectra of the purified
polymers.
Fig. 3 Normalized SEC traces (CHCl3) of the macromonomers and
comb polymers P1 to P5.
Fig. 4 1H NMR spectrum (300 MHz, CDCl3) of P3 together with the
structural assignment of the observed peaks.
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Self-assembly behavior in aqueous media
To investigate the self-assembly behavior of the amphiphilic
comb polymers P1–P5 in water, aqueous suspensions were pre-
pared by dropping THF polymer solutions into water. During
the evaporation of THF, the formed structures were aged for a
minimum of two days at room temperature. Subsequently, DLS
and cryo-TEM measurements were performed.
Fig. 5 shows the resulting size distributions obtained from
DLS of the copolymer assemblies P2–P5, i.e. the heterografted
comb polymers synthesized using the macromonomers
LA10MA and EtOx5MA along with representative cryo-TEM
micrographs. Only in the case of the most hydrophilic copoly-
mer P5, DLS revealed a bimodal size distribution of the self-
assembled polymer structures, as is apparent by the overlay of
the intensity, volume, and number weighted size distributions.
Obviously, larger aggregates are visible in the intensity
weighted distributions. Cryo-TEM measurements confirmed
the presence of smaller (ca. 10 nm) and larger (ca. 40–50 nm)
structures, which is in accordance with the DLS results.
Presumably, the weight fraction of the hydrophilic EtOx is too
high (wEtOx = 0.73) in the case of P5 and capable of shielding
the hydrophobic PLA segments even without the formation of
defined copolymer assemblies.
Monomodal size distributions were evident from DLS for
the suspensions of the comb polymers P3 and P4 with a lower
EtOx weight fraction of wEtOx around 0.6. Homogeneous and
densely packed spherical micelles with diameters around
15 nm were visualized by cryo-TEM analysis. This value
roughly corresponds to the double length of a PLA with a DP
of 10 in the all-trans conformation. Hence, one might assume
that the micelles are formed by a spherical arrangement of
several macromolecules with the PLA chains pointing towards
the inside and the PEtOx side chains pointing to the outside.
Already a slight increase in the weight fraction of hydrophobic
PLA side chains resulted in spherical micelles with increased
diameters of around 30 nm in the case of P3. Both obser-
vations are in accordance with the hydrodynamic diameters
obtained from DLS measurements.
Further decrease of the EtOx content (P2, wEtOx = 0.4)
resulted in a mixture of self-assembled structures: spherical
and worm-like micelles as well as large vesicles were found in
the cryo-TEM micrographs. Accordingly the hydrodynamic dia-
meters from DLS are increased with a rather high polydisper-
sity index (PDI = 0.27, compare Table S1†). The diameter of the
spherical and worm-like micelles (17 and 14 nm, respectively)
corresponds well with the length of the PLA side chains of the
comb polymer, as does the bilayer thickness of the vesicles
(13 nm).
A similar variety of self-assembled structures was found by
investigation of P1 (Fig. 6), which is in good agreement with
the bimodal intensity size distribution from DLS. In terms of
the macromonomer mol fraction, this comb polymer has a
similar composition as P2. However, the PLA side chains
feature an increased DP of 15 since LA15MA was used during
its synthesis, resulting in a further decreased wEtOx of 0.36. In
agreement with the length of the respective hydrophobic PLA
side chains of the heterografted comb polymer P1, the micelles
revealed slightly increased diameters (around 19 nm) in com-
parison to the structures formed by P2. Also the membrane
thickness of the vesicular structures is slightly increased
(21 nm). In addition, more complex morphologies were
visualized by cryo-TEM investigations (Fig. 6b–d), which may
be due to a hampered phase ordering due to the fact that
hydrophilic and hydrophobic segments are covalently bound
to the same comb polymer backbone. This would restrict the
side chain mobility when compared with simple linear block
copolymers.
Fig. 5 DLS plots and cryo-TEM images of the suspensions obtained from P2 to P5 in water (c = 5 mg mL−1).
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Fig. 6 shows examples of structures found for P1. In particu-
lar the large aggregates (up to 400 nm in diameter) featured
diﬀerent morphologies; however, no clearly defined structure
can be elucidated in this case. Structures vary from segmented
vesicles (b) (as reported by Mansfeld et al.36 or Parry et al.37),
distorted vesicles (c) as well as lamellar vesicles (d).
The transition from spherical micelles to vesicles has been
predicted for heterografted comb polymers, and experimental
confirmation has recently been provided by Luo et al. for
heterografts with PEG and PLA side chains.38,39 However,
researchers in this field rather concentrate on an alteration of
the side chain lengths of the comb polymers in analogy to vari-
ation of the block lengths in linear diblock copolymers. In
fact, in these cases the only diﬀerence with linear block copoly-
mers is the covalent junction at the comb polymer backbone
(Fig. 7). We found that similar transitions are possible by
keeping the DP of the side chains constant but altering the
fraction of each type of side chain in the heterografted comb
polymer.
Cytotoxicity and cellular uptake
As both segments of the comb polymers, i.e. the hydrophilic
PEtOx and the hydrophobic PLA represent non-toxic polymers
it was expected that the comb polymers P1–P5 are highly bio-
compatible as well. Hence, an assay based on resazurin was
performed to measure the metabolic activity of L929 mouse
fibroblast cells after addition of polymer suspensions in water
at varying concentrations. As depicted in Fig. 8, all polymers
showed no significant reduction in cell viability after 24 hours
at the tested conditions. Moreover, no influence of the
diﬀerent structural compositions of the polymers was
observed. Due to the hydrophobic nature, it could be assumed
that the PLA-pyrene side chains are located in the core of the
self-assembled structure encompassed by the methacrylate
backbone and PEtOx side chains (Fig. 7). Hence, the hydro-
philic PEtOx arms, which shape the outer part of the self-
assembled structures, indeed promote a high biocompatibility
of the systems. A degradation of PLA combined with the
release of pyrene would result in severe lethal eﬀects, as this
highly hydrophobic molecule would intercalate into cellular
membranes.40,41
Based on these promising results, further biological investi-
gations concerning the cellular uptake were performed. Since
the pyrene at the end groups of the PLA side chains of the
comb polymers enables easy detection of the polymeric struc-
tures,42,43 it was possible to examine their intracellular distri-
bution without the need to encapsulate any fluorescent probe.
A representative UV-vis fluorescence emission spectrum is pro-
vided in Fig. S2† for P4. The ratio of the emission bands
caused by the vibrational fine structure of pyrene corresponds
very well to that of pyrene encapsulated into PLA-based nano-
carriers,44 confirming the assumption that the only potentially
Fig. 6 DLS plots and cryo-TEM images of the suspensions formed by
P1 in water (c = 5 mg mL−1; scale bars show 100 nm).
Fig. 7 Formation of spherical and worm-like micelles from comb poly-
mers with mixed PEtOx and PLA side chains.
Fig. 8 Relative viability of L929 cells after 24 hours of incubation with
heterografted comb polymers (P1 to P5) at the indicated concentrations.
Values represent the mean ± S.D. (n = 3).
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toxic compound is not exposed to the surface of any polymeric
structures formed in aqueous media. Therefore, HEK cells
were incubated with P1 to P5 for 4 hours. Confocal live cell
imaging revealed a high cellular internalization for all tested
polymers at 37 °C (Fig. 9, top and Fig. SI 4 to SI 8†). The
detected pyrene signal (magenta) was equally distributed
within the cytosol, but was just rarely co-localized within the
lysosomes (green) and not detectable within the nucleus. This
could indicate either a fast endosomal release or cellular
uptake via translocation through the cell membrane.
It is known that nanocarriers or nanoparticles possessing
diameters from 20 to 500 nm enter cells in an active manner,
mainly through endocytosis.45,46 Furthermore, it is assumed
that particles smaller than 20 nm may also internalize by
passive diﬀusion47 through channels, protein carriers or by
translocation. Uptake studies of P1 were performed at 4 °C, to
investigate if the polymers are internalized into the cells by a
passive process. Compared to the uptake at 37 °C, decreased
pyrene fluorescence was detected within the cells. This indi-
cates that a minor fraction of comb polymers is able to enter
the cells by passive penetration. However, the predominant
uptake mechanism for P1 is an energy-driven process.
Conclusions
We present a convenient synthetic strategy for a series of fluo-
rescent amphiphilic heterografted comb polymers comprising
oligomeric biocompatible side chains via combination of ROP,
CROP, and RAFT polymerizations. For this purpose, well-
defined methacrylate ω-end-functional macromonomers based
on PLA and PEtOx were prepared in separate one-pot pro-
cedures and were subsequently copolymerized via RAFT to
obtain comb polymers with varying hydrophilicity simply by
altering the feed ratio of both macromonomers. Cryo-TEM
studies of the heterografted comb polymers in water revealed
morphologies ranging from vesicular structures to spherical
micelles. The morphology of the self-assembled structures
correlated well with the hydrophilic character of the comb
polymers. The fluorescent pyrene moieties attached to the PLA
side chains of the comb polymers enabled performing cellular
uptake studies without the need of encapsulation of any
tracker molecules revealing that only a slight fraction is
localized inside late endosomes/lysosomes. This is favorable
for delivery applications, which will be in the focus of our
future research as the PLA part of the polymer is biodegradable
and a hydrophobic drug could be encapsulated into the self-
assembled structures to be slowly released by degradation of
the hydrophobic segments.
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Figure S1. Normalized SEC traces (THF, PLA calibration) of the PLA macromonomers with 
RI and UV detection at 340 nm. 
Figure S2. (A) UV-vis absorption spectrum recorded from the aqueous suspension of P4 (c = 
1 mg mL-1). Overlay of fluorescence emission spectra (c = 50 g mL-1) (B) with the excitation 
wavelength set at 346 nm. (C) with the excitation wavelength set at 405 nm 
Figure S3. Overlay of the 1H NMR spectra (300 MHz, CDCl3) of all comb polymers P1 to 
P5. For clarity, the spectra were normalized according to the signal of the methine protons of 
PLA. Only the signals used for calculation of the copolymer composition are labelled. 
Table S1. Characterization results of the polymer suspension in water by means of DLS (the 
mean particle size was approximated as the effective (Z-average) diameter and the width of 
the distribution as the polydispersity index of the particles (PDI) obtained by the cumulants 
method).a
Polymer
Z-avg
[d, nm] PDI
P1 59 ± 0.7 0.349 ± 0.001
P2 103 ± 0.4 0.270 ± 0.01
P3 65 ± 0.6 0.178 ± 0.01
P4 19 ± 0.1 0.122 ± 0.002
P5 81 ± 0.3 0.309 ± 0.003
ac = 5 mg mL-1 in water.
Confocal live cell microscopy
Uptake studies I: Negative Control
Figure S4. Confocal live cell imaging: HEK cells were cultivated for 4 h in serum-reduced 
media serving as negative control. The cell nucleus was stained with NucRed (grey) and the 
lysosomes with LysoTracker Green (green); pyrene is depicted in magenta (scale bars 
represent 10 m).
Uptake studies II: P2
Figure S5: Confocal live cell imaging: For uptake studies, HEK cells were cultivated with P2 
for 4 h in serum-reduced media. The cell nucleus was stained with NucRed (grey) and the 
lysosomes with LysoTracker Green (green); pyrene is depicted in magenta (scale bars 
represent 10 m). 
Uptake studies III: P3
Figure S6: Confocal live cell imaging: For uptake studies, HEK cells were cultivated with P3 
for 4 h in serum-reduced media. The cell nucleus was stained with NucRed (grey) and the 
lysosomes with LysoTracker Green (green); pyrene is depicted in magenta (scale bars 
represent 10 m). 
Uptake studies IV: P4
Figure S7: Confocal live cell imaging: For uptake studies, HEK cells were cultivated with P4 
for 4 h in serum-reduced media. The cell nucleus was stained with NucRed (grey) and the 
lysosomes with LysoTracker Green (green); pyrene is depicted in magenta (scale bars 
represent 10 m). 
Uptake studies V: P5
Figure S8: Confocal live cell imaging: For uptake studies, HEK cells were cultivated with P5 
for 4 h in serum-reduced media. The cell nucleus was stained with NucRed (grey) and the 
lysosomes with LysoTracker Green (green); pyrene is depicted in magenta (scale bars 
represent 10 m). 
𝑐2 = 𝑎2 + 𝑏2 ‒ 2𝑎𝑏𝑐𝑜𝑠(109.5) 𝑐 = 2.42 Å = 0.242 𝑛𝑚
Length of one lactide unit = 3c
Figure S9: Estimation of the length of a fully stretched PLA side chain.
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ABSTRACT: Controlling the size and charge of nanometer-
sized objects is of upmost importance for their interactions
with cells. We herein present the synthesis of poly(2-
oxazoline) based nanogels comprising a hydrophilic shell and
an amine containing core compartment. Amine groups were
cross-linked using glutaraldehyde resulting in imine based
nanogels. As a drug model, amino ﬂuorescein was covalently
immobilized within the core, quenching excessive aldehyde
functions. By varying the amount of cross-linker, the zeta
potential and, hence, the cellular uptake could be adjusted.
The ﬂuorescence of the nanogels was found to be dependent
on the cross-linking density. Finally, the hemocompatibility of
the described systems was studied by hemolysis and erythrocyte aggregation assays. While cellular uptake was shown to be
dependent on the zeta potential of the nanogel, no harmful eﬀects to red blood cells was observed, rendering the present system
as an interesting toolbox for the production of nanomaterials with a deﬁned biological interaction proﬁle.
■ INTRODUCTION
Nanomedicine, the use of nanoscopic objects for biomedical
applications such as diagnostics or treatment of diseases, has
attracted increasing interest in recent years.1,2 By using
(polymeric) carriers, it is possible to solubilize, protect, and
deliver drug molecules to the desired site of action in the body.
Nanogels, such as (reversibly) cross-linked polymer micelles,3
are particularly valuable in this context as, if the chemistry is
chosen appropriately, premature drug release or disassembly
can be reduced.4 In the nanomedicine based treatment of
cancer, the enhanced permeability and retention (EPR) eﬀect is
used to generate a tumor speciﬁc accumulation of the drug.5
The concept exploits the leaky nature of tumor tissue and the
passive accumulation of nanosized objects within those cavities.
However, in order to take advantage of the EPR eﬀect, a drug
carrier has to exhibit long blood circulation times and a low
level of unspeciﬁc cellular interactions. Many parameters such
as size, shape, hydrophilicity or charge inﬂuence the cellular
uptake,6,7 and with regard to new nanomedicines, the ability to
tailor the cellular interaction in an easy way is highly beneﬁcial.
It was shown that a positively charged surface signiﬁcantly
increases the uptake of nanoparticles.6,8−12 This eﬀect is also
used in gene therapy approaches in terms of a complexation of
negatively charged genetic material by positively charged
polymers in order to penetrate cellular membranes.13 However,
a positively charged surface usually also increases the
cytotoxicity induced by the system.14,15 In addition, in the
context of the EPR eﬀect, a hydrophilic, low fouling surface is
indispensable to maintain low protein adsorption levels. Poly(2-
oxazoline)s (POx) display a promising material in a biomedical
context, as certain derivatives bearing small side chains, like
poly(2-methyl-2-oxazoline) (PMeOx) or poly(2-ethyl-2-oxazo-
line) (PEtOx), show excellent biocompatibility.16−18 Indeed,
their performance in biological applications is often compared
to poly(ethylene glycol) (PEG), since they also show a stealth
eﬀect.19,20 Recent studies show that in terms of circulation time
in the bloodstream and unspeciﬁc accumulation in the body,
PEtOx is even more advantageous than PEG.21 Their versatile
functionalization chemistry displays another advantage.22 There
are sparse examples of POx based nanogels using PEtOx or
PMeOx as a polymer shell23,24 and only a few were utilized for
biomedical applications.25,26
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Recently, we reported the synthesis of nanogels based on the
self-assembly of POx block copolymers consisting of an amine-
containing, cationic block (poly(4-amino-butyl-2-oxazoline
(PAmOx))27 and a hydrophilic PEtOx segment.26 The
nanogels maintained low toxicity levels while possessing a
positive zeta potential. Within the present contribution, the
inﬂuence of the cross-linking process on the properties of
nanogels, in particular, on the cellular uptake, is investigated.
■ RESULTS AND DISCUSSION
A highly deﬁned POx-based diblock copolymer P(EtOx98-b-
BocOx32), 1, Đ = 1.07, Table 1, was synthesized via cationic
ring opening polymerization by sequential monomer addition.
The Boc-group was abstracted using triﬂuoroacetic acid to yield
P(EtOx98-b-AmOx32), 2 with a dispersity of 1.07. To produce
nanogels this polymer was dissolved in chloroform, which leads
to the formation of micellar structures comprising an PAmOx
core. The charged nature of the amine groups leads to a phase
segregation of the PAmOx block while PEtOx is readily soluble
in chloroform, stabilizing the micelle.
Cross-linking was applied using glutaraldehyde (GA)
resulting in the formation of nanogels cross-linked by imine
bonds, which are pH responsive.28 To quench the gelation and
to obtain systems that are stable within an aqueous environ-
ment, 6-amino ﬂuorescein (6AF) was used. The free amino
group of 6AF reacts with residual aldehyde groups of the cross-
linker resulting in a reversible covalent attachment to the
nanogel (Scheme 1). In order to use these systems in drug
delivery applications, the interaction of the produced nanogels
with cells is of utmost importance. Therefore, the content of
cross-linker was varied to alter the charge of the resulting
nanogels (3 to 7). A higher degree of cross-linking and,
consequently, a lower amount of free amine groups should
result in a reduced zeta potential and, henceforth, in a reduction
of the cellular uptake. The content of GA was varied between 1
and 3 equiv. (per 2 amine groups) (Table 2).
As displayed in Figure 1, an increase of GA leads to a
reduction of the zeta potential from ζ = 28 mV for equimolar
cross-linking to ζ = 7 mV for a 3-fold excess of GA. Moreover,
an increase in size, as detected by DLS, can be observed for
compounds 3 to 7. These ﬁndings seem best explained by
increased amounts of water present during gelation. GA was
applied in a 70 wt % aqueous solution and during the cross-
linking reaction water is produced as a byproduct. The
additional water will accumulate within the hydrophilic core
compartment of the micelle and swell the nanostructure prior
to or during cross-linking resulting in larger nanogel sizes. This
assumption is supported by cryoTEM measurements showing
an increase in size with an increasing cross-linking density
(Figure 2).
The obtained values are, however, smaller compared to DLS
data indicating a falsiﬁcation of the DLS derived values possibly
caused by the presence of a small fraction of agglomerates. A
third parameter investigated, depending on the cross-linking
density, was the dye-loading of the resulting systems by
evaluating their absorption and ﬂuorescence. Based on its
absorbance, the amount of 6AF conjugated to the nanogels can
be estimated to values between 17 and 27 wt %, without an
obvious dependence on the degree of cross-linking. However,
determined by ﬂuorescence intensity, a steady increase in the
amount of dye could be monitored up to values which would
correspond to a loading eﬃciency above 100 wt % when
Table 1. Composition and Analytical Data of the POx Block
Copolymers
NMR SEC
sample composition (NMR) Mn (g mol
−1) Mn (g mol
−1) Đ
1a P(EtOx98-b-BocOx32) 17 500 8 200 1.07
2b P(EtOx98-b-AmOx32) 14 200 13 900 1.11
aSEC measurement in CHCl3.
bSEC Measurement in DMAc.
Scheme 1. Schematic Representation of the Synthesis and Self-Assembly of P(EtOx-b-AmOx) in Chloroform to Form Micelles
with a Cationic Core and a PEtOx Shell, as Well as the Subsequent Cross-Linking and 6AF Conjugation to Obtain Dye-Loaded
Nanogels
Table 2. Characterization of POx Nanogels in an Aqueous
Environment
sample
cross-linker (equiv
per 2 NH2)
sizea
(nm, r) ζ (mV)
content of
6AF (wt %)
sizeb
(r, nm)
3 1 13 28 17 12
4 1.5 17 13 27 13
5 2 20 10 20 14
6 2.5 22 8 24 15
7 3 24 7 17 15
aDetermined by DLS. bdetermined by cryo-TEM.
Figure 1. Dependency of zeta potential, as well as size by DLS on the
cross-linking density of POx nanogels.
Bioconjugate Chemistry Article
DOI: 10.1021/acs.bioconjchem.7b00067
Bioconjugate Chem. 2017, 28, 1229−1235
1230
compared to a calibration of free 6AF, indicating a boost in
ﬂuorescence intensity by varying the core composition (Figure
S1). To study this eﬀect in detail, ﬂuorescence lifetime
measurements were conducted (Figure 3).
The investigations revealed an increase in ﬂuorescence
lifetime with increasing degree of cross-linking except for 2.5
equiv. of GA. Also, the integrals of the decay curves, which
serve as a measure of the ﬂuorescence quantum yield, increase
within the series. As depicted in Figure S1, the absolute amount
of dye within the nanogels is relatively constant between 17 and
27 wt %. It is described for ﬂuorescein and its derivatives that
electrostatic interactions between the dye and a cationic
(surfactant) micelle are able to stabilize the anionic form of
the molecule which leads to an increase in ﬂuorescence lifetime
and quantum yield.29 However, the cationic character decreases
with a higher degree of cross-linking and can, therefore, be held
responsible for a general boost of ﬂuorescence compared to
pure 6AF, but not for the increasing lifetimes within the series.
Also, the dye−dye distance can be estimated as roughly
constant. Therefore, dye−dye interactions such as excimer
formation are unlikely to be responsible for the observed
eﬀects. Presumably, increasing the amount of cross-linker will
increase the stiﬀness of the core. Thus, the increases in
quantum yield and emission lifetime could be explained by
frozen degrees of freedom, resulting in a reduced rate constant
for nonradiative decay processes.30,31 This is supported by
proton NMR measurements of the nanogels (Figure S2). In
contrast to the precursor polymer, only signals of the PEtOx
constituting the shell are visible, while PAmOx signals are
absent. This indicates a restriction of degrees of freedom of the
block forming the core compartment of the micellar structure
and supports the hypothetic cause for the increase in quantum
yield.
In order to determine the inﬂuence of the varying cross-
linking density on the cellular uptake, ﬂow cytometry
investigations were performed using L929 mouse ﬁbroblasts
(Figure 4). The decrease in mean ﬂuorescence with an
increasing cross-linking degree within the series of nanogels
demonstrates the inﬂuence of the zeta potential on the
internalization for all concentrations investigated. Moreover,
time dependent uptake experiments visualize this behavior. The
Figure 2. CryoTEM images of nanogels (3 to 7) in water. Scale bars represent 100 nm.
Figure 3. Fluorescence lifetime measurements of POx nanogels with varying degrees of cross-linking. (A) Fluorescence decay curves. (B)
Fluorescence life times and decay integrals of nanogels 3 to 7.
Figure 4. Cellular internalization of nanogels 3 to 7 dependent on the
concentration (A) after 24 h incubation at 37 °C or at varying
incubation times (B) at a concentration of 0.5 mg mL−1 at 37 °C.
Bioconjugate Chemistry Article
DOI: 10.1021/acs.bioconjchem.7b00067
Bioconjugate Chem. 2017, 28, 1229−1235
1231
diﬀerence in the ﬂuorescence intensity between the nanogels
was considered by referencing to the absolute ﬂuorescence
intensity of the measurement. This ﬁnding is in agreement with
literature reports where objects having a positive net charge are
described to be taken up more eﬃciently as compared to
neutral or anionic structures.32 The reported investigation
shows that the cellular uptake, which displays a crucial factor for
the utilization as a drug delivery agent, can be ﬁne-tuned for the
presented nanogel systems.
In order to investigate the nature of the cellular internal-
ization, uptake studies at 4 °C were performed (Figure S3).
The diminished uptake at low temperatures suggests an energy
dependent internalization via endocytosis as expected for
objects in such a size range.7,33
Besides cellular uptake, the biocompatibility of the drug
carriers represents an essential parameter. It was reported that
an increase in zeta potential of nanoparticles negatively aﬀects
the cell viability.14,15 Nanogel 3, investigated in a previous
study, possesses the highest zeta potential (ζ = +28 mV) within
the series and is, therefore, expected to induce the highest
toxicity, although the system did not interfere with the
metabolism of L929 mouse ﬁbroblasts in a negative way up
to a concentration of 5 mg mL−1.26 While this is a promising
indication regarding the biocompatibility of the material, the
most important environment a drug delivery system is facing is
the bloodstream. Long circulation times, leading to a passive
targeting, require a low level of interaction with the
components of the blood. An interaction with erythrocytes
resulting in clotting or disruption is highly undesired. The
hemolytic activity of 6AF loaded nanogels was studied
depending on the applied concentration (Figure 5A). All
nanogels in a concentration range between 10 and 100 μg mL−1
resulted in hemolytic activity values well below 2%, which is
deﬁned as the threshold for a hemolysis (according to the
ASTM F756−00 standard).
Furthermore, the erythrocyte aggregation was investigated
and found to be negligible in the given concentration range
with absorbance values comparable with the negative control
(Figure 5B, Figure S4).
These ﬁndings are remarkable, since positively charged
nanomaterials are expected to feature a decreased blood
compatibility. In contrast to nanoparticle systems with an
altered surface chemistry, the charge of the nanogels presented
herein results from amine groups within the core of the micellar
structure, whereas the periphery is covered with noncharged
PEtOx chains. While this setup enables tailoring of the cellular
interaction, as shown by the cellular uptake studies, the
biocompatibility of the nanogels is maintained in all cases.
■ CONCLUSION
Within this contribution, we present a straightforward synthetic
route to poly(2-oxazoline)-based polymeric nanogels with a
tailored cellular uptake. The gels are produced by phase
segregation of a diblock copolymer, containing a cationic and a
neutral block forming micellar structures in chloroform. Cross-
linking is conducted using glutaraldehyde and the ﬂuorescent
dye 6-amino ﬂuorescein is loaded covalently. By changing the
cross-linking density, it is possible to alter the properties of the
nanogels in terms of ﬂuorescence intensity and zeta potential.
Hence, it is possible to adjust their cellular uptake as shown by
ﬂow cytometry measurements. Due to the unique nature of the
nanogels, which carry the charged units within the core of the
micellar structure, the biocompatibility is not aﬀected by the
variation in charge as demonstrated by hemocompatibility
experiments. Therefore, the herein presented material displays
a versatile toolbox for the production of drug delivery vehicles.
Further studies will focus on the extension of the concept to in
vivo investigations as well as on the loading of anticancer drugs
such as doxorubicin, and the utilization of drug loaded nanogels
in vitro and in vivo.
■ EXPERIMENTAL SECTION
Material and Instrumentation. Chemicals and solvents
were purchased from Sigma-Aldrich, Merck, Fluka, and Acros.
2-Ethyl-2-oxazoline (EtOx) and methyl tosylate (MeOTos)
were distilled to dryness prior to use. EtOx was dried using
barium oxide before distillation. 2-(4-((tert-Butoxycarbonyl)-
amino)butyl)-2-oxazoline (BocOx) was synthesized as de-
scribed in a previous publication.27 If not stated otherwise,
cell culture media and supplements (L-Glutamin, antibiotics)
were obtained from Biochrom (Merck Millipore, Germany).
The Initiator Sixty single-mode microwave synthesizer from
Biotage, equipped with a noninvasive IR sensor (accuracy: 2%),
was used for polymerizations under microwave irradiation.
Microwave vials were heated overnight to 110 °C and allowed
to cool to room temperature under an argon atmosphere before
use. All polymerizations were carried out under temperature
control. Size-exclusion chromatography (SEC) measurements
of the protected polymers were performed on a Shimadzu
system equipped with a SCL-10A system controller, a LC-
10AD pump, a RID-10A refractive index detector, and a PSS
SDV column with chloroform/triethylamine (NEt3)/iso-prop-
anol (94:4:2) as eluent. The column oven was set to 50 °C.
SEC of the deprotected statistical copolymers was performed
on a Shimadzu system with a LC-10AD pump, a RID-10A
refractive index detector, a system controller SCL-10A, a
degasser DGU-14A, and a CTO-10A column oven using N,N-
Figure 5. Induction of hemolysis (A) as well as erythrocyte aggregation (B) by 6AF loaded nanogels (3 to 7) in a concentration range between 10
and 100 μg mL−1 using sheep blood of three diﬀerent donor batches.
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dimethylacetamide (DMAc) with 2.1 g L−1 LiCl as the eluent
and the column oven set to 50 °C. Poly(styrene) (PS) samples
were used as calibration standards for both solvent systems.
Proton NMR spectroscopy (1H NMR) measurements were
performed at room temperature on a Bruker AC 300 and 400
MHz spectrometer, using CDCl3 or N,N-dimethylformamide
(DMF)-D7 as solvents. The chemical shifts are given in ppm
relative to the signal of the residual nondeuterated solvent.
Batch dynamic light scattering (DLS) was performed on a
Zetasizer Nano ZS (Malvern Instruments, Herrenberg,
Germany). All measurements were performed in folded
capillary cells (DTS1071, Malvern Instruments, Herrenberg,
Germany). After an equilibration time of 180 s, 3 × 30 s runs
were carried out at 25 °C (λ = 633 nm). The counts were
detected at an angle of 173°. Each measurement was performed
in triplicate. Apparent hydrodynamic radii, Rh, were calculated
according to the Stokes−Einstein equation.
Laser Doppler velocimetry was used to measure the
electrokinetic potential, also known as zeta potential. The
measurements were performed on a Zetasizer Nano ZS
(Malvern Instruments, Herrenberg, Germany) in folded
capillary cells (DTS1071). For each measurement, 15 runs
were carried out using the fast-ﬁeld and slow-ﬁeld reversal
mode at 150 V. Each experiment was performed in triplicate at
25 °C. The zeta potential (ζ) was calculated from the
electrophoretic mobility (μ) according to the Henry equation.34
The Henry coeﬃcient, f(ka), was calculated according to
Ohshima.35
CryoTEM investigations were conducted utilizing a FEI
Tecnai G2 20 at 200 kV acceleration voltage. Specisms were
vitriﬁed by a Vitrobot Mark V system on Quantifoil grids (R2/
2). The blotting time was 1 s with blotting force oﬀset of 0. The
amount of solution was 7 μL. Samples were plunge frozen in
liquid ethane and stored under liquid nitrogen until transferred
to the Gatan cryo-holder and brought into the microscope.
Images were acquired with a 4k × 4k CCD Eagle camera.
Absorbance and ﬂuorescence spectra as well as hemolysis and
erythrocyte aggregation assays were recorded using a Tecan
M200 Pro ﬂuorescence microplate reader (Crailsheim,
Germany) by the use of black well plates with a ﬂat and
transparent bottom.
The cellular uptake studies of nanogels were performed with
a Beckmann Coulter Cytomics FC-500 equipped with a
Uniphase Argon ion laser (488 nm, 20 mW output) and
analyzed with the Cytomics CXP software.
Block Copolymer of 2-Ethyl-2-oxazoline (EtOx) and 2-
(4-((tert-Butoxycarbonyl)amino)butyl)-2-oxazoline
(BocOx) (P(EtOx-b-BocOx)), (1). In a microwave vial, EtOx
(757 μL, 7.5 mmol), MeOTos (16.2 μL, 0.107 mmol) and
acetonitrile (3.4 mL) were mixed under inert conditions. After
heating in the microwave synthesizer at 140 °C for 25 min the
vial was introduced into a glovebox with nitrogen atmosphere
and BocOx (803 μL, 3.2 mmol) was added. The closed vial was
heated again in the microwave synthesizer (140 °C, 20 min).
The solution was precipitated in cold (−80 °C, 300 mL)
diethyl ether. The white precipitate was ﬁltered and dried in
high vacuum (1.4 g, 92%).
1H NMR (CDCl3, 300 MHz): δ = 7.66, (d, 8.1 Hz, 0.019 H,
tosylate), 7.14 (d, 8.21 Hz, 0.019 H, tosylate), 3.45 (s, 4 H,
backbone), 3.10 (s, 0.58 H, CH2−CH2−NH (BocOx)), 2.50−
2.15 (m, 1.96 H, CH2 (EtOx)/CH2−CH2−NHBoc), 1.62 (s,
0.52 H, CH2−CH2−CH2 (BocOx)), 1.52 (s, 0.52 H, CH2−
CH2−CH2 (BocOx)), 1.42 (s, 2.3 H, CH3 (BocOx)), 1.21
(s, 2.1 H, CH3 (EtOx)) ppm.
SEC (eluent: CHCl3/iso-propanol/NEt3, PS-standard):
Mn = 8200 g mol
−1, Đ = 1.07.
Deprotection of P(EtOx-b-BocOx) (1) to yield (P(EtOx-
b-AmOx), (2). P(EtOx-b-BocOx) (1, 1.3 g) was dissolved in
TFA (5 mL) and heated to 60 °C for 1 h. After stirring for 12 h
at room temperature, the mixture was diluted with 10 mL
methanol and precipitated in 400 mL of cold (−80 °C) diethyl
ether. The precipitate was redissolved in methanol (100 mL)
and stirred with Amberlyst A21 for 48 h. Subsequently, the
solvent was removed, the polymer was dissolved in deionized
water and freeze-dried (−80 °C, 0.003 mbar). The polymer was
obtained as white powder (1.2 g, 92%).
1H NMR (DMF-D7, 300 MHz): δ = 4.9 (s, 2.3 H, NH2),
3.51 (s, 4 H, backbone), 3.07 (s, 0.49 H, CH2−CH2−NH2),
2.44 (m, 2.1 H, CH2 (EtOx)/CH2−CH2−CO (AmOx)), 1.9−
1.54 (m, 0.96 H, CH2−CH2−CH2−CH2 (AmOx)), 1.2 (s, 2,3
H, CH3 (EtOx)) ppm.
SEC (eluent: DMAc/LiCl, PS-standard): Mn = 13 900 g
mol−1, Đ = 1.11.
General Procedure for Self-Assembly and Cross-
Linking (3−7). To create nanostructures, block copolymer
(2, 90 mg, 0.006 mmol) was dissolved in CHCl3, (5 mg mL
−1)
and stirred for 3 h. Subsequently, glutaraldehyde (30 mg,
0.3 mmol, 1.5 equiv per amine (4)) was added and the solution
was stirred another 3 h. With proceeding reaction time the
color of the solution changed from colorless to yellow. To
quench the excess of aldehyde functionalities, 6-amino
ﬂuorescein (50 mg) was added and the mixture was stirred
for 12 h. Subsequently, the amount of solvent was reduced
under an argon stream and the residual was precipitated in 100
mL cold diethyl ether (−80 °C). To purify the self-assembled
structures from residual capping agent and cross-linker, dialysis
in MeOH/water (1:4) was applied using a membrane with a
molar mass cut oﬀ of 3500 g mol−1 (Roth Zellutrans). After the
extraction was ﬁnished, the dialysis medium was changed to
pure water and the aqueous solution was freeze-dried to yield
an orange powder.
Determination of Dye Loading Content by Absorb-
ance/Fluorescence. The absorbance/ﬂuorescence of 6AF
loaded nanostructures was investigated under alkaline con-
ditions (1 mol L−1 NaOH in water) in diluted solution (0.1 mg
mL−1). The absorbance was determined at a wavelength of
490 nm and compared to a sequential dilution series of 6AF in
the same aqueous NaOH solution. A 100-fold excess of
glutaraldehyde was added to the control to ensure that only the
imine species of 6AF is present. Emission was detected at an
excitation wavelength of 450 nm. Nanogels as well as 6AF
calibration exhibit an emission maximum at 510 nm. The
readout was accomplished using a Tecan M200 Pro
ﬂuorescence microplate reader (Crailsheim, Germany).
Fluorescence Lifetime Measurements. The emission
decay curves were obtained by time-correlated-single-photon-
counting. After excitation with a frequency-doubled Ti-sapphire
laser adjusted to 870 nm (Tsunami, Newport Spectra-Physics
GmbH, pulse-to-pulse repetition rate 400 kHz after passing a
pulse selector, model 3980, Newport Spectra-Physics GmbH),
i.e., at λex = 435 nm, the luminescence of the sample was
collected in a 90°-geometry and detected with a Becker & Hickl
PMC-100-4 photon-counting module. A long-pass ﬁlter
(455 nm) is inserted in the detection beam path. The samples
were adjusted to yield optical densities <0.03 at the excitation
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wavelength in aqueous NaOH (0.1 mol L−1). The measure-
ments were accumulated at count rates <3% of the rep.-rate
until 15 000 counts in the maximum were reached.
Blood Compatibility Measurements. To assess the
hemolytic activity of the polymer solutions, blood from sheep
collected in heparinized tubes (Institute of Laboratory Animal
Science and Animal Welfare, Friedrich Schiller University Jena)
was centrifuged at 4500 × g for 5 min, and the pellet was
washed three times with cold 1.5 mmol L−1 phosphate buﬀered
saline (PBS, pH 7.4). After dilution with PBS in a ratio of 1:7,
aliquots of erythrocyte suspension were mixed 1:1 with the
polymer solution and incubated in a water bath at 37 °C for 60
min. After centrifugation at 2400 × g for 5 min the hemoglobin
release was determined by measuring the absorbance of the
supernatant with a microplate reader at 544 nm wavelength.
Complete hemolysis (100%) was achieved using 1% Triton X-
100 serving as positive control. Thereby, PBS served as negative
control (0%). A value less than 2% hemolysis rate was taken as
nonhemolytic. Experiments were run in triplicate and were
performed with three diﬀerent batches of donor blood.
The hemolytic activity of the polycations was calculated as
follows (eq 1):
= ×
−A A
A
%Hemolysis 100
( )Sample Negative control
Positive control (1)
For the examination of the erythrocyte aggregation, the
erythrocyte suspension was mixed with the same volume of
polymer solution in a clear ﬂat-bottomed 96-well plate. The
cells were incubated at 37 °C for 2 h, and the absorbance was
measured at 645 nm in a microplate reader. 25 kDa bPEI (50
μg mL−1) was used as positive control, and as negative control,
cells were treated with PBS. Absorbance values of the test
solutions lower than negative control were regarded as
aggregation. Experiments are the result of triplicates and were
performed with three diﬀerent donor blood batches.
Investigation of the Cellular Uptake. The evaluation of
the nanogel uptake was performed with the cell line L929
(CCL-1, ATCC). In general, the cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum (FCS), 100 U mL−1 penicillin and
100 μg mL−1 streptomycin at 37 °C in a humidiﬁed 5% CO2
atmosphere. For the uptake studies, cells were seeded at
105 cells per mL in a 24-well plate and incubated for 24 h.
For the time-dependent uptake studies, cells were incubated
with nanogels at a concentration of 0.5 mg mL−1 for 30 min to
24 h, whereas the concentration-dependent uptake was
investigated over an incubation time of 24 h using nanogel
concentrations in the range between 0.1 and 1 mg mL−1. Cells
incubated with culture medium only served as control. For
uptake studies at low temperature, the cells were incubated with
nanogels (0.5 mg mL−1) for 4 h at 4 and 37 °C, respectively,
and the internalization was monitored using FC analysis as
described above.
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(measured in D2O).  
 
4 
 
 
Figure S3: Temperature dependent cellular internalization of nanogel 3 (0.5 mg ml-1) after an 
incubation period of 4 h. 
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ABSTRACT
The synthesis of a new nanogel drug carrier system loaded with the anti-cancer 
drug doxorubicin (DOX) is presented. Poly(2-oxazoline) (POx) based nanogels from 
block copolymer micelles were cross-linked and covalently loaded with DOX using pH-
sensitive Schiff’ base chemistry. DOX loaded POx based nanogels showed a toxicity 
profile comparable to the free drug, while unloaded drug carriers showed no toxicity. 
Hemolytic activity and erythrocyte aggregation of the drug delivery system was found 
to be low and cellular uptake was investigated by flow cytometry and fluorescence 
microscopy. While the amount of internalized drug was enhanced when incorporated 
into a nanogel, the release of the drug into the nucleus was delayed. For in vivo 
investigations the nanogel drug delivery system was combined with a metronomic 
treatment of DOX. Low doses of free DOX were compared to equivalent DOX loaded 
nanogels in a xenograft mouse model. Treatment with POx based nanogels revealed 
a significant tumor growth inhibition and increase in survival time, while pure DOX 
alone had no effect on tumor progression. The biodistribution was investigated 
by microscopy of organs of mice and revealed a predominant localization of DOX 
within tumorous tissue. Thus, the POx based nanogel system revealed a therapeutic 
efficiency despite the low DOX concentrations and could be a promising strategy to 
control tumor growth with fewer side effects. 
www.oncotarget.com                               Oncotarget, 2018, Vol. 9, (No. 32), pp: 22316-22331
INTRODUCTION
In modern oncology it is a major challenge to 
deliver therapeutic agents more safely and directly 
to the tumor. Doxorubicin (DOX) is an anthracycline 
antibiotic and is one of the most effective as well as 
commonly used chemotherapeutic drugs. It is used as a 
first-line treatment of various types of cancer, including 
hematologic malignancies, breast and ovarian carcinoma, 
neuroblastoma as well as soft tissue and bone sarcoma. 
The antitumor activity of DOX can be triggered by 
different mechanisms: (i) By intercalating into DNA 
strands and (ii) prevention of replication and transcription 
of DNA by inhibiting the enzyme topoisomerase II or, (iii) 
formation of free radicals leading to membrane and DNA 
damage as well as apoptosis [1, 2] However, the clinical 
benefit of DOX is limited by different side effects, i.e. 
cardiotoxicity [3, 4]. 
                             Research Paper
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The use of nanosized drug carriers is rapidly 
emerging and can help to reduce these side effects as 
well as improve the drugs solubility [5], blood circulation 
time [6] and tissue distribution [7]. In particular nanogels, 
hydrogel nanoparticles with crosslinked hydrophilic 
polymers, offer several advantages for their use as a drug 
delivery system [8]. For this reason, the utilization of 
nanocarriers (e.g. nanoparticles) in terms of delivery of 
anti-cancer drugs has increased significantly during the last 
years [9–11]. Nanogels enable a high drug loading capacity, 
can protect and shield drugs until they reach their desired 
target and are highly biocompatible and biodegradable 
[12]. Due to the leaky structure of cancerous tissue 
together with the lack of effective lymphatic drainage, 
nanogels tend to accumulate in the tumor tissue known as 
enhanced permeability and retention (EPR) effect [13]. To 
achieve an effective delivery of the drug to the tumor it is 
also very important to prevent a premature disassembly or 
drug release from the carrier. A common strategy is the use 
of covalently cross-linked drug delivery systems (i.e. core 
cross-linked micelles or other nanogels) and a likewise 
covalently but reversibly attached drug [14–16]. 
The majority of drug delivery systems utilize a 
poly(ethylene glycol) (PEG) shell to shield themselves 
from unspecific interactions with healthy tissue or the 
components of the blood stream. However, reports 
about complement activation by PEG [17–19] and 
vacuolation [20–22] in the body have raised concerns 
about safety and reliability of the polymer. Poly(2-
oxazoline)s (POx) represent a promising alternative as 
they are biocompatible, [13, 23, 24] and show a stealth 
behavior similar to PEG when the side chain substitution 
is chosen correctly [25, 26]. Recent studies elucidate the 
pharmacokinetic behavior of the polymer dependent on 
its molar mass, demonstrating superior behavior when 
compared to PEG [27, 28]. The first clinical study using 
a POx derivative is currently ongoing (SER-214, phase I) 
[14] and the polymer was approved by the federal food 
administration (FDA) as an indirect additive used in food 
contact substances (21CFR175.105) in 2016. In addition, 
POx based formulations of the cancer drug paclitaxel 
show great promise in vivo [5]. One major advantage of 
the polymer over PEG is its versatile functionalization 
chemistry [29] enabling easy access to a multitude of 
functional polymers and materials [15]. POx based 
nanogels have been reported, [30] but far have not been 
exploited for the use as a cancer drug delivery system. 
Recently, we reported the synthesis of nanogels 
based on double hydrophilic POx block copolymers. 
They were based on micellar architecture with a cationic 
block forming the core and a poly(2-ethyl-2-oxazoline)
(P(EtOx)) shell. The material was cross-linked and 
dye loaded by imine bonds [31]. The materials showed 
excellent biocompatibility and their charge and cellular 
uptake could be tailored by varying the cross-linking 
density [32]. Within this contribution, DOX is to be 
used as a payload in order to increase the efficiency 
and specificity of the drug towards cancer cells in vitro 
and in vivo. Drug attachment as well as cross-linking is 
accomplished using pH sensitive Schiff’s base chemistry, 
to enable intracellular drug release [31, 33]. 
In addition to the drug delivery system itself, the 
regime of drug administration is of particular interest. 
Conventional chemotherapy relies on the administration 
of the maximum tolerated dose (MTD) to achieve 
the desired effect without unacceptable side effects. 
Because of the high toxicity and potential development 
of chemoresistance other concepts of drug administration 
are evolving. Metronomic chemotherapy is defined as a 
chronic administration of low doses of cytotoxic agents 
and can help to improve the efficiency of cancer treatment 
[34, 35]. Herein we report the straightforward synthesis 
of a POx based nanogel in a one pot approach, reversibly 
linked to (or loaded with) the anti-cancer drug DOX. The 
drug delivery system is biocompatible and able to release 
its payload as shown by in vitro investigations. In addition, 
in vivo experiments in mice show a promising increase in 
survival rate as compared to pure DOX at relatively low 
concentrations.
RESULTS AND DISCUSSION
Synthesis and loading of the poly(2-oxazoline)-
based nanogels
Polymers were synthesized by sequential monomer 
addition using microwave technology employing 
2-ethyl-2-oxazoline (EtOx) for the first and 2-(4-((tert-
butoxycarbonyl)amino)butyl)-2-oxazoline (BocOx) for 
the second block. The second monomer was introduced 
within a glove box under nitrogen atmosphere to reduce 
termination prior to block extension. P(EtOx98-b-BocOx32) 
(1) was synthesized with a narrow dispersity of Ð = 1.07, 
which did not increase drastically after deprotection of 
the amine groups to yield poly(2-ethyl-2-oxazoline)-
block-(poly(2-(4-amino)butyl)-2-oxazoline)) (P(EtOx-
b-AmOx)) (Supplementary Table 1, Supplementary 
Scheme 1, Supplementary Figures 1–2). While size 
exclusion chromatography (SEC) measurements of initial 
polymers could be performed in chloroform, deprotected 
P(EtOx98-b-AmOx32) (2) had to be measured in N,N-
dimethylacetamide (DMAc), explaining the difference in 
molar mass compared to the precursor polymer. 
While DOX is fluorescent and can, therefore, 
be tracked directly within cells, its emission is highly 
dependent on the environment [36, 37]. To circumvent this 
issue and create nanogels, which can be tracked independent 
of their DOX release, polymer 2 was labeled with a 
fluorescent dye prior to the nanogel preparation. To this 
end, a dye with a near-infra red fluorescence (Alexafluor 
660) was chosen to not interfere with the fluorescence 
of the drug. The dye possesses a N-hydroxy succinimide 
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(NHS) ester function, able to react with the amine groups 
of the P(AmOx) block of polymer 2. One equivalent of dye 
per polymer chain was applied to retain a sufficient amount 
of free amine groups for further self-assembly processes, 
and cross-linking reactions. To separate the labeled polymer 
3 from unreacted dye molecules, precipitation in diethyl 
ether, as well as dialysis in deionized water was performed. 
The success of the attachment was confirmed by SEC 
measurements (Supplementary Figure 2) comparing the 
refractive index (RI). and UV traces of the polymer. The 
lack of an UV signal at high elution volumes indicates the 
absence of unbound dye. The fluorescence maximum of the 
dye coupled to the polymer was found to be similar to the 
free chromophore (Supplementary Figure 3). The coupling 
efficiency as determined by the emission of the polymer 
was determined via UV/Vis measurements and found to be 
30%.
The self-assembly of these systems to form 
polymeric micelles was conducted as reported previously 
[31]. Briefly, the polymers were dissolved in chloroform, 
which leads to the formation of micellar structures 
comprising a P(AmOx) core and a P(EtOx) shell. Cross-
linking was performed using glutaraldehyde (GA) resulting 
in the formation of nanogels. As previous investigations 
[32] showed a reduced cellular uptake of systems with a 
higher cross linking density, three equivalents of cross-
linker (in respect to amine groups) were used. A reduced 
positive charge density is supposed to lead to prolonged 
circulation times in vivo. Drug loading was performed by 
reacting excessive aldehyde functionalities with DOX. 
The free amine groups of the molecule reacts with free 
aldehyde groups of the cross-linker resulting in a covalent 
attachment to the nanogel (Figure 1). As the imine 
function, which stabilizes the nanogel core and the drug, 
is labile at low pH values, created systems are expected 
to be disintegrating. Alexafluor-labeled (referred to as 
“labeled DOX-nanogel”), as well as unlabeled DOX-
containing (referred to as “unlabeled DOX-nanogel”) 
nanogels were produced. As a non-toxic equivalent DOX-
free 6-aminofluorescein (6AF) loaded nanogels (referred 
to as “DOX-free nanogel”) were synthesized using the 
same method.
Characterization of the nanogels
Due to the fact that the drug is not encapsulated 
into, but covalently bound to the nanogel, the term 
loading efficiency is used instead of the commonly 
utilized encapsulation efficiency. To determine the loading 
efficiency of produced nanogels the absorbance of the 
system was measured and compared to a calibration of 
the small molecule (Supplementary Figure 4). In the 
case of DOX-free nanogels, absorbance was measured 
at λex = 490 nm whereas for labeled and unlabeled DOX-nanogels the absorbance was detected at λex = 480 nm. 
A three-fold difference in mass loading was observed 
between fluorescein (17 wt%) and DOX (5 to 6 wt%) 
immobilization, (Table 1), while loading was relatively 
independent on the presence of Alexafluor 660 labels on 
the polymer chain. The difference can be explained by the 
nature of the cargo molecules. While both possess an amine 
functionality, which can be coupled covalently to aldehyde 
functionalities, 6AF also possesses a carboxylic acid 
function, which can interact in an electrostatic way with 
the positively charged core of the nanogel, leading to an 
increase in loading efficiency by electrostatic interaction.
As shown in Supplementary Figure 4, the 
fluorescence spectrum of DOX broadens significantly 
when incorporated into nanogels. The emission properties 
of the chromophore are known to be highly dependent on 
Figure 1: (A) Schematic representation of nanogels obtained from P(EtOx98-b-BocOx32) with a P(AmOx) core loaded with 
DOX and a P(EtOx) shell, cryo-TEM image of unlabeled DOX-nanogel in water (scale bar represents 100 nm), and (B) a 
schematic depiction of the drug delivery route of DOX. 
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environmental factors [36, 37]. The presence of amine 
groups within the core of the nanogel and other factors are 
likely to influence the fluorescence of DOX. In the case 
of the Alexafluor 660 labeled systems a high wavelength 
shoulder is visible in the emission spectrum indicating 
the presence of the near-IR dye. Upon excitation at 
λex = 600 nm a pronounced fluorescence with a maximum 
at λem = 675 nm can be observed (Supplementary Figure 5).
To visualize the synthesized nanostructures, cryoTEM 
measurements were performed (Figure 1, Supplementary 
Figure 6). The images showed monodisperse spherical 
structures for all samples. For DOX-free and labeled DOX-
nanogels an average diameter of 15 nm was obtained while 
the diameter of unlabeled DOX-nanogels was found to 
be 20 nm (Table 1, Supplementary Figure 6B and 6C). In 
addition, in the case of unlabeled DOX-nanogels a core-shell 
structure could be visualized showing a dark center and a 
lighter corona. The core is likely to be compact in water due 
to the presence of the hydrophobic DOX, whereas the shell 
is water swollen resulting in a lower contrast. For DOX-free 
nanogels and labeled DOX-nanogels this structure could not 
be visualized, which is possibly a result of the dense packing 
of nanostructures on the TEM grid. If the P(EtOx) shell is 
partially not visible due to overlap and lacking contrast this 
could explain the size discrepancy between the nanogels. 
The size was confirmed by dynamic light scattering (DLS) 
measurements (Table 1). Zeta potential measurements 
show positive values for all nanogels, which was expected 
due to the cationic nature of the micellar core. Fluorescein 
loaded nanogels show a lower zeta potential as compared 
to DOX loaded samples, which can be explained by the 
compensation of cationic charges by the anionic nature of 
fluorescein. This finding is in line with the increased loading 
of fluorescein quenched nanogels as compared to structures 
with DOX as a cargo.
The most important requirement for a drug carrier 
is the site specific release of the drug. As cargo molecules 
within the produced nanogels are attached via imine 
bonds, which are known to be reversible at pH values 
below 7, [38] a release within endosomal or lysosomal 
cellular compartments is likely as previously shown by 
M. Hruby and co-workers [39]. In order to investigate 
the stability of the nanogels at 4° C (storage temperature) 
and 37° C (human body temperature) at a pH value of 
7.4, the z-average and the polydispersity index (PDI) as 
well as the number mean size value of the nanogels was 
determined using DLS measurements (Supplementary 
Figure 7). Nanogels were determined to be stable during 
the entire measurement time of two weeks, revealing no 
significant changes in size or PDI. Furthermore, it was 
necessary to determine the possibility of a drug release at 
a lysosomal pH value of 5. J. S. Basuki et al. previously 
investigated iron oxide nanoparticles that were loaded with 
DOX via pH sensitive imine bond via DLS measurements, 
revealing an increase in the particle size at a pH value 
of 5, caused by drug release [40]. Since glycine was 
determined to be essential for cancer cell proliferation and, 
consequently, is present within tumorous compartments, 
[41] DLS investigations of the labeled DOX-nanogels 
were conducted in phosphate buffered saline (PBS) and 
glycine was added representing a competitive amine to 
the imine bond (Supplementary Figure 8). While labeled 
DOX-nanogels did not reveal significant changes in size 
or PDI at a pH value of 7.4, both increase at a pH value of 
5.0. Herein, it is noteworthy that after a second addition 
of glycine, this trend further increases. This might be 
beneficial for triggering the endosomal burst, as recently 
shown in gene transfection applications within our group 
[42]. In order to obtain additional qualitative information 
about the release of DOX from the labeled DOX-nanogel, 
diffusion order spectroscopy (DOSY) NMR measurements 
were also conducted (Supplementary Figures 9 and 10). 
Hereby, the diffusion coefficients of labeled DOX-nanogels 
in NaCl were compared to labeled DOX-nanogels in 150 
mM PBS (pH = 5.0), which contained glycine. Pure DOX 
and glycine were evaluated for comparison. A stacking of 
the spectra suggests the release of DOX at pH 5.0, while no 
DOX release could be determined in NaCl (Supplementary 
Figure 9). Unfortunately, a quantification of the DOX 
release from the labeled DOX-nanogels was not possible 
by the applied methods.
In vitro cytotoxicity of nanogels
One major mechanism of DOX is the intercalation 
into the minor groove of DNA [3]. Therefore, the molecule 
Table 1: Analytical data of nanogels formed by the self-assembly of polymers 2 and 3
Sample Precursorpolymer
Capping
agent
Size
(DLS)
[d, nm]
ζ
[mV]
Content of
capping agent
[wt%]
Size
(cryoTEM)
[d, nm]
DOX-free 
nanogel 2 6AF 24 7 17 15
Unlabeled 
DOX-nanogel 2 DOX 26 18 5 20
Labeled 
DOX-nanogel 3 DOX 15 25 6 15
DLS and zeta potential values are determined in water. Sizes determined by DLS are derived from the number distribution.
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must penetrate the barrier of the nucleus to take effect. In 
order to verify whether DOX loaded nanogels are able 
to release DOX within cells, the cytotoxicity of labeled 
DOX-nanogels in comparison to free DOX and DOX-free 
nanogels was investigated (Figure 2, Supplementary Figure 
11). The influence of the materials on the cell viability was 
probed using two different cell lines. L292 mouse fibroblasts 
are known to be sensitive to cytotoxic substances [43] and 
are used in the general assessment of biocompatibility (ISO 
10993-5). Cytotoxicity tests were also performed with the 
human colorectal cancer cells HT-29, due to their ability to 
form tumors in nude mice and their usage for the nanogel in 
vivo studies that are described in later sections. 
Cells were treated with nanogels or pure drug at 
varying concentrations for 24 h (Supplementary Figure 
11) and 72 h (Figure 2), respectively. The amount of DOX 
loaded nanogels was chosen, so that the concentration of 
cargo drug matches the concentration of the free drug used 
for the tests. The concentration of DOX-free nanogels 
used, was identical to its DOX carrying equivalent in 
order to investigate the influence of the bare drug delivery 
system. DOX-free nanogels showed no adverse effects 
on both cell lines independent of incubation time or 
concentration. This was expected as P(EtOx) is considered 
to be biocompatible [13, 23, 24] and proves that neither 
cationic charges, nor potentially released 6AF influence 
the metabolism of the cells in a negative way. In contrast 
free DOX, as well as labeled DOX-nanogels, both show 
a time- and concentration-dependent decrease in cell 
viability for both cell lines. The effect is more pronounced 
for L929 mouse fibroblasts as they are more sensitive to 
cytotoxic effects. A 72 h treatment of L929 cells (Figure 
2A) with labeled DOX-nanogels showed an increased 
cytotoxicity revealing an IC50 value of 0.043 µg mL–1 
compared to a 24 h treatment (Supplementary Figure 11). 
Cytotoxicity of pure DOX was found to be lower, with 
an IC50 value of 0.547 µg mL–1 (72 h). This might be 
attributed to an enhanced internalization of the nanogels 
compared to the free drug [44]. For HT-29 cells (Figure 
2B) this difference is less pronounced, with IC50 values of 
labeled DOX-nanogels of 0.752 µg mL–1 and pure DOX of 
1.998 µg mL–1, respectively. From the reduced viability of 
cells a release of DOX from the nanogels can be assumed, 
which is essential for the known toxic effect of the drug. 
Cellular uptake and biocompatibility in vitro
To investigate whether the improved performance 
of nanogels is a result of an enhanced cellular uptake, flow 
cytometry measurements were performed after incubation 
with labeled DOX-nanogels and free DOX (Figure 3A and 
Supplementary Figure 12). HT-29 cells were used for the 
experiments as an in vitro cancer model, which was later 
used for xenograft mouse experiments. The fluorescence 
of DOX was quantified to determine the amount of DOX 
internalized within the cells. To elucidate the nature of 
uptake (energy dependent vs. energy independent) the 
experiments were performed at 37° C and 4° C [45], 
respectively. For an energy dependent uptake, a significant 
decrease of the amount of internalized drug would be 
expected as the metabolism of cells at 4° C is considerably 
slowed down. Incubation of HT-29 cells with labeled DOX-
nanogels or pure DOX at 4° C reduced the cellular uptake 
compared to an incubation at 37° C. Therefore, cellular 
uptake seems to be energy-dependent, which would suggest 
an uptake by endocytosis. Additionally, cells treated with 
labeled DOX-nanogels possessed a higher fluorescence 
signal after 24 h treatment at 37° C compared to DOX 
Figure 2: Cytotoxicity of DOX-free nanogels, labeled DOX-nanogels as well as free DOX were determined by XTT 
assay. L292 mouse fibroblasts (A) as well as HT-29 human colorectal carcinoma cells (B) were incubated for 72 h with testing substances. 
DOX-nanogels were used at a concentration where the amount of loaded drug resembles the amount of DOX used per data point (polymer 
concentration 17 times higher than DOX concentration). DOX-free nanogels were used at the same polymer concentration as DOX-
nanogels. Data are expressed as mean ± SD of six determinations. 
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alone. These findings suggest a higher accumulation of the 
nanogels in the cells [44, 46] caused by a P-glycoprotein 
mediated efflux of the pure drug, mostly known from multi 
drug resistant breast cancer cells [47, 48]. 
Besides cellular uptake and intracellular drug 
release, a further requirement of a drug carrier that 
strives to target cancerous tissue by i.e. the EPR effect 
is a low level of unspecific interaction with i.e. healthy 
tissue or the components of the blood stream. For this 
reason P(EtOx) was chosen as a shell material as it is 
well-known that P(EtOx) exhibits stealth properties and 
shows a blood circulation behavior in vivo similar to 
PEG [27] One prerequisite for a prolonged circulation 
in the blood stream is the hemocompatibility of the 
compound comprising the absence of blood clotting as 
well as lysis of red blood cells. The biocompatibility 
of labeled DOX-nanogels was tested against sheep 
blood (Figure 3B and 3C). The compound induced no 
major aggregation of red blood cells as compared to 
the positive control branched poly(ethylene imine) 
(bPEI) (25 kDa) as demonstrated in Figure 3B. While 
the high cationic charge density of PEI results in blood 
clotting, the cationic charges of the nanogels are shielded 
within the core of the structure and cannot directly lead 
to a precipitation of erythrocytes. Also, hemolysis as 
measured by the absorbance intensity in the blood 
plasma caused by leakage of hemoglobin release from 
red blood cells supports the biocompatibility of the 
drug carrier. While nanogels show slight hemoglobin 
release of erythrocytes, the total amount as compared to 
the surfactant Triton-X100 which served as a positive 
control is well below 2%, which is generally considered 
as a threshold for hemolytic activity (according to the 
ASTM F756-00 standard).
To elucidate the uptake and intracellular activity 
of the nanogels further, their intracellular localization 
in L929 (Supplementary Figure 13) and HT-29 cells 
(Figure 4) was investigated using confocal laser scanning 
microscopy (CLSM). The nucleus was stained using 
Hoechst 33342 in order to examine its colocalization with 
DOX, which is indicative for release and activity of the 
drug. Lysosomal cellular compartments were stained using 
LysoTracker Green DND-26 and DOX was monitored via 
its fluorescence between λem = 600 to 650 nm. In addition, 
the polymer was tracked using the attached Alexafluor 
label measuring the emission between λem = 725 to 800 nm 
(Supplementary Figure 14). A first measurement was 
conducted after 6 h (Figure 4). Free DOX mainly shows 
a diffuse localization in the cytosol but is also to a certain 
extend present in the nucleus. Previous studies already 
reported a successful uptake and nucleus co-localization 
of DOX after 3 h incubation time, while the drug in 
polymersomes exhibited significantly longer times to enter 
the cell nucleus [46, 49]. In contrast, DOX-nanogels do 
not show a colocalization with the staining of the nucleus. 
For the labeled DOX- nanogels the overlap between red 
and green channel as well as the dotted structure of the 
signal suggests a lysosomal localization, which indicates 
an endocytic uptake mechanism [50] The presence of a 
polymer signal at the same position indicates that these 
signals represent intact nanogels that have not yet released 
the drug or been degraded. 
Previous studies within our group already showed 
slower drug accumulation of the drug within the nucleus 
when using polymeric nanoparticles as drug delivery 
scaffolds [51]. For this reason, a second set of images 
was taken after 24 h incubation. After this time, the free 
drug is mostly localized in the nucleus of the cell. It can 
be assumed that DOX has either intercalated into the DNA 
in the nucleus or was excreted by the cells. However, also 
in the case of labeled DOX-nanogels a release of DOX 
into the nucleus was observed. The, in comparison to the 
DOX fluorescence, faint signal of the polymer suggests a 
partial degradation of the micelles. In addition, the signal 
is mostly associated with an extra nuclear localization. 
For longer incubation times it was increasingly difficult 
to locate intact cells for imaging due to the toxicity of the 
drug loaded system.
Figure 3: (A) Cellular uptake of DOX and labeled DOX-nanogels into HT-29 cells (0.01 mg mL–1) in dependence on the incubation time 
and temperature. Statistical differences are displayed as *p < 0.05 and according to a Student’s t-test. For amount of fluorescent cells see 
Supplementary Figure 12. (B) Erythrocyte aggregation of DOX-nanogels compared to PBS (negative control) and branched poly(ethylene 
imine) (positive control) using sheep blood of three different donors. (C) Hemolytic activity of DOX-nanogels compared to PBS (negative 
control) and bPEI (positive control) using sheep blood of three different donors. 
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These results suggest that the uptake of nanogels is 
partially realized through endocytosis and that the material 
is degraded intracellularly, which leads to a release of the 
drug. Toxicity levels of the drug delivery system as well 
as co-localization studies indicate an accumulation of 
DOX in the nucleus after delivery to the cell. The kinetic 
as compared to the free drug is markedly slowed, which is 
probably associated to the release kinetic from the nanogel. 
An additional reason could be found in the dependence of 
the fluorescence of DOX on its environment. It is reported 
that the fluorescence signal of the drug strongly decreases 
upon intercalation with genetic material [36] and can be 
increased by incorporation in membranes or micelles [37]. 
Consequently, in the case of DOX associated nanogels, 
the fluorescence of the drug carrier in the cytosol is likely 
to outshine the intercalated drug. The similar toxicity of 
both, the free drug and the nanogel, however, suggests an 
efficient uptake and release of DOX within the cell. 
In vivo biocompatibility and biodistribution
The conclusion that can be drawn from the in vitro 
results is that DOX loaded nanogels are relatively stable 
outside cells but will release the drug once taken up into 
the endosome, which can later on fuse with a lysosome 
due to pH sensitivity in acidic compartments. Furthermore, 
they represent ideal candidates to exploit the EPR effect, 
since they reveal optimal sizes of approximately 20 nm in 
diameter as well as the P(EtOx) shell, which will shield 
them to a certain extend from unspecific interactions. 
To test this hypothesis in vivo studies on male athymic 
nude mice (Crl:CD1-Foxn1nu) with HT-29 originated 
tumors were conducted. In comparison to other studies 
with DOX loaded drug delivery systems [39] a relatively 
low DOX concentration was used in line with the concept 
of metronomic chemotherapy. In a first stage of the 
investigation the general biocompatibility was probed. 
Tumor-free nude mice were injected via tail vein with 
a single dose of labeled DOX-nanogels (corresponding 
to a DOX concentration of 0.3 or 1 mg kg–1) or with 
the same volume of the 0.9 wt% NaCl solution as the 
negative control. Body weight was monitored for 2 weeks 
(Supplementary Figure 15). As expected, no negative 
influence on the development of body weight was detected 
and no obvious signs of toxicity (changes in physical 
activity or constitution) were observed for these low DOX 
Figure 4: CLSM images of free DOX and labeled DOX-nanogels incubated with HT-29 colorectal carcinoma for 6 h or 
24 h. Lysosomal cellular compartments were stained green using LysoTracker Green DND-26 and the nucleus was labeled with Hoechst 
33342 (blue). The fluorescence of DOX is depicted in red and the Alexafluor label of the polymer is shown in white. 
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concentrations. For further analysis the 1 mg kg–1 DOX 
concentration was chosen.
It is already known that the biodistribution of drugs 
can be influenced by polymeric drug carriers, [52] i.e. 
when equipped with targeting units [53, 54]. Furthermore, 
the blood clearance and organ accumulation rates of POx-
DOX conjugates were determined to be advantageous 
for cancer therapy, as the conjugates express high blood 
circulation times of more than 24 h (t1/2 DOX = 4 min 
[55]) and tumor accumulation [39]. For this reason, the 
biodistribution of the drug carrier within the body was 
investigated using male nude mice, which received a 
subcutaneous injection of HT-29 cells (1 × 106 cells in 250 
µL) into the flank. When the tumor reached 6 to 8 mm, 
mice were treated with a single dose of either labeled 
DOX-nanogels at 1 mg kg–1 (150 µl) or of a NaCl solution 
with the same volume. The mice were sacrificed after 
predetermined time points (6, 48, and 72 h) and several 
organs (heart, liver, and kidney) as well as the tumor 
were excised and prepared for cryo-sections. Sections of 
mentioned organs were cut to a thickness of 8 µm and 
embedded in a water-based mounting medium on glass 
slides. The obtained samples were investigated by CLSM 
in order to monitor the accumulation of DOX in different 
body compartments. Histological samples of the tumor 
clearly show an accumulation of DOX as evident by the 
inhomogeneous red fluorescence (Figure 5, Supplementary 
Figure 16). The fluorescence signal is most pronounced 6 h 
after the injection and is still detectable after 48 h, but 
to a lesser extent. This phenomenon is also known from 
other studies. M. Hruby and coworkers determined the 
radioactive intensity of a 125I-labeled DOX carrier. Here, 
the mean radioactive intensity decreases significantly 
between 24 h and 72 h. Furthermore, the main amount of 
the carrier remains within the blood [39]. Since we used 
a comparable polymer system, a similar pharmacokinetic 
behavior might be favorable. Traces of DOX could also 
be observed in the liver in the form of small aggregates of 
about 1 μm size. The number of these aggregates increases 
over time, which points into the direction of either an 
accumulation in liver tissue or an excretion via the organ. 
Previously, a diminished accumulation of DOX loaded 
glycolchitosan nanoparticles within the heart could be 
determined [52]. Also in our study, only minor traces of 
DOX could be detected in the heart, which is promising, 
as cardiotoxicity is the most common side effect of DOX. 
No signal could be detected in the kidney indicating either 
a fast renal clearance of the nanogels or, more probably, no 
involvement of the kidney on the excretion of the nanogels. 
Small polymer-drug conjugates and nanoparticles with an 
average size below 5 nm are preferably renal excreted 
[56] and consequently accumulate within the kidney [39]. 
However, the utilized nanogels within this study possess an 
average diameter of around 20 nm and for this reason, an 
accumulation within the liver is more likely [56]. 
In vivo anti-tumor efficiency
To test the therapeutic efficiency of labeled DOX-
nanogels, a xenograft mouse model was established by 
subcutaneous injection of HT-29 cells. When the tumor 
volume reached 100–200 mm3 mice received 6 doses of 
Figure 5: Confocal fluorescence images of histological samples derived from organs of mice that were treated with 
labeled DOX-nanogels at 1 mg kg-1. Fluorescence of DOX is shown in red. See Supplementary Figure 16 for control sample and 72 h 
labeled DOX-nanogel sample. See Supplementary Figure 17 for transmitted light images. 
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drug or control every three days (day 0–15) according 
to a metronomic schedule. Mice were treated with saline 
(control), low dose of free DOX (1 mg kg–1), DOX-free 
nanogels and labeled DOX-nanogels (corresponding to 
1 mg kg–1 DOX.). The absolute tumor volume was 
monitored until it reached the termination condition 
of 1500 mm3 (Supplementary Figure 18). No negative 
influence on the development of body weight was detected 
(Supplementary Figure 19). The individual time course 
of tumor development for each animal in the different 
treatment groups (n = 7–8) is shown in Figure 6A. The 
use of labeled DOX-nanogels reduced the tumor growth 
of mice compared to a treatment with NaCl, DOX-
free nanogels or free DOX. These results are supported 
by the Kaplan–Meier survival of the HT-29 xenograft 
model (Figure 6B). Treatment with NaCl or DOX-free 
nanogels did not slow down the tumor growth, while the 
median survival time was 37 days for NaCl or 24 days 
for DOX-free nanogels, respectively. Administration of 
1 mg kg1 DOX also had no effect on tumor inhibition 
compared to control groups with a median survival time 
of 39 days (p = 0.202). This might be attributed to the 
low DOX concentration used in this study. However, 
even though pure DOX did not seem to be able to reduce 
tumor progression in the xenograft model, the labeled 
DOX-nanogels were highly effective. Mice treated with 
labeled DOX-nanogels had a significant prolonged median 
survival time of 73 days compared to the NaCl control (p = 
0.002) or pure DOX (p = 0.031). This might be explained 
by the more direct impact of DOX-nanogels on tumor 
tissue due to the EPR effect. As DOX is shielded within 
the nanogel, protected by a P(EtOx) shell, a prolonged 
circulation time can be expected, as shown for linear 
P(EtOx) [27]. These findings are in agreement with a 
recently published study by O. Sedlacek et al., prolonging 
the median survival time of DOX-POx conjugates from 19 
to 36 days [39]. However, the utilized DOX dose within 
the mentioned study was 20 mg kg1, while our nanogels 
already possess an effect at an administration of 1 mg 
kg1. With an equal or higher toxicity after cellular uptake, 
as demonstrated by in vitro investigations the nanogels 
are able to interfere with tumor growth more efficiently 
than the free drug. Combined with their excellent 
biocompatibility the presented drug carriers proved to be 
a promising material for cancer therapy.
MATERIALS AND METHODS
Material and instrumentation
Chemicals and solvents were purchased from 
Sigma-Aldrich, Merck, Fluka, and Acros. Hoechst 33342 
trihydrochloride as well as LysoTracker® Green DND-26 
were obtained from Life Technologies (Thermo Fisher, 
Germany). 2-Ethyl-2-oxazoline (EtOx) and methyl 
tosylate (MeOTos) were distilled to dryness prior to use. 
EtOx was dried using barium oxide before distillation. 
2-(4-((tert-Butoxycarbonyl)amino)butyl)-2-oxazoline 
(BocOx) was synthesized as described in a previous 
publication [57]. Consumables for cell culture, like 
pipettes and cell culture plates (96 well) were obtained 
from Greiner Bio-one (Austria/ Germany). If not 
stated otherwise, cell culture media and supplements 
(L-Glutamin, antibiotics) were obtained from Biochrom 
(Merck Millipore, Germany). 
Figure 6: Anti-tumor activity of the DOX-nanogels was evaluated in a xenograft mouse model. Male nude mice received a 
subcutaneous injection of HT-29 cells into the flank. When tumors reached 100 to 200 mm3 mice received 6 doses of 0.9 wt% NaCl, DOX 
(1 mg kg–1), DOX-free nanogel and labeled DOX-nanogel (corresponding to 1 mg kg–1 DOX) via tail vein injection from day 0 to day 15. (A) 
Development of the relative tumor volume is illustrated over time. Results are indicated as median + semi interquartile range. (B) Survival 
of mice bearing HT-29 derived tumors presented as a Kaplan–Meier survival curve. The individual endpoint of each animal was achieved 
when the tumor volume reached 1500 mm3. Statistical differences are displayed as *p < 0.05 and **p < 0.01 according to the log-rank test.
Oncotarget22325www.oncotarget.com
The Initiator Sixty single-mode microwave 
synthesizer from Biotage, equipped with a non-invasive 
IR sensor (accuracy: 2%), was used for polymerizations 
under microwave irradiation. Microwave vials were 
heated overnight to 110° C and allowed to cool to room 
temperature under an argon atmosphere before use. All 
polymerizations were carried out under temperature control. 
Size-exclusion chromatography (SEC) measurements of the 
protected polymers were performed on a Shimadzu system 
equipped with a SCL-10A system controller, a LC-10AD 
pump, a RID-10A refractive index detector and a PSS SDV 
column with chloroform/triethylamine (NEt3)/iso-propanol 
(94:4:2) as eluent. The column oven was set to 50° C. SEC 
of the deprotected statistical copolymers was performed 
on a Shimadzu system with a LC-10AD pump, a RID-10A 
refractive index detector, a system controller SCL-10A, a 
degasser DGU-14A, and a CTO-10A column oven using 
N,N-dimethyl acetamide (DMAc) with 2.1 g L–1 LiCl as 
the eluent and the column oven set to 50° C. Poly(styrene) 
(PS) samples were used as calibration standards for both 
solvent systems. Proton NMR spectroscopy (1H NMR) 
measurements were performed at room temperature on a 
Bruker AC 300 and 400 MHz spectrometer, using CDCl3 or 
N,N-dimethyl formamide (DMF)-D7 as solvents. Diffusion-
ordered spectroscopy (DOSY) NMR measurements were 
performed at room temperature on a Bruker AC 400 MHz 
spectrometer using D2O as the deuterated solvent. The 
chemical shifts are given in ppm relative to the signal of 
the residual non-deuterated solvent.
Batch dynamic light scattering (DLS) was 
performed on a Zetasizer Nano ZS (Malvern Instruments, 
Herrenberg, Germany). All measurements were performed 
in folded capillary cells (DTS1071, Malvern Instruments, 
Herrenberg, Germany). After an equilibration time of 180 s, 
3 × 30 s runs were carried out at 4° C, 25° C or 37° C 
(λ = 633 nm). If not stated explicitly, 25° C was used for 
measurements. The counts were detected at an angle of 
173°. Each measurement was performed in triplicate. 
Apparent hydrodynamic radii, Rh, were calculated 
according to the Stokes–Einstein equation.
Laser Doppler velocimetry was used to measure the 
electrokinetic potential, also known as zeta potential. The 
measurements were performed on a Zetasizer Nano ZS 
(Malvern Instruments, Herrenberg, Germany) in folded 
capillary cells (DTS1071). For each measurement, 15 
runs were carried out using the fast-field and slow-field 
reversal mode at 150 V. Each experiment was performed 
in triplicate at 25° C. The zeta potential (ζ) was calculated 
from the electrophoretic mobility (μ) according to the 
Henry Equation [58]. The Henry coefficient, f(ka), was 
calculated according to Ohshima [59]. 
cryoTEM investigations were conducted with a FEI 
Tecnai G2 20 at 200 kV acceleration voltage. Specisms 
were vitrified by a Vitrobot Mark V system on Quantifoil 
grids (R2/2). The blotting time was 1 s with blotting force 
offset of 0. The amount of solution was 7 µL. Samples 
were plunge frozen in liquid ethane and stored under 
liquid nitrogen until transferred to the Gatan cryo-holder 
and brought into the microscope. Images were acquired 
with a 4k × 4k CCD Eagle camera. 
Absorbance and fluorescence spectra were recorded 
using a Tecan Infinite M200 Pro micro plate reader 
(Crailsheim, Germany) by the use of black well plates 
with a flat and transparent bottom.
Block copolymer of 2-ethyl-2-oxazoline (EtOx) 
and 2-(4-((tert-butoxycarbonyl)amino)butyl)-2-
oxazoline (BocOx) (P(EtOx-b-BocOx)), (1)
In a microwave vial, EtOx (757 µL, 7.5 mmol), 
MeTos (16.2 µL, 0.107 mmol) and acetonitrile (3.4 mL) 
were mixed under inert conditions. After heating in the 
microwave synthesizer at 140° C for 25 min the vial was 
introduced into a glove box with nitrogen atmosphere, a 
sample was taken for NMR and SEC measurements and 
BocOx (803 µL, 3.2 mmol) was added. The closed vial 
was heated again in the microwave synthesizer (140° C, 
20 min). The solution was precipitated in cold (−80° C, 
300 mL) diethyl ether. The white precipitate was filtered 
and dried in high vacuum (1.4 g, 92%).
1H NMR (CDCl3, 300 MHz) (6): δ = 7.66, (d, 8.1 Hz, 
0.019 H, tosylate), 7.14 (d, 8.21 Hz, 0.019 H, tosylate), 
3.45 (s, 4 H, backbone), 3.10 (s, 0.58 H, CH2-CH2-NH 
(BocOx)), 2.50–2.15 (m, 1.96 H, CH2 (EtOx)/CH2-CH2-
NHBoc), 1.62 (s, 0.52 H, CH2-CH2-CH2 (BocOx)), 1.52 
(s, 0.52 H, CH2-CH2-CH2 (BocOx)), 1.42 (s, 2.3 H, CH3 
(BocOx)), 1.21 (s, 2.1 H, CH3 (EtOx)) ppm. 
SEC (eluent: CHCl3/iso-propanol/NEt3, PS-standard): 
Mn = 8,200 g mol–1, Mw = 9.900 g mol–1, Ð = 1.07.
Deprotection of (P(EtOx-b-BocOx)) (1) to yield 
(P(EtOx-b-AmOx)), (2) 
P(EtOx-b-BocOx) (1, 1.3 g) was dissolved in TFA 
(5 mL) and heated to 60° C for 1 h. After stirring for 12 
h at room temperature, the mixture was diluted with 10 
mL methanol and precipitated in 400 mL of cold (−80° C) 
diethyl ether. The precipitate was re-dissolved in methanol 
(100 mL) and stirred with Amberlyst A21 for 48 h. 
Subsequently, the solvent was removed, the polymer was 
dissolved in de-ionized water and freeze dried (−80° C, 
0.003 mbar). The polymer was obtained as white powder 
(1.2 g, 92%).
1H NMR (DMF-D7, 300 MHz) (2): δ = 4.9 (s, 2.3 H, 
NH2), 3.51 (s, 4 H, backbone), 3.07 (s, 0.49 H, CH2-CH2-
NH2), 2.44 (m, 2.1 H, CH2 (EtOx)/CH2-CH2-CO (AmOx)), 
1.9–1.54 (m, 0.96 H, CH2-CH2-CH2-CH2 (AmOx)), 1.2 (s, 
2,3 H, CH3 (EtOx)) ppm.
SEC (eluent: DMAc/LiCl, PS-standard): 
Mn = 13,900 g mol–1, Ð = 1.11.
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Labeling of (P(EtOx-b-AmOx)) (2) using Alexafluor 
660, (3)
P(EtOx-b-AmOx) (2, 14 mg) was dissolved in 
DMF (5 mL) and Alexfluor 660® (1 mg, ~1 eq. per 
macromolecule) as well as triethyl amine (1 µL) were 
added under stirring. The solution was stirred at room 
temperature overnight and subsequently precipitated in 
cold diethyl ether, (300 mL, –80° C). The precipitated 
was filtered off, dissolved in water and transferred to a 
dialysis tube (6,000 to 8,000 g mol–1 cut off, Spectra/Por®). 
The polymer was dialysed against water until the solution 
outside the tube stayed colorless. After freeze drying, the 
product was obtained as deep blue powder (8 mg, 53%, 
degree of functionalization = 30%).
SEC (eluent: DMAc/LiCl, PS-standard): 
Mn = 14,600 g mol–1, Ð = 1.11.UV/Vis: λAbs = 660 nm, λEm (excitation at 600 nm) 
= 690 nm.
Self-assembly and cross-linking
To create nanostructures, the unlabeled block 
copolymer (2, 90 mg, 0.006 mmol) or a mixture of the 
polymers 2 and 3 (9:1, 90 mg, 0.006 mmol) were dissolved 
in CHCl3, (5 mg mL–1) and stirred for 3 h. Subsequently, 
glutaraldehyde (30 mg, 0.3 mmol, 1.5 eq. per amine) 
was added and the solution was stirred another 3 h. 
With proceeding reaction time the colour of the solution 
changed from colourless to yellow. To quench the excess 
of aldehyde functionalities, 6-amino fluorescein (50 mg) or 
DOX (50 mg) were added, respectively, and stirred for 12 
h. Subsequently, the amount of solvent was reduced under 
an argon stream and the residual was precipitated in 100 mL 
cold diethyl ether (−80° C). To purify the self-assembled 
structures from residual capping agent and cross-
linker, dialysis in MeOH/water (1:4) was applied using 
a membrane with a molar mass cut off of 3,500 g mol–1 
(Roth Zellutrans). After the extraction was finished, 
the dialysis medium was changed to pure water and the 
aqueous solution was freeze dried to yield an orange or, in 
the case of DOX, a red powder.
Determination of dye loading content by 
absorbance/fluorescence
The absorbance/fluorescence of 6AF loaded 
nanostructures was investigated under alkaline conditions 
(1 mol L–1 NaOH in water) in diluted solution (0.1 mg mL–1). 
The absorbance was determined at a wavelength of 490 
nm and compared to a dilution series of 6AF in the same 
aqueous NaOH solution. To the 6AF stock solution a 
100 fold excess of glutaraldehyde was added to ensure 
that only the imine species of 6AF is present. Emission 
was detected at an excitation wavelength of λ = 450 nm. 
Micellar samples as well as 6AF calibration exhibit an 
emission maximum at λ = 510 nm. 
DOX conjugated samples were measured in water 
(0.1 mg mL–1) and compared to a dilution series of 
DOX in water. All measurements were carried out in a 
96 well-plate format with 200 µL per well and double 
determination for each measuring point. The read out was 
accomplished using a Tecan Infinite M200 Pro micro plate 
reader (Crailsheim, Germany).
Determination of the nanogel stability
Labeled DOX-nanogels were dissolved in 150 
mM phosphate buffered saline (PBS) buffer (pH = 7.4) 
and measured by means of size (z-average and number 
mean) and uniformity (PDI) using DLS measurements as 
described above. Measurements were conducted at 4° C or 
37° C, and nanogel solutions were stored at the respective 
temperature in between measurements.
Determination of the DOX release
Labeled DOX-nanogels were dissolved in 0.9 wt % 
NaCl or 150 mM phosphate buffered saline (PBS) buffer 
(pH = 5.0) containing 200 mM glycine. Qualitative DOX 
release was determined using DOSY NMR measurements 
as described above. A sample containing pure DOX 
dissolved in 0.9 wt % NaCl was used for comparison. 
Determination of the cytotoxicity by XTT assay
Cytotoxicity studies were performed with the 
sensitive mouse fibroblast cell line L929, as recommended 
by ISO10993-5, and with the human colorectal 
adenocarcinoma cell line HT-29. The L929 cells were 
routinely cultured in Dulbecco’s modified eagle’s medium 
(DMEM) and HT-29 cells in RPMI 1640 supplemented 
with 10% fetal calf serum (FCS), 100 U mL–1 penicillin 
and 100 µg mL–1 streptomycin at 37° C in a humidified 
5% (v/v) CO2 atmosphere. Cells were seeded at 104 cells 
per well in a 96-well plate and incubated for 24 h, whereas 
no cells were seeded in the outer wells. Afterwards, the 
testing substances (nanogels or DOX) at indicated end 
concentrations were added to the cells and the plates 
were incubated for further 24 h. Subsequently, a XTT 
assay (Cell Proliferation Kit II, Roche Diagnostics) was 
performed according to supplier’s information. After a 
further incubation of 4 h, the absorbance was measured at 
a wavelength of λ = 450 nm and a reference wavelength 
of λ = 630 nm with untreated cells on the same well 
plate serving as negative controls. The negative control 
was standardized as 0% of metabolism inhibition and 
referred as 100% viability. Cell viability below 70% was 
considered indicative of cytotoxicity. Data are expressed 
as mean ± SD of six determinations. The half maximal 
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inhibitory concentration (IC50) was calculated with the 
GraphPad Prism Software.
Blood compatibility measurements
To assess the hemolytic activity of the polymer 
solutions, blood from sheep, collected in heparinized-tubes 
(Institut für Versuchstierkunde und Tierschutz/Laboratory 
of Animal Science and Animal Welfare, Friedrich Schiller 
University Jena), was centrifuged at 4500 × g for 5 min, 
and the pellet was washed three times with cold 1.5 
mmol L–1 phosphate buffered saline (PBS, pH 7.4). After 
dilution with PBS in a ratio of 1:7, aliquots of erythrocyte 
suspension were mixed 1:1 with the polymer solution 
and incubated in a water bath at 37° C for 60 min. After 
centrifugation at 2400 × g for 5 min the hemoglobin release 
into the supernatant was determined spectrophotometrically 
using a microplate reader (TECAN Infinite M200 PRO) at 
λ = 544 nm wavelength. Complete hemolysis (100%) was 
achieved using 1% Triton X-100 serving as positive control. 
Thereby, PBS served as negative control (0%). A value 
less than 2% hemolysis rate was taken as non-hemolytic. 
Experiments were run in triplicates and were performed 
with three different blood donors.
For the examination of the erythrocyte aggregation, 
erythrocytes were isolated as described above. An 
erythrocytes suspension was mixed with the same volume of 
polymer solution in a clear flat bottomed 96-well plate. The 
cells were incubated at 37° C for 2 h, and the absorbance 
was measured at λ = 645 nm in a microplate reader 
(TECAN Infinite M200 Pro). 25 kDa bPEI (50 µg mL–1) 
was used as positive control and PBS treated cells 
served as negative control. Absorbance values of the test 
solutions lower than negative control were regarded as 
aggregation. Experiments are the result of triplicates and 
were performed with three different donor blood batches.
Confocal microscopy
For live CLSM analysis of cell uptake, HT-29 cells 
(0.2 × 106 cells mL–1) were seeded in glass-bottomed, 
4-chamber dishes (CELLVIEW, Greiner Bio-One) 
and cultured for 24 h. One hour prior to nanogel/ drug 
treatment, a media change with fresh culture media 
occurred. Cells were incubated with nanogel or DOX 
(10 µg mL–1) for 6 h or 24 h, respectively. For examination 
of nanogel/ drug co-localization with cell organelles, 
the lysosomes were stained with LysoTracker Green® 
DND-26 and the cell nuclei were counterstained with 
Hoechst 33342. Live cell CLSM images were acquired 
using a Zeiss LSM 880, Elyra PS.1 system (Carl Zeiss, 
Germany) with excitation wavelengths/emission filters 
of 405nm/BP 405–480 nm for Hoechst 33342, 488 nm/
BP 505 to 530 nm for LysoTracker® Green DND-26 and 
488 nm/BP 585 to 615 nm for DOX and 633 nm/BP 724 
to 777 nm for Alexafluor 660®. Images were captured 
with a 1.4 NA Plan-Apochromat 63 × oil objective and in 
multitrack mode, enabling single excitation and emission 
of fluorescence dyes. Co-localization was visualized in 
overlay images of the multiple channels. 
The imaging of histological tissue sections (heart, 
liver, kidney, tumor) were performed with excitation 
wavelengths/ emission filters of 488 nm/BP 580 to 
615 nm and a 1.4 NA Plan-Apochromat 40 × oil objective.
Cellular uptake studies
The evaluation of the nanogel and free DOX uptake 
was performed by flow cytometry (FC) measured on a 
Beckmann Coulter Cytomics FC-500 equipped with an 
Uniphase Argon ion laser (488 nm, 20 mW output) and 
analyzed with the Cytomics CXP software. In brief, HT-
29 cells (0.2 × 106 cells mL–1 seeded in 24-well plates) 
were incubated for 6 h and 24 h with labeled labeled 
DOX-nanogel or free DOX (0.01 mg mL–1) at 37° C or 
4° C, respectively. In the case of the 4° C uptake study, 
cell culture media was supplemented with 15 mM HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 
Biochrom, Merck) as buffering agent. Afterwards, cells 
were harvested by trypsinization and trypan blue (1:10) 
was added to quench the outer fluorescence. 104 cells were 
measured by flow cytometry, whereby the number of all 
viable cells, showing signals at 575 nm, were gated. Cells 
incubated with culture medium only served as control. 
The experiments were performed at least three times 
independently. 
Animals
Male athymic nude mice (Crl:CD1-Foxn1nu), 6 to 
8 weeks age, were purchased by Charles River and were 
kept in a standard pathogen-free barrier facility accredited 
by the Association for Assessment and Accreditation of 
Laboratory Animal Care. All experiments were approved 
by the local Institutional Animal Care and Use Committee 
(Jena, 02-011/15). Mice had free access to standard chow 
and tap water at all times. Body weight and tumor size 
(measured with a digital caliper) were monitored twice 
a week. Tumor volume was calculated with the formula 
(L × W2)/2, were L is the longest and W the shortest 
diameter (mm) of the tumor.
In vivo toxicity and biodistribution
Safety evaluation of the nanogels was carried out 
on healthy male nude mice without tumors, which were 
randomly assigned to 3 groups (4 mice per group). A single 
dose (150 µl) of saline (control) or nanogels corresponding 
to a DOX concentration of 0.3 and 1 mg kg–1 
body weight were injected via tail vein. Body weight, 
animal constitution and physical activity were monitored 
for 2 weeks.
For biodistribution experiments HT-29 cells (1 × 106 
in 250 µl) were injected subcutaneously into the flank of 
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nude mice. Mice bearing tumors approximately 6–8 mm 
received a single dose (150 µl) of saline or nanogels with 
a DOX concentration of 1 mg kg–1 via tail vein injection. 
At 6, 48 and 72 h after injection mice were sacrificed and 
tumor, heart, liver and kidney were excised for further 
analysis, immediately frozen with liquid nitrogen and 
stored at –70° C prior to tissue sectioning. Single tissue 
sections (8 µm thickness) of organs and tumors were 
cut with a CM 1860 Crystat (Leica Biosystems, Wetzlar, 
Germany), air-dried on glass slides and embedded in a 
water-based mounting media (Aquatex, Merck).
Anti-tumor activity in vivo
The xenograft model was established by 
subcutaneous injection of HT-29 cells (1 × 106 in 250 µl) 
into the flank of male nude mice. When tumors reached 
a volume of 100–200 mm3 mice were assigned to 4 
treatment groups (10 mice per group) with no significant 
differences in body weight or tumor volume between 
the groups. Mice were injected with treatment solutions 
(saline, 1 mg kg–1 DOX, labeled DOX loaded nanogel 
(6) (corresponding to 1 mg kg–1 DOX), and Dox-free 
nanogel at the same concentration as nanogel 6) via tail 
vein injection on day 0, 3, 6, 9, 11 and 15. Mice were 
sacrificed when the tumor volume reached 1500 mm3, 
which was determined as the individual end point of 
the survival curve. After sacrifice tumors were excised 
and weighed. Mice reaching any termination condition 
(maximum tumor volume, weight loss over 15%, infected 
wound or limited mobility) before the end of the treatment 
period were excluded from the survival study.
Statistical analysis
The values represent the mean ± SD (standard 
deviation). For uptake studies direct comparison of two 
different groups was done with two-tailed, non-paired 
Student’s t-test. A value of p < 0.05 was considered as 
statistically significant. The body weight or tumor volume 
of the nude mice were tested regarding normal distribution 
and homogeneity of variances with the IBM SPSS software. 
Statistical differences were calculated according to a one-
way ANOVA. Survival analysis was performed with SPSS 
and calculated with the Kaplan–Meier method. Significant 
differences were assessed with the log-rank test. A value of 
p < 0.05 was considered as statistically significant.
CONCLUSIONS
Within this report, a straightforward approach to 
POx based nanogels, covalently loaded with the anti-
cancer drug DOX is presented. Nanogels were synthesized 
via cross-linking of a block copolymer micelle with a 
cationic poly(2-(4-aminobutyl)-2-oxazoline) core and a 
poly(2-ethyl-2-oxazoline) shell. Cross-linking as well 
as drug loading was accomplished by pH responsive 
imine chemistry. Moreover, the amine groups of the drug 
delivery system allowed the irreversible labeling with a 
near infra-red fluorescent dye. In in vitro studies DOX 
loaded POx based nanogels showed a toxicity profile 
comparable to the free drug, while unloaded drug carriers 
showed no toxicity. The blood compatibility of the drug 
delivery system was found to be suitable for the envisioned 
application, therefore the cellular uptake was investigated 
by flow cytometry and fluorescence microscopy. While 
the amount of internalized drug was enhanced when 
incorporated into a nanogel, the release of the drug into 
the nucleus was delayed compared to free DOX. This is 
beneficial as a lower amount of drug is required to yield 
the same effect. Furthermore, the nanogels were shown to 
be more tumor specific than DOX, which reduces side-
effects during therapy. In vivo investigation on xenograft 
mouse models were conducted to assess the ability of the 
designed system to reduce tumor growth. In combination 
to the new nanogel-based drug delivery system a 
metronomic schedule of DOX treatment was applied. 
Initial studies on healthy mice showed no adverse effects 
of the DOX-free nanogels or low dosed labeled DOX-
nanogels on body weight and behavior. The biodistribution 
was investigated by microscopy of organs of mice treated 
with labeled DOX-nanogels and showed a localization 
of DOX within tumorous tissue, most likely associated 
to the enhanced permeability and retention (EPR) effect. 
Finally, the therapeutic efficiency of the POx based drug 
delivery system was investigated in a survival study of 
xenograft mice. While the low doses of pure DOX did 
not show a significant reduction in tumor progression, 
the metronomic schedule of the labeled DOX-nanogels 
proved a significant tumor growth inhibition and increase 
in survival time. Future studies will focus on detailed 
investigations of the pharmacokinetics of the presented 
system as well as on studying the biocompatibility of 
higher drug doses.
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SUPPLEMENTARY MATERIALS
Supplementary Scheme 1: Schematic representation of the production of poly(2-oxazoline) block copolymers using 
cationic ring opening polymerization followed by deprotection of the Boc protected amine groups. Labelling was conducted 
by amidation of amine groups with Alexafluor 660 NHS ester.
Supplementary Table 1: Composition and analytical data of the POx block copolymers
Sample
NMR SEC
Composition Mn [g mol–1] Mn [g mol–1] Ð
1a P(EtOx98-b-BocOx32) 17,500 8,200 1.07
2b P(EtOx98-b-AmOx32) 14,200 13,900 1.11
3b P(EtOx98-b-[AmOx31-stat-FOx1]) 15,300 14,100 1.12
aSEC measurement in CHCl3; bSEC Measurement in DMAc. A poly(styrene) calibration was used in both cases.
Supplementary Figure 1: 1H-NMR spectra (300 MHz, top: MeOD, middle and bottom: CDCl3) of poly(2-oxazoline) block 
copolymers.
Supplementary Figure 2: SEC traces (DMAc, PS-cal.) of block copolymers before (A), and after (B) deprotection (in CHCl3) as well as after 
labelling (C).
Supplementary Figure 3: Absorption and emission spectra (λEx = 600 nm) of Alexafluor 660 and labeled poly(2-oxazoline) 
(3).
Supplementary Figure 4: (A) Absorption and emission spectra (excitation at λ = 450 nm) of DOX treated with a 10-fold excess of glutaraldehyde 
and the unlabeled DOX-nanogel. (B) Absorption calibration of DOX for the determination of nanogel loading efficiency.
Supplementary Figure 5: Fluorescence spectra of DOX and the labeled DOX-nanogel excited at λ = 480 nm and Alexafluor 
660 and the labeled DOX-nanogel excited at λ = 600 nm.
Supplementary Figure 6: (A) CryoTEM micrographs of DOX-free as well as labeled and unlabeled DOX-nanogels. (B) Size distribution 
histograms derived from cryoTEM image analysis using ImageJ. (C) Number weighted size distribution histograms as derived from Malvern 
Zetasizer software.
Supplementary Figure 8: Properties of labeled DOX-nanogels in 150 mM PBS (pH = 7.4 or 5.0) determined by DLS 
measurements. Nanogels were incubated at 37° C for a certain time. Measurements were conducted at 37° C. Grey boxes indicate time points 
of the addition of 100 mmol Glycine. (A) Actual values obtained by DLS measurements (n = 3, three measurements each). (B) Size and PDI ratios 
calculated by division of the value obtained on a certain day by the initial value (day 0).
Supplementary Figure 7: Properties of labeled DOX-nanogels in 150 mM PBS (pH = 7.4) determined by DLS measurements. 
Nanogels were incubated at indicated temperatures for a certain time. Measurements were conducted at the indicated temperatures. 
PDI is derived from z-average.
Supplementary Figure 9: Spectra of DOSY NMR (400 MHz, D2O) data of DOX in NaCl (red), the labeled DOX-nanogel in 
NaCl (purple), glycine (pink), and the labeled DOX-nanogel in PBS (pH = 5.0) + glycine. Peak superimpositions indicate similar 
diffusion coefficients of substances. Encircled area denotes water peak caused by the buffer. Peak overlays indicate similar diffusion coefficients 
of substances caused by the molar mass.
Supplementary Figure 10: Spectra of DOSY NMR (400 MHz, D2O) data of the labeled DOX-loaded nanogel in PBS pH 5.0 
+ glycine, the labeled DOX-loaded nanogel in NaCl, DOX in NaCl and glycine (top to bottom).
Supplementary Figure 11: Cytotoxicity of DOX-free nanogels, labeled DOX-nanogels as well as free DOX were determined 
by XTT assay. L292 mouse fibroblasts (A) as well as HT-29 human colorectal carcinoma cells (B) were incubated for 24 h. DOX loaded 
nanogels were used at a concentration where the amount of loaded drug resembles the amount of DOX used per data point (polymer concentration 
17 times higher than DOX concentration). DOX-free nanogels were used at the same polymer concentration as labeled DOX-nanogels. Data are 
expressed as mean ± SD of six determinations.
Supplementary Figure 12: Uptake of DOX and labeled DOX-nanogels into HT-29 cells (0.01 mg mL–1) in dependence on the 
cultivation time and temperature. For MFI see Figure 3.
Supplementary Figure 13: CLSM images of free DOX as well as the labeled DOX-nanogels incubated with L929 mouse 
fibroblasts for 6 h. Lysosomal cellular compartments were stained green using LysoTracker Green DND-26 and the nucleus was labeled with 
Hoechst 33342 (blue). The fluorescence of DOX is depicted in red and the Alexafluor label of the polymer is shown in white. 
Supplementary Figure 14: Absorption and emission spectra of dyes and compounds used in colocalization studies by CLSM.
Supplementary Figure 15: Body weight development of male athymic nude mice after injection (dashed line) of a solution of 
labeled DOX-nanogel (corresponding to a DOX concentration of 0.3 or 1 mg kg–1) dissolved in a 0.9 wt% NaCl solution or 
with the same volume of the 0.9 wt% NaCl solution as the negative control. Data are expressed as mean ± SD of 4 mice per group.
Supplementary Figure 16: Confocal fluorescence images of histological samples derived from organs of mice that were 
treated with either labeled DOX-nanogel (6) at 1 mg kg–1 or the same volume of a solution of 0.9 wt% NaCl in water. 
Fluorescence of DOX is shown in red. See Figure 7 for 6 h and 24 h samples of labeled DOX-nanogels (6).
Supplementary Figure 17: Transmitted light CLSM measurements of histological samples derived from organs of mice that 
were treated with either labeled DOX-nanogel at 1 mg kg–1 or the same volume of a solution of 0.9 wt% NaCl in water. See 
Figure 7 for fluorescence pictures.
Supplementary Figure 18: Development of absolute tumor volume for each animal is illustrated over time from the beginning 
of treatment (day 0) until the maximum tumor volume of 1500 mm3 was reached. Male nude mice were subcutaneously injected 
with HT-29 cells. When tumors reached a volume of 100 to 200 mm3, mice received six doses of 0.9 wt% NaCl, DOX (1 mg kg-1), DOX-free 
nanogel and labeled DOX-nanogel (corresponding to 1 mg kg–1 DOX) via tail vein injection from day 0 to day 15. Individual animals were 
excluded from the study due to several reasons: 1Termination because of infected wound, 2Termination because of weight loss > 15%, 3Termination 
because of maximum tumor volume before last injection, 4Deceased during injection, 5 No palpable tumor.
Supplementary Figure 19: Body weight development of male athymic nude mice over time from the beginning of the survival 
study until the maximum tumour volume of 1500 mm3 was reached. Mice bearing HT-29 derived tumors received 6 doses of 0.9 wt% 
NaCl, DOX (1 mg kg–1), DOX-free nanogel and labeled DOX-nanogel (corresponding to 1 mg kg–1 DOX) via tail vein injection from day 0 to day 
15 (shown as grey area). Data are expressed as mean ± SD of 7–8 mice per group.
